Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3001122	p-ferrit	ug/l (ug/l)	116945	324639	0.02%
3001122	s-ferrit	ug/l (ug/l)	74421	159244	0.00%
3001122	p-ferrit	— (—)	29584	56667	100.00%	Distribution not available
3001122	p-ferritiini	ug/l (ug/l)	634	850	0.00%
3001122	ferritiini	ug/l (ug/l)	364	434	0.00%
3001122	s-ferritiini	ug/l (ug/l)	255	362	0.00%
3001122	s-ferritiini(pi)	ug/l (ug/l)	106	193	0.00%
3001122	s-ferritiini(ko)	ug/l (ug/l)	74	97	0.00%
3001122	ferritiini(ferrit)	ug/l (ug/l)	74	95	0.00%
3001122	ferritiini	— (—)	32	42	100.00%	Distribution not available
3001122	s-ferritiini	— (—)	6	7	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Arthropathies

27061

111758

1.40

321.59

3.1

2.7

111.28

109.81

ug/l

0.35

25363

104609

Systemic connective tissue disorders

8548

60356

1.86

321.27

3.7

2.8

136.31

118.35

ug/l

5.15

7957

55540

Benign neoplasms

27812

126626

1.39

321.25

3.2

2.7

118.04

117.38

ug/l

0.13

26035

118273

Finngen Rheumatological endpoints

27072

125572

1.40

321.13

3.2

2.7

128.95

112.33

ug/l

14.75

25334

117343

Disorders of thyroid, IBD co-morbidities

5409

24736

2.16

319.22

3.4

2.4

100.14

91.68

ug/l

2.22

5040

23432

Other gastritis (incl. Duodenitis)

5171

32472

2.17

319.00

4.1

2.7

130.65

148.29

ug/l

4.43

4834

29738

Diseases of the musculoskeletal system and connective tissue

17493

67385

1.51

318.54

3.0

2.6

105.64

102.28

ug/l

0.74

16420

63253

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

11182

55330

1.93

318.28

3.7

2.9

51.34

57.95

ug/l

10.26

10649

52981

Hypo-osmolality and hyponatraemia

3777

21766

2.52

318.00

3.8

2.6

192.71

142.69

ug/l

7.31

3418

19646

Other obstetric conditions, not elsewhere classified

11365

56409

1.91

316.17

3.6

2.9

51.75

58.59

ug/l

10.93

10823

54019

Pain, not elsewhere classified

6915

46794

1.97

315.62

3.5

2.6

114.90

105.73

ug/l

2.27

6474

43568

Ischemic heart diseases

16844

80968

1.51

315.11

3.5

2.7

151.20

152.61

ug/l

0.20

15567

74148

Nausea and vomiting

6658

43918

1.97

312.10

4.2

2.7

132.68

112.90

ug/l

7.47

6183

40513

Acute upper respiratory infections

28314

145810

1.38

312.04

3.2

2.8

118.70

116.40

ug/l

0.36

26409

135538

Sciatica+with lumbago

12505

88865

1.62

311.48

3.1

2.8

115.54

124.60

ug/l

3.70

11731

82823

Acute tubulo-interstitial nephritis

15408

105487

1.55

311.16

3.7

2.6

142.37

108.81

ug/l

30.94

14245

97276

Mucosal proctocolitis

3477

20270

2.83

310.31

4.0

2.8

95.72

114.98

ug/l

4.33

3324

19033

Follow-up examination after treatment for conditions other than malignant neoplasms

12504

60750

1.62

309.00

3.1

2.5

104.45

111.22

ug/l

0.76

11695

56502

Dental caries 3 and operation codes

24533

101404

1.41

308.85

3.1

2.7

122.81

126.96

ug/l

1.24

22595

94464

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

4770

30158

2.34

308.42

3.9

2.8

98.47

117.25

ug/l

5.88

4562

28348

Pneumonias (Asthma/COPD co-morbidities)

25999

147175

1.39

307.77

3.6

2.7

176.31

108.98

ug/l

74.33

24257

137123

Azathioprine

4229

24131

2.90

307.65

4.9

2.7

127.84

108.49

ug/l

4.18

4088

22551

Extracorporeal dialysis

1742

7140

8.01

307.65

15.1

2.7

356.20

154.94

ug/l

106.73

1725

6579

Low back pain

20580

118097

1.64

307.65

3.2

2.8

115.28

117.47

ug/l

0.51

19119

110210

Persons encountering health services for other counselling and medical advice, not elsewhere classified

33531

138267

1.73

307.65

3.5

2.7

116.04

119.79

ug/l

1.50

31727

128530

Adjustment and management of implanted device

4227

23871

2.66

307.65

4.2

2.6

157.40

143.75

ug/l

0.54

3910

21466

Disorders of the thyroid gland

28366

136170

1.71

307.65

3.4

2.8

105.27

117.23

ug/l

13.06

26351

126899

Tramadol

22407

99328

1.83

307.65

3.6

2.6

136.17

119.37

ug/l

11.05

20708

92509

Implicit bacterial Sepsis

9344

51860

2.30

307.65

4.7

2.6

211.46

147.54

ug/l

33.87

8644

47000

Unspecified kidney failure

2346

11282

3.72

307.65

6.6

2.5

225.12

148.41

ug/l

24.70

2222

10111

Benzodiazepine use

27092

152069

1.48

307.65

3.2

2.8

121.11

120.41

ug/l

0.12

24615

142159

Presence of cardiac and vascular implants and grafts

10349

48260

2.17

307.65

3.8

2.6

160.93

168.73

ug/l

0.70

9548

43749

Other special examinations and investigations of persons without complaint or reported diagnosis

20504

72860

1.73

307.65

3.2

2.5

123.79

121.55

ug/l

0.41

19204

67703

Other diseases of urinary system

30235

129497

1.59

307.65

3.2

2.8

111.17

115.73

ug/l

2.11

28103

120673

Medical observation and evaluation for suspected diseases and conditions

20643

72848

1.79

307.65

3.3

2.5

131.82

121.54

ug/l

2.07

19142

67694

Examination and observation for other reasons

18841

72158

2.14

307.65

3.7

2.5

112.22

121.14

ug/l

3.85

17802

67099

Preparatory care for dialysis

1286

4973

12.58

307.65

13.8

2.7

299.12

154.22

ug/l

44.21

1279

4578

General examination and investigation of persons without complaint and reported diagnosis

19121

72729

1.69

307.65

3.3

2.5

118.75

121.53

ug/l

0.66

17977

67603

Inflammatory bowel disease

8879

56094

2.32

307.65

4.0

2.8

103.18

119.94

ug/l

7.78

8479

52513

Asthma, unspecified (mode)

14433

81051

1.76

307.65

3.3

2.6

119.25

108.04

ug/l

4.46

13475

75373

Diseases of liver

8341

52049

2.29

307.65

3.9

2.8

215.88

135.12

ug/l

27.29

7771

48138

Viral Sepsis

4671

27729

2.52

307.65

5.0

2.7

188.70

125.86

ug/l

20.88

4363

25345

Factors influencing health status and contact with health services

8721

27622

1.90

307.65

2.9

2.2

142.57

133.96

ug/l

1.31

8055

25714

Chronic gastritis

6576

39882

2.32

307.65

3.9

2.6

123.15

151.38

ug/l

10.29

6010

36215

Other diseases of anus and rectum

6801

44891

1.97

307.65

3.6

2.6

122.18

140.51

ug/l

6.13

6208

41114

Explicit Sepsis

10424

66340

1.99

307.65

4.7

2.7

212.03

128.64

ug/l

54.57

9704

60765

Persons encountering health services for specific procedures and health care

30615

145270

1.55

307.65

3.8

2.6

159.37

108.46

ug/l

68.39

28617

135289

Coronary atherosclerosis

14338

68045

1.61

307.65

3.6

2.7

155.04

161.97

ug/l

1.48

13178

61886

GI-bleeding

7387

46772

2.14

307.65

4.5

2.8

135.61

151.90

ug/l

3.95

6816

42535

Autoimmune diseases excluding thyroid diseases, strict definition

29914

123083

1.63

307.65

3.5

2.6

133.50

117.20

ug/l

11.50

28137

114690

Iron deficiency anaemia secondary to blood loss (chronic)

4207

22175

3.31

307.65

6.0

2.6

121.29

134.76

ug/l

2.47

3938

20199

Presence of other functional implants

12105

62151

1.64

307.65

3.4

2.6

158.20

149.91

ug/l

1.96

10544

56523

Hyperlipidaemia, other/unspecified

8093

51403

1.88

307.65

3.7

2.6

157.26

160.16

ug/l

0.35

7364

46479

AV-block

3725

18893

2.47

307.65

3.8

2.5

149.48

163.52

ug/l

2.53

3385

16851

Other diseases of hard tissues of teeth

17309

95897

1.64

307.65

3.4

2.7

107.99

119.68

ug/l

6.70

16096

89731

Diseases of arteries, arterioles and capillaries (FINNGEN)

5709

22107

2.45

307.65

4.4

2.2

167.41

147.10

ug/l

4.26

5324

20248

Mood disorders

31438

145724

1.82

307.65

3.2

2.8

101.81

119.88

ug/l

24.55

29107

136236

Bacterial Sepsis

10775

60007

2.17

307.65

4.6

2.6

207.83

142.30

ug/l

43.17

9971

54589

31664

137752

1.37

307.65

3.3

2.7

125.77

114.73

ug/l

3.99

29397

128090

Persons encountering health services for examination and investigation

19529

72860

1.57

307.65

3.1

2.5

119.38

121.55

ug/l

0.46

18209

67703

Anaemias

10727

27312

7.36

307.65

5.9

2.2

130.51

72.95

ug/l

43.08

10268

26122

Cardiomyopathy (excluding other)

2867

14794

2.96

307.65

4.0

2.5

183.38

167.88

ug/l

0.84

2723

13436

Care involving dialysis

2479

9389

9.57

307.65

13.9

2.5

324.29

141.92

ug/l

141.76

2458

8653

Other and unspecified iron deficiency

11566

52356

6.11

307.65

6.1

2.6

88.78

124.27

ug/l

38.46

10867

48139

Other and unspecified anaemias

13298

58535

4.71

307.65

5.3

2.6

201.09

138.28

ug/l

29.02

12462

52997

Non-rheumatic valve diseases

11094

50177

2.13

307.65

3.7

2.5

167.47

148.71

ug/l

1.68

10190

45676

Diseases of the skin and subcutaneous tissue

30172

119618

1.46

307.65

3.2

2.7

125.69

115.51

ug/l

5.19

28090

111545

Septicaemia

9637

59953

2.05

307.65

4.8

2.7

222.85

130.41

ug/l

58.87

8955

54564

Constipation

22852

119794

1.68

307.65

3.3

2.8

129.47

128.47

ug/l

0.18

20829

111152

Ulcer of lower limb, not elsewhere classified

3156

17208

2.96

307.65

5.4

2.7

167.93

157.92

ug/l

1.42

2912

15589

Benign neoplasm of colon, rectum, anus and anal canal

13579

62401

2.07

307.65

3.7

2.7

134.50

128.39

ug/l

1.40

12591

57366

Implicit viral Sepsis

4660

27657

2.52

307.65

5.0

2.7

188.51

125.93

ug/l

20.71

4352

25281

Acute renal failure

4957

25853

3.15

307.65

5.5

2.5

261.99

153.46

ug/l

41.50

4672

23321

Depression

29588

140903

1.90

307.65

3.3

2.8

99.70

118.23

ug/l

24.10

27445

131947

Diseases of oral cavity, salivary glands and jaws

25456

103386

1.45

307.65

3.2

2.7

125.83

121.87

ug/l

1.17

23551

96231

Asthma, hospital admission 2, infections

14805

110337

1.59

307.65

3.5

2.8

115.11

119.43

ug/l

0.94

13893

102281

Diseases of the digestive system

11603

75324

2.09

307.65

4.2

2.8

127.50

137.78

ug/l

3.11

10770

69113

Mood disorders, excluding more controls

28980

122729

1.85

307.65

3.2

2.7

105.25

120.34

ug/l

15.74

26784

114972

Other headache syndromes

11378

82195

1.77

307.65

3.2

2.7

95.48

108.40

ug/l

7.65

10657

76953

Gastrointestinal diseases

19977

71230

1.72

307.65

3.2

2.4

108.05

97.67

ug/l

5.01

18776

66695

Hypertension

20718

88255

1.56

307.65

3.7

2.5

144.86

120.20

ug/l

12.68

19481

82412

Excluding asthma or asthma-COPD overlap

23880

92458

1.51

307.65

3.2

2.6

129.55

105.37

ug/l

12.99

22315

86210

Iron deficiency anaemia

14211

67518

4.73

307.65

5.8

2.6

98.47

127.56

ug/l

29.92

13319

61981

Asthma (mode)

23121

92131

1.69

307.65

3.2

2.6

105.32

105.57

ug/l

0.05

21786

85900

Provisional assignment of new diseases of uncertain etiology

12636

88140

1.97

307.65

3.7

2.8

159.26

103.67

ug/l

68.16

12063

82428

Any reimbursement code in KELA

18985

72626

1.55

307.65

3.3

2.4

108.49

81.31

ug/l

29.80

17960

68495

Other arrhythmias

16276

91150

1.66

307.65

3.2

2.6

122.40

118.93

ug/l

0.96

15054

84663

Spondylosis

12110

75474

1.66

307.65

3.1

2.7

132.76

146.43

ug/l

4.18

11101

69580

Ulcerative colitis

6593

41992

2.26

307.65

3.9

2.8

104.07

121.91

ug/l

6.20

6278

39262

Dental caries

6441

40961

2.12

307.65

5.2

2.6

176.94

127.30

ug/l

19.76

6111

38282

Implicit Sepsis

19005

100708

1.89

307.65

4.1

2.6

170.04

126.47

ug/l

45.96

17499

92703

Infections, IBD-co-morbidities

4388

16666

2.75

307.65

4.6

2.3

185.03

118.61

ug/l

17.87

4124

15652

Autoimmune diseases excluding thyroid diseases

30728

126054

1.63

307.65

3.6

2.6

132.83

116.87

ug/l

11.77

28902

117437

Sleep apnoea, including avohilmo

26135

122126

1.73

307.65

3.2

2.8

132.25

130.34

ug/l

0.48

24093

113885

Dental caries 1 and operation codes

23337

95234

1.44

307.65

3.1

2.7

124.91

129.04

ug/l

1.14

21460

88645

Hernia of abdominal wall, postoperative

4220

23357

2.62

307.65

4.0

2.3

139.02

122.69

ug/l

3.19

3930

21601

ILD medications: azathioprine

4229

23880

2.95

307.65

4.9

2.6

127.84

105.36

ug/l

5.47

4088

22327

Dermatitis and eczema

30546

156086

1.52

307.65

3.3

2.8

115.31

118.50

ug/l

0.96

28554

145341

Asthma (only as main-diagnosis), excluding more controls

20313

87035

1.70

307.65

3.2

2.5

105.18

102.45

ug/l

0.73

19124

81199

ILD medications

35102

139539

1.71

307.65

3.7

2.6

148.21

107.50

ug/l

48.76

32987

129839

Continuous positive airway pressure

4441

20220

2.65

307.65

3.8

2.3

175.16

156.77

ug/l

0.74

4012

18721

Care involving use of rehabilitation procedures

15819

112863

1.60

307.65

3.5

2.6

123.74

117.63

ug/l

2.04

14887

104514

Glomerular disorders in diseases classified elsewhere

2960

15372

3.57

307.65

9.1

2.7

228.97

144.73

ug/l

59.37

2863

14181

ILD medications: prednisolone, methylprednisolone, prednisone

33664

136145

1.75

307.65

3.7

2.6

149.46

108.71

ug/l

45.82

31579

126639

Inflammatory bowel disease treatment related agents

35147

144217

1.73

307.65

3.5

2.7

140.05

111.83

ug/l

25.92

33007

134144

Other diseases of intestines

31920

136329

1.67

307.65

3.5

2.7

121.94

115.01

ug/l

3.51

29844

127355

Cardiovascular diseases (excluding rheumatic etc)

19605

87293

1.54

307.65

3.5

2.6

120.25

87.50

ug/l

22.12

18659

82478

Noninfective enteritis and colitis

12990

85737

2.09

307.65

3.9

2.8

113.21

119.37

ug/l

1.54

12294

79861

Spinal stenosis

11188

61229

1.75

307.65

3.1

2.7

135.41

158.58

ug/l

14.77

10170

55784

Transplanted organ and tissue status

2766

12073

5.55

307.65

9.0

2.6

281.84

139.50

ug/l

43.58

2721

11260

Pain in limb

22654

117623

1.76

307.65

3.4

2.8

116.35

115.89

ug/l

0.09

20984

109666

Atrial fibrillation and flutter

7865

30183

2.24

307.65

3.5

2.2

168.46

137.39

ug/l

10.73

7323

27882

Insulin medication

14131

89725

1.61

307.65

4.3

2.7

142.86

140.60

ug/l

0.37

13052

82933

Polyarthropathies

18646

90565

1.67

307.65

3.7

2.7

156.86

120.37

ug/l

34.77

17433

84456

Crohn disease

3676

21098

3.01

307.65

4.6

2.8

100.04

110.06

ug/l

1.98

3548

19791

Asthma (diagnoses ohter than nonallergic)

23261

157125

1.49

307.65

3.3

2.8

108.48

116.37

ug/l

4.25

21848

146075

Non-ischemic cardiomyopathy

6684

32387

2.38

307.65

3.9

2.6

187.01

163.49

ug/l

1.75

6214

28983

Any mental disorder

32518

125764

1.52

307.65

3.1

2.8

118.65

121.31

ug/l

0.77

29927

117685

Asthma

23508

91635

1.68

307.65

3.2

2.6

107.77

105.45

ug/l

0.66

22142

85446

Bleeding

19558

106502

1.59

307.65

3.9

2.7

149.63

138.88

ug/l

3.74

18003

98072

Other functional intestinal disorders

11324

73008

1.91

307.65

3.4

2.7

123.50

124.47

ug/l

0.12

10468

67216

All anxiety disorders

19171

106963

1.94

307.65

3.3

2.8

84.42

102.21

ug/l

19.29

17884

101139

Non-invasive ventilation

5486

30529

2.34

307.65

3.4

2.4

121.31

121.20

ug/l

0.01

5349

28578

Irritable bowel syndrome

7487

49604

2.12

307.65

3.4

2.7

102.34

106.97

ug/l

0.74

6969

46270

Cardiomyopathy

4026

21490

2.79

307.65

4.0

2.5

174.08

163.09

ug/l

0.77

3812

19555

Kidney transplant status

1554

6334

8.48

307.65

11.3

2.6

260.98

138.84

ug/l

40.41

1542

5896

Other diseases of the digestive system

7452

46732

2.19

307.65

4.5

2.8

135.77

151.52

ug/l

3.75

6870

42508

Condition for Implicit Sepsis (Organ dysfunction codes)

22006

116681

1.67

307.65

3.8

2.6

164.52

119.42

ug/l

55.19

20318

107991

Obesity

17456

122792

1.88

307.65

3.8

2.8

112.15

110.07

ug/l

0.26

16384

115118

Asthma, unspecified (mode), excluding more controls

14146

76868

1.83

307.65

3.3

2.5

119.07

105.13

ug/l

6.39

13226

71516

Benign neoplasm: Colon

11990

77608

2.01

307.65

3.8

2.8

134.00

155.07

ug/l

10.83

11088

70578

Insulin, intermediate and long-acting

12910

91280

1.72

307.65

4.2

2.8

139.01

143.68

ug/l

1.14

11925

84163

Certain infectious and parasitic diseases

30014

117300

1.49

307.65

3.4

2.6

134.10

102.35

ug/l

44.71

28064

109365

Heart failure, not strict

20292

81665

2.47

307.65

4.6

2.5

179.13

143.40

ug/l

19.11

19029

74549

Hypertension, essential

20478

84788

1.66

307.65

3.6

2.5

147.77

122.61

ug/l

12.52

19205

79086

Dental operations

17304

67233

1.53

307.65

2.9

2.7

133.74

135.75

ug/l

0.33

15897

62305

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

24331

122152

1.44

307.65

3.6

2.7

172.93

105.21

ug/l

69.36

22691

113792

Second line medication for Crohn's disease

14639

105851

1.76

307.65

3.6

2.8

136.08

118.38

ug/l

9.01

13864

98598

Hypertensive diseases (excluding secondary)

14806

60783

1.75

307.65

3.8

2.4

139.48

103.30

ug/l

17.14

14048

57275

Use of hypnotics and sedatives

28533

130963

1.46

307.65

3.1

2.8

131.13

124.54

ug/l

2.49

26349

122310

ILD medications: immunosuppressive drugs

17914

113589

2.06

307.65

4.2

2.6

153.81

110.53

ug/l

53.45

17034

105830

Obesity, other/unspecified

9508

63230

2.19

307.65

4.1

2.8

103.16

104.81

ug/l

0.11

9027

59518

Complications of surgical and medical care, not elsewhere classified

26990

144409

1.64

307.65

3.6

2.8

136.19

119.23

ug/l

14.58

25172

134209

Hypothyroidism, strict autoimmune

22883

105544

1.87

307.65

3.4

2.6

103.68

111.02

ug/l

4.44

21220

98195

24331

122152

1.44

307.65

3.6

2.7

172.93

105.21

ug/l

69.36

22691

113792

Pain (limb, back, neck, head abdominally)

22010

80808

1.61

307.65

3.1

2.6

122.21

125.02

ug/l

0.56

20509

75115

COPD differential diagnosis

23769

92160

1.50

307.65

3.2

2.6

129.10

105.57

ug/l

12.28

22223

85926

Secondary hypertension

2076

9116

4.06

307.65

8.2

2.3

228.70

135.79

ug/l

25.77

2008

8367

Autoimmune diseases related-to ILD

24104

153655

1.73

307.65

3.6

2.8

122.67

118.36

ug/l

1.37

22628

142990

Gout

6019

31275

2.43

307.65

4.7

2.7

219.43

178.45

ug/l

9.68

5603

28290

Glomerular diseases

4465

25714

2.75

307.65

8.0

2.7

210.67

139.66

ug/l

63.14

4300

23743

Hypothyroidism, drug reimbursement

4372

17730

2.52

307.65

3.5

2.1

101.78

76.54

ug/l

9.67

4078

16939

Complications of procedures, not elsewhere classified

21419

138022

1.65

307.65

3.6

2.8

128.84

119.99

ug/l

3.98

20056

128203

Episodal and paroxysmal disorders

34362

130966

1.63

307.65

3.2

2.8

110.94

115.87

ug/l

2.53

31990

122175

Metabolic disorders

25527

113628

1.72

307.65

3.7

2.6

155.85

125.30

ug/l

22.16

23668

105484

Other specific joint derangements/joint disorders

21226

108274

1.59

307.65

3.2

2.7

105.04

109.00

ug/l

1.26

19902

101482

Migraine, single triptan purchase ok & required. ICD-code if available is included

22243

115172

1.60

307.65

3.0

2.8

81.52

106.37

ug/l

55.97

21098

108044

Codes for special purposes

12652

88256

1.97

307.65

3.8

2.8

159.18

103.66

ug/l

68.15

12077

82528

Diseases of oesophagus, stomach and duodenum

31426

134938

1.79

307.65

3.6

2.7

122.87

122.86

ug/l

0.00

29142

125795

Other disorders of skin and subcutaneous tissue

16458

113394

1.61

307.65

3.7

2.8

134.12

129.06

ug/l

1.40

15159

104612

Codeine or tramadol medication

34115

141326

1.63

307.65

3.3

2.8

123.16

118.35

ug/l

2.04

31702

131761

Depression or dysthymia

21913

76252

2.15

307.65

3.1

2.7

113.30

133.43

ug/l

15.82

20167

71378

Soft tissue disorders

30877

125755

1.48

307.65

3.1

2.8

113.44

115.09

ug/l

0.46

28818

117323

Covid-19 confirmed case

8083

48855

2.70

307.65

4.0

2.9

195.18

115.03

ug/l

66.02

7660

45289

Gingivitis and periodontal diseases

24800

102600

1.42

307.65

3.1

2.7

121.93

121.96

ug/l

0.00

22865

95544

Other diseases of liver

4311

25872

2.56

307.65

3.8

2.8

184.84

126.29

ug/l

14.08

3987

24027

Hypothyroidism, levothyroxine purchases

10191

31235

2.96

307.65

3.5

2.2

91.27

70.77

ug/l

23.25

9603

29851

Diseases of arteries, arterioles and capillaries

14341

80374

1.57

307.65

4.1

2.7

158.37

151.56

ug/l

1.74

13247

73234

Triptan medication for migraine, single purchase ok

22243

115172

1.60

307.65

3.0

2.8

81.52

106.37

ug/l

55.97

21098

108044

Malaise and fatigue

14081

71127

2.35

307.65

3.7

2.6

148.53

118.00

ug/l

20.26

12986

65469

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

33922

135142

2.94

307.65

4.8

2.4

157.71

113.07

ug/l

58.84

31823

125414

Pain in joint

17656

76949

1.99

307.65

3.2

2.6

106.32

122.97

ug/l

10.56

16506

71743

Depression medications

11489

32847

2.51

307.65

3.0

2.2

91.07

72.13

ug/l

18.04

10794

31402

Intestinal infectious diseases

25449

156457

1.48

307.65

3.6

2.8

130.29

114.58

ug/l

10.43

23833

145622

Heart failure, strict

13974

59771

2.37

307.65

4.3

2.6

181.30

162.96

ug/l

3.35

13072

53736

Symptoms and signs involving the circulatory and respiratory systems

32248

117871

1.68

307.65

3.3

2.7

114.60

110.53

ug/l

1.57

30199

110319

Antihypertensive medication - note that there are other indications

19697

81323

1.60

307.65

3.4

2.6

104.60

84.58

ug/l

21.70

18665

76873

Pure hypercholesterolaemia

17186

80038

1.77

307.65

3.3

2.6

149.30

146.22

ug/l

0.65

15842

73296

Dorsopathies

30405

124379

1.43

307.65

3.1

2.8

112.91

115.61

ug/l

0.80

28373

116075

Mood [affective] disorders

31393

145578

1.82

307.65

3.2

2.8

101.78

119.83

ug/l

24.46

29067

136104

Cardiovascular diseases

19839

81602

1.60

307.65

3.4

2.5

105.98

83.26

ug/l

28.49

18882

77175

Type 2 diabetes, wide definition

19613

90492

1.74

307.65

3.9

2.6

143.04

143.40

ug/l

0.06

18084

83385

Other disorders of urethra and urinary system

18798

109691

1.53

307.65

3.3

2.8

115.45

110.09

ug/l

1.90

17331

102027

Other joint disorders

25930

111550

1.41

307.65

3.0

2.7

108.49

109.85

ug/l

0.33

24242

104411

Restless leg syndrome

3420

17287

4.47

307.65

3.6

2.8

103.08

122.27

ug/l

6.92

3119

15995

Symptoms and signs involving the digestive system and abdomen

30074

113484

1.57

307.65

3.2

2.6

125.52

121.90

ug/l

1.02

28000

105652

Diaphragmatic hernia

8836

54822

2.31

307.65

3.9

2.7

113.70

144.90

ug/l

16.72

8191

50075

Persons encountering health services in other circumstances, wide

36245

139114

1.64

307.65

3.4

2.7

122.68

119.90

ug/l

0.79

33964

129231

Cardiomyopathies, Primary/intrinsic

2814

14163

3.10

307.65

4.0

2.5

184.00

169.54

ug/l

0.74

2676

12889

Pneumonia, organism unspecified

22863

132397

1.43

307.65

3.6

2.7

173.37

113.16

ug/l

75.20

21215

123099

Symptoms and signs involving the urinary system

18216

107553

1.54

307.65

3.4

2.8

144.59

134.32

ug/l

3.87

16540

99365

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

12226

40545

1.86

307.65

3.0

2.3

114.66

96.03

ug/l

9.53

11460

38145

Pain in throat and chest

24417

108024

1.68

307.65

3.2

2.7

122.10

116.27

ug/l

2.90

22624

100959

Asthma, including avohilmo

33328

153452

1.47

307.65

3.1

2.8

107.16

120.10

ug/l

12.10

31307

142727

Asthma (only as main-diagnosis)

20698

91635

1.65

307.65

3.2

2.6

105.56

105.45

ug/l

0.02

19459

85446

Abnormalities of heart beat

9082

60333

1.96

307.65

3.4

2.7

113.96

118.53

ug/l

1.10

8397

55822

Gastro-oesophageal reflux disease

17921

109386

1.87

307.65

3.4

2.7

121.60

132.16

ug/l

4.09

16434

101489

Other heart diseases, wide

25700

120131

1.59

307.65

3.5

2.7

139.78

111.32

ug/l

14.10

24095

112383

Haemorrhage from respiratory passages

7958

46404

2.08

307.65

3.8

2.6

149.77

151.06

ug/l

0.09

7285

42294

ILD differential diagnosis

23754

92131

1.50

307.65

3.2

2.6

129.13

105.57

ug/l

12.30

22209

85900

Hypothyroidism and >3 levothyroxin purchases

10191

31235

2.96

307.65

3.5

2.2

91.27

70.77

ug/l

23.25

9603

29851

Fever of other and unknown origin

15157

93588

1.97

307.65

4.0

2.6

194.00

112.09

ug/l

71.17

14253

86798

Abnormalities of breathing

28035

117444

1.79

307.65

3.4

2.7

127.56

110.48

ug/l

8.30

26168

109909

Ischaemic heart disease, wide definition

16584

79001

1.53

307.65

3.5

2.6

151.52

154.68

ug/l

0.56

15298

72301

Oedema, not elsewhere classified

7620

47929

2.17

307.65

3.8

2.6

153.32

122.40

ug/l

4.09

7030

43981

Anxiety disorders, excluding more controls

25041

115581

1.85

307.65

3.3

2.7

103.46

115.99

ug/l

7.30

23327

108568

Hypothyroidism (congenital or acquired)

10251

31349

2.96

307.65

3.5

2.2

91.79

70.76

ug/l

24.42

9659

29963

Other dorsopathies, not elsewhere classified

30194

123754

1.51

307.65

3.1

2.8

113.33

115.82

ug/l

0.77

28196

115473

Dialysis, with operation codes

3716

15900

5.88

307.65

11.4

2.5

305.16

146.89

ug/l

112.00

3662

14631

General symptoms and signs

34658

124222

1.73

307.65

3.4

2.6

135.97

107.23

ug/l

39.22

32418

115877

Hypothyroidism, strict autoimmune, 3 medication purchases required

24559

126674

1.63

307.65

3.3

2.8

104.46

110.78

ug/l

3.47

22697

118170

Dyspnoea

24562

134112

1.78

307.65

3.6

2.8

138.31

122.23

ug/l

6.02

22802

124448

Aplastic and other anaemias

14360

63290

4.46

307.65

5.5

2.6

206.12

137.54

ug/l

38.26

13461

57398

Obesity due to excess calories

12775

88842

1.97

307.65

3.9

2.8

111.03

109.67

ug/l

0.26

11994

83410

Other disorders of fluid, electrolyte and acid-base balance

7129

40678

2.42

307.65

4.3

2.6

187.00

144.51

ug/l

12.13

6536

36866

COPD/asthma related infections

30068

122474

1.40

307.65

3.3

2.7

133.75

105.04

ug/l

25.27

28009

114096

Asthma, excluding more controls

22898

87035

1.73

307.65

3.2

2.5

106.32

102.45

ug/l

1.41

21601

81199

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

26201

135674

1.57

307.65

3.9

2.7

144.20

113.89

ug/l

25.15

24175

126679

Cough

10026

68567

1.74

307.65

3.3

2.6

121.53

121.78

ug/l

0.03

9285

63508

Heart failure and bmi 25plus

7789

31341

2.41

307.65

4.3

2.7

186.41

164.13

ug/l

2.03

7241

27933

Dizziness and giddiness

18609

116681

1.53

307.65

3.2

2.8

121.50

126.41

ug/l

1.52

17186

108146

Syncope and collapse

10706

66802

1.75

307.65

3.4

2.6

135.14

123.31

ug/l

3.65

9741

61287

L04AD Calcineurin inhibitors

3000

14752

4.50

307.65

8.2

2.7

234.60

125.50

ug/l

49.86

2947

13826

Headache

19485

114103

1.84

307.65

3.3

2.6

94.93

101.34

ug/l

3.84

18279

106622

Bacterial infection, other or unspecified

13114

75344

2.13

307.65

4.3

2.7

249.66

129.07

ug/l

100.74

12222

68770

Used for control exclusion in common control thyroid runs

33208

119829

1.74

307.65

3.4

2.6

121.12

116.88

ug/l

1.58

31093

111689

Other systemic involvement of connective tissue (FG)

6462

42416

2.07

307.65

3.5

2.7

125.70

115.13

ug/l

1.58

5982

39005

Hypertensive diseases

20741

88338

1.56

307.65

3.7

2.5

144.83

120.17

ug/l

12.71

19505

82492

Other nutritional deficiencies

18830

127337

1.98

307.65

4.0

2.8

108.00

110.01

ug/l

0.58

17722

119270

Abdominal and pelvic pain

29866

113467

1.56

307.65

3.2

2.6

120.47

121.91

ug/l

0.35

27804

105635

Diverticular disease of intestine

17853

78151

1.94

307.65

3.5

2.6

140.46

148.84

ug/l

2.80

16406

71816

Dentinal caries

5617

35480

2.17

307.65

5.2

2.6

182.06

129.16

ug/l

18.21

5322

33171

Nephropathy related operations

3534

15621

5.65

307.65

11.6

2.6

307.26

151.59

ug/l

102.16

3483

14414

Endocrine, nutritional and metabolic diseases

26767

95030

1.79

307.65

3.4

2.4

114.78

106.14

ug/l

4.97

25105

89244

Spondylopathies

20136

92012

1.57

307.65

3.1

2.7

135.18

135.92

ug/l

0.11

18522

85267

Sleep disorders (combined)

27808

132225

1.72

307.65

3.3

2.8

127.76

124.36

ug/l

1.18

25680

123406

Other anaemias

13411

59063

4.67

307.65

5.3

2.6

201.01

138.09

ug/l

29.52

12570

53491

Codeine

29568

117281

1.72

307.65

3.2

2.7

120.36

108.54

ug/l

9.19

27560

109587

Obesity related asthma

8274

54730

2.09

307.65

3.7

2.8

116.12

131.08

ug/l

6.66

7774

50853

Nutritional anaemias

16179

78384

4.05

307.65

5.6

2.6

105.77

130.45

ug/l

20.18

15132

71799

Recurrent or chronic depression

14031

54749

2.95

307.65

3.3

2.6

88.41

112.86

ug/l

23.42

13124

51875

Selective serotonin reuptake inhibitors

30638

115583

1.71

307.65

3.0

2.8

109.83

125.75

ug/l

16.51

28195

108110

Non-selective monoamine reuptake inhibitors

8947

60482

1.78

307.65

3.2

2.7

111.41

136.61

ug/l

14.53

8099

56067

Inflammatory bowel disease, strict (require KELA)

6661

40605

2.56

307.65

4.0

2.8

98.00

115.62

ug/l

6.49

6390

38185

Renal tubulo-interstitial diseases

24642

132426

1.85

307.65

4.5

2.6

172.60

110.82

ug/l

132.03

23041

122665

Other soft tissue disorders, not elsewhere classified

28039

123841

1.77

307.65

3.3

2.8

114.20

115.16

ug/l

0.21

26091

115534

Other septicaemia

8568

53850

2.09

307.65

4.9

2.7

225.89

130.79

ug/l

52.82

7960

48944

Other pulmonary diagnosis

23968

92458

1.52

307.65

3.2

2.6

128.80

105.37

ug/l

12.83

22413

86210

Lower back pain or/and sciatica

28324

154418

1.50

307.65

3.2

2.8

116.58

119.08

ug/l

0.76

26376

143829

Abnormal findings on examination of blood, without diagnosis

10339

68187

1.79

307.65

3.6

2.9

182.21

150.71

ug/l

11.81

9717

62513

5-aminosalicylic acid

6034

36399

2.51

307.65

3.8

2.7

101.99

112.04

ug/l

1.75

5755

34093

Gout, idiopatic and unspecified

5005

30898

2.23

307.65

4.7

2.8

213.54

175.82

ug/l

7.20

4655

27954

Anxiety (asthma-related co-morbidities)

18801

100333

2.01

307.65

3.3

2.7

85.31

103.31

ug/l

18.63

17538

94994

COPD/asthma/ILD related infections

30068

122474

1.40

307.65

3.3

2.7

133.75

105.04

ug/l

25.27

28009

114096

Neurotic, stress-related and somatoform disorders

26834

136014

1.80

307.65

3.3

2.8

100.13

113.26

ug/l

8.76

25020

127537

Use of pramipexole

5479

31285

2.87

307.65

3.7

2.8

116.81

138.59

ug/l

12.60

4976

28674

Hypothyreosis and Thyroxine purchase for inclusion criteria

27528

133876

1.71

307.65

3.4

2.8

103.82

114.24

ug/l

10.09

25536

124800

Neurological diseases, wide definition

10772

36073

1.90

307.65

3.2

2.4

94.09

86.24

ug/l

2.91

10123

34169

Complications of medical and surgical care

18711

132419

1.65

307.65

3.7

2.8

134.27

122.87

ug/l

5.81

17448

122721

Valvular heart disease excluding rheumatic fever

11167

50574

2.13

307.65

3.7

2.6

167.59

148.13

ug/l

1.79

10259

46058

IBD patients in KELA-register

6661

40151

2.61

307.65

4.0

2.8

98.00

115.73

ug/l

6.52

6390

37769

Other anxiety disorders

13912

87092

1.91

307.65

3.3

2.8

83.16

94.63

ug/l

5.73

13006

82479

Sleep apnoea

23953

117495

1.71

307.65

3.2

2.8

137.73

133.46

ug/l

1.38

22042

109413

Opioids

30629

119751

1.62

307.65

3.3

2.7

126.04

107.54

ug/l

19.75

28622

111877

All-cause Heart Failure

13688

58848

2.35

307.65

4.3

2.6

181.44

163.18

ug/l

3.22

12796

52883

Genitourinary diseases

17233

62323

1.63

307.65

3.3

2.4

133.01

126.41

ug/l

1.64

16114

58335

Other heart diseases

13718

61626

1.87

307.65

3.7

2.4

149.71

101.47

ug/l

13.17

12971

58037

Glucagon-like peptide-1 (GLP-1) analogues

12824

68762

2.03

307.65

3.8

2.7

136.32

163.82

ug/l

21.99

11695

62698

Pacemaker

7190

43724

2.20

307.65

3.8

2.8

149.46

163.15

ug/l

4.50

6589

39216

Any gastric operation

27015

94579

1.78

307.65

3.4

2.4

125.15

90.99

ug/l

50.35

25265

88605

Heart failure,strict

13001

51965

2.66

307.65

4.3

2.4

182.43

161.68

ug/l

3.69

12197

46646

Oxycodone

7679

49738

1.88

307.65

3.7

2.6

258.45

147.09

ug/l

37.99

7046

45414

Obesity and other hyperalimentation

17531

123288

1.87

307.65

3.8

2.8

112.36

110.25

ug/l

0.26

16451

115578

Heart failure and antihypertensive medication

6898

19714

3.80

307.65

4.7

2.2

193.38

154.67

ug/l

3.92

6538

18087

First line medication for Crohn's disease

34404

136328

1.70

307.65

3.6

2.6

150.61

104.91

ug/l

55.12

32348

126846

Benign neoplasm of colon, rectum, anus and anal canal

14512

86882

1.98

307.65

3.7

2.7

134.95

153.55

ug/l

9.18

13448

79144

Gout, FINNGEN

6019

37669

2.13

307.65

4.7

2.7

219.43

172.69

ug/l

13.32

5603

33961

Other antidepressants

33074

115113

1.96

307.65

3.1

2.8

115.18

125.79

ug/l

7.76

30468

107667

Renal failure

12133

56310

3.37

307.65

6.4

2.5

231.56

151.35

ug/l

86.36

11483

50830

Dorsalgia

29467

123254

1.53

307.65

3.1

2.8

114.91

116.01

ug/l

0.27

27471

114994

Neurological diseases

27412

103825

1.58

307.65

3.2

2.7

110.39

110.79

ug/l

0.08

25586

97368

Hypothyroidism, other/unspecified

26846

129435

1.74

307.65

3.4

2.8

103.83

114.62

ug/l

10.38

24912

120682

Conduction disorders

6513

33412

2.14

307.65

3.6

2.5

144.32

149.46

ug/l

0.85

5937

30255

Budesonide

3802

21369

3.08

307.65

4.3

2.7

103.33

109.25

ug/l

0.67

3629

19921

Psychiatric diseases

32064

123361

1.53

307.65

3.1

2.7

118.97

120.78

ug/l

0.42

29535

115542

Cystitis

25788

118219

1.66

307.65

3.2

2.8

98.01

107.72

ug/l

9.15

24049

110080

L04AX Other immunosuppressants

14026

102663

1.72

307.65

3.6

2.8

137.27

118.82

ug/l

9.70

13271

95581

Other CVD (FINNGEN)

2627

10048

3.20

307.65

3.9

2.2

167.12

148.31

ug/l

1.72

2362

9033

Other extrapyramidal and movement disorders in other diseases

5425

33248

2.48

307.65

3.4

2.9

112.69

135.05

ug/l

12.11

4928

30579

Cardiac arrhythmias

17379

84251

1.67

307.65

3.4

2.5

126.50

104.35

ug/l

21.98

16311

79212

L04AA Selective immunosuppressants

5491

34800

2.35

307.65

5.6

2.8

171.79

118.63

ug/l

31.40

5272

32454

Anxiety disorders

27034

136932

1.79

307.65

3.3

2.8

100.35

113.59

ug/l

8.99

25203

128362

Oral corticosteroids

31609

137377

1.74

307.65

3.5

2.7

147.45

114.55

ug/l

27.73

29590

127683

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

15084

111649

1.66

307.65

3.7

2.8

132.48

125.25

ug/l

2.29

14062

103289

Symptoms and signs involving cognition, perception, emotional state and behaviour

25334

140226

1.47

307.65

3.2

2.8

123.99

122.04

ug/l

0.45

23368

130590

Other bacterial diseases

24750

124249

1.68

307.65

3.9

2.7

206.36

116.67

ug/l

135.77

23008

115117

Asthma-related infections

14805

110337

1.59

307.65

3.5

2.8

115.11

119.43

ug/l

0.94

13893

102281

Parasetamol

25994

91988

1.79

307.65

3.2

2.6

120.09

110.18

ug/l

5.92

24315

86392

Migraine

15120

91932

1.87

307.65

3.3

2.7

76.17

90.17

ug/l

17.93

14382

86732

Disorders of lipoprotein metabolism and other lipidaemias

19974

89070

1.71

307.65

3.4

2.6

152.83

141.73

ug/l

2.79

18420

81939

Colectomy operation

3918

22808

2.67

307.65

3.9

2.8

105.97

147.39

ug/l

15.72

3672

20797

Benign neoplasm: Colon

11772

56831

2.15

307.65

3.8

2.7

133.94

131.59

ug/l

0.36

10892

52070

Chronic kidney disease

8456

38790

4.25

307.65

7.7

2.5

232.20

151.81

ug/l

83.64

8085

34867

Hypertensive heart and/or renal disease

5295

24864

2.13

307.65

4.6

2.4

177.15

173.30

ug/l

0.30

4845

22155

Diseases of the eye and adnexa

24919

100005

1.43

307.65

3.2

2.7

113.34

109.40

ug/l

1.23

23413

94285

Diarrhoea and gastroenteritis of presumed infectious origin

18563

132400

1.50

307.65

3.7

2.8

130.40

113.20

ug/l

9.36

17359

123403

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

13893

104139

1.64

307.65

3.7

2.8

127.66

126.55

ug/l

0.17

12955

96328

Autoimmune diseases

34779

127184

1.73

307.65

3.5

2.6

121.70

116.43

ug/l

2.39

32589

118492

GASTRO-related operations

27015

94579

1.78

307.65

3.4

2.4

125.15

90.99

ug/l

50.35

25265

88605

Atrial fibrillation and flutter with reimbursement

6414

21671

2.65

307.65

3.4

2.1

164.18

151.03

ug/l

1.96

5936

19754

Erysipelas

12142

79765

1.67

307.65

3.7

2.6

164.73

134.65

ug/l

16.91

11191

72971

All pneumoniae

26161

147890

1.39

302.43

3.6

2.7

175.62

108.97

ug/l

73.70

24413

137809

Dental caries 1

20925

84654

1.44

301.94

3.0

2.7

128.61

130.31

ug/l

0.29

19218

78729

Dental caries, including avohilmo

20908

84596

1.44

301.78

3.0

2.7

128.54

130.28

ug/l

0.30

19201

78672

Behavioural syndromes associated with physiological disturbances and physical factors

9024

65813

1.84

299.96

3.6

2.9

84.59

92.70

ug/l

3.60

8476

62026

Insulin, combination of fast acting with intermediate-acting or long-acting

14151

99543

1.54

299.87

4.3

2.8

142.77

140.80

ug/l

0.32

13068

91759

Bronchitis

28682

155570

1.36

299.53

3.4

2.8

124.32

115.17

ug/l

3.93

26671

144869

Extrapyramidal and movement disorders

8071

56723

1.82

299.28

3.2

2.9

119.30

142.97

ug/l

15.91

7309

51886

Dental pulpitis 2

19034

76316

1.46

298.08

3.0

2.7

128.59

129.01

ug/l

0.06

17467

70959

Gout, unspecified

4099

24690

2.34

297.95

4.8

2.8

209.15

175.61

ug/l

7.78

3812

22300

Gastroduodenal ulcer

5517

35321

2.00

296.50

4.2

2.7

149.61

165.95

ug/l

2.36

5079

31973

Dental operations, only avohilmo

18074

72012

1.47

295.65

2.9

2.8

129.63

139.36

ug/l

3.80

16560

66811

Other intervertebral disc disorders

21571

105716

1.43

295.54

3.0

2.8

119.72

125.88

ug/l

2.54

20125

98442

Disorders of other endocrine glands

10980

80605

1.67

294.07

4.2

2.8

122.38

110.10

ug/l

5.82

10223

74843

Calcific aortic valvular stenosis, operated

5978

38584

1.97

292.99

3.9

2.8

169.75

167.26

ug/l

0.10

5476

34465

Calcific aortic valvular stenosis

5978

38584

1.97

292.99

3.9

2.8

169.75

167.26

ug/l

0.10

5476

34465

Gout, strict definition

3614

21171

2.48

292.42

5.0

2.8

217.34

179.62

ug/l

4.91

3376

19105

Ulcerative colitis (strict definition, require KELA)

4425

27868

2.37

292.08

3.9

2.8

97.33

115.71

ug/l

5.23

4227

26193

Dental pulpitis 2, only avohilmo

19315

77761

1.45

292.07

3.0

2.7

129.05

130.50

ug/l

0.22

17720

72308

Operations 2 for CAVS

5965

38506

1.97

292.03

3.9

2.8

169.79

167.50

ug/l

0.09

5465

34392

Calcific aortic valvular stenosis, diagnosis (helper)

5965

38506

1.97

292.03

3.9

2.8

169.79

167.50

ug/l

0.09

5465

34392

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

4288

26828

2.41

291.61

3.9

2.8

97.00

115.69

ug/l

5.19

4098

25213

Chronic lower respiratory diseases

33184

150433

1.33

291.05

3.2

2.8

113.28

118.05

ug/l

2.02

31128

140117

Nerve, nerve root and plexus disorders

27223

140964

1.37

290.38

3.2

2.8

125.62

124.07

ug/l

0.24

25299

131097

Calcific aortic valvular stenosis, including rheumatic fever

5981

38651

1.96

289.97

3.9

2.8

170.25

167.24

ug/l

0.12

5481

34517

Influenza and pneumonia

27836

151484

1.36

288.85

3.6

2.7

170.26

106.27

ug/l

74.83

25986

141285

Exposure to unspecified factor

25306

161705

1.38

285.18

3.2

2.8

122.86

116.80

ug/l

2.54

23217

151048

Other arthrosis

11877

63148

1.59

283.39

3.1

2.6

126.24

144.44

ug/l

10.45

10915

58386

Persons encountering health services in other circumstances

9740

71669

1.69

279.74

3.5

2.7

122.42

110.58

ug/l

2.30

8840

66708

Triptan medication for migraine, min. 3 purchases

16032

100513

1.54

279.02

3.1

2.8

72.27

87.77

ug/l

35.20

15331

94935

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

25044

144735

1.37

277.83

3.6

2.7

171.71

112.27

ug/l

55.09

23326

134800

Dental caries 3

22254

91655

1.41

277.50

3.0

2.7

124.64

127.99

ug/l

0.79

20455

85349

Nonorganic sleeping disorders, excluding more controls

4850

31572

2.21

277.07

3.5

2.7

89.11

100.88

ug/l

5.89

4553

29881

Diseases of pulp and periapical tissues

8244

58743

1.74

276.39

4.1

2.7

160.54

130.03

ug/l

12.24

7705

54848

11175

83648

1.62

272.33

3.5

2.8

106.19

112.68

ug/l

1.38

10475

77965

Dental caries 1, only avohilmo

21112

86637

1.41

271.69

3.0

2.8

126.20

132.29

ug/l

1.85

19383

80629

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2324

8429

2.79

271.29

3.4

2.2

197.34

155.92

ug/l

5.22

2141

7789

Benign neoplasms

22379

102888

1.40

271.21

3.3

2.8

111.20

97.89

ug/l

10.19

21089

96717

Hypertensive Heart Disease

4578

23129

2.05

270.58

4.1

2.4

168.15

175.06

ug/l

0.58

4145

20559

Other cataract

9011

49982

1.67

270.24

3.6

2.7

150.89

153.60

ug/l

0.37

8176

45829

Personality disorders, excluding more controls

7016

49335

1.87

269.92

3.4

2.7

93.39

97.40

ug/l

0.58

6450

46922

Gastric ulcer

3828

23082

2.26

269.25

4.2

2.7

142.58

158.18

ug/l

2.16

3532

20880

Osteopathies and chondropathies

12651

91939

1.56

268.84

3.7

2.8

134.55

126.08

ug/l

2.81

11690

84826

Dysphagia

5385

35521

1.99

267.65

3.3

2.7

133.75

139.14

ug/l

0.41

4895

32513

Disorders of gallbladder, biliary tract and pancreas

24494

129841

1.37

266.78

3.4

2.8

139.78

124.33

ug/l

10.99

22654

120614

Heart failure and coronary heart disease

6548

33210

1.85

264.45

4.4

2.8

167.82

174.48

ug/l

0.97

6071

29551

Other diseases of upper respiratory tract

30258

132049

1.33

264.31

3.0

2.8

116.22

122.01

ug/l

2.39

28163

122560

Disorders of lens

14469

70234

1.49

263.12

3.6

2.7

160.49

149.96

ug/l

3.27

13145

64862

Type 2 diabetes

24871

121589

1.36

261.83

3.6

2.7

134.33

124.32

ug/l

5.64

23041

113228

Other noninfective gastroenteritis and colitis

5906

40253

1.95

261.52

4.0

2.8

127.55

116.39

ug/l

1.84

5540

37291

Asthma, hospital admissions , main diagnosis only

21470

157457

1.39

260.87

3.2

2.8

104.77

115.80

ug/l

7.32

20169

146552

Benign neoplasm: Colon, unspecified

4905

31719

2.04

260.39

3.9

2.8

142.20

138.76

ug/l

0.33

4455

28850

Symptoms and signs involving the skin and subcutaneous tissue

16871

134429

1.46

259.91

3.3

2.8

122.22

118.48

ug/l

0.79

15766

125000

Ulcerative colitis, NAS

3613

22264

2.47

259.41

4.1

2.8

103.57

116.24

ug/l

1.99

3441

20859

Other retinal disorders

13564

84082

1.51

258.27

3.8

2.8

148.92

144.89

ug/l

0.82

12192

76987

Acute upper respiratory infections of multiple and unspecified sites

19982

121581

1.41

256.97

3.4

2.8

117.75

109.70

ug/l

2.45

18690

113752

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

13837

99679

1.50

256.88

3.4

2.8

167.63

138.31

ug/l

11.54

12771

91405

Valvular operations

2950

16650

2.45

256.72

3.7

2.5

170.58

172.87

ug/l

0.04

2743

15024

Dental caries 3, only avohilmo

22442

93460

1.38

254.33

3.0

2.8

123.11

129.74

ug/l

2.34

20612

87074

Angina pectoris

12034

61419

1.54

252.75

3.4

2.7

145.88

165.02

ug/l

9.53

11111

55626

Myocardial infarction, without ST-elevation

7796

51150

1.70

252.04

3.8

2.8

160.63

171.16

ug/l

2.17

7142

46016

Paroxysmal tachycardia

5414

30338

1.93

251.54

3.5

2.4

124.21

113.30

ug/l

2.68

5062

28139

Disorders of eyelid, lacrimal system and orbit

20624

132126

1.40

251.07

3.2

2.8

119.72

124.29

ug/l

1.42

18989

122631

Dermatitis

14543

114711

1.49

250.93

3.4

2.8

135.92

121.25

ug/l

5.14

13547

106535

Paralytic ileus and intestinal obstruction

5343

35411

1.91

250.30

3.8

2.6

145.80

150.15

ug/l

0.36

4916

32256

Senile cataract

12890

60872

1.51

250.20

3.5

2.7

163.44

156.15

ug/l

1.44

11631

55909

Coxibs

7889

29446

1.72

249.68

2.9

3.0

121.13

125.12

ug/l

0.54

7309

27353

Nonalcoholic fatty liver disease

2300

12655

3.21

249.03

3.6

2.8

176.60

125.56

ug/l

16.27

2147

11835

Other systemic involvement of connective tissue

6572

46446

1.87

247.69

3.5

2.8

126.26

115.86

ug/l

1.60

6085

42778

Disorders of choroid and retina

17715

103198

1.42

247.50

3.6

2.8

146.80

141.23

ug/l

1.71

16021

95017

Insulin, fast-acting

8384

61249

1.70

247.33

4.6

2.8

143.77

132.41

ug/l

2.81

7785

56806

Shoulder lesions

18733

92140

1.41

246.69

3.0

2.7

132.29

134.66

ug/l

0.43

17411

85486

Other Crohn's disease

1977

10525

3.73

244.71

4.7

2.7

101.70

110.14

ug/l

0.83

1928

9891

Special screening examination for infectious and parasitic diseases

7593

40635

1.76

244.47

2.9

2.5

79.93

95.19

ug/l

9.39

7153

38581

Symptoms and signs involving the nervous and musculoskeletal systems

13609

106879

1.50

244.47

3.2

2.9

119.34

124.54

ug/l

1.23

12744

98983

Concussion

12781

85451

1.50

243.37

3.0

2.7

118.90

112.24

ug/l

1.64

11762

80245

Coxarthrosis

10715

54179

1.55

241.97

3.0

2.6

145.91

153.47

ug/l

1.68

9790

49655

Unspecified haematuria

8589

53574

1.64

240.61

3.6

2.8

162.18

158.27

ug/l

0.49

7763

49098

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

23553

118700

1.35

240.23

3.6

2.6

135.99

127.14

ug/l

4.11

21718

110486

Diseases of the respiratory system

18944

76325

1.41

239.85

3.1

2.6

120.38

104.09

ug/l

11.38

17648

70942

Asthma-related pneumonia

7983

57949

1.69

239.03

3.7

2.8

136.82

134.01

ug/l

0.27

7492

53051

Asthma, hospital admissions 3, pneumonia

8001

58101

1.69

238.99

3.7

2.8

136.68

133.98

ug/l

0.26

7509

53195

Asthma-related pneumonia or sepsis

8001

58101

1.69

238.99

3.7

2.8

136.68

133.98

ug/l

0.26

7509

53195

Gonarthrosis [arthrosis of knee](FG)

17586

82528

1.41

238.79

3.0

2.7

139.09

138.42

ug/l

0.10

16161

76317

Colorectal cancer, excluding all cancers (controls excluding all cancers)

5503

35946

1.88

238.55

2.9

2.8

128.73

140.31

ug/l

1.67

5091

32626

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

3874

24308

2.16

237.81

3.1

2.9

113.07

138.94

ug/l

9.03

3602

22007

Other and unspecified dermatitis

12123

94208

1.53

237.63

3.5

2.8

136.37

119.12

ug/l

5.42

11320

87489

Chronic periapical parodontitis

4638

30471

2.02

236.77

4.7

2.6

186.19

140.23

ug/l

12.63

4353

28362

Other diseases of intestine

2656

15121

2.60

236.43

4.3

2.6

145.28

149.01

ug/l

0.16

2485

13823

Functional dyspepsia

6270

44073

1.84

236.12

3.5

2.7

108.60

120.71

ug/l

3.57

5817

40926

Diabetes mellitus

26513

132471

1.33

235.62

3.6

2.7

132.59

119.04

ug/l

9.83

24593

123636

Gonarthrosis

15200

68343

1.45

235.33

3.0

2.7

138.19

140.85

ug/l

0.46

13977

63274

Diabetes, varying definitions

26324

131613

1.33

235.26

3.6

2.7

133.14

119.52

ug/l

9.81

24413

122812

Coxarthrosis [arthrosis of hip](FG)

11439

62690

1.52

235.12

3.0

2.6

145.09

150.38

ug/l

1.09

10438

57265

Other external causes of accidental injury

24506

101757

1.35

233.97

3.0

2.8

118.85

112.54

ug/l

2.27

22688

95594

Hernia

22691

127145

1.35

233.51

3.4

2.8

131.66

128.95

ug/l

0.57

21054

118109

Disorders of conjunctiva

21295

147680

1.38

233.44

3.1

2.8

104.45

110.10

ug/l

1.21

19955

137912

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

8803

50333

1.62

233.29

3.0

2.8

150.77

137.68

ug/l

2.57

8172

45856

Other symptoms and signs involving cognitive functions and awareness

9344

65342

1.60

231.38

3.1

2.8

126.83

146.67

ug/l

11.73

8492

59701

STROKE

12475

66622

1.50

231.28

3.3

2.5

151.63

143.32

ug/l

0.86

11506

61346

Polyarthrosis

4164

25538

2.05

231.11

3.3

2.6

125.38

143.21

ug/l

4.61

3776

23204

Other specified/unspecified arthritis

6329

44569

1.80

230.75

3.4

2.7

145.35

122.96

ug/l

4.97

5906

41412

Dental caries 2 and operation codes

19895

130289

1.39

229.28

3.2

2.8

91.25

109.16

ug/l

19.31

18585

122514

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

11808

57407

1.52

228.55

3.3

2.4

129.41

101.48

ug/l

21.08

11167

54020

Falls/tendency to fall

31308

133270

1.30

228.32

3.0

2.8

118.73

113.08

ug/l

2.42

29013

125010

Excessive, frequent and irregular menstruation

12168

52903

1.58

228.08

3.4

2.7

74.63

78.83

ug/l

1.70

11395

49542

Cardiodefibrillation

7009

50048

1.72

227.94

3.5

2.9

167.99

172.63

ug/l

0.53

6398

45308

Reimbursement for rheumatic diseases

13729

108625

1.48

227.19

3.3

2.8

133.01

119.58

ug/l

5.72

12894

100724

Chronic rhinitis, nasopharyngitis and pharyngitis

7704

56529

1.71

227.09

3.2

2.8

104.49

117.46

ug/l

5.44

7196

52844

Type 2 diabetes, definitions combined

23089

114156

1.35

226.43

3.4

2.6

132.56

127.63

ug/l

1.63

21351

106118

Pain and other conditions associated with female genital organs and menstrual cycle

6135

42408

1.94

226.40

3.3

2.7

66.69

71.06

ug/l

1.89

5777

40071

Other arthritis (FG)

7250

52506

1.72

225.61

3.4

2.7

143.50

121.37

ug/l

5.98

6777

48767

Fibrosis and cirrhosis of liver

1748

9029

3.59

225.45

4.7

2.8

172.78

139.03

ug/l

3.89

1662

8294

Benign neoplasm of other and ill-defined parts of digestive system

3791

24243

2.19

225.33

4.3

2.8

114.35

120.27

ug/l

0.88

3540

22217

Type 2 diabetes, strict (exclude DM1)

23145

114583

1.34

224.95

3.3

2.6

132.68

128.18

ug/l

1.41

21402

106514

Dental caries 2

20182

131188

1.38

223.55

3.1

2.8

91.72

109.97

ug/l

20.18

18851

123338

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2951

17632

2.40

223.17

4.3

2.8

240.50

166.78

ug/l

10.05

2765

16201

Neoplasms

22492

99771

1.36

222.79

3.1

2.7

128.22

96.01

ug/l

17.24

21244

93793

Cerebrovascular diseases (FINNGEN)

6955

35030

1.69

222.76

3.5

2.3

161.82

124.01

ug/l

4.25

6469

32522

Other/unspecified dorsalgia

9076

67827

1.61

222.02

3.3

2.8

114.26

120.19

ug/l

0.80

8388

62991

Disorders resulting from impaired renal tubular function

984

4143

7.56

220.89

12.3

2.8

280.49

146.37

ug/l

26.68

969

3808

Diabetes, insulin treatment (Kela reimbursement)

24504

125222

1.33

220.08

3.6

2.7

136.04

129.20

ug/l

2.75

22585

116519

Symptoms and signs concerning food and fluid intake

2479

14281

2.68

219.20

3.7

2.6

132.78

115.68

ug/l

3.07

2283

13136

Sleep disorders

5460

38379

1.93

218.07

3.5

2.9

93.08

104.36

ug/l

5.46

5120

36048

Intracranial trauma

14900

88654

1.43

217.52

3.0

2.7

126.21

110.88

ug/l

7.34

13703

83281

Arthrosis

17553

77693

1.39

216.82

3.0

2.7

133.10

133.25

ug/l

0.02

16255

72233

Crohn's disease of small intestine

1903

10437

3.50

216.24

4.9

2.7

99.56

108.34

ug/l

0.89

1846

9784

Accidents

24340

101757

1.33

216.03

3.0

2.8

119.24

112.54

ug/l

2.44

22551

95594

Other disorders of lacrimal gland

7743

57471

1.69

215.01

3.4

2.8

114.39

119.90

ug/l

1.25

7133

53194

Myalgia

5742

40622

1.86

214.51

3.5

2.8

99.35

108.45

ug/l

2.13

5326

37997

Chronic sinusitis

10399

80202

1.54

213.20

3.2

2.8

113.68

120.03

ug/l

1.57

9722

74822

Insulin, fast-acting or short human

8422

62973

1.62

212.96

4.6

2.8

143.52

132.77

ug/l

2.59

7821

58374

Other reaction to severe stress, and adjustment disorders

9789

75460

1.59

212.91

3.5

2.8

112.68

96.16

ug/l

3.70

9163

71475

Dental pulpitis 4

29897

132481

1.30

212.31

3.1

2.8

116.99

116.63

ug/l

0.07

27573

123760

Other diseases of blood and blood-forming organs, wide

4826

33002

1.95

211.71

4.1

2.8

261.56

129.03

ug/l

21.88

4510

30481

Dental pulpitis 1

29890

132524

1.29

211.34

3.1

2.8

117.01

116.65

ug/l

0.07

27565

123801

Ulcerative colitis (strict definition, all Crohn cases excluded)

3614

23374

2.22

211.21

3.7

2.8

97.03

115.97

ug/l

4.52

3440

21944

Intestinal stricture

6278

44728

1.74

210.90

3.9

2.8

147.17

145.47

ug/l

0.13

5804

40855

Benign neoplasm: Colon, unspecified

4905

33478

1.90

210.05

3.9

2.8

142.20

156.27

ug/l

2.43

4455

30425

Polyneuropathies and other disorders of the peripheral nervous system

4412

29479

1.97

209.71

4.1

2.9

168.88

155.36

ug/l

1.00

4089

26947

Diseases of pulp and periapical tissues, including avohilmo

29845

132375

1.29

209.61

3.1

2.8

116.63

116.59

ug/l

0.01

27528

123658

Type 2 diabetes, definitions combined, including avohilmo

23221

114807

1.33

208.89

3.3

2.6

133.28

126.73

ug/l

2.56

21467

106840

Vocal cord dysfunction

3197

18128

2.15

207.79

3.3

2.3

120.40

112.06

ug/l

0.75

2963

17080

Myocardial infarction

9765

52958

1.53

206.31

3.7

2.7

161.88

172.58

ug/l

2.28

8987

47893

Lumbar disc prolapse

15161

97071

1.41

204.85

3.0

2.8

118.68

128.99

ug/l

5.20

14208

90502

Disorders of lacrimal system

9467

72728

1.57

204.73

3.3

2.8

113.72

119.68

ug/l

1.70

8721

67209

Other (not insulin) diabetes medications

23372

118029

1.32

204.51

3.4

2.7

128.93

129.08

ug/l

0.03

21552

109735

Vascular disorders of the intestines

1468

7165

3.40

204.25

6.6

2.6

127.75

158.57

ug/l

2.61

1391

6432

Menorrhagia

9866

41880

1.60

204.22

3.5

2.7

82.73

89.10

ug/l

2.27

9194

39139

Peripheral artery disease

8524

51087

1.58

204.06

4.5

2.7

164.61

166.43

ug/l

0.21

7826

45949

Rheumatoid arthritis

7326

48780

1.65

203.61

3.1

2.7

138.33

129.40

ug/l

1.66

6831

44988

Conjunctivitis

19320

140143

1.37

203.35

3.1

2.8

101.01

105.67

ug/l

0.82

18137

131090

Hard cardiovascular diseases

16349

84737

1.39

203.31

3.5

2.7

154.03

150.33

ug/l

0.40

15105

77750

Other and unspecified polyneuropathies, also in other diseases

3848

25152

2.05

202.95

4.2

2.8

161.55

159.27

ug/l

0.17

3576

22931

Rotator cuff syndrome

13719

81066

1.43

200.90

3.0

2.7

134.55

142.63

ug/l

1.95

12737

74960

Biguanides

22736

117300

1.32

200.74

3.3

2.7

126.38

132.11

ug/l

2.14

20906

108972

Diabetes medication

26083

134472

1.30

200.08

3.6

2.7

129.00

121.18

ug/l

3.97

24118

125479

Diseases of the ear and mastoid process

32284

140721

1.27

199.90

3.0

2.8

117.60

115.74

ug/l

0.35

29881

131796

Visual disturbances and blindness

11573

91391

1.49

199.86

3.3

2.9

117.07

122.78

ug/l

1.47

10672

84617

Disorders of mineral metabolism

1886

10321

3.01

199.79

6.4

2.6

245.85

129.72

ug/l

14.66

1776

9499

Paracetamol of NSAID medication

5469

18538

1.76

199.42

2.8

2.7

111.06

104.23

ug/l

0.71

5076

17331

Oter anti-inflammatory and antirheumatic agents, non-steroids

5221

19454

1.79

199.34

3.0

3.1

136.90

160.00

ug/l

4.67

4768

17902

Nonorganic sleeping disorders

4850

34028

1.96

198.28

3.5

2.9

89.11

100.35

ug/l

5.67

4553

31997

Vitamin B12 deficiency anaemia

2339

13481

2.51

198.00

4.5

2.5

128.84

147.78

ug/l

1.31

2167

12176

Other CVD

3853

25281

2.02

197.48

3.7

2.9

165.62

148.95

ug/l

2.49

3441

22823

Viral pneumonia

2911

18022

2.32

197.44

4.1

2.7

269.88

120.93

ug/l

11.79

2765

16699

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1888

10663

3.33

197.42

4.4

2.8

97.41

104.80

ug/l

0.82

1827

10019

Osteoporosis

5116

33949

1.83

197.10

3.7

2.8

141.20

133.32

ug/l

0.96

4615

30575

Crohn's disease NAS

1759

9654

3.37

196.32

4.9

2.8

101.14

111.44

ug/l

1.36

1699

9053

Crohn disease (strict definition, require KELA)

1788

9980

3.48

195.63

4.5

2.8

96.99

104.41

ug/l

0.78

1737

9375

Female infertility

9135

43546

1.64

195.52

3.2

2.7

67.14

76.03

ug/l

4.87

8705

41114

Hypotension

3308

21025

2.14

195.34

3.7

2.9

165.66

151.99

ug/l

1.58

2940

18926

Migraine with aura

6649

49430

1.76

195.22

3.3

2.8

73.95

82.99

ug/l

6.09

6347

46753

Benign neoplasm of other and ill-defined parts of digestive system

3791

25122

2.07

194.80

4.3

2.8

114.35

136.12

ug/l

6.78

3540

23041

Crohn disease (strict definition, require KELA, min 2 HDR)

1761

9803

3.52

194.61

4.5

2.8

97.42

104.20

ug/l

0.67

1712

9214

Infections of the skin and subcutaneous tissue

13531

108416

1.43

194.58

3.7

2.8

137.12

122.07

ug/l

6.13

12674

101314

Temporomandibular joint disorders

4220

28568

1.98

194.37

3.3

2.6

91.14

94.63

ug/l

0.42

3967

26818

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

11950

92617

1.46

194.31

3.1

2.8

126.72

131.55

ug/l

0.67

11124

86337

Major coronary heart disease event

14007

74573

1.41

193.56

3.5

2.7

153.82

162.82

ug/l

2.69

12928

67792

Acetic acid derivatives and related substances

7648

28995

1.61

193.18

2.9

3.0

115.91

126.14

ug/l

2.33

7068

26926

Fibromyalgia

2424

14817

2.79

193.09

3.6

2.7

80.36

88.29

ug/l

2.34

2285

13920

Irregular menses

13688

90794

1.48

192.79

3.4

2.8

72.14

76.62

ug/l

2.52

12921

85757

Dental caries 2, only avohilmo

19665

129853

1.35

191.91

3.0

2.8

89.56

109.43

ug/l

23.45

18348

122140

Other bacterial intestinal infections

3961

26400

1.99

191.74

4.4

2.7

178.76

127.67

ug/l

10.00

3710

24167

Atopic dermatitis

15066

105291

1.42

190.37

3.1

2.8

85.74

95.68

ug/l

9.15

14167

99350

Female infertility, cervigal, vaginal, other or unspecified origin

8200

42010

1.67

189.16

3.2

2.7

66.67

76.81

ug/l

5.12

7833

39679

Polyuria

4658

32143

1.86

189.14

3.3

2.8

133.76

149.07

ug/l

2.31

4238

29520

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

5041

35299

1.81

188.49

3.7

2.7

119.78

147.28

ug/l

12.89

4690

32928

Primary_lymphoid and hematopoietic malignant neoplasms

4709

32407

1.83

188.22

3.7

2.8

354.03

133.45

ug/l

30.53

4417

29583

Other disorders of kidney and ureter

2704

16673

2.35

186.96

7.1

2.8

199.28

144.71

ug/l

17.40

2575

15324

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

23018

126601

1.31

186.31

3.2

2.8

135.67

128.67

ug/l

2.92

21328

117624

Retention of urine

6686

41134

1.64

186.28

3.4

2.8

162.55

163.27

ug/l

0.05

6006

37518

Fall on same level

30891

149171

1.26

185.93

3.1

2.8

128.75

113.92

ug/l

14.59

28436

139755

Noninflammatory disorders of female genital tract

13422

54571

1.48

185.30

3.1

2.7

68.70

77.47

ug/l

8.56

12569

51108

Visual disturbances

10705

84676

1.49

183.50

3.3

2.9

114.62

121.79

ug/l

2.01

9925

78494

All influenza

5510

39344

1.74

183.04

3.9

2.7

149.59

121.24

ug/l

7.10

5107

36359

3383

22387

2.17

182.38

4.2

2.7

121.88

101.93

ug/l

1.64

3170

20946

Dentofacial anomalies [including malocclusion]

7046

52291

1.65

182.11

3.4

2.7

98.95

97.16

ug/l

0.14

6663

49329

Oxicams

5848

23376

1.69

181.19

2.9

3.1

132.75

143.19

ug/l

1.32

5401

21615

Generalized anxiety disorder

4327

30417

2.01

181.16

3.4

2.8

73.96

81.21

ug/l

2.68

4044

28864

Cardiomyopathy, other and unspecified

1702

9136

2.84

181.12

4.2

2.5

181.69

156.25

ug/l

0.87

1612

8326

Other disorders of teeth and supporting structures

4632

32168

1.83

180.04

4.1

2.7

163.12

132.88

ug/l

7.35

4322

29872

Degeneration of macula and posterior pole

8825

55571

1.52

179.73

3.2

2.8

147.10

159.11

ug/l

3.18

7811

50016

Temporomandibular joint disorders, including avohilmo

11262

90645

1.50

179.31

3.2

2.9

80.95

87.19

ug/l

2.72

10633

85388

Other or unspecified ileus, impaction or obstruction

3618

23657

1.94

179.21

3.9

2.6

150.70

152.76

ug/l

0.14

3329

21499

Laparoscopic right hemicolectomy

1274

6479

4.01

177.11

3.3

2.8

82.68

149.65

ug/l

18.30

1180

5870

Migraine without aura

5709

42244

1.81

176.70

3.4

2.8

68.65

76.41

ug/l

5.40

5479

40119

Dental pulpitis 4, only avohilmo

29956

135393

1.26

176.60

3.0

2.8

114.86

118.52

ug/l

1.13

27617

126496

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1711

9370

2.88

176.60

4.4

2.8

251.26

141.20

ug/l

17.59

1597

8492

Benign neoplasm: Stomach

2095

12300

2.62

175.96

4.5

2.8

107.46

121.50

ug/l

1.88

1948

11261

Chronic periodontitis

3052

19463

2.10

175.61

5.5

2.6

210.10

154.39

ug/l

12.58

2889

18021

Diabetic nephropathy, excluding more controls

3134

17000

2.20

175.53

7.7

3.0

206.90

142.77

ug/l

30.16

2995

15549

Cirrhosis of liver, NAS

1161

5665

4.12

175.43

5.0

2.7

194.48

156.23

ug/l

2.86

1112

5158

Coagulation defects, purpura and other haemorrhagic conditions

4395

30757

1.90

175.25

4.1

2.9

211.78

117.08

ug/l

14.46

4173

28564

Disturbances of skin sensation

6711

50555

1.68

174.89

3.2

2.9

101.16

104.04

ug/l

0.50

6285

47498

Major coronary heart disease event excluding revascularizations

12569

69226

1.41

174.22

3.6

2.7

157.52

166.18

ug/l

2.19

11556

62791

Sulfasalazine

6703

49993

1.63

172.59

3.1

2.7

128.94

116.02

ug/l

3.00

6287

46463

Personality disorders

7016

53350

1.65

172.07

3.4

2.8

93.39

98.53

ug/l

0.83

6450

50505

External causes of morbidity and mortality

19923

83494

1.33

172.02

3.0

2.7

114.97

108.87

ug/l

1.88

18520

78422

Hyperkalaemia

1183

5695

3.52

171.57

6.6

2.6

225.33

156.03

ug/l

8.05

1116

5118

Coronary revascularization (ANGIO or CABG)

8788

46836

1.51

171.03

3.5

2.7

157.77

175.42

ug/l

4.82

8093

42232

Dental pulpitis 1, only avohilmo

29968

135798

1.26

170.93

3.0

2.8

114.71

118.61

ug/l

1.25

27616

126886

Insomnia

3969

27581

2.00

170.86

3.5

2.8

92.68

101.94

ug/l

3.27

3724

25932

Bacterial intestinal infections, IBD co-morbidities

3936

26878

1.91

170.32

4.5

2.8

179.23

130.34

ug/l

9.15

3681

24642

Chronic diseases of tonsils and adenoids

20863

111743

1.31

169.46

2.9

2.8

98.96

114.06

ug/l

5.90

19740

104622

Artrosis, including avohilmo

20775

95805

1.31

169.40

2.9

2.8

129.04

134.13

ug/l

1.80

19294

89465

Atherosclerosis, excluding cerebral and coronary sclerosis

7796

47035

1.54

169.30

4.4

2.7

164.91

169.14

ug/l

0.57

7147

42185

Gonarthrosis,primary

19237

101257

1.32

168.61

3.0

2.8

139.06

146.48

ug/l

2.75

17569

93346

Haemorrhoids and perianal venous thrombosis

5917

43054

1.64

168.25

3.2

2.6

118.91

147.31

ug/l

15.25

5418

39196

Sequelae of external causes of morbidity and mortality

5301

38448

1.73

166.16

3.7

2.8

152.83

133.76

ug/l

3.06

4938

35411

Persistent mood disorders

4583

32454

1.81

165.86

3.3

2.8

101.60

114.97

ug/l

4.13

4206

30287

Benign neoplasm: Sigmoid colon

3459

23010

1.96

165.81

3.7

2.8

126.42

136.05

ug/l

1.31

3229

20933

Asthma/COPD (KELA code 203)

24723

149814

1.28

165.73

3.1

2.8

107.78

118.11

ug/l

6.89

23172

139530

Anaemia in chronic diseases classified elsewhere

648

2517

7.94

165.18

11.6

2.5

387.06

146.57

ug/l

21.98

630

2274

Undetermined asthma, excluding more controls

2940

18911

2.10

165.08

3.3

2.5

115.26

106.88

ug/l

1.08

2739

17488

Myeloproliferative diseases

1833

10591

2.73

163.70

4.0

2.8

160.43

141.87

ug/l

0.85

1709

9664

Deforming dorsopathies

6421

48081

1.62

162.40

3.2

2.8

103.86

119.27

ug/l

6.23

5977

44642

Other neurological diseases

15451

102770

1.35

161.20

3.3

2.8

129.68

139.20

ug/l

4.05

14239

94359

Myocardial infarction, strict

8852

49818

1.48

160.99

3.6

2.7

160.89

174.83

ug/l

3.22

8153

45011

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

7543

58240

1.57

159.72

3.4

2.8

108.73

114.50

ug/l

1.51

7036

54147

Rheumatism, unspecified

3224

21524

2.04

159.45

3.4

2.7

97.68

113.84

ug/l

4.88

2998

19904

Venous thromboembolism

11201

87328

1.42

158.77

3.5

2.8

164.76

139.17

ug/l

8.06

10353

79945

Sequelae with surgical and medical care as external cause

4158

29220

1.85

158.29

3.8

2.8

157.16

134.75

ug/l

3.17

3869

26845

Cholelithiasis, broad definition with cholecystitis

20705

120734

1.30

157.49

3.3

2.8

130.85

122.57

ug/l

3.58

19081

111973

Disorders of adult personality and behaviour

7360

57017

1.59

157.26

3.3

2.8

92.90

97.64

ug/l

0.78

6762

53995

Primary_lymphoid and hematopoietic malignant neoplasms

4709

33601

1.74

156.96

3.7

2.9

354.03

143.21

ug/l

27.95

4417

30603

Peripheral arterial reconstruction

3166

20828

1.96

156.79

4.7

2.8

173.39

168.99

ug/l

0.33

2902

18642

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

7225

55611

1.58

156.66

3.3

2.7

92.90

93.76

ug/l

0.10

6673

52897

Other medical care

8415

63923

1.50

156.27

3.0

2.6

251.50

128.10

ug/l

63.20

7792

58378

Any operation in hilmo

1392

3337

2.66

156.24

2.6

1.8

118.55

72.51

ug/l

5.44

1295

3232

Noninfectious colitis NAS

3126

20879

2.06

155.97

4.0

2.8

125.84

114.95

ug/l

1.61

2939

19362

Hypokalaemia

2423

15109

2.22

155.92

3.9

2.6

164.28

128.07

ug/l

6.59

2243

13767

Crohn's disease of large intestine

1383

7569

3.39

155.77

4.7

2.7

96.92

112.31

ug/l

2.99

1336

7080

Cholelithiasis

19974

119039

1.30

154.86

3.3

2.8

128.54

122.33

ug/l

2.17

18388

110376

Benign neoplasm: Stomach

2095

12803

2.47

153.92

4.5

2.8

107.46

135.14

ug/l

5.63

1948

11695

Symptoms and signs involving speech and voice

7106

54585

1.57

153.62

3.2

2.9

120.34

124.29

ug/l

0.34

6589

50417

Fenamates

4039

18826

1.83

151.63

3.1

3.0

96.24

119.15

ug/l

4.74

3795

17565

Crohn disease (strict definition, all UC cases excluded)

1366

7573

3.46

151.43

4.4

2.8

99.00

106.81

ug/l

0.60

1330

7112

Myeloproliferative diseases (CML excluded)

1663

9565

2.76

151.36

3.9

2.8

149.37

142.54

ug/l

0.22

1544

8720

Volume depletion

1883

10974

2.41

151.14

4.3

2.7

193.12

140.50

ug/l

7.79

1720

9898

Complications of internal orthopaedic prosthetic devices, implants and grafts

4329

30627

1.76

150.56

3.3

2.7

149.55

144.41

ug/l

0.56

3930

27706

Intracranial injury

13241

105323

1.37

150.45

3.1

2.8

125.11

123.28

ug/l

0.27

12080

97828

Other maternal disorders predominantly related to pregnancy

15837

84060

1.38

149.91

3.1

2.8

72.21

80.54

ug/l

6.50

14938

79252

Abnormal findings on diagnostic imaging of lung

9168

70398

1.45

149.87

3.4

2.8

182.51

152.97

ug/l

7.30

8434

64090

Soft tissue disorders related to use, overuse and pressure

5532

40799

1.63

149.55

3.2

2.7

123.42

139.72

ug/l

5.31

5131

37688

Undetermined asthma

2940

19373

2.02

149.41

3.3

2.5

115.26

109.93

ug/l

0.57

2739

17972

Benign neoplasm: Rectum, anus and anal canal

3729

25692

1.83

149.31

3.6

2.8

141.91

135.41

ug/l

0.52

3459

23409

Gonarthrosis, primary, with knee surgery

10821

70964

1.41

148.93

3.0

2.8

139.96

157.14

ug/l

6.81

9761

64526

Statin medication

17309

81198

1.32

148.85

3.3

2.6

128.78

122.49

ug/l

2.05

16174

76202

Certain disorders involving the immune mechanism

4098

29012

1.81

148.65

4.9

2.8

170.19

128.58

ug/l

5.74

3898

26968

Disorders of synovium and tendon

12620

93262

1.38

148.23

3.1

2.7

114.84

119.93

ug/l

1.26

11756

87041

7570

55010

1.51

147.25

3.2

2.9

149.82

155.83

ug/l

0.67

6805

49465

Iron deficiency

776

3900

25.26

146.90

8.0

2.8

49.51

60.75

ug/l

2.05

758

3668

Primary gonarthrosis, bilateral

9825

68577

1.43

144.48

3.1

2.8

137.72

153.85

ug/l

5.76

8898

62496

Mouth breathing

8350

65585

1.48

144.30

3.1

2.9

128.82

143.86

ug/l

6.43

7785

61178

Injuries to the abdomen, lower back, lumbar spine and pelvis

8529

66902

1.48

144.03

3.3

2.9

130.18

124.68

ug/l

0.77

7768

61788

Deposits [accretions] on teeth

1647

9215

2.66

143.51

6.4

2.6

171.21

114.50

ug/l

12.76

1582

8642

Injury, poisoning and certain other consequences of external causes

16421

68754

1.33

143.40

3.0

2.7

109.80

107.09

ug/l

0.58

15313

64526

Migraine without aura and triptan purchases

4520

33538

1.85

143.32

3.4

2.9

64.58

73.88

ug/l

7.40

4343

31859

Emergency coronary revascularization (for ACS)

10175

58249

1.41

143.26

3.4

2.8

157.42

173.16

ug/l

4.84

9352

52536

Hernia of abdominal wall

9333

74480

1.44

142.76

3.5

2.8

138.29

142.97

ug/l

0.80

8679

68793

Skin changes due to chronic exposure to nonionizing radiation

7045

51222

1.52

142.52

3.2

2.9

150.06

157.89

ug/l

0.91

6315

45918

Nonischemic cardiomyopathy

1222

6417

3.08

142.35

3.8

2.6

197.64

169.36

ug/l

0.66

1169

5886

Benign neoplasm: Ascending colon

2443

15627

2.13

141.63

3.9

2.8

132.31

136.24

ug/l

0.28

2273

14177

Injuries to the head

27912

159361

1.24

141.51

3.0

2.8

131.29

115.17

ug/l

8.42

25589

148885

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1046

5276

3.59

141.21

4.8

2.8

191.12

140.45

ug/l

4.91

971

4759

Hyperkinetic disorders, excluding more controls

2828

18542

2.12

141.19

3.4

2.7

66.22

66.53

ug/l

0.05

2666

17755

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

13759

113212

1.36

140.99

3.1

2.8

97.48

99.21

ug/l

0.16

12932

106180

Voice disturbances

5770

43683

1.63

140.98

3.2

2.9

112.83

120.10

ug/l

0.80

5407

40472

Persons with potential health hazards related to communicable diseases

10143

82080

1.45

140.90

3.5

2.9

104.71

88.59

ug/l

6.34

9477

77822

Somatoform disorder

3880

27662

1.84

140.57

3.5

2.8

101.56

107.57

ug/l

0.65

3609

25941

Benign neoplasm: Rectum

3275

22293

1.88

140.27

3.6

2.8

137.39

136.38

ug/l

0.07

3045

20293

Specific personality disorders

6049

46435

1.63

140.08

3.4

2.8

92.90

96.06

ug/l

0.36

5573

43955

Other disorders of veins

8473

67260

1.47

139.33

3.1

2.8

114.34

121.91

ug/l

2.26

7756

62268

KRA_PSY_EATING, excluding more controls

2762

19112

2.36

139.12

3.8

2.8

53.70

55.87

ug/l

0.49

2597

18235

Actinic keratosis

6811

49641

1.53

138.89

3.2

2.9

149.90

158.97

ug/l

1.11

6093

44452

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

2207

13743

2.16

138.86

3.0

2.9

116.76

139.83

ug/l

3.70

2031

12363

Combinations of oral blood glucose lowering drugs

5227

38575

1.62

138.64

3.4

2.7

116.01

173.43

ug/l

43.42

4835

35456

Transient ischemic attack

10091

67180

1.41

137.50

3.2

2.8

137.57

154.16

ug/l

6.87

9258

60947

Bipolar affective disorders

4717

34871

1.72

136.83

3.1

2.8

96.77

98.44

ug/l

0.26

4373

33057

Diseases of male genital organs

9796

38850

1.40

136.49

3.0

2.7

183.72

198.71

ug/l

2.91

9035

36222

Substance abuse, excluding more controls

12309

88467

1.35

136.24

3.1

2.7

156.00

132.95

ug/l

8.47

11196

82930

Migraine with aura and triptan purchases

4194

31018

1.87

136.00

3.3

2.9

70.24

75.29

ug/l

1.63

4007

29382

Benign neoplasm: Caecum

1951

11981

2.33

135.58

3.7

2.8

133.76

135.72

ug/l

0.10

1813

10878

Cervicalgia

4486

32650

1.69

134.77

3.1

2.8

110.12

126.47

ug/l

4.75

4157

30200

Seropositive rheumatoid arthritis

5320

39543

1.61

134.74

3.1

2.7

135.86

129.02

ug/l

0.89

4981

36266

DVT of lower extremities and pulmonary embolism

8221

64728

1.45

134.50

3.5

2.8

173.01

143.64

ug/l

6.69

7599

59053

Allergic conjunctivitis

14285

118612

1.34

134.36

3.1

2.9

97.52

99.28

ug/l

0.17

13425

111240

5237

34269

1.60

134.32

3.3

2.8

143.06

159.87

ug/l

4.12

4575

30524

Benign neoplasm: Sigmoid colon

3459

24083

1.83

134.08

3.7

2.8

126.42

155.51

ug/l

7.82

3229

21940

Diabetic nephropathy

3158

21687

1.97

133.26

7.6

3.2

206.64

142.72

ug/l

33.45

3016

19854

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

3512

24350

1.78

132.49

2.9

138.32

143.82

ug/l

0.34

3217

22035

Fissure and fistula of anal and rectal regions

5144

38227

1.61

132.16

3.3

2.6

132.57

132.71

ug/l

0.01

4754

35460

Subjective visual disturbances

5350

40488

1.63

131.68

3.3

2.8

99.25

115.80

ug/l

10.67

4965

37575

Cholecystectomy

15981

119878

1.31

131.66

3.3

2.8

123.46

123.47

ug/l

0.00

14784

110981

Endometriosis

9707

46862

1.46

131.31

3.1

2.7

82.72

83.69

ug/l

0.16

9082

43893

Purpura and other haemorrhagic conditions

2888

19664

1.98

131.19

4.1

2.8

262.11

122.25

ug/l

14.45

2746

18179

Benign neoplasm: Transverse colon

1912

11766

2.30

131.02

4.0

2.8

133.34

139.06

ug/l

0.41

1804

10724

Open wound of head

10850

87150

1.37

130.92

3.1

2.8

146.23

140.06

ug/l

1.13

9795

80743

Other symptoms and signs involving the nervous and musculoskeletal systems

9438

76477

1.43

130.75

3.2

2.9

114.38

118.19

ug/l

0.60

8900

71130

Collagenous colitis

1975

12451

2.37

130.57

4.1

2.8

135.40

117.85

ug/l

1.10

1855

11495

Disorders of parathyroid gland

4098

29139

1.72

130.32

5.3

2.7

156.64

130.69

ug/l

6.91

3749

26432

Disorders of iron metabolism

444

1658

15.09

129.76

12.1

2.5

238.72

146.37

ug/l

4.93

430

1545

Viral pneumonia (unknown virus, not influenza)

1559

9233

2.65

129.73

4.1

2.7

322.06

119.76

ug/l

40.92

1511

8593

Hypertensive Renal Disease

779

3504

3.73

129.72

8.4

2.3

230.77

180.28

ug/l

4.78

746

3102

Panic disorder

4018

29471

1.82

129.58

3.3

2.8

75.57

82.34

ug/l

2.76

3716

27965

Heartburn

2328

15126

2.11

128.94

3.4

2.6

100.33

116.62

ug/l

3.85

2156

14037

Unspecified fall

10602

86094

1.38

128.88

3.1

2.9

129.77

126.36

ug/l

0.50

9635

79636

Exclusions for E4_PCOS_BROAD

3842

27735

1.79

128.11

3.7

2.9

120.27

110.00

ug/l

1.90

3613

25964

Chronic pancreatitis

2351

15192

2.04

127.70

3.8

2.7

178.24

164.35

ug/l

1.06

2189

13989

Glomerulonephritis

2138

13678

2.19

127.49

7.0

2.8

192.25

135.67

ug/l

19.22

2059

12675

Propionic acid derivatives

8017

31337

1.45

127.45

2.8

3.0

114.13

121.41

ug/l

1.31

7443

29154

Pulmonary heart disease, diseases of pulmonary circulation

6085

46560

1.53

127.11

3.7

2.8

178.88

144.81

ug/l

5.59

5665

42336

Oesophageal varices

913

4563

3.68

126.86

5.1

2.7

162.36

160.68

ug/l

0.04

861

4176

Direct fill therapy

2980

20587

1.94

126.55

5.4

2.8

152.08

116.77

ug/l

10.44

2860

19258

Carpal tunnel syndrome

13507

102334

1.33

125.86

3.1

2.8

123.71

126.01

ug/l

0.21

12524

94994

Mycoses

5562

42462

1.59

125.63

3.6

2.9

145.62

125.86

ug/l

2.61

5169

39345

Polycystic ovarian syndrome, consortium definition

19861

104270

1.29

125.19

3.2

2.8

82.26

81.91

ug/l

0.09

18477

97709

Injuries to the thorax

9058

73008

1.41

124.36

3.2

2.8

146.73

143.23

ug/l

0.48

8257

67370

Disorder of lipoprotein metabolism, unspecified

2540

16735

1.94

123.99

3.7

2.6

181.57

159.20

ug/l

0.50

2297

15088

Amiodarone users

1896

11788

2.24

123.87

4.0

2.8

186.27

170.87

ug/l

0.24

1794

10711

Abnormal serum enzyme levels

5453

40705

1.56

123.27

3.1

2.9

193.35

176.05

ug/l

1.90

5138

37155

Allergic asthma (mode), excluding more controls

6290

47943

1.53

122.70

3.1

2.6

87.44

84.43

ug/l

0.60

6011

45148

Acute sinusitis

12915

101110

1.34

122.69

3.4

2.8

116.76

105.81

ug/l

1.56

12094

95039

Malignant neoplasm of colon

2776

18791

1.90

122.22

3.1

2.9

116.80

154.96

ug/l

11.60

2560

16935

Ventral hernia

4753

35401

1.62

122.04

3.6

2.8

131.61

141.64

ug/l

1.52

4392

32501

Other diseases of blood and blood-forming organs

1464

8626

2.61

121.93

4.0

2.8

149.73

136.44

ug/l

0.62

1341

7933

Weight loss

2075

13427

2.23

121.83

3.5

2.9

138.12

124.07

ug/l

2.00

1904

12354

Biological medication for rheuma

3646

26404

1.80

121.64

3.7

2.8

110.42

104.90

ug/l

0.58

3513

24901

Other acute lower respiratory infections

12021

95467

1.34

121.56

3.6

2.8

134.90

122.26

ug/l

3.52

11122

88426

Coronary artery bypass grafting

4981

28060

1.58

121.48

3.6

2.7

159.72

190.14

ug/l

8.66

4591

25019

Non-allergic asthma (mode), excluding more controls

4265

30830

1.64

121.26

3.2

2.5

103.80

108.10

ug/l

0.68

4005

28384

Disorders of skin appendages

11323

94319

1.37

120.29

3.4

2.8

111.37

107.40

ug/l

0.80

10649

88393

Hyperplasia of prostate

6404

27700

1.48

120.03

3.0

2.8

190.55

213.53

ug/l

4.29

5781

25512

Acute bronchitis

8934

70798

1.40

120.02

3.7

2.8

137.05

124.15

ug/l

2.52

8232

65269

Vasomotor and allergic rhinitis

9534

76980

1.40

119.73

3.0

2.8

96.06

102.07

ug/l

0.81

8982

72408

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1668

10187

2.38

119.54

4.6

2.8

211.17

134.96

ug/l

10.41

1553

9218

Cutaneous abscess, furuncle and carbuncle

5554

42626

1.56

119.51

3.9

2.8

139.67

122.32

ug/l

4.02

5199

39867

Cervical disc disorders

7412

58582

1.44

118.95

3.1

2.7

125.71

145.87

ug/l

9.89

6869

54186

Other disorders of eyelid

8583

66788

1.41

118.87

3.1

2.8

130.41

144.59

ug/l

3.67

7808

60798

Coxarthrosis, primary

11193

80213

1.35

118.59

3.0

2.8

143.42

155.08

ug/l

4.42

10197

72832

Coronary angioplasty

6872

41052

1.46

118.49

3.4

2.7

154.60

176.42

ug/l

5.80

6325

36889

Benign neoplasm: Rectum, anus and anal canal

3729

26870

1.72

118.44

3.6

2.8

141.91

154.04

ug/l

1.21

3459

24466

Rheumatoid arthritis, including avohilmo

8101

65191

1.44

117.91

3.1

2.8

134.78

126.05

ug/l

1.93

7554

59908

Monoamine oxidase A inhibitors

2468

16416

1.95

117.68

3.2

2.7

102.09

136.22

ug/l

16.58

2257

15343

COPD (mode)

5734

34514

1.51

117.53

3.4

2.6

162.97

147.57

ug/l

2.45

5170

31195

Need for other prophylactic measures

1255

7214

2.85

116.77

4.3

2.8

178.24

124.86

ug/l

2.88

1217

6690

Other diseases of stomach and duodenum

1326

7603

2.59

116.68

4.6

2.6

123.20

141.85

ug/l

1.42

1244

6966

Cervicobrachial syndrome

4869

36735

1.60

116.60

3.1

2.7

110.34

122.04

ug/l

1.09

4610

34268

Coeliac disease

2837

19820

1.94

116.57

3.5

2.8

101.92

106.08

ug/l

0.55

2679

18470

Colorectal cancer

4245

31204

1.63

116.35

2.9

135.37

159.84

ug/l

3.65

3902

28187

Polymyalgia rheumatica

2468

16526

1.95

115.66

3.4

2.8

168.29

147.91

ug/l

1.30

2226

14807

Excessive attrition of teeth

10088

45038

1.41

115.58

3.2

2.7

98.93

104.03

ug/l

1.17

9342

42261

Injuries to the hip and thigh

9455

70509

1.38

115.37

3.2

2.9

150.09

136.38

ug/l

2.58

8592

64608

Inflammatory diseases of female pelvic organs

16308

106374

1.31

115.33

3.2

2.9

81.52

82.62

ug/l

0.33

15248

99660

Other disorders of ear

20916

121289

1.24

115.17

3.0

2.8

137.27

129.41

ug/l

2.75

18987

112762

Injuries to the ankle and foot

17038

134044

1.28

115.10

3.1

2.8

102.85

109.39

ug/l

3.35

15865

126098

Other symptoms and signs involving the digestive system and abdomen

3608

26051

1.73

115.05

3.5

2.6

123.18

108.04

ug/l

1.56

3293

24131

Enlarged lymph nodes

3411

24307

1.74

115.01

3.4

2.6

195.58

117.91

ug/l

16.25

3223

22540

Anti-inflammatory and antirheumatic products, non-steroids

7927

31341

1.43

115.01

2.9

3.0

112.31

121.39

ug/l

1.92

7338

29158

Ulcerative rectosigmoiditis

1919

12342

2.23

114.90

3.8

2.7

103.32

117.80

ug/l

1.26

1824

11565

Benign neoplasm: Ascending colon

2443

16435

1.97

114.65

3.9

2.8

132.31

154.01

ug/l

3.14

2273

14953

Benign neoplasm: Caecum

1951

12547

2.17

114.03

3.7

2.8

133.76

151.50

ug/l

1.78

1813

11400

Abnormal weight loss

1852

11848

2.26

113.72

3.4

2.9

139.63

128.99

ug/l

1.18

1691

10885

Alcohol use disorder, Swedish definition

11517

88946

1.33

113.21

3.1

2.8

175.45

141.93

ug/l

14.58

10510

82830

6-mercaptopurine

860

4518

3.99

112.70

4.2

2.7

114.96

94.89

ug/l

0.79

834

4236

Colon adenocarcinoma

2207

14494

2.00

112.47

3.0

2.9

116.76

157.99

ug/l

9.71

2031

13058

Other menopausal disorders

6165

27597

1.52

111.87

2.8

2.7

86.85

105.27

ug/l

11.17

5761

25739

Allergic asthma (mode)

6290

48559

1.50

111.67

3.1

2.6

87.44

86.44

ug/l

0.15

6011

45752

Viral infections characterized by skin and mucous membrane lesions

9031

73910

1.39

111.20

3.7

2.8

143.66

120.68

ug/l

5.91

8449

68800

Exposure to other specified factors

17468

141987

1.26

110.70

3.1

2.8

116.24

117.93

ug/l

0.37

16171

132898

Procreative management

7306

49230

1.45

110.17

3.3

2.8

102.12

109.14

ug/l

1.34

6967

46522

Ovarian cyst

10317

49595

1.39

110.16

3.1

2.7

81.87

81.25

ug/l

0.13

9630

46476

Other diseases of lip and oral mucosa

3230

22992

1.74

109.52

3.4

2.6

133.67

133.39

ug/l

0.02

3007

21302

Benign neoplasm: Rectum

3275

23435

1.75

109.23

3.6

2.8

137.39

155.04

ug/l

2.75

3045

21345

Diabetic retinopathy, excluding more controls

5173

22275

1.59

108.68

4.7

3.0

150.24

134.99

ug/l

4.00

4741

20414

Idiopathic gout

1644

10153

2.22

108.45

4.7

2.7

229.54

178.59

ug/l

2.75

1528

9194

Intestinal adhesions without obstruction

1629

10028

2.22

108.43

4.0

2.6

136.20

139.71

ug/l

0.15

1508

9144

Other ulcerative colitis

1385

8385

2.60

108.16

4.5

2.7

108.83

116.52

ug/l

0.36

1325

7855

Type 1 diabetes

5674

44007

1.51

108.07

4.8

2.7

142.60

121.81

ug/l

5.18

5286

41175

Benign neoplasm: Transverse colon

1912

12379

2.13

108.04

4.0

2.8

133.34

154.91

ug/l

2.77

1804

11278

Sensorineural hearing loss

15424

92195

1.27

107.58

2.9

2.8

150.27

144.44

ug/l

1.16

13851

84857

Fitting and adjustment of other devices

6537

47805

1.45

107.36

3.0

2.6

155.00

140.76

ug/l

2.89

5913

43097

Spondylolisthesis/Spondylolysis

3671

26800

1.67

106.94

3.1

2.7

114.63

136.25

ug/l

5.47

3405

24788

False labour

9049

47441

1.46

106.89

3.1

2.9

58.21

65.93

ug/l

5.00

8605

45441

Hyperparathyroidism

3523

25266

1.69

106.38

5.5

2.7

161.72

130.60

ug/l

10.82

3229

22887

Pulmonary embolism

5491

42452

1.50

106.34

3.6

2.8

185.26

143.84

ug/l

6.73

5107

38638

Missing teeth due to accident, extraction or parodontitis

2290

15368

1.94

106.34

4.0

2.6

156.92

142.23

ug/l

1.32

2157

14212

Streptococcal septicaemia

1678

10502

2.19

106.02

4.7

2.6

220.31

132.49

ug/l

13.32

1566

9587

Persons encountering health services for specific procedures, not carried out

1759

11306

2.24

106.00

4.0

2.6

108.91

105.33

ug/l

0.29

1614

10528

Type 1 diabetes, wide definition, subgroup 1

4769

36348

1.57

105.83

4.7

2.7

134.63

114.96

ug/l

6.73

4436

34125

Endometriosis of pelvic peritoneum

4138

30928

1.68

105.77

3.1

2.7

72.26

82.07

ug/l

5.96

3890

29226

Fracture of rib(s), sternum and thoracic spine

5554

43023

1.50

105.77

3.2

2.8

157.25

152.30

ug/l

0.48

5035

39485

Enterocolitis due to Clostridium difficile

2137

14167

1.99

105.59

5.1

2.8

233.27

134.52

ug/l

12.30

1994

12909

Pain in thoracic spine

3346

24250

1.73

105.47

3.2

2.8

104.55

114.62

ug/l

2.18

3188

22626

Pulmonary heart disease

5491

42505

1.50

105.39

3.6

2.8

185.26

143.76

ug/l

6.76

5107

38691

Meniscus derangement

12090

69248

1.31

105.32

2.9

2.7

140.47

139.93

ug/l

0.06

11137

64204

Essential (haemorrhagic) thrombocythaemia

847

4446

3.47

104.98

4.0

2.7

128.52

119.26

ug/l

0.52

791

4048

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2891

20443

1.80

104.21

4.2

2.8

158.07

132.43

ug/l

2.93

2642

18782

Unstable angina pectoris

6903

45365

1.43

103.94

3.5

2.8

143.31

172.90

ug/l

14.67

6345

40761

Cerebrovascular diseases

14504

88606

1.28

103.90

3.4

2.8

155.83

150.06

ug/l

0.63

13232

81065

Colorectal adenocarcinoma

3512

25517

1.66

103.46

2.9

138.32

162.86

ug/l

2.75

3217

23004

Barrett oesophagus

964

5214

2.92

103.13

3.7

2.6

118.69

170.48

ug/l

8.10

889

4757

Other sleep disorders

2322

15759

1.92

103.03

3.6

2.7

113.12

134.64

ug/l

5.72

2194

14674

Osteoporosis with pathological fracture (FG)

1300

7690

2.44

102.53

3.8

2.6

129.26

123.07

ug/l

0.28

1175

6855

Non-allergic asthma (mode)

4265

31710

1.58

102.22

3.2

2.5

103.80

110.75

ug/l

1.37

4005

29250

Tumor necrosis factor alpha inhibitors

3258

23849

1.77

102.18

3.5

2.8

106.73

103.20

ug/l

0.30

3134

22523

Conductive and sensorineural hearing loss

16560

98922

1.25

101.89

2.9

2.8

147.78

140.61

ug/l

1.71

14944

91297

Disorders of vitreous body

9196

74319

1.36

101.85

3.4

2.8

137.25

143.18

ug/l

0.82

8425

67982

Amputation

1811

11565

2.04

101.41

6.1

2.7

196.37

167.73

ug/l

4.52

1675

10416

Thrombocytopenia, unspecified

1470

9116

2.37

101.37

4.1

2.8

350.01

131.07

ug/l

10.69

1385

8380

Internal derangement of knee

8254

67118

1.38

101.27

3.0

2.7

123.04

128.40

ug/l

1.06

7588

62576

Disorders of sclera, cornea, iris and ciliary body

11877

100609

1.31

101.11

3.2

2.8

124.68

124.24

ug/l

0.06

11101

93655

Fracture of lumbar spine and pelvis

4123

30889

1.60

101.09

3.4

2.8

152.85

136.43

ug/l

1.63

3715

28088

L01XX Other antineoplastic agents

1130

6520

2.70

100.92

4.0

2.8

175.88

152.12

ug/l

1.38

1055

5894

Phobic anxiety disorders

3439

25506

1.74

100.81

3.3

2.7

87.85

82.54

ug/l

0.46

3188

24243

Cellulitis

4393

33347

1.58

100.57

4.0

2.8

150.87

132.18

ug/l

3.29

4096

30956

Postmenopausal bleeding

5580

23680

1.50

100.38

2.9

2.7

111.64

119.73

ug/l

1.55

5050

21723

Explicit bacterial Sepsis

2047

13549

1.97

100.36

4.6

2.6

207.38

132.01

ug/l

13.07

1913

12416

Disorders of vitreous body and globe

9451

76422

1.35

99.96

3.4

2.8

137.67

142.91

ug/l

0.70

8657

69921

Trochanteric bursitis

2816

20003

1.79

99.64

3.2

2.7

103.87

118.65

ug/l

3.56

2597

18426

Other diseases of pleura

8257

59598

1.37

99.33

3.8

2.8

200.15

155.36

ug/l

19.06

7541

54134

Total colectomy

983

5548

3.05

98.95

5.2

2.7

101.19

127.00

ug/l

2.73

936

5171

Total colectomy operation

983

5548

3.05

98.95

5.2

2.7

101.19

127.00

ug/l

2.73

936

5171

Congenital malformations, deformations and chromosomal abnormalities

14652

121399

1.28

98.71

3.5

2.8

105.25

103.58

ug/l

0.17

13790

114205

Superficial injury of head

4753

36586

1.54

98.34

3.0

2.8

132.54

119.91

ug/l

0.54

4360

33933

Other blood glucose lowering drugs, excl. Insulins

3079

22081

1.69

97.60

3.8

2.7

115.70

162.68

ug/l

21.40

2845

20042

Other necrotizing vasculopathies (FG)

1208

7102

2.47

97.43

4.3

2.6

177.55

139.95

ug/l

3.67

1130

6468

3649

25419

1.61

96.96

3.3

2.9

144.83

155.06

ug/l

1.25

3152

22614

Other metabolic disorders

2926

21173

1.78

96.94

3.6

2.7

120.26

99.92

ug/l

4.53

2724

19764

Urticaria and erythema

8479

70304

1.39

96.85

3.4

2.9

112.08

102.56

ug/l

1.82

7903

65910

Amputation of toe

1317

7923

2.34

96.78

6.3

2.8

195.05

165.15

ug/l

4.13

1224

7165

Endocarditis

729

3623

3.23

96.55

5.1

2.4

209.43

164.69

ug/l

3.39

694

3299

Spondyloarthritis

3895

29175

1.60

96.52

3.4

2.8

128.76

121.59

ug/l

0.64

3653

27161

Disturbance of activity and attention

2728

19532

1.89

96.52

3.4

2.9

65.45

68.64

ug/l

0.74

2572

18571

Exclusions for E4_PCOS_CONSORTIUM

19219

106189

1.25

96.40

3.2

2.8

93.78

91.44

ug/l

0.76

17845

99687

Haemolytic anaemias

821

4428

3.45

96.34

6.7

2.8

333.36

123.24

ug/l

6.62

782

4065

Cholangitis (primary sclerosing, PSC)

1261

7565

2.42

95.66

3.9

2.7

148.88

134.43

ug/l

0.97

1188

6928

Eating disorder

2766

20649

2.04

95.60

3.8

2.9

53.68

57.18

ug/l

0.91

2601

19583

Persons encountering health services in circumstances related to reproduction

12876

74293

1.29

95.29

2.9

2.7

102.91

121.21

ug/l

11.24

12231

69948

Peripheral artery operations in Hilmo

2270

15355

1.81

94.85

5.6

2.7

184.19

167.67

ug/l

1.77

2093

13769

Malignant neoplasm of digestive organs

6743

53198

1.40

94.84

3.0

2.9

154.79

163.63

ug/l

0.95

6215

48023

Tonsillectomy and adenotomy

15383

93208

1.27

94.68

3.0

2.9

84.43

92.48

ug/l

1.49

14699

88418

Convulsions, not elsewhere classified

5087

39037

1.49

94.11

3.2

2.6

132.60

111.55

ug/l

3.35

4655

36355

12162

95006

1.28

92.98

3.1

2.8

173.59

138.60

ug/l

16.38

11081

88502

Other disorders involving the immune mechanism, not elsewhere classified

740

3890

3.58

92.87

8.2

2.8

221.98

134.28

ug/l

6.59

724

3622

Other hammer toe(s) (acquired)

3207

21844

1.65

92.50

2.9

2.7

118.62

143.61

ug/l

8.03

2876

19771

Artificial opening status

1068

6196

2.61

92.24

4.1

2.6

146.46

144.03

ug/l

0.11

1008

5680

Acute pancreatitis

3667

27305

1.59

92.23

3.6

2.8

172.26

149.85

ug/l

2.65

3363

25096

Candidiasis

2923

21393

1.77

92.13

3.8

2.9

129.69

107.24

ug/l

2.82

2705

19894

Unspecified/other endometriosis

2574

18741

1.93

91.87

3.3

2.8

66.08

67.67

ug/l

0.32

2448

17797

Basal cell carcinoma, including avohilmo

10492

69323

1.31

91.60

3.1

2.9

153.30

154.66

ug/l

0.12

9406

62709

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2100

14228

1.88

91.46

4.0

2.7

117.13

170.93

ug/l

19.77

1911

12933

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

699

3635

3.74

91.18

8.4

2.8

213.94

134.94

ug/l

8.44

684

3387

Pruritus

2406

17037

1.87

91.02

4.0

2.8

107.54

106.99

ug/l

0.05

2250

15792

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

5310

38642

1.53

90.82

3.3

2.9

65.97

68.84

ug/l

0.95

4981

36752

Thyrotoxicosis, other and/or unspecified

4301

33222

1.57

90.67

3.3

2.7

103.37

106.33

ug/l

0.43

3994

30954

Artificial joint operation, meniscal resection

19253

112599

1.22

90.67

2.9

2.8

140.47

142.19

ug/l

0.33

17633

104005

Other hearing loss

5074

38854

1.47

90.53

3.2

2.9

155.63

149.75

ug/l

0.33

4444

35286

Hyperkinetic disorders

2848

20740

1.82

90.31

3.4

2.9

66.01

69.65

ug/l

0.89

2686

19712

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

609

2940

3.67

89.97

5.5

2.8

464.54

138.86

ug/l

28.99

577

2657

Mental and behavioural disorders due to alcohol, excluding acute intoxication

8906

73885

1.33

89.91

3.0

2.8

169.64

146.75

ug/l

5.99

8103

68822

Basal cell carcinoma

10204

68177

1.31

89.78

3.1

2.9

154.72

154.78

ug/l

0.00

9142

61641

Abnormalities of gait and mobility

2233

15489

1.86

89.61

3.5

2.9

137.05

146.10

ug/l

0.69

2061

14119

Disorders of calcium metabolism

1258

7703

2.35

89.15

4.6

2.6

247.18

127.47

ug/l

9.76

1175

7066

Left bundle-branch block

1314

8004

2.20

88.83

3.3

2.5

151.06

151.19

ug/l

0.01

1191

7257

Deviated nasal septum

6406

51442

1.40

88.78

2.9

2.8

143.89

156.74

ug/l

2.22

5972

47773

Alcohol use disorder, ICD-based

8243

68075

1.35

88.56

3.0

2.8

167.92

145.98

ug/l

5.16

7502

63452

Ascites

1369

8505

2.20

88.44

4.5

2.6

234.10

140.52

ug/l

15.08

1307

7768

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

740

3855

3.10

88.14

5.3

2.8

541.61

139.55

ug/l

17.83

700

3493

Other diseases of pericardium

867

4730

2.74

87.87

4.4

2.4

199.55

152.22

ug/l

4.93

820

4306

Eating disorders

3096

23552

1.83

87.84

3.8

2.9

65.00

66.08

ug/l

0.11

2913

22261

Thyroiditis, ILD-related definition

2695

19689

1.80

87.60

3.7

2.8

96.97

94.29

ug/l

0.30

2500

18390

Pregnancy examination and test

4975

24899

1.60

87.51

3.2

2.8

56.47

62.81

ug/l

1.85

4705

23805

Spondylopathies (FG)

3090

22795

1.67

87.32

3.2

2.7

115.04

112.11

ug/l

0.18

2912

21395

Other enthesopathies

6306

50868

1.41

87.31

3.0

2.7

110.03

126.44

ug/l

7.19

5869

47406

Alcoholic liver disease

1756

11550

1.96

87.16

3.6

2.8

291.64

172.69

ug/l

11.86

1614

10606

12849

98856

1.27

87.01

3.1

2.8

170.95

136.39

ug/l

17.54

11714

92173

Asthma and allergy, excluding more controls

3487

26006

1.64

87.00

3.2

2.6

78.82

76.37

ug/l

0.29

3343

24629

Disorders of vestibular function (Vertigo)

9263

77307

1.33

86.70

3.0

2.9

122.21

131.95

ug/l

2.18

8414

71059

Faecal incontinence

1788

11964

1.98

85.88

3.3

2.6

111.61

116.65

ug/l

0.28

1613

10922

Substance abuse

12309

100936

1.27

85.52

3.1

2.8

156.00

135.15

ug/l

7.01

11196

94263

Seronegative rheumatoid arthritis

2379

16784

1.78

85.50

3.1

2.7

138.34

126.82

ug/l

1.05

2211

15435

Chronic ulcer of skin, not elsewhere classified

1314

8188

2.23

85.49

4.9

2.7

162.92

146.89

ug/l

1.52

1234

7473

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

3496

25580

1.62

85.40

4.6

2.8

138.67

109.73

ug/l

1.27

3329

23954

Mental and behavioural disorders due to psychoactive substance use

12736

103464

1.26

84.72

3.1

2.8

156.82

133.85

ug/l

8.62

11569

96661

Other symptoms and signs involving the urinary system

1974

13462

1.88

84.65

3.4

2.8

136.22

147.99

ug/l

1.09

1868

12393

Postprocedural endocrine and metabolic disorders, not elsewhere classified

2683

19591

1.76

84.64

3.6

2.7

118.59

98.94

ug/l

3.85

2500

18290

Supervision of high-risk pregnancy

5984

29541

1.50

84.58

3.1

2.8

61.08

70.73

ug/l

7.90

5675

28238

Thoracic aortic aneurysm

2328

16315

1.76

84.53

3.3

2.7

182.29

185.36

ug/l

0.14

2121

14846

In situ neoplasms

7337

57776

1.38

84.19

3.2

2.9

119.68

104.24

ug/l

8.68

6674

53251

Sicca syndrome [Sjögren]

1846

12649

2.01

83.96

3.4

2.8

119.34

108.09

ug/l

0.87

1700

11684

Asthma and allergy

3486

26162

1.62

83.50

3.2

2.6

78.84

77.75

ug/l

0.11

3342

24786

Glucosamine medication

9215

61649

1.32

83.07

2.9

2.8

134.94

150.84

ug/l

5.43

8203

55765

Ulcerative proctitis

1432

9358

2.24

82.75

3.9

2.7

97.92

109.73

ug/l

1.30

1359

8758

IgA nephropathy (IgA glomerulonephritis)

582

2935

4.02

82.71

8.4

2.7

195.28

138.67

ug/l

7.57

573

2730

Abnormal results of function studies

1787

12142

1.98

82.30

3.8

2.8

149.93

119.82

ug/l

2.35

1630

11276

Maternal care for other conditions predominantly related to pregnancy

5789

47087

1.50

82.11

3.4

2.9

61.71

66.84

ug/l

2.05

5464

45066

Carcinoma in situ of skin of other and unspecified parts of face

1351

8512

2.13

82.10

3.6

2.8

146.42

139.96

ug/l

0.50

1200

7579

Abnormal involuntary movements

2682

19596

1.72

81.88

3.2

2.8

114.82

124.02

ug/l

1.69

2486

18126

Other diseases of oesophagus

1801

12068

1.89

81.70

3.6

2.7

135.78

148.67

ug/l

1.20

1625

11036

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

7225

60148

1.39

81.61

3.3

2.9

92.90

93.95

ug/l

0.12

6673

56914

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

9164

52525

1.31

81.36

3.1

2.8

154.17

132.96

ug/l

7.80

8256

47843

Other (seronegative) rheumatoid arthritis, wide

3802

29228

1.56

81.16

3.3

2.8

144.63

125.92

ug/l

2.82

3528

26855

Chronic periodontitis, complicated

1753

11819

1.95

80.78

5.7

2.7

223.06

151.09

ug/l

14.09

1664

10923

Poisoning by drugs, medicaments and biological substances

5556

44962

1.45

80.52

3.2

2.8

107.54

101.17

ug/l

0.73

5100

42429

Hypopituitarism

1408

9073

2.12

80.33

3.5

2.8

132.16

130.56

ug/l

0.10

1348

8507

Viral hepatitis, IBD co-morbidity

1183

7172

2.17

80.07

3.2

2.3

124.93

106.97

ug/l

1.72

1086

6823

Injuries to the knee and lower leg

29977

155953

1.17

79.93

3.0

2.9

121.60

115.95

ug/l

2.02

27820

145412

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

8809

50710

1.32

79.71

3.1

2.8

154.37

133.22

ug/l

4.64

7917

46132

Erosion of teeth, including avohilmo

4708

36240

1.50

79.54

3.5

2.7

99.51

100.60

ug/l

0.13

4373

34183

Other necrotizing vasculopathies

1385

8938

2.14

79.53

4.6

2.8

182.01

133.85

ug/l

6.60

1297

8161

Fungal Sepsis

793

4443

2.92

79.34

5.5

2.6

251.29

135.84

ug/l

6.33

736

4043

Post-traumatic stress disorder

2255

16494

1.93

79.31

3.6

2.8

69.58

68.91

ug/l

0.07

2119

15686

Type 1 diabetes, wide definition

4881

38676

1.46

79.22

4.7

2.7

135.00

116.47

ug/l

6.26

4542

36259

Ulcerative ileocolitis

976

5856

2.65

79.19

4.6

2.7

100.52

115.85

ug/l

0.67

920

5502

Presence of other devices

4182

32337

1.49

79.11

2.9

2.7

141.71

142.65

ug/l

0.08

3948

29341

Maternal care for other known or suspected fetal problems

7343

39808

1.44

79.00

3.3

2.9

53.10

60.38

ug/l

8.68

6956

38227

Acute pancreatitis (for exclusion)

3667

27964

1.54

79.00

3.6

2.8

172.26

150.00

ug/l

2.63

3363

25736

Postmenopausal atrophic vaginitis

5064

24067

1.46

78.93

2.7

97.66

117.43

ug/l

10.31

4731

22190

Hydronephrosis

2149

15087

1.79

78.92

3.9

2.6

199.65

125.89

ug/l

13.97

2014

13790

Misadventures to patients during surgical and medical care

2835

21021

1.68

78.91

3.9

2.8

139.48

123.42

ug/l

2.05

2665

19471

Recurring oral aphthae, including avohilmo

2863

21359

1.69

78.87

3.4

2.9

124.77

110.75

ug/l

1.17

2655

19811

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

8964

51609

1.31

78.70

3.0

2.8

152.76

132.80

ug/l

4.33

8064

46986

TMD related operations

3675

28453

1.59

78.68

3.2

2.8

95.72

104.91

ug/l

2.07

3492

26795

Other malignant neoplasms of skin (=non-melanoma skin cancer)

9905

66169

1.29

78.38

3.1

2.9

159.15

154.45

ug/l

0.48

8846

59831

Diabetes mellitus in pregnancy

9833

55105

1.36

78.07

3.4

2.9

58.74

62.95

ug/l

4.06

9330

52836

Urticaria

6906

57400

1.39

77.96

3.4

2.9

109.66

98.03

ug/l

2.06

6431

53913

Postpartum care and examination

4432

22722

1.60

77.64

3.3

2.8

54.07

61.02

ug/l

4.32

4116

21746

Parodontitis and operation codes

18526

127955

1.21

77.45

3.2

2.8

145.13

130.24

ug/l

7.67

16880

119149

Adalimumab

1987

14027

1.89

77.25

3.7

2.8

116.41

105.60

ug/l

0.75

1917

13219

Early onset COPD, excluding more controls

3629

27482

1.51

77.09

3.4

2.5

145.21

145.79

ug/l

0.04

3317

25263

Emotionally unstable personality disorder

3239

25028

1.68

76.82

3.4

2.9

82.05

78.05

ug/l

0.30

2974

23794

Other benign neoplasms of skin

7229

58785

1.35

76.78

3.1

2.8

127.42

115.04

ug/l

3.32

6643

54116

Colonic or urogenital fistula

5413

43674

1.42

76.57

3.3

2.8

133.24

133.13

ug/l

0.01

5003

40526

Haemorrhage, not elsewhere classified

757

4167

2.80

76.56

5.1

2.6

179.97

130.89

ug/l

2.70

703

3779

Maternal care related to the fetus and amniotic cavity and possible delivery problems

12184

62553

1.30

76.51

3.0

2.8

66.34

76.23

ug/l

10.76

11531

59391

Diseases of salivary glands

3946

30617

1.51

76.49

3.1

2.7

117.33

120.48

ug/l

0.38

3670

28514

Cervicocranial syndrome

2273

16303

1.76

76.23

3.3

2.7

104.74

116.64

ug/l

1.91

2152

15138

Pain associated with micturition

2386

17323

1.74

75.95

3.4

2.8

108.04

116.33

ug/l

1.18

2180

16038

Implicit fungal Sepsis

733

4079

3.00

75.57

5.4

2.6

239.00

136.03

ug/l

5.61

681

3724

Mental and behavioural disorders due to alcohol

10469

87138

1.27

75.44

3.0

2.8

165.34

141.26

ug/l

7.71

9519

81241

Myocarditis

940

5421

2.32

75.38

4.9

2.3

140.64

134.82

ug/l

0.27

900

5023

Poisoning by medicine

5026

40556

1.46

75.32

3.2

2.9

106.76

99.39

ug/l

0.90

4622

38289

Familial hypercholesterolemia

2735

20027

1.62

75.18

3.4

2.6

158.55

161.68

ug/l

0.19

2502

18017

Psychotic depression

1330

8541

2.08

75.14

3.2

2.7

102.44

113.61

ug/l

1.12

1225

8028

Other skin changes

3222

24475

1.59

75.09

3.8

2.8

144.67

132.94

ug/l

1.18

2992

22455

Cystic kidney disease

742

4187

3.06

75.09

9.0

2.7

202.93

126.15

ug/l

17.91

732

3891

Other postsurgical states

1271

8149

2.17

74.92

3.9

2.7

110.18

125.23

ug/l

0.66

1206

7547

Polyp of the female genital tract

7458

36087

1.36

74.92

3.0

2.7

92.35

96.11

ug/l

0.85

6928

33645

Sulfonylureas

6290

40749

1.36

74.79

4.0

2.7

133.74

178.07

ug/l

29.16

5664

36530

Thyrotoxicosis

5357

43532

1.44

74.71

3.3

2.8

104.24

107.65

ug/l

0.61

4970

40421

Bacterial pneumoniae

8241

61167

1.31

74.64

3.7

2.7

167.58

126.94

ug/l

6.71

7792

56167

Tinnitus

4511

35750

1.46

74.41

2.9

2.8

125.71

135.12

ug/l

0.66

4152

33171

Other disorders of bladder

2169

15398

1.74

74.11

3.3

2.8

143.86

155.94

ug/l

1.32

1879

14091

Diseases of inner ear

10756

90667

1.27

73.95

3.0

2.9

125.75

134.90

ug/l

2.19

9788

83424

Umbilical hernia

5127

41174

1.42

73.93

3.5

2.8

142.59

148.08

ug/l

0.63

4791

38302

Benign paroxysmal vertigo

5511

44796

1.41

73.88

3.1

2.9

119.14

129.45

ug/l

2.02

4978

41175

Aortic aneurysm

3817

28841

1.48

73.28

3.3

2.7

185.44

182.18

ug/l

0.22

3465

26008

Coxarthrosis, primary, with hip surgery

8236

65672

1.31

72.74

2.9

146.47

156.90

ug/l

2.79

7465

59395

Acute gastritis

1471

9711

1.96

72.58

3.8

2.6

124.41

138.29

ug/l

0.85

1384

8928

Traumatic subdural haemorrhage

2153

14871

1.68

72.21

3.2

2.7

176.62

171.17

ug/l

0.27

1924

13493

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

5184

41946

1.42

72.09

3.0

2.8

136.44

127.12

ug/l

1.55

4850

38506

Blepharochalasis

5235

42297

1.41

71.95

3.0

2.8

128.11

142.57

ug/l

2.70

4726

38508

Seropositive rheumatoid arthritis, wide

5317

43137

1.41

71.83

3.1

2.8

135.88

127.31

ug/l

1.40

4979

39563

Acquired haemolytic anaemia

552

2874

3.70

71.69

6.4

2.7

410.11

130.25

ug/l

5.63

528

2628

Diabetic retinopathy

6282

32744

1.40

71.48

4.6

3.3

151.05

139.47

ug/l

3.11

5720

30137

Nephrotic syndrome

706

3964

3.00

71.47

9.2

2.8

208.67

133.24

ug/l

9.97

686

3661

Supplementary factors related to causes of morbidity and mortality classified elsewhere

6380

52818

1.37

71.25

3.3

2.9

130.02

120.17

ug/l

1.02

5925

49200

Parodontitis or operation codes

19753

130316

1.19

71.24

3.2

2.8

147.33

129.33

ug/l

11.14

18013

121316

Malignant neoplasm of skin

11392

73967

1.25

70.85

3.0

2.9

157.68

152.24

ug/l

0.66

10195

67152

Hallux valgus (acquired)

7041

42251

1.34

70.74

2.8

2.7

110.75

123.92

ug/l

3.77

6431

39025

Bacterial pneumonia, not elsewhere classified

7764

57576

1.32

70.72

3.7

2.7

165.43

127.31

ug/l

5.55

7358

52802

Zoster [herpes zoster]

3298

25280

1.55

70.66

3.8

2.8

173.12

132.09

ug/l

4.19

3031

23093

Other/unspecified seropositive rheumatoid arthritis

5250

42623

1.41

70.47

3.0

2.8

136.31

127.45

ug/l

1.45

4914

39102

Other diseases of pancreas

1381

9105

2.01

70.43

3.6

2.7

162.80

147.42

ug/l

1.31

1266

8312

Osteomyelitis

1204

7694

2.12

70.35

5.9

2.8

173.37

148.98

ug/l

2.91

1129

7060

Parodontitis

19719

130279

1.19

70.33

3.2

2.8

147.36

129.34

ug/l

11.13

17982

121280

Chronic hepatitis, not elsewhere classified

765

4435

2.85

70.33

3.8

2.7

209.73

113.06

ug/l

5.72

722

4103

Injuries to the shoulder and upper arm

18035

134839

1.20

70.22

3.0

2.8

136.02

130.80

ug/l

1.49

16579

125057

Elevated blood glucose level

1641

11280

1.91

70.18

4.2

2.8

152.03

127.02

ug/l

1.91

1528

10428

Chronic periodontitis, including avohilmo

19624

130134

1.19

70.08

3.2

2.8

147.56

129.41

ug/l

11.19

17896

121139

Ischaemic Stroke, excluding all haemorrhages

10211

66042

1.27

70.05

3.4

2.8

157.22

158.87

ug/l

0.10

9247

59915

Malignant neoplasm of bronchus and lung

1637

22460

0.60

69.54

2.5

2.9

243.14

166.61

ug/l

11.00

1466

20068

ILD, hospital admission 2, with pulmonary infections

1661

11322

1.84

69.38

3.6

2.7

216.18

146.43

ug/l

9.11

1536

10244

Benign neoplasm: Descending colon

1179

7531

2.13

69.10

4.0

2.8

134.60

139.10

ug/l

0.29

1120

6860

Malignant neoplasm of respiratory system and intrathoracic organs

2012

26105

0.63

69.08

2.5

2.9

251.47

164.90

ug/l

14.14

1818

23385

Diseases of peritoneum

1955

13871

1.78

69.01

6.0

2.8

173.93

134.00

ug/l

8.39

1855

12792

Adenomyosis (Endometriosis of uterus)

2816

21305

1.62

68.68

3.2

2.7

92.52

103.23

ug/l

1.96

2619

19732

Allergic rhinitis

7576

63611

1.34

68.45

3.0

2.9

91.82

90.68

ug/l

0.09

7152

60120

Other general symptoms and signs

1171

7518

2.21

68.04

3.6

2.6

96.46

91.02

ug/l

0.48

1071

7031

Other diseases of arteries and capillaries

1728

12004

1.83

67.97

5.1

2.7

133.32

135.16

ug/l

0.13

1618

10985

Other and unspecified effects of external causes

6192

51586

1.37

67.52

3.3

2.9

106.34

101.59

ug/l

0.78

5767

48487

Presbycusis

2331

16791

1.62

67.26

3.1

2.9

168.46

155.27

ug/l

0.42

1921

14967

Other disorders of glucose regulation and pancreatic internal secretion

1705

11884

1.85

67.25

4.8

2.8

137.35

121.88

ug/l

1.92

1584

11000

Chronic nephritic syndrome

831

4937

2.54

67.14

8.1

2.7

221.39

142.29

ug/l

14.40

811

4551

Other eating disorders

1541

11079

2.24

66.94

3.9

2.8

55.73

55.78

ug/l

0.01

1455

10488

Obsessive-compulsive disorder

1674

11865

1.95

66.72

3.4

2.7

68.45

75.46

ug/l

1.70

1568

11250

Multiple myeloma, excluding all cancers (controls excluding all cancers)

854

5066

2.41

66.62

4.0

2.8

319.32

140.94

ug/l

14.67

805

4581

Postprocedural disorders of digestive system, not elsewhere classified

693

3943

2.87

66.54

5.1

2.7

137.84

131.75

ug/l

0.19

661

3619

Ulcer of oesophagus

1243

8038

2.00

66.27

3.9

2.7

127.02

166.98

ug/l

6.38

1150

7320

Mixed and other personality disorders

1835

13140

1.85

66.22

3.5

2.8

93.70

102.34

ug/l

1.61

1682

12438

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1888

13512

1.80

66.06

4.3

2.8

177.24

126.92

ug/l

6.92

1772

12500

Diseases of the myoneural junction and muscle

2196

15991

1.68

65.91

3.4

2.9

165.21

140.88

ug/l

3.14

1986

14690

Cholangitis (primary sclerosing, PSC), with reimbursement 202

458

2314

4.14

65.73

4.7

2.8

108.95

108.54

ug/l

0.01

445

2156

Fracture of femur

4592

33449

1.40

65.68

3.2

2.8

170.07

144.86

ug/l

5.63

4102

30073

427

8685

0.41

65.54

2.7

2.9

379.42

182.90

ug/l

4.37

379

7900

Endometriosis of ovary

3961

31550

1.49

65.51

3.1

2.7

82.28

87.63

ug/l

0.67

3718

29601

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

7281

61419

1.35

65.41

3.3

2.9

90.96

79.17

ug/l

0.91

6862

58311

Arthropathies in other diseases classified elsewhere

763

4450

2.60

65.36

6.5

2.6

148.93

137.95

ug/l

0.65

712

4141

Later onset COPD, excluding more controls

3498

21011

1.48

65.24

3.4

2.6

170.80

151.77

ug/l

1.90

3137

18633

Methotrexate

3009

23047

1.55

65.03

3.2

2.7

123.82

113.46

ug/l

1.18

2806

21299

Congenital malformations of the urinary system

1267

8490

2.11

64.89

7.0

2.8

159.86

107.05

ug/l

18.01

1235

7896

Intestinal malabsorption

987

6243

2.35

64.84

4.4

2.7

135.19

116.02

ug/l

1.08

914

5782

Testicular dysfunction

639

3449

2.64

64.80

3.2

2.6

161.68

205.65

ug/l

3.97

600

3240

Testicular hypofunction

575

2997

2.80

64.75

3.2

2.5

163.08

210.92

ug/l

3.92

542

2821

Radiculopathy

3085

23585

1.52

64.47

3.2

2.8

131.60

145.35

ug/l

0.70

2810

21591

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1831

13108

1.81

64.46

3.8

2.7

147.75

111.11

ug/l

3.62

1729

12170

Stroke, excluding SAH

10884

69973

1.24

64.34

3.4

2.8

161.41

157.54

ug/l

0.27

9866

63592

Multiple myeloma and malignant plasma cell neoplasms

843

5032

2.38

64.30

4.0

2.8

322.78

141.10

ug/l

14.81

794

4548

In situ neoplasms

7337

62200

1.32

64.24

3.2

2.9

119.68

119.98

ug/l

0.04

6674

57118

Other viral diseases

6679

56062

1.34

64.22

3.7

2.8

129.61

100.28

ug/l

9.42

6321

52826

Acute peritonitis

1203

7848

2.04

64.21

7.7

2.8

210.73

145.86

ug/l

11.01

1153

7188

Extreme obesity with alveolar hypoventilation

816

4902

2.51

63.79

4.4

2.7

120.48

137.63

ug/l

1.56

727

4533

Phlebitis and thrombophlebitis (not including DVT)

4321

34689

1.43

63.69

3.5

2.8

146.37

132.99

ug/l

1.50

4002

31990

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

10261

60384

1.25

63.62

3.1

2.8

152.93

130.02

ug/l

9.74

9284

55265

Female genital prolapse

6505

31216

1.35

63.49

2.9

2.7

93.75

103.82

ug/l

2.71

6027

28940

Psoriatic and enteropathic arthropathies

2319

17128

1.64

63.45

3.4

2.7

128.73

123.96

ug/l

0.43

2179

15968

Carcinoma in situ of skin of other and unspecified parts of face

1351

9066

1.95

63.37

3.6

2.8

146.42

154.41

ug/l

0.62

1200

8072

Other complications of surgical and medical care, not elsewhere classified

2002

14580

1.74

63.23

3.8

2.7

144.62

111.59

ug/l

2.93

1892

13554

Superficial injury of lower leg

5287

43556

1.39

63.05

3.4

2.8

115.16

108.60

ug/l

0.28

4884

40606

Redundant prepuce, phimosis and paraphimosis

3179

24043

1.46

62.90

3.0

2.7

176.17

196.55

ug/l

2.23

2941

22581

Contact with and exposure to communicable diseases

8130

69741

1.31

62.89

3.1

2.9

86.47

81.02

ug/l

1.57

7541

66333

Polycythaemia vera

676

3837

2.68

62.63

3.7

2.7

117.26

136.06

ug/l

0.96

635

3464

Special screening examination for other diseases and disorders

1830

13001

1.74

62.43

3.6

2.5

114.79

113.75

ug/l

0.07

1742

12050

Type of accident

5816

48352

1.36

62.22

3.2

2.9

129.80

120.58

ug/l

0.83

5404

44989

Cytomegalovirus infection, IBD co-morbidity

506

2688

3.54

62.16

7.4

2.7

337.85

127.43

ug/l

10.54

498

2490

Diagnoses used for exclusion with ILD

4673

37785

1.39

62.15

3.6

2.8

158.71

145.65

ug/l

1.15

4288

34666

Benign neoplasm of other and unspecified endocrine glands

2367

17665

1.63

62.01

3.4

2.8

130.84

116.13

ug/l

1.64

2201

16326

Other inflammatory liver diseases

1313

8868

1.99

61.91

4.0

2.7

222.58

120.75

ug/l

6.09

1252

8192

Diseases of external ear

6640

55854

1.33

61.86

3.2

2.9

124.82

128.01

ug/l

0.35

5945

51833

Adrenocortical insufficiency

780

4723

2.63

61.81

4.5

2.7

136.06

113.22

ug/l

1.97

737

4366

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

1953

13957

1.67

61.67

3.6

2.9

169.78

146.10

ug/l

3.23

1752

12455

Retinal detachments and breaks

6225

51881

1.33

61.30

3.3

2.8

144.35

154.27

ug/l

1.98

5685

47425

Enthesopathies of lower limb, excluding foot

4442

35877

1.41

61.25

3.2

2.7

109.57

125.92

ug/l

4.77

4128

33474

Adverse effects, not elsewhere classified

4380

35701

1.45

61.25

3.4

2.9

101.48

98.30

ug/l

0.36

4099

33498

Social phobias

2041

15088

1.74

61.14

3.1

2.7

79.96

80.59

ug/l

0.07

1882

14315

Chronic laryngitis and laryngotracheitis

2684

20403

1.57

61.00

3.4

2.8

118.54

133.55

ug/l

2.80

2408

18855

Speech therapy

5190

42746

1.38

60.74

3.3

2.9

133.98

130.81

ug/l

0.28

4973

39352

Papulosquamous disorders

7694

65573

1.29

60.53

3.1

2.8

136.74

132.14

ug/l

0.63

7101

60770

Wet age-related macular degeneration

2821

21094

1.53

60.51

3.3

2.9

150.11

154.57

ug/l

0.31

2463

18756

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

2248

16558

1.61

60.48

3.3

2.8

374.00

137.43

ug/l

25.15

2093

15072

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

14161

103255

1.22

60.43

3.0

2.9

93.79

96.37

ug/l

0.74

13310

97025

Other and unspecified disorders of vitreous body

7197

60673

1.30

60.18

3.0

2.8

129.69

143.93

ug/l

2.43

6583

55438

Other abnormal findings of blood chemistry

912

5771

2.35

59.90

3.8

2.8

163.34

124.10

ug/l

3.09

868

5325

Preparation and fitting of bite rail to mouth

2915

22693

1.56

59.71

3.2

2.8

95.51

106.19

ug/l

2.07

2794

21374

Familial hypercholesterolemia, with ischemic heart disease

1592

11078

1.77

59.59

3.6

2.7

149.31

174.85

ug/l

3.87

1441

9859

Duodenal ulcer

1814

12819

1.67

59.56

4.0

2.7

173.83

170.06

ug/l

0.12

1655

11581

Delirium, not induced by alcohol and other psychoactive substances

1875

13403

1.68

59.42

3.4

2.9

175.40

156.43

ug/l

1.36

1679

12112

All influenza (not pneumonia)

2951

22722

1.51

59.36

3.8

2.7

139.13

119.46

ug/l

2.08

2741

21146

Atopic dermatitis, strict definition with reimbursement

7676

63968

1.31

59.34

3.1

2.8

84.86

84.05

ug/l

0.16

7240

60561

Pleural effusion

2595

19591

1.55

59.32

4.0

2.8

232.39

157.43

ug/l

20.86

2401

17705

Enteropathic arthropathies

562

3145

3.13

58.73

4.6

2.6

103.04

114.42

ug/l

0.56

544

2945

Other symptoms and signs involving the circulatory and respiratory systems

1280

8609

1.92

58.68

3.6

2.6

125.73

123.10

ug/l

0.17

1184

7988

Acute posthaemorrhagic anaemia

683

3931

2.50

58.63

5.5

2.5

167.27

134.24

ug/l

1.71

626

3547

Gestational diabetes (for exclusion)

10567

66281

1.29

58.59

3.3

2.9

58.61

63.99

ug/l

7.09

9969

63481

Other shoulder lesions

1921

14017

1.71

58.51

3.3

2.7

115.61

118.40

ug/l

0.16

1777

13085

Cytomegaloviral disease

522

2861

3.29

58.41

7.3

2.7

329.57

125.30

ug/l

10.56

514

2651

Other respiratory diseases principally affecting the interstitium

2996

23182

1.50

57.88

3.7

2.9

204.54

154.39

ug/l

9.27

2762

20984

ILD, hospital admissions

2485

18779

1.57

57.62

3.4

2.9

202.22

156.20

ug/l

7.33

2280

17016

Unspecified privation

2125

15825

1.66

57.40

4.0

2.8

122.57

124.12

ug/l

0.12

2004

14683

Dysplasia of cervi uteri

6182

40483

1.35

57.03

2.9

2.7

73.75

76.80

ug/l

0.79

5833

38242

Primary biliary cholangitis (PBC)

486

2596

3.26

56.95

3.9

2.5

125.23

106.95

ug/l

0.89

455

2385

DVT of lower extremities

3447

27232

1.45

56.84

3.4

2.8

160.06

144.77

ug/l

1.44

3160

24899

Superficial injury of hip and thigh

2755

21189

1.53

56.70

3.4

2.8

151.22

124.85

ug/l

1.53

2498

19420

Seborrhoeic keratosis

3877

31107

1.42

56.57

3.4

2.7

132.32

144.10

ug/l

2.00

3586

28345

Primary coxarthrosis, bilateral

4841

39714

1.36

56.49

3.0

2.9

142.77

157.95

ug/l

3.81

4391

35865

Other and unspecified mood [affective] disorders

1736

12696

1.80

56.37

3.2

2.7

85.87

81.65

ug/l

0.59

1625

12052

Supervision of normal pregnancy

6360

30968

1.37

56.33

2.9

2.8

58.52

69.35

ug/l

7.75

5995

29576

Ankylosing spondylitis

1797

12989

1.70

56.23

3.3

2.7

112.72

130.52

ug/l

3.39

1696

12166

Abnormal findings on diagnostic imaging of other body structures

2417

18410

1.59

56.22

3.4

2.8

153.21

121.22

ug/l

3.01

2275

16981

Neuromuscular dysfunction of bladder

1691

12119

1.73

55.99

3.6

2.7

126.72

137.16

ug/l

1.06

1560

11195

Outcome of delivery

4882

25284

1.44

55.98

3.1

2.8

53.59

65.88

ug/l

7.05

4706

24207

Other specified/unspecified bacterial intestinal infections

1262

8625

1.94

55.89

3.9

2.8

117.93

127.28

ug/l

0.65

1182

7939

Injuries to the neck

4890

40524

1.38

55.88

3.2

2.9

107.94

109.39

ug/l

0.16

4559

38032

Other and unspecified nerve root and plexus disorders, also in other diseases

3583

28585

1.45

55.85

3.0

2.8

115.17

132.05

ug/l

4.13

3355

26670

Other and unspecified drugs and medicaments

1674

12122

1.78

55.75

3.8

2.8

150.76

114.89

ug/l

3.21

1584

11225

Ulcerative enterocolitis

737

4516

2.55

55.66

4.9

2.7

97.74

116.41

ug/l

1.43

691

4219

Oesophagitis

1012

6540

2.05

55.63

3.7

2.7

140.19

149.10

ug/l

0.52

939

6004

Fall on same level involving ice and snow

11939

105702

1.22

55.57

3.0

2.8

122.32

122.88

ug/l

0.08

10991

98140

Decubitus ulcer and pressure area

1005

6470

2.03

55.28

5.1

2.7

201.37

153.33

ug/l

4.89

901

5821

Stroke, including SAH

11511

74798

1.22

55.24

3.4

2.8

160.27

155.76

ug/l

0.35

10443

68148

Gout due to impairment of renal function

252

1060

6.32

55.23

10.0

2.6

281.91

163.46

ug/l

8.02

246

965

Other disorders of white blood cells

1093

7301

2.06

55.19

4.2

2.8

195.34

126.02

ug/l

2.45

1014

6724

Other disorders of eye and adnexa

2887

22658

1.53

55.08

3.4

2.9

104.42

ug/l

0.00

2704

21142

Bacterial pneumonia (organism specified)

8719

68597

1.25

55.06

3.7

2.8

175.74

136.20

ug/l

6.18

8235

62756

Other and unspecified myopathies

1494

10488

1.78

54.95

3.4

2.8

174.76

147.82

ug/l

2.64

1326

9575

Impingement syndrome of shoulder

4477

36482

1.37

54.85

3.0

2.7

131.00

151.59

ug/l

5.53

4145

33824

Benign neoplasm: Descending colon

1179

7960

1.96

54.82

4.0

2.8

134.60

154.15

ug/l

2.19

1120

7255

Maternal care for known or suspected abnormality of pelvic organs

6886

41008

1.35

54.80

3.2

2.9

60.65

67.72

ug/l

2.96

6596

39262

Vitamin deficiency, wide

991

6484

2.12

54.67

4.4

2.7

126.61

117.59

ug/l

0.56

933

5983

Vitamin deficiency

991

6484

2.12

54.67

4.4

2.7

126.61

117.59

ug/l

0.56

933

5983

Hepatic failure, not elsewhere classified

707

4245

2.46

54.64

4.7

2.7

394.07

138.73

ug/l

5.81

675

3883

Vitreous haemorrhage

1792

13028

1.69

54.56

5.2

2.8

180.01

143.84

ug/l

4.83

1666

11969

Glaucoma

10267

78823

1.23

54.26

3.0

2.9

139.91

147.63

ug/l

2.07

9215

71792

Open wound of lower leg

2812

21894

1.51

54.06

3.5

2.8

148.43

125.26

ug/l

0.62

2581

20280

Other coagulation defects

1559

11281

1.83

54.03

4.3

2.8

111.91

100.66

ug/l

0.89

1474

10533

Amenorrhoea

1946

14811

1.78

53.87

3.6

2.8

66.07

61.47

ug/l

0.85

1852

14074

Fracture of shoulder and upper arm

6820

57984

1.29

53.76

3.1

2.8

137.31

131.03

ug/l

0.77

6243

53406

Transport accidents

10862

84771

1.22

53.76

3.0

2.8

114.00

112.09

ug/l

0.13

10169

79876

Contraceptive management

9169

56031

1.25

53.72

2.9

2.7

94.16

114.03

ug/l

14.49

8762

53021

Other disorders of the musculoskeletal system and connective tissue

2649

20480

1.53

53.69

3.2

2.8

125.34

135.06

ug/l

1.52

2469

18884

Interstitial lung disease

2499

19085

1.54

53.64

3.4

2.9

201.82

156.05

ug/l

7.34

2294

17286

Interstitial lung disease endpoints

2499

19085

1.54

53.64

3.4

2.9

201.82

156.05

ug/l

7.34

2294

17286

Other specified and unspecified personality disorders

2035

15322

1.67

53.61

3.6

2.8

98.03

102.22

ug/l

0.35

1890

14465

Left ventricular outflow tract obstruction (LVOTO), broad definition

1803

13139

1.67

53.58

3.8

2.8

165.03

146.67

ug/l

0.28

1710

12328

Disorders of ocular muscles, binocular movement, accommodation and refraction

10648

93253

1.23

53.55

3.2

2.9

103.48

105.05

ug/l

0.25

9914

87514

Other interstitial pulmonary diseases

2499

19090

1.53

53.55

3.4

2.9

201.82

155.94

ug/l

7.38

2294

17284

Other benign neoplasms of skin

7229

61942

1.28

53.54

3.1

2.9

127.42

131.64

ug/l

0.58

6643

56923

Keratitis

7149

61233

1.29

53.54

3.2

2.8

120.00

123.15

ug/l

0.50

6680

56978

Colitis, primary sclerosing

349

1718

4.32

53.44

4.7

2.7

109.65

112.98

ug/l

0.10

340

1606

Other abnormal uterine and vaginal bleeding

4984

29441

1.37

53.36

3.2

2.7

98.56

99.43

ug/l

0.09

4461

27206

Fibroblastic disorders

4231

34336

1.37

53.29

3.2

2.8

145.02

152.97

ug/l

0.80

3901

31519

Hypoglycaemia, other or unspecified

1347

9396

1.85

53.29

4.8

2.8

138.17

121.26

ug/l

1.86

1255

8705

Other noninflammatory disorders of vulva and perineum

2096

15915

1.66

52.82

3.3

2.7

80.54

83.87

ug/l

0.38

1971

14902

Other disorders of adrenal gland

959

6345

2.18

52.72

4.4

2.7

129.92

105.75

ug/l

2.75

908

5877

Immunodeficiencies

1013

6766

2.12

52.69

4.8

2.8

160.68

108.37

ug/l

3.02

973

6289

ILD, hospital admissions 3, with pneumonia sepsis

1383

9626

1.78

52.34

3.7

2.7

230.31

148.28

ug/l

9.12

1281

8688

Anosmia

425

2087

2.77

51.83

3.3

1.8

119.23

111.91

ug/l

0.29

395

1927

Multiple myeloma and malignant plasma cell neoplasms

843

5347

2.18

51.77

4.0

2.8

322.78

154.88

ug/l

12.74

794

4817

COPD

7778

55058

1.26

51.57

3.4

2.8

160.18

167.29

ug/l

0.90

7021

49871

Inflammatory disease of uterus

3517

28837

1.49

51.34

3.4

2.9

72.26

74.06

ug/l

0.28

3321

27231

Other enthesopathy of foot (+metatarsalgia)

2051

15454

1.62

51.02

3.2

2.7

97.70

112.66

ug/l

3.31

1890

14363

Inflammatory diseases of prostate (prostatitis)

1961

14391

1.57

50.98

2.8

171.26

211.26

ug/l

6.47

1791

13305

Other and unspecified local infections of skin and subcutaneous tissue

1802

13307

1.67

50.96

4.4

2.8

133.73

125.64

ug/l

0.69

1702

12339

Aortic valve malfunction, age under 60 years

1636

11822

1.69

50.92

3.8

2.8

171.45

154.13

ug/l

0.23

1551

11088

Other local infections of skin and subcutaneous tissue

1902

14166

1.64

50.56

4.3

2.8

134.50

126.75

ug/l

0.64

1793

13129

Injuries to the elbow and forearm

15499

126460

1.18

50.50

3.0

2.8

112.81

114.97

ug/l

0.55

14259

117686

Benign neoplasm: Small intestine

731

4514

2.31

50.50

4.8

2.7

105.60

129.40

ug/l

2.81

681

4109

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3736

30535

1.43

50.49

3.3

2.9

106.97

97.05

ug/l

1.08

3414

28938

ILD, hospital admissions 1, main diag only

2195

16626

1.56

50.40

3.4

2.9

200.87

154.84

ug/l

6.52

2010

15058

Varicose veins

12774

85970

1.20

50.10

3.0

2.8

130.11

134.97

ug/l

1.07

11742

79038

Charcot foot

368

1847

3.48

50.03

7.6

2.4

187.82

161.65

ug/l

1.14

349

1705

Parkinson's disease, excluding more controls

2116

15342

1.53

49.97

2.7

144.41

174.00

ug/l

6.95

1881

13916

Non-follicular lymphoma, hilmo, excluding all cancers

1547

11073

1.70

49.96

3.2

2.8

400.60

139.31

ug/l

21.60

1440

10098

Artificial joint re-operation

1190

8203

1.88

49.85

3.3

2.8

145.34

143.22

ug/l

0.09

1089

7420

Metatarsalgia

1902

14229

1.64

49.77

3.2

2.7

98.69

112.26

ug/l

2.67

1751

13192

Benign neoplasm of other and unspecified endocrine glands

2367

18268

1.55

49.75

3.4

2.8

130.84

128.47

ug/l

0.15

2201

16900

Hypertrophy of breast in women and men

4219

34984

1.40

49.61

3.2

2.8

92.49

96.53

ug/l

0.60

3949

32812

Other bursopathies

2341

17889

1.52

49.53

3.3

2.7

140.79

149.98

ug/l

0.78

2145

16435

Melanocytic naevi

6088

51976

1.31

49.36

3.4

2.9

108.33

97.59

ug/l

2.36

5778

48555

Personal history of other diseases and conditions

2725

21640

1.55

49.31

3.6

2.8

80.79

73.83

ug/l

1.40

2531

20494

Problems related to lifestyle

2170

16563

1.58

49.20

3.3

2.6

129.79

109.90

ug/l

1.39

1964

15543

UC patients in KELA-register (code 208), prior to 1994

856

5521

2.12

49.13

4.2

2.7

123.53

146.47

ug/l

2.24

809

5112

Scoliosis

1949

14793

1.65

48.97

3.3

2.8

81.84

87.84

ug/l

0.77

1819

13757

Parkinson's disease, strict definition, excluding more controls

1962

14199

1.55

48.95

2.7

145.33

174.06

ug/l

6.02

1741

12851

Sarcoidosis

2470

19159

1.52

48.89

4.0

2.8

159.27

133.36

ug/l

1.50

2323

17796

Adhesive capsulitis of shoulder

3073

24366

1.44

48.88

3.2

2.7

126.54

142.28

ug/l

2.91

2838

22501

Carcinoma in situ of skin

1292

9034

1.79

48.75

3.6

2.8

142.61

135.74

ug/l

0.55

1179

8152

Thyrotoxicosis with diffuse goitre

2959

23633

1.48

48.59

3.2

2.8

97.97

100.50

ug/l

0.27

2775

22167

Alcohol abuse, main dg, excluding more controls

2764

21638

1.46

48.43

3.0

2.7

135.09

134.48

ug/l

0.03

2542

20396

Trigger finger

2683

21006

1.48

48.38

3.3

2.7

118.49

128.50

ug/l

1.70

2472

19498

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

20355

109878

1.15

48.35

2.9

2.8

178.58

109.81

ug/l

49.17

18974

102665

Malignant neoplasm, wide definition for exclusion

20359

109904

1.15

48.28

2.9

2.8

178.50

109.80

ug/l

49.10

18981

102690

Carbimazole or st.post thyroidectomy, condition for graves disease

4299

35766

1.38

48.26

3.2

2.9

100.51

104.58

ug/l

0.65

3998

33409

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

20357

109895

1.15

48.23

2.9

2.8

178.51

109.80

ug/l

49.11

18979

102683

Colitis, primary sclerosing, strict definition

279

1318

4.95

47.92

4.5

2.6

92.76

102.81

ug/l

0.55

273

1235

Diabetic retinopathy, strict definition

3208

22767

1.46

47.83

5.5

3.3

165.78

139.98

ug/l

6.86

2931

21054

SLE (Finngen)

754

4802

2.29

47.79

4.0

2.6

153.72

93.00

ug/l

7.34

721

4478

Lymphoid leukaemia

961

6353

1.97

47.79

4.0

2.9

330.74

133.11

ug/l

2.50

900

5787

Other inflammation of eyelid

2474

19307

1.52

47.77

3.2

2.8

111.01

120.80

ug/l

1.79

2277

17856

Leisure time condition

3483

28294

1.42

47.55

3.1

2.8

130.14

117.39

ug/l

0.77

3186

26295

Osteonecrosis

1050

7133

1.93

47.40

4.1

2.7

178.40

138.13

ug/l

5.10

993

6538

Iridocyclitis

4400

36541

1.36

47.33

3.3

2.8

133.71

127.76

ug/l

0.49

4122

33958

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

4159

34937

1.42

47.31

3.3

2.9

70.91

71.86

ug/l

0.16

3916

32942

Fracture of foot, except ankle

4977

41882

1.33

47.28

3.2

2.8

108.99

112.34

ug/l

0.57

4626

39286

Suicide or other Intentional self-harm

5299

44864

1.32

47.28

3.2

2.8

110.49

108.01

ug/l

0.23

4828

42267

Other disorders of patella

3768

30859

1.39

47.12

3.0

2.7

102.58

110.03

ug/l

1.27

3521

29084

Drug-induced adrenocortical insufficiency

407

2240

3.55

46.91

4.7

2.8

131.96

110.78

ug/l

1.06

388

2079

Cardiac arrest

1035

5836

1.80

46.79

4.2

2.1

189.77

168.23

ug/l

1.16

973

5221

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

986

6504

1.88

46.76

3.4

2.8

100.99

146.80

ug/l

8.32

921

5885

Other embolism and thrombosis

2344

18125

1.51

46.53

3.8

2.8

143.58

135.33

ug/l

0.84

2173

16619

Flat foot [pes planus] (acquired)

1768

13156

1.62

46.36

3.1

2.6

109.62

121.93

ug/l

1.34

1591

12153

Substance use, excluding alcohol

3892

31967

1.37

46.35

3.2

2.8

119.07

117.94

ug/l

0.07

3508

30097

Other and unspecified diseases of blood and blood-forming organs

523

3055

2.73

46.28

5.1

2.7

176.69

133.92

ug/l

0.95

492

2810

Pericarditis

650

3914

2.23

46.22

4.3

2.5

191.78

151.35

ug/l

3.00

613

3577

Abscess of anal and rectal regions

1564

11379

1.65

45.89

3.5

2.6

143.52

136.91

ug/l

0.38

1472

10641

Disorders of muscles

1929

14562

1.58

45.84

3.3

2.7

141.77

127.24

ug/l

1.20

1832

13522

Conjunctivitis (acute, non atopic)

5847

49876

1.30

45.71

3.3

2.9

105.39

108.57

ug/l

0.52

5472

46704

Secondary right heart disease

755

4797

2.15

45.62

4.9

2.8

129.61

143.83

ug/l

0.82

716

4315

Disorders of oesophagus in diseases classified elsewhere

418

2276

3.03

45.54

4.5

2.6

160.66

145.75

ug/l

0.50

388

2050

Laparoscopic left hemicolectomy

366

1932

3.50

45.51

2.5

2.7

88.67

145.88

ug/l

4.38

350

1759

Lichen simplex chronicus and prurigo

1189

8341

1.82

45.44

3.9

2.7

124.15

131.50

ug/l

0.46

1097

7692

Macular pucker

2347

18222

1.51

45.38

3.1

2.8

152.27

160.73

ug/l

0.76

2096

16478

Other diseases of biliary tract

1480

10729

1.68

45.28

3.7

2.7

185.66

136.60

ug/l

5.14

1384

9765

Diseases of tongue

1200

8434

1.81

45.04

3.1

2.7

118.70

121.03

ug/l

0.14

1097

7810

Hallux rigidus

2384

18467

1.48

44.86

2.8

2.6

120.42

152.01

ug/l

7.73

2148

16886

Other chronic obstructive pulmonary disease, including avohilmo

9297

67967

1.22

44.80

3.3

2.8

155.43

162.15

ug/l

1.02

8392

61857

Other problems related to primary support group, including family circumstances

2752

21615

1.51

44.73

3.7

2.9

85.29

76.44

ug/l

1.30

2603

20495

Alcohol dependence

4770

39869

1.31

44.64

3.1

2.8

170.13

157.86

ug/l

1.27

4343

37064

Pollen allergy

4509

37667

1.36

44.52

3.1

2.9

85.50

80.52

ug/l

0.29

4237

35732

Other and unspecified coagulation defects

1064

7488

1.99

44.51

4.5

2.8

109.37

96.95

ug/l

0.68

1022

7003

Other chronic obstructive pulmonary disease

7410

53285

1.24

44.50

3.4

2.8

157.49

167.52

ug/l

1.49

6687

48225

Other and unspecified urticaria

4218

35303

1.37

44.49

3.4

2.9

112.90

100.24

ug/l

1.41

3926

33124

Diseases of middle ear and mastoid

13999

103806

1.18

44.47

3.2

2.9

101.39

102.14

ug/l

0.06

13098

97565

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

1857

13895

1.56

44.45

3.7

2.8

209.27

145.90

ug/l

12.25

1689

12590

Reactive arthropathies

1704

12680

1.61

44.42

3.2

2.7

147.10

125.78

ug/l

1.25

1609

11828

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

4858

24559

1.30

44.32

2.8

2.9

244.43

182.51

ug/l

13.54

4350

22482

Other and unspecified disorders of white blood cells

802

5266

2.13

44.19

4.1

2.8

216.29

127.22

ug/l

2.28

743

4827

Immunodeficiency with predominantly antibody defects

583

3593

2.59

44.11

5.0

2.7

173.70

108.45

ug/l

2.84

565

3344

Other specified/unspecified inflammatory spondylopathies

1069

7456

1.91

43.93

3.3

2.7

109.23

99.58

ug/l

0.59

1011

7011

Squamous cell neoplasms and carcinomas of the skin

1953

14781

1.54

43.93

3.6

2.9

169.78

160.88

ug/l

0.68

1752

13177

Psoriasis

5391

45837

1.30

43.83

3.2

2.8

142.38

131.90

ug/l

1.47

4985

42610

Superficial injury of abdomen, lower back and pelvis

3063

24773

1.43

43.78

3.3

2.8

108.73

109.50

ug/l

0.06

2811

23113

Other viral diseases, not elsewhere classified

3855

31855

1.37

43.68

3.8

2.9

123.30

105.26

ug/l

2.54

3642

29947

Pyogenic arthritis

1158

8028

1.76

43.66

4.0

2.7

200.07

146.21

ug/l

3.14

1079

7408

Localized swelling, mass and lump of skin and subcutaneous tissue

6069

52158

1.28

43.56

3.2

2.8

135.03

125.84

ug/l

1.09

5680

48304

Covid-19 suspected case

4752

40331

1.34

43.23

3.3

2.8

108.62

92.06

ug/l

5.27

4594

37978

Other pulmonary heart/vessel disease

821

5377

2.02

43.21

4.8

2.8

128.77

142.52

ug/l

0.84

778

4842

Other crystal arthropathies

360

1877

3.09

43.18

3.8

2.6

155.02

156.37

ug/l

0.04

323

1695

Female infertility, associated with anovulation

2278

18269

1.61

43.07

3.3

2.8

54.16

57.22

ug/l

0.84

2166

17458

Carcinoma in situ of other and unspecified digestive organs

463

2639

2.70

43.01

3.6

2.7

129.72

142.19

ug/l

0.54

436

2388

Other/unspecified rheumatoid arthritis

2266

17669

1.50

42.96

3.4

2.8

146.56

128.08

ug/l

1.75

2104

16095

L04AC Interleukin inhibitors

992

6843

1.93

42.90

4.2

2.7

146.30

114.21

ug/l

1.62

963

6434

Diplopia

2388

18783

1.49

42.85

3.2

2.8

132.97

128.11

ug/l

0.34

2210

17381

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

4704

23365

1.31

42.84

2.8

2.9

246.32

183.86

ug/l

12.94

4206

21346

Unspecified mental disorder

8851

78194

1.22

42.82

3.0

2.8

103.83

115.91

ug/l

3.96

8143

73410

Schizophrenia or delusion, excluding more controls

6116

52065

1.27

42.77

2.8

2.7

114.60

117.23

ug/l

0.23

5594

49128

Agranulocytosis

2028

15654

1.55

42.71

3.6

2.8

328.31

121.87

ug/l

22.78

1922

14473

IBD (strict) with PSC

254

1208

4.72

42.60

4.9

2.7

88.23

101.87

ug/l

0.89

249

1133

Crystal arthropathies, rheuma endpoint

360

1887

3.07

42.59

3.8

2.6

155.02

154.11

ug/l

0.03

323

1689

Hypertrophy of breast

3783

31611

1.39

42.53

3.2

2.8

82.31

85.77

ug/l

0.51

3540

29693

Retinal vascular occlusion

1934

14704

1.54

42.48

3.7

2.8

144.47

156.84

ug/l

1.60

1759

13259

Nontoxic multinodular goitre

3608

29679

1.37

42.45

3.0

2.7

105.32

124.39

ug/l

6.53

3308

27162

Excessive vomiting in pregnancy

2081

16513

1.63

42.41

3.4

2.8

68.47

68.77

ug/l

0.04

1930

15683

Sequelae of injuries, of poisoning and of other consequences of external causes

4456

37364

1.33

42.39

3.1

2.8

121.92

132.06

ug/l

1.59

4140

34965

Other specified/unspecified systemic involvement of connective tissue

1200

8635

1.83

42.34

3.6

2.8

113.16

102.20

ug/l

1.03

1135

8042

Lesion of ulnar nerve

2511

19822

1.46

42.24

3.3

2.8

133.64

143.62

ug/l

0.97

2334

18462

Antenatal screening

6498

31907

1.30

42.12

2.9

2.8

59.14

69.35

ug/l

6.62

6190

30459

Heart failure and hypertrophic cardiomyopathy

350

1846

3.24

42.10

5.3

2.7

173.71

164.53

ug/l

0.27

331

1668

Nonalcoholic steatohepatitis

207

925

6.51

41.76

4.4

2.5

223.49

111.49

ug/l

4.67

196

859

Bulimia nervosa (incl. atypical)

1026

7527

2.23

41.74

3.7

2.9

51.21

53.66

ug/l

0.50

968

7131

Postmenopausal osteoporosis with pathological fracture

1029

7167

1.87

41.61

3.6

2.8

124.33

115.23

ug/l

0.38

917

6373

conjunctival haemorrhage

1285

9272

1.72

41.57

3.7

2.8

135.77

142.11

ug/l

0.41

1191

8479

Memory loss

1566

11647

1.63

41.54

3.1

2.8

106.03

148.74

ug/l

18.02

1449

10559

Acidosis

384

2080

2.91

41.46

4.7

2.6

207.30

160.85

ug/l

1.29

354

1899

Carcinoma in situ of skin of trunk

509

2993

2.44

41.23

3.8

2.8

149.57

146.24

ug/l

0.12

454

2679

Atopic dermatitis, strict definition

7292

62917

1.26

41.17

3.2

2.9

83.31

82.79

ug/l

0.09

6893

59609

Mixed connective tissue disease

1319

9703

1.76

41.17

3.6

2.8

116.83

103.46

ug/l

1.04

1243

9026

Spontaneous rupture of synovium and tendon

1421

10383

1.65

41.08

3.2

2.7

140.26

141.99

ug/l

0.06

1288

9528

Rash and other nonspecific skin eruption

1901

14646

1.56

41.00

3.5

2.8

124.91

115.19

ug/l

0.52

1779

13557

Benign neoplasm: Small intestine

731

4771

2.13

40.93

4.8

2.8

105.60

143.31

ug/l

5.84

681

4332

Other disorders of conjunctiva

2428

19201

1.46

40.75

3.3

2.8

132.68

143.35

ug/l

1.39

2235

17607

Retinal vascular disorders

1956

14975

1.51

40.64

3.7

2.8

145.83

156.72

ug/l

1.30

1779

13491

Anankastic personality disorder

872

6013

2.07

40.64

3.3

2.7

81.75

94.49

ug/l

1.38

813

5672

Alcohol-induced chronic pancreatitis

1065

7397

1.78

40.61

3.5

2.8

186.00

176.23

ug/l

0.41

983

6865

Viral and other specified intestinal infections

4958

41261

1.31

40.59

3.6

2.7

97.68

85.18

ug/l

4.06

4694

38754

Right hemicolectomy

1019

7070

1.83

40.43

3.9

2.8

135.51

146.18

ug/l

0.39

954

6404

Brachial plexus disorders

2000

15620

1.56

40.42

3.1

2.8

98.65

102.86

ug/l

0.35

1897

14771

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

1625

12106

1.57

40.29

3.7

2.8

213.29

145.19

ug/l

11.63

1479

11004

Stomatitis and related lesions

1640

12369

1.60

40.16

3.5

2.7

130.44

110.46

ug/l

2.40

1519

11596

Atrophic disorders of skin

2733

22071

1.44

40.08

3.2

2.7

99.41

108.09

ug/l

1.09

2517

20413

malignant neoplasm of male genital organs

6387

34776

1.25

40.08

2.8

3.0

240.91

195.44

ug/l

9.41

5657

31677

Ankylosing spondylitis, ICD10

1731

13184

1.58

40.07

3.3

2.8

111.82

127.18

ug/l

2.55

1637

12354

Small fibre neuropathy

522

3169

2.48

39.83

4.3

2.8

169.14

149.67

ug/l

0.88

479

2910

Other abnormal products of conception

8966

53522

1.25

39.81

3.1

2.9

62.75

68.52

ug/l

3.60

8598

51228

Unspecified urinary incontinence

1644

12459

1.61

39.77

3.1

2.8

113.93

110.73

ug/l

0.17

1400

11421

Other disorders of gingiva or/and edentulous alveolar ridge

961

6649

1.87

39.75

5.1

2.6

137.08

115.12

ug/l

2.05

920

6189

Appendectomy

14932

131305

1.16

39.67

2.9

111.25

112.70

ug/l

0.31

14020

123122

Fracture of lower leg, including ankle

11186

100095

1.18

39.60

3.1

2.8

132.50

126.69

ug/l

0.92

10317

92913

Acute and subacute iridocyclitis

3666

30442

1.36

39.59

3.3

2.8

136.65

127.97

ug/l

0.65

3439

28328

Medical treatment for female infertility

5603

48988

1.33

39.58

3.2

3.0

60.94

63.61

ug/l

0.56

5396

46908

Gingival hyperplasia

648

4143

2.20

39.47

5.9

2.6

138.41

114.75

ug/l

1.68

624

3858

Follow-up examination after treatment for malignant neoplasms

1706

12798

1.53

39.43

2.9

2.5

139.32

148.13

ug/l

0.69

1558

11539

Infections with a predominantly sexual mode of transmission

7412

65464

1.25

39.42

3.2

2.9

89.52

85.26

ug/l

0.92

6938

62065

Emotional disorders starting during childhood or adolecense, excluding more controls

1214

8737

1.81

39.33

3.5

2.7

76.32

52.71

ug/l

0.53

1117

8285

Malignant neoplasm of prostate

6234

33742

1.25

39.31

2.8

3.0

242.26

196.37

ug/l

9.15

5513

30680

Anterior Iridocyclitis

3880

32424

1.34

39.29

3.3

2.9

134.33

127.76

ug/l

0.48

3638

30159

Organic, including symptomatic, mental disorders

8364

53117

1.21

39.21

3.0

2.9

149.03

159.14

ug/l

2.44

7318

48053

Bronchiectasis

1344

9847

1.66

38.90

3.3

2.7

141.48

148.70

ug/l

0.33

1228

8917

Disorders of breast

11306

94840

1.19

38.88

3.0

2.9

85.62

89.03

ug/l

1.09

10584

88573

Dislocation, sprain and strain of joints and ligaments at neck level

3313

27502

1.39

38.81

3.1

2.8

93.01

96.90

ug/l

0.56

3101

25941

Any event in hilmo or specialist outpatient

209

419

3.44

38.61

2.4

1.7

132.60

64.64

ug/l

3.40

193

402

Cholecystitis

2389

18903

1.44

38.38

3.4

2.8

160.95

140.89

ug/l

1.79

2190

17188

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

1955

15059

1.49

38.35

2.7

2.9

158.10

142.76

ug/l

0.73

1796

13673

Abnormal findings in secretions and smears from cervix uteri vagina vulva

12280

87869

1.19

38.32

2.9

75.39

78.77

ug/l

1.74

11685

82960

Anorexia (incl.atypical)

1581

12238

1.70

38.28

3.7

2.8

68.87

70.10

ug/l

0.07

1494

11516

Unspecified acute lower respiratory infection

2736

22061

1.41

38.27

3.5

2.8

153.11

132.25

ug/l

2.82

2573

20574

Sequelae of cerebrovascular disease

5890

44506

1.25

38.17

3.5

2.8

151.82

160.00

ug/l

1.35

5266

40229

Benign lipomatous neoplasm

5249

44991

1.27

38.03

2.9

2.8

127.87

120.21

ug/l

1.23

4854

41546

Benign neoplasm: Skin of eyelid, including canthus

2608

20962

1.42

37.92

3.1

2.8

120.56

118.56

ug/l

0.15

2409

19203

Benign neoplasm: Adrenal gland

1228

8928

1.70

37.87

3.4

2.8

143.39

125.69

ug/l

0.97

1139

8228

Superficial injury of thorax

2728

22045

1.41

37.87

3.4

2.8

132.15

131.09

ug/l

0.08

2484

20440

Other noninflammatory disorders of uterus, except cervix

4172

23857

1.32

37.80

3.0

2.7

109.77

114.55

ug/l

0.62

3811

21868

Diabetic neuropathy

1912

14853

1.54

37.75

5.2

3.4

159.65

152.46

ug/l

0.64

1786

13636

Dermatophytosis

2212

17453

1.46

37.71

3.5

2.8

144.95

144.09

ug/l

0.05

2057

16133

Ocular pain

1654

12746

1.61

37.66

3.5

2.8

93.50

98.80

ug/l

0.58

1549

11895

Otitis externa

4297

36424

1.32

37.65

3.3

2.9

113.87

119.04

ug/l

0.66

3910

33999

Other autoimmune haemolytic anaemias

268

1359

3.89

37.65

4.3

2.7

572.37

125.34

ug/l

3.86

254

1242

Other disorders of penis

1408

10289

1.57

37.60

3.3

2.8

177.57

199.78

ug/l

1.23

1283

9566

Other diseases of the respiratory system

3326

27327

1.35

37.57

3.9

2.9

168.99

151.93

ug/l

1.81

3039

24769

Other respiratory disorders and diseases

3326

27327

1.35

37.57

3.9

2.9

168.99

151.93

ug/l

1.81

3039

24769

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

479

2830

2.37

37.57

3.9

2.7

451.61

150.37

ug/l

1.58

440

2540

Chronic lymphocytic leukaemia, helper endpoint

479

2830

2.37

37.57

3.9

2.7

451.61

150.37

ug/l

1.58

440

2540

Unspecified misadventure during surgical and medical care

1001

7097

1.84

37.55

3.8

2.8

162.88

127.99

ug/l

1.88

934

6551

Chronic myeloproliferative disease

286

1482

3.60

37.43

5.5

2.6

381.94

151.12

ug/l

3.02

274

1337

Carcinoma in situ of skin

1292

9490

1.67

37.42

3.6

2.8

142.61

149.52

ug/l

0.54

1179

8534

Ptosis of eyelid

1819

14036

1.53

37.42

3.3

2.8

145.21

143.77

ug/l

0.05

1682

12815

Erosion of teeth

380

2176

3.01

37.34

6.8

2.6

139.21

101.95

ug/l

1.83

362

2070

Melanocytic naevi

6088

53139

1.26

37.29

3.4

2.9

108.33

110.53

ug/l

0.24

5778

49655

Fall on and from stairs and steps

4802

41058

1.29

37.24

3.2

2.8

128.09

126.09

ug/l

0.19

4398

38032

Endometriosis ASRM stages 1,2

4217

36133

1.35

37.21

3.1

2.9

72.91

77.44

ug/l

1.70

3962

34155

Benign neoplasm: Duodenum

469

2806

2.49

37.18

4.9

2.7

105.02

131.81

ug/l

2.04

430

2537

Seborrhoeic dermatitis

1701

13011

1.54

37.00

3.5

2.8

151.17

138.31

ug/l

0.81

1583

12027

Invasive ventilation

1268

9300

1.67

36.94

4.4

2.8

194.87

139.92

ug/l

4.29

1151

8534

Lymphoid leukaemia

961

6720

1.81

36.94

4.0

2.9

330.74

146.75

ug/l

2.22

900

6115

Non-follicular lymphoma

1547

11666

1.57

36.77

3.2

2.9

400.60

152.89

ug/l

19.50

1440

10618

Sleep disorders, other/unspecified

760

5205

2.09

36.65

3.8

2.8

77.40

86.45

ug/l

1.32

714

4893

Sub-endpoint used in defining T1D endpoints

5969

50908

1.25

36.53

4.7

2.8

141.94

123.23

ug/l

5.05

5550

47306

COPD related to multimorbidity

6435

47099

1.24

36.52

3.5

2.9

153.98

168.82

ug/l

2.44

5808

42562

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

804

5493

1.95

36.35

5.9

2.7

154.39

112.24

ug/l

7.01

753

5269

Reactive arthropathies, FINNGEN

1370

10204

1.63

36.31

3.2

2.7

151.42

119.74

ug/l

1.73

1308

9518

Speech and linguistic disorders, excluding more controls

1738

12612

1.54

36.27

3.5

2.7

110.44

78.43

ug/l

0.55

1636

11952

Carcinoma in situ of other and unspecified digestive organs

463

2786

2.49

36.25

3.6

2.7

129.72

154.73

ug/l

1.42

436

2515

Hyperhidrosis

705

4749

2.12

36.18

3.1

2.6

97.44

85.83

ug/l

0.79

648

4434

Single delivery by caesarean section

5160

26013

1.33

36.14

3.1

3.0

62.01

65.87

ug/l

0.85

4932

24854

Dental caries 2 and operation codes, only avohilmo

17114

97985

1.15

36.07

3.0

93.96

111.81

ug/l

17.39

15916

91678

Abnormal findings on examination of urine, without diagnosis

847

5860

1.91

36.03

5.5

2.8

152.20

127.34

ug/l

2.80

813

5404

Vascular diseases of the intestine

646

4154

2.03

35.99

5.4

2.6

173.36

146.14

ug/l

0.73

610

3721

Psoriatic arthropathies

1834

14186

1.50

35.93

3.1

2.6

136.11

132.65

ug/l

0.24

1711

13220

Other mental disorders due to brain damage and dysfunction and to physical disease

1846

14308

1.50

35.86

3.3

2.9

131.64

148.52

ug/l

2.25

1644

13010

Unknown and unspecified causes of morbidity

1416

10575

1.59

35.81

3.5

2.6

116.48

112.78

ug/l

0.31

1369

9795

Herpesviral [herpes simplex] infections

2280

18304

1.46

35.76

3.5

2.9

145.43

108.76

ug/l

5.29

2137

17082

Impotence

807

5403

1.83

35.76

3.7

2.8

191.22

209.78

ug/l

0.67

751

5007

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

8541

76233

1.21

35.62

3.0

2.8

95.04

96.67

ug/l

0.28

7951

72088

Childhood asthma (age<16), excluding more controls

3707

24745

1.35

35.51

3.1

2.6

66.60

63.38

ug/l

0.90

3521

23557

Amputation of foot

449

2673

2.44

35.51

7.4

2.7

213.99

173.69

ug/l

2.45

418

2417

Disorders of refraction and accommodation

5675

49297

1.26

35.37

3.3

2.9

98.62

99.42

ug/l

0.08

5282

46344

Other infectious diseases

1407

10558

1.60

35.36

4.6

2.8

182.28

132.13

ug/l

4.81

1321

9699

Hypermobility syndrome

1325

10160

1.76

35.27

3.6

2.8

67.62

67.58

ug/l

0.00

1278

9616

Cyst of kidney

1123

8135

1.70

35.20

4.1

2.7

151.68

151.96

ug/l

0.01

1050

7412

Paralytic ileus

647

4170

1.99

35.12

3.9

2.6

139.82

149.20

ug/l

0.47

596

3787

Mixed hyperlipidaemia

693

4548

1.95

35.03

3.9

2.5

176.57

164.07

ug/l

0.41

636

4123

Fracture of skull and facial bones

3904

32848

1.31

35.03

3.0

2.8

140.19

134.06

ug/l

0.56

3591

30710

Giant cell arteritis

708

4729

1.99

34.89

3.5

2.7

180.00

136.74

ug/l

2.50

646

4244

Chronic tubulo-interstitial nephritis

743

4999

1.94

34.85

5.7

2.5

177.91

108.06

ug/l

10.92

705

4574

Haemorrhage in early pregnancy

6740

58380

1.25

34.80

3.1

2.8

75.90

77.58

ug/l

0.23

6340

55328

Mental and behavioural disorders due to sedatives or hypnotics

1302

9711

1.64

34.72

3.2

2.7

120.29

118.49

ug/l

0.05

1168

9119

Disorders of continuity of bone

1803

14105

1.52

34.55

3.6

2.7

123.23

112.39

ug/l

1.04

1685

13184

Benign neoplasm: Rectosigmoid junction

679

4488

1.99

34.44

3.4

2.7

126.92

137.17

ug/l

0.50

638

4086

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

1781

13642

1.47

34.41

3.2

2.9

164.78

159.50

ug/l

0.42

1608

12293

Sequelae of other external causes

983

7006

1.76

34.39

3.6

2.8

146.83

125.19

ug/l

1.44

923

6473

Childhood asthma (age<16)

3707

24834

1.34

34.32

3.1

2.6

66.60

63.92

ug/l

0.69

3521

23651

Other pleural conditions

1625

12419

1.51

34.12

4.2

2.8

226.82

156.92

ug/l

10.60

1507

11224

Ethmoidectomy

2426

19658

1.42

34.04

3.0

2.8

119.70

124.32

ug/l

0.47

2211

18408

Congenital malformations of the circulatory system

2747

21859

1.39

33.95

3.4

2.9

125.04

110.71

ug/l

0.34

2576

20501

Epilepsy

5937

51565

1.23

33.81

3.0

2.8

139.40

128.57

ug/l

1.43

5457

47869

Malnutrition

405

2407

2.62

33.81

4.0

2.9

210.11

114.91

ug/l

0.98

373

2203

Striking against or struck by other objects

6437

56549

1.23

33.50

3.0

2.9

120.14

123.25

ug/l

0.36

5943

53122

Progressive vascular leukoencephalopathy

568

3639

2.12

33.47

3.3

2.8

121.16

146.20

ug/l

1.71

536

3218

Maternal care for known or suspected fetal abnormality and damage

4240

32766

1.35

33.44

3.2

3.0

51.86

62.46

ug/l

12.20

4036

31502

D07AA Corticosteroids, weak (group I)

3394

28570

1.35

33.35

3.2

2.9

100.03

92.89

ug/l

0.66

3191

26866

Other and unspecified injuries of head

1130

8298

1.68

33.33

3.1

2.8

111.72

119.92

ug/l

0.69

1031

7668

Secondary polycythaemia

436

2619

2.40

33.32

3.2

2.7

140.65

149.61

ug/l

0.31

402

2396

Other degenerative diseases of the nervous system

4954

32179

1.26

33.27

2.7

142.98

139.67

ug/l

0.26

4377

29586

Postviral fatigue syndrome

241

1311

5.58

33.25

5.2

2.9

80.77

67.61

ug/l

0.92

235

1245

Autoimmune hyperthyroidism

1243

9304

1.65

33.17

3.3

2.6

102.38

96.32

ug/l

0.42

1175

8726

Atypical facial pain

998

7237

1.77

33.17

3.4

2.7

114.72

110.65

ug/l

0.09

935

6712

Renal tubulo-interstitial disorders in diseases classified elsewhere

226

1126

3.99

33.17

6.8

2.5

188.24

126.36

ug/l

4.44

213

1019

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

7049

54549

1.21

33.13

2.6

2.8

322.83

131.14

ug/l

81.87

6541

49871

Systemic lupus erythematosus

754

5239

1.99

33.12

4.0

2.7

153.72

92.49

ug/l

7.65

721

4875

Correction of physiology of bite - demanding therapy visit

1492

11578

1.61

33.10

3.4

2.8

82.78

90.95

ug/l

1.76

1405

10888

Other disorders of nervous system

1128

8267

1.67

33.01

3.7

2.8

140.71

144.48

ug/l

0.20

1025

7617

Diseases of spleen

359

2083

2.78

32.85

5.4

2.7

289.21

127.00

ug/l

2.40

345

1919

Other noninflammatory disorders of vagina

1633

12756

1.54

32.63

3.2

2.7

89.90

90.27

ug/l

0.03

1527

11898

Attention to artificial openings

650

4281

1.95

32.62

3.8

2.5

153.36

145.68

ug/l

0.30

606

3890

Folate deficiency anaemia

191

888

4.35

32.55

4.5

2.4

304.15

135.83

ug/l

4.91

179

815

Cardiac murmurs and other cardiac sounds

1945

15261

1.47

32.51

3.3

2.7

88.76

92.81

ug/l

0.46

1823

14236

Deficiency of other B group vitamins

426

2577

2.43

32.42

4.9

2.6

115.11

128.13

ug/l

0.63

397

2350

Other and unspecified visual disturbances

1744

13720

1.51

32.30

3.4

2.8

113.36

115.70

ug/l

0.13

1624

12713

Prurigo nodularis

475

2970

2.32

32.21

4.2

2.7

122.70

140.33

ug/l

0.65

435

2710

SLE, ICD10

726

5051

2.01

32.06

4.0

2.7

147.97

92.43

ug/l

7.26

694

4693

SLE, strict definition

726

5051

2.01

32.06

4.0

2.7

147.97

92.43

ug/l

7.26

694

4693

Hypertrophic cardiomyopathy

703

4773

1.93

31.94

4.4

2.8

151.37

150.51

ug/l

0.03

664

4359

Carcinoma in situ of colon

265

1402

3.25

31.93

3.6

2.6

113.43

145.06

ug/l

1.46

244

1269

Convalescence

1031

7529

1.71

31.92

3.5

2.6

111.12

107.51

ug/l

0.25

943

6977

Other diseases of jaws

1327

10047

1.59

31.90

3.4

2.6

132.39

114.62

ug/l

1.25

1228

9407

Carcinoma in situ of skin of trunk

509

3225

2.19

31.79

3.8

2.8

149.57

158.32

ug/l

0.38

454

2888

Infection of intervertebral disc (pyogenic)

254

1316

3.24

31.77

4.8

2.6

202.16

167.85

ug/l

0.79

232

1191

FESS (DNB20)

2330

18948

1.41

31.72

3.0

2.8

119.60

124.50

ug/l

0.49

2120

17746

Injuries to unspecified part of trunk, limb or body region

1815

14358

1.49

31.71

3.7

2.8

123.61

120.87

ug/l

0.23

1681

13291

Right bundle-branch block

597

3862

1.96

31.66

3.7

2.4

140.84

154.66

ug/l

0.61

544

3500

Ganglion

4408

37951

1.28

31.54

2.9

2.7

107.55

110.99

ug/l

0.32

4145

35554

Other disorders of bone

3958

33805

1.30

31.51

3.1

2.8

114.62

114.36

ug/l

0.02

3696

31678

Drug-induced osteoporosis with pathological fracture

310

1751

2.99

31.37

4.6

2.7

143.91

120.66

ug/l

0.78

293

1583

Spontaneous abortion

11446

71224

1.18

31.36

3.1

2.9

74.04

81.14

ug/l

4.40

10735

67126

Agoraphobia

762

5388

1.97

31.30

3.2

2.7

82.74

74.10

ug/l

0.72

700

5110

Other disorders starting during childhood or adolecense, excluding more controls

1125

8095

1.68

31.25

3.5

2.7

60.70

61.38

ug/l

0.08

1063

7695

Discitis, unspecified

314

1751

2.77

31.18

4.3

2.7

187.84

151.06

ug/l

1.86

296

1586

Bullous disorders

999

7273

1.71

31.04

3.5

2.8

145.06

133.83

ug/l

0.58

924

6643

Hydrocele

1723

13309

1.44

31.02

3.4

2.8

179.62

205.17

ug/l

2.14

1581

12213

Other/unspecified synovitis and tenosynovitis

2182

17600

1.41

30.96

3.1

2.7

120.84

124.59

ug/l

0.32

2000

16315

Tongue abnormality

1077

7970

1.68

30.88

3.1

2.8

116.96

125.07

ug/l

0.60

980

7316

Lichen ruber planus, wide definition including periferal and oral lichen planus

3632

30818

1.30

30.80

2.9

2.8

121.27

131.58

ug/l

1.62

3334

28391

Congenital malformations of heart and great arteries

2452

19469

1.39

30.79

3.4

2.9

127.02

111.35

ug/l

0.33

2297

18248

Suggestive for eosinophilic asthma

1582

12294

1.50

30.70

3.1

2.7

113.86

141.54

ug/l

6.16

1472

11340

Dermatographic urticaria

1428

11132

1.60

30.70

3.4

2.8

97.42

89.47

ug/l

0.58

1321

10451

Tubulo-interstitial nephritis, not specified as acute or chronic

1306

9895

1.57

30.69

3.9

2.6

134.54

109.70

ug/l

2.70

1212

9038

Benign neoplasm: Duodenum

469

2965

2.29

30.68

4.9

2.7

105.02

151.50

ug/l

4.57

430

2694

Nail disorders

1530

11889

1.53

30.64

3.9

2.8

119.14

118.48

ug/l

0.05

1427

11056

Temporal arteritis

627

4202

1.99

30.61

3.4

2.7

176.84

137.67

ug/l

1.80

571

3766

Alzheimer disease, excluding more controls

2708

14691

1.34

30.57

2.7

150.57

170.20

ug/l

2.93

2294

13167

Carcinoma in situ of skin of scalp and neck

379

2235

2.43

30.57

4.1

2.8

167.51

152.68

ug/l

0.62

343

2018

Other specified/unspecified soft tissue disorders

922

6619

1.72

30.46

3.5

2.6

111.91

120.47

ug/l

0.40

843

6049

Synovial cyst of popliteal space [Baker]

1262

9503

1.57

30.31

3.2

2.7

137.71

137.47

ug/l

0.01

1157

8684

Nontoxic goitre/thyroid nodule

5561

48845

1.24

30.26

3.0

2.8

106.82

119.66

ug/l

4.88

5117

44735

Other follicular disorders

1425

11059

1.57

30.12

3.7

2.8

128.12

106.80

ug/l

1.90

1345

10392

Malignant neoplasm of breast

8335

66831

0.85

30.12

2.5

2.8

134.60

101.81

ug/l

15.91

7547

61868

Neuralgia and neuritis, unspecified

956

6946

1.71

30.08

3.4

2.7

117.70

120.67

ug/l

0.16

894

6440

Isolated proteinuria

569

3782

2.10

30.08

6.6

2.8

169.45

128.72

ug/l

4.29

548

3506

Other abnormalities of plasma proteins

305

1735

2.91

29.98

4.6

2.7

250.91

132.31

ug/l

3.21

286

1580

TMD related pain

791

5726

1.95

29.80

3.6

2.8

84.96

78.22

ug/l

0.21

738

5365

Viral warts

1985

16041

1.45

29.80

4.2

2.8

115.15

104.12

ug/l

1.63

1899

15006

Seropositive rheumatoid arthritis, strict definition

2768

23048

1.36

29.77

2.9

2.8

135.53

122.62

ug/l

1.55

2601

21289

Oesophageal obstruction

590

3881

1.94

29.68

3.3

2.6

127.67

164.36

ug/l

3.23

536

3515

Psoriasis vulgaris

3346

28262

1.31

29.64

3.2

2.8

149.76

136.76

ug/l

1.29

3101

26267

Glaucoma suspect

6167

54457

1.22

29.63

3.1

2.9

132.11

142.64

ug/l

2.53

5594

49730

Kela-code for severe mental illness

7596

67983

1.19

29.55

2.9

2.8

108.29

119.75

ug/l

2.88

6953

63748

Arthropathy in ulcerative colitis

305

1775

3.09

29.52

4.4

2.8

93.45

96.12

ug/l

0.11

294

1670

Insulin, fast-acting (human)

2949

24676

1.34

29.47

4.9

2.8

132.30

111.87

ug/l

6.54

2760

23154

Asthma and opportunity respiratory infection

790

5576

1.80

29.42

3.5

2.7

146.40

141.53

ug/l

0.06

737

5033

Benign neoplasm: Adrenal gland

1228

9313

1.59

29.39

3.4

2.8

143.39

140.84

ug/l

0.09

1139

8561

Oral lichen ruber planus wide, hypothyreosis or thyroxin

943

6909

1.73

29.22

3.0

2.8

109.45

115.28

ug/l

0.37

858

6346

Myeloid leukaemia

458

2875

2.18

29.19

4.3

2.7

532.73

129.81

ug/l

8.69

439

2615

Rosacea

2179

17827

1.42

29.15

3.3

2.8

121.52

108.54

ug/l

0.82

2044

16615

Postprocedural musculoskeletal disorders, not elsewhere classified

1158

8713

1.61

29.11

3.2

2.8

129.11

138.94

ug/l

0.90

1085

7985

Nasal polyp

3320

27981

1.30

29.11

2.9

2.8

129.74

153.80

ug/l

5.87

3072

25885

Olecranon bursitis

947

6807

1.64

29.06

3.4

2.7

170.17

184.60

ug/l

0.90

875

6247

Need for immunization against other single viral diseases

385

2340

2.41

28.84

9.5

2.7

199.11

140.97

ug/l

4.54

375

2169

Carcinoma in situ of colon

265

1457

3.07

28.83

3.6

2.7

113.43

154.02

ug/l

2.19

244

1324

Giant cell arteritis with polymyalgia rheumatica

627

4261

1.94

28.78

3.4

2.8

176.84

138.90

ug/l

1.71

571

3821

Malignant neoplasm

19801

109474

1.12

28.67

2.9

2.8

185.91

112.16

ug/l

53.12

18402

102150

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

11197

90064

1.17

28.49

3.3

2.9

78.56

79.86

ug/l

0.35

10645

84869

Benign neoplasm of mouth and pharynx

1844

14726

1.43

28.48

3.2

2.8

136.03

120.32

ug/l

1.61

1671

13601

Chronic lymphocytic leukaemia

479

3060

2.12

28.47

3.9

2.8

451.61

157.99

ug/l

1.51

440

2740

Hepatomegaly and splenomegaly, not elsewhere classified

217

1117

3.47

28.44

5.3

2.5

204.64

123.53

ug/l

1.69

209

1024

Hypoparathyroidism

667

4633

1.92

28.27

4.2

2.7

127.07

111.52

ug/l

0.46

602

4228

Injury of muscle and tendon at shoulder and upper arm level

5909

52130

1.21

28.10

2.9

2.8

150.03

163.71

ug/l

2.51

5451

48121

Congenital iodine-deficiency syndrome/hypothyroidism

598

4073

1.99

27.95

3.4

2.7

107.49

107.23

ug/l

0.01

557

3742

Systemic lupus erythematosus, unspecified

633

4420

2.01

27.81

4.0

2.8

146.10

90.50

ug/l

6.23

602

4108

COPD-related respiratory insufficiency

1789

14209

1.42

27.79

4.0

2.8

161.63

168.13

ug/l

0.24

1620

12785

Open wound of forearm

1694

13477

1.46

27.78

3.5

2.8

115.75

123.55

ug/l

0.90

1524

12508

Acute appendicitis, no complications

12348

113302

1.14

27.76

2.9

111.80

116.28

ug/l

1.36

11659

106566

Fracture of forearm

11284

96770

1.15

27.67

3.0

2.8

115.89

115.86

ug/l

0.00

10389

89615

Other/unspecified enthesopathies of lower limb, excluding foot

1364

10573

1.53

27.66

3.2

2.7

100.00

113.25

ug/l

1.54

1260

9866

Visual impairment including blindness (binocular or monocular)

1162

8782

1.57

27.62

3.7

2.8

145.44

123.94

ug/l

1.28

1013

7995

Use of disulfiram, acamprosate or naltrexone

1472

11463

1.48

27.52

2.8

163.41

148.73

ug/l

0.51

1335

10828

Cerebral palsy and other paralytic syndromes

2052

16673

1.40

27.48

3.3

2.8

152.79

121.17

ug/l

0.62

1878

15474

Vasculitis limited to skin, not elsewhere classified

484

3161

2.13

27.32

3.9

2.7

171.41

132.88

ug/l

1.12

451

2887

Dronedarone medication

468

2979

2.05

27.27

3.1

2.4

136.19

164.05

ug/l

1.98

410

2662

Malignant neoplasm of breast, HER2-negative

8048

65486

0.85

27.20

2.5

2.8

135.45

102.67

ug/l

15.02

7280

60559

Disorders of tooth development and eruption

1087

7989

1.62

27.19

5.0

2.6

102.60

83.99

ug/l

1.59

1037

7576

Endometriosis of rectovaginal septum and vagina

1601

12769

1.49

27.17

3.0

2.8

87.90

93.10

ug/l

0.32

1475

11868

Otalgia

1530

12156

1.51

27.14

3.4

2.9

93.86

97.08

ug/l

0.34

1403

11344

Other or ill-defined heart diseases

851

6059

1.65

27.12

4.4

2.5

153.96

143.95

ug/l

0.46

801

5577

Orchitis and epididymitis

1284

9713

1.48

27.02

3.1

2.8

192.80

207.15

ug/l

0.61

1192

8990

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

511

3352

2.02

27.01

3.7

2.7

144.88

136.51

ug/l

0.32

479

3048

Maternal care for known or suspected malpresentation of fetus

5075

33703

1.28

26.98

3.1

3.0

55.72

61.51

ug/l

3.10

4858

32422

Premature rupture of membranes

5834

38438

1.25

26.96

3.0

2.9

60.80

63.90

ug/l

0.79

5435

36834

Other female pelvic inflammatory diseases

3336

28622

1.31

26.96

3.2

2.8

93.15

91.19

ug/l

0.24

3063

26693

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

2254

23013

0.76

26.74

2.6

2.8

232.49

145.94

ug/l

19.07

2048

20754

Special screening examination for neoplasms

733

5113

1.72

26.68

3.6

2.5

176.68

156.33

ug/l

0.44

659

4674

Anomalies of dental arch relationship, including avohilmo

4219

33054

1.27

26.61

3.1

2.8

78.79

89.23

ug/l

3.44

3959

31111

Cramp and spasm

877

6462

1.72

26.60

3.4

2.8

113.85

118.57

ug/l

0.30

823

5997

Filling of root of tooth

588

4033

1.96

26.53

4.7

2.7

136.62

122.61

ug/l

0.57

562

3729

Open wound of ankle and foot

1850

14947

1.42

26.49

4.0

2.8

135.15

124.43

ug/l

1.01

1720

13922

Malignant neoplasm of stomach

795

5648

1.69

26.49

3.4

2.8

98.28

162.35

ug/l

12.86

744

5078

Lateral epicondylitis

2443

20257

1.34

26.22

2.9

2.7

111.78

130.34

ug/l

3.24

2287

19006

Benign neoplasm: Skin of eyelid, including canthus

2608

21815

1.34

26.20

3.1

2.8

120.56

133.28

ug/l

1.78

2409

20004

Any prescribed medicine buy

120

227

3.63

26.20

2.5

126.36

57.57

ug/l

2.66

114

214

Other and unspecified immunodeficiencies with predominantly antibody defects

278

1620

2.94

26.18

5.4

2.7

200.50

98.29

ug/l

2.10

270

1502

Other and unspecified vascular occlusions

1438

11227

1.47

26.14

3.6

2.8

142.26

156.21

ug/l

1.50

1294

10124

Benign neoplasm: Rectosigmoid junction

679

4768

1.82

26.13

3.4

2.7

126.92

151.77

ug/l

1.75

638

4318

Postpartum haemorrhage

6467

50828

1.23

26.12

3.2

2.9

63.94

67.81

ug/l

1.66

6115

48564

Abnormal findings on antenatal screening of mother

2331

19861

1.45

26.07

3.5

2.9

45.82

53.96

ug/l

5.75

2246

19008

Sacrococcygeal disorders, not elsewhere classified

637

4465

1.89

25.87

3.2

2.7

97.07

99.86

ug/l

0.15

609

4162

Other and unspecified vasculitis limited to skin

442

2867

2.16

25.78

3.9

2.7

175.97

133.21

ug/l

1.15

410

2620

Acute pharyngitis

3146

26659

1.30

25.73

3.2

2.8

99.59

95.26

ug/l

0.50

2972

25222

Vulvovaginal ulceration/inflammation in other diseases

1418

11430

1.58

25.72

3.4

2.9

71.42

63.87

ug/l

1.06

1332

10787

Other and unspecified aplastic anaemias

235

1288

3.04

25.63

6.0

2.6

447.94

118.28

ug/l

8.50

224

1171

Early onset COPD

3629

31134

1.26

25.60

3.4

2.8

145.21

161.83

ug/l

2.48

3317

28632

Viral pneumonia (known virus, not influenza)

438

2841

2.16

25.54

4.8

2.8

326.35

132.49

ug/l

0.90

416

2604

Melanocytic naevi of trunk

2202

18243

1.38

25.51

3.5

2.9

113.64

101.43

ug/l

2.09

2082

17013

Sacroiliitis, not elsewhere classified

1045

7976

1.63

25.44

3.1

2.7

106.15

87.75

ug/l

0.58

997

7543

Degenerative macular diseases

1917

15553

1.39

25.31

3.3

2.8

152.04

150.04

ug/l

0.11

1697

14014

Other and unspecified abdominal hernia

698

4945

1.77

25.26

3.8

2.7

114.74

138.64

ug/l

2.33

649

4513

Dissociative [conversion] disorders

900

6797

1.74

25.26

3.4

2.7

67.67

74.19

ug/l

0.54

829

6402

Injuries to the wrist and hand

23209

158570

1.10

25.20

3.0

2.9

117.90

116.74

ug/l

0.27

21464

148195

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

7722

55776

0.85

25.14

2.5

2.8

133.17

89.22

ug/l

27.30

7044

51903

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

7720

55761

0.85

25.12

2.5

2.8

133.20

89.21

ug/l

27.33

7042

51888

Thyroiditis

1406

11178

1.51

25.11

3.4

2.8

109.31

97.11

ug/l

0.92

1298

10437

Endometriosis diagnosis and infertility diagnosis occurring together

2527

21545

1.38

24.98

3.2

2.9

67.44

71.65

ug/l

0.49

2418

20481

Arthropathy in Crohn disease

244

1399

3.21

24.98

4.7

2.7

90.65

102.33

ug/l

0.62

236

1304

Plantar fascial fibromatosis

1781

14414

1.41

24.94

3.1

2.7

107.91

120.19

ug/l

1.49

1655

13417

Other and unspecified acquired haemolytic anaemias

199

1047

3.39

24.87

7.3

2.7

427.70

125.39

ug/l

6.04

189

956

Palmar fascial fibromatosis [Dupuytren]

2383

19686

1.32

24.80

3.1

2.8

167.69

180.46

ug/l

0.99

2179

17842

Primary open-angle glaucoma

5074

43528

1.21

24.76

2.9

148.85

155.66

ug/l

0.83

4436

39093

Lichen planus, including avohilmo

3052

25999

1.29

24.71

2.9

2.8

125.54

132.91

ug/l

0.80

2793

23921

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

2332

19338

1.34

24.65

2.8

2.9

327.30

133.53

ug/l

23.56

2182

17720

Cardiomyopathy, Hypertrophic obstructive

326

1945

2.29

24.59

4.7

2.5

161.45

152.58

ug/l

0.22

307

1760

Carcinoma in situ of skin of upper limb, including shoulder

361

2234

2.24

24.49

3.9

2.7

168.70

141.53

ug/l

1.20

327

1990

Other peripheral vascular diseases

1457

11584

1.47

24.47

3.6

2.7

102.90

114.80

ug/l

0.76

1364

10711

Benign lipomatous neoplasm

5249

46476

1.21

24.47

2.9

127.87

136.08

ug/l

1.23

4854

42954

Postprocedural disorders of nervous system

1616

13157

1.48

24.42

3.3

2.9

78.23

84.59

ug/l

1.04

1548

12449

Urethral stricture

858

6250

1.61

24.40

3.3

2.8

176.15

190.52

ug/l

0.59

766

5712

Other and unspecified disorders of skin and subcutaneous tissue

1147

8849

1.54

24.36

3.6

2.7

172.20

123.09

ug/l

2.14

1003

8162

Overexertion and strenuous or repetitive movements

1803

14672

1.40

24.31

2.9

2.8

116.25

124.29

ug/l

0.81

1696

13722

Alcohol withdrawal state with delirium

1052

7934

1.54

24.31

3.1

2.8

206.95

176.81

ug/l

1.63

939

7356

Other chondrocalcinosis

226

1239

2.95

24.30

3.9

2.7

161.90

153.86

ug/l

0.23

203

1111

Other and unspecified rosacea

1558

12537

1.46

24.27

3.4

2.8

129.28

112.27

ug/l

0.96

1471

11665

Superficial injury of shoulder and upper arm

2034

16745

1.37

24.26

2.9

2.8

116.12

121.02

ug/l

0.42

1838

15585

Pregnancy hypertension

10169

84578

1.16

24.23

3.3

2.9

77.25

77.58

ug/l

0.07

9669

79939

Drug-induced cataract

442

2914

2.11

24.18

6.0

2.7

182.01

130.42

ug/l

2.64

417

2688

COPD, hospital admissions

7447

56744

1.17

24.16

3.4

2.8

157.02

165.18

ug/l

1.11

6718

51444

Myeloid leukaemia

458

3020

2.03

24.08

4.3

2.8

532.73

142.88

ug/l

8.19

439

2752

Corns and callosities

1170

9045

1.52

24.01

4.1

2.7

146.66

130.42

ug/l

1.24

1088

8331

Amyloidosis, other/unspecified

305

1821

2.42

23.99

4.6

2.5

191.69

149.20

ug/l

2.47

285

1644

Opening and dilatation of root channel of tooth

1241

9745

1.53

23.98

3.9

2.8

120.76

107.82

ug/l

0.74

1163

9159

Disorders of magnesium metabolism

153

744

4.13

23.91

4.9

2.4

387.80

138.33

ug/l

2.46

145

683

Cluster headache, wide

751

5461

1.72

23.90

3.7

2.6

98.69

111.96

ug/l

1.12

716

5128

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

1402

11177

1.48

23.64

3.9

2.8

122.91

116.40

ug/l

0.63

1328

10353

Amyloidosis

356

2210

2.20

23.64

4.5

2.6

187.10

149.87

ug/l

2.28

330

2008

Other epidermal thickening

778

5706

1.69

23.53

3.9

2.7

130.56

124.64

ug/l

0.33

735

5236

Lichen sclerosus et atrophicus

1711

13907

1.41

23.50

3.0

2.7

99.43

112.62

ug/l

1.52

1562

12741

Malignant immunoproliferative diseases

188

979

3.24

23.47

4.9

2.7

221.99

135.70

ug/l

2.48

180

886

Superficial injury of wrist and hand

4049

35486

1.25

23.42

3.1

2.9

93.19

101.91

ug/l

2.86

3764

33364

Monoarthritis, not elsewhere classified

784

5730

1.67

23.42

3.1

2.6

137.40

123.04

ug/l

0.62

733

5344

severe traumatic brain injury, does not include concussion

3507

30204

1.25

23.34

3.1

2.9

166.88

156.56

ug/l

0.89

3152

27473

Correction of physiology of bite - very demanding therapy visit

620

4475

1.92

23.31

3.4

2.8

80.03

88.53

ug/l

0.88

587

4208

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

153

746

3.84

23.16

4.8

2.7

206.40

135.47

ug/l

1.80

147

680

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

1429

11290

1.43

23.15

2.7

2.8

169.96

145.57

ug/l

0.93

1302

10257

Urolithiasis

5522

49130

1.20

23.14

3.3

2.9

152.80

155.86

ug/l

0.22

5070

45203

Idiopathic thrombocytopenic purpura

572

4016

1.88

23.06

4.0

2.8

178.07

113.04

ug/l

1.88

550

3685

Other and/or unspecified nontoxic goitre

1411

11228

1.45

23.05

2.9

2.7

98.61

117.40

ug/l

4.64

1324

10351

543

3899

2.11

22.99

3.5

2.7

79.05

63.37

ug/l

1.66

502

3673

Biomechanical lesions, not elsewhere classified

850

6356

1.65

22.97

3.3

2.8

109.27

127.11

ug/l

2.12

786

5871

Dermatitis due to substances taken internally

1046

8058

1.56

22.94

3.6

2.8

154.54

109.08

ug/l

1.92

966

7465

Viral hepatitis

1347

10685

1.47

22.87

3.1

2.8

133.84

116.67

ug/l

1.12

1235

10081

Isolated proteinuria with specified morphological lesion

235

1342

2.85

22.83

7.1

2.6

214.61

132.40

ug/l

3.64

228

1231

Emotional disorders and disorders of social functioning with onset specific to childhood

1306

10371

1.54

22.80

3.5

2.9

55.25

54.48

ug/l

0.10

1205

9808

Suppurative and unspecified otitis media

8638

70082

1.16

22.77

3.3

2.9

89.29

91.25

ug/l

0.37

8100

66214

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

1467

11650

1.42

22.75

2.7

2.9

168.23

145.53

ug/l

0.88

1339

10572

Other viral hepatitis

1168

9113

1.51

22.73

3.1

2.8

132.93

112.14

ug/l

1.47

1073

8625

Nummular dermatitis

1352

10711

1.45

22.62

3.3

2.8

146.33

140.96

ug/l

0.31

1243

9853

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

5261

46764

1.20

22.62

2.9

2.8

132.24

135.50

ug/l

0.35

4882

43617

COPD, early/later onset

7478

57058

1.16

22.56

3.4

2.8

157.79

165.30

ug/l

0.98

6745

51736

Trigeminal neuralgia

1058

8163

1.54

22.53

3.0

2.7

102.95

116.79

ug/l

1.41

978

7545

Benign neoplasm: Pituitary gland, craniopharyngeal duct

937

7139

1.60

22.40

3.1

2.8

110.47

107.07

ug/l

0.26

874

6650

Inguinal hernia

11224

69565

1.13

22.30

2.9

2.8

159.43

157.43

ug/l

0.19

10341

64400

Mental disorders, not otherwise specified

1756

14497

1.41

22.29

3.4

2.8

81.11

91.76

ug/l

2.42

1650

13708

Fall involving bed

495

3362

1.90

22.29

3.5

2.8

163.98

139.34

ug/l

0.61

450

3022

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

1558

12585

1.42

22.27

2.9

2.7

104.41

109.80

ug/l

0.54

1456

11893

Acne

2415

20560

1.35

22.27

3.5

2.8

74.59

70.91

ug/l

0.66

2289

19435

Alcohol abuse, main dg

2764

23545

1.29

22.22

3.0

2.8

135.09

133.74

ug/l

0.08

2542

22063

Cluster headache, strict

702

5120

1.72

22.22

3.8

2.6

93.49

110.56

ug/l

2.03

669

4822

Carcinoma in situ of skin of scalp and neck

379

2447

2.13

22.17

4.1

2.9

167.51

168.66

ug/l

0.03

343

2198

Other secondary gonarthrosis

848

6326

1.60

22.08

3.2

2.8

142.37

147.84

ug/l

0.26

785

5826

Other/unspecified reactive arthropathies

1215

9593

1.50

22.01

3.2

2.8

151.88

117.43

ug/l

1.69

1160

8923

Myositis

465

3130

1.93

22.00

3.3

2.6

160.29

136.78

ug/l

1.00

443

2862

Calculus of kidney and ureter

5109

45415

1.20

21.86

3.3

2.9

153.17

155.01

ug/l

0.12

4712

41822

Injury of unspecified body region

1337

10677

1.46

21.85

3.8

2.8

121.48

119.76

ug/l

0.12

1237

9870

Etanercept

1205

9549

1.51

21.83

3.0

2.8

109.25

102.33

ug/l

0.33

1147

8965

Complications predominantly related to the puerperium

6157

55920

1.20

21.70

3.2

2.9

72.60

75.21

ug/l

0.48

5798

52939

Diseases of appendix

16712

142882

1.11

21.68

2.9

118.82

119.53

ug/l

0.13

15722

133619

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

673

4844

1.69

21.67

3.4

2.7

215.25

150.97

ug/l

4.30

606

4400

Pneumocystosis

288

1759

2.41

21.54

5.1

2.6

379.67

149.45

ug/l

2.40

277

1604

Disorders of psychological development

2515

19836

1.32

21.52

3.3

2.8

99.25

78.44

ug/l

0.49

2347

18715

Delivery, wide proxy

8361

40776

1.17

21.49

2.9

72.15

84.81

ug/l

9.21

7737

37820

Arterial embolism and thrombosis

897

6719

1.54

21.46

4.4

2.7

160.58

157.58

ug/l

0.12

833

6049

Appendicitis, broad definition

16585

142296

1.11

21.46

2.9

118.59

119.40

ug/l

0.15

15605

133099

Hypertension, Pulmonary Arterial

184

985

3.11

21.38

6.1

2.4

111.86

120.90

ug/l

0.20

179

894

Bell's palsy

2070

17271

1.34

21.37

3.1

2.8

115.82

127.99

ug/l

1.78

1886

15994

Carcinoma in situ of skin of ear and external auricular canal

223

1243

2.57

21.34

4.3

2.7

172.11

161.21

ug/l

0.28

206

1119

Strabismus

5362

47998

1.20

21.25

3.1

2.9

107.58

107.11

ug/l

0.05

4991

44935

Unspecified nephritic syndrome

406

2682

2.02

21.24

6.5

2.6

193.50

141.77

ug/l

2.89

392

2460

Polycystic ovarian syndrome, broad definition

3045

26854

1.33

21.12

3.3

3.0

54.95

55.82

ug/l

0.21

2900

25622

Other juvenile arthritis

947

7368

1.61

21.09

3.7

2.8

85.78

73.48

ug/l

0.56

913

6928

Malignant immunoproliferative diseases

188

1021

3.05

21.05

4.9

2.7

221.99

153.42

ug/l

1.67

180

924

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1333

10731

1.46

21.02

3.4

2.8

96.26

99.10

ug/l

0.25

1242

10034

Abrasion of teeth

5620

37120

1.20

21.01

3.0

2.7

100.13

111.64

ug/l

3.67

5210

34795

Other aneurysm

832

6205

1.57

20.99

4.0

2.7

180.83

166.44

ug/l

0.55

775

5595

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

655

4774

1.72

20.88

3.5

2.7

138.05

122.42

ug/l

0.49

618

4373

Primary open-angle glaucoma, strict

4080

35771

1.22

20.81

2.9

152.03

155.23

ug/l

0.25

3561

32141

Erythema intertrigo

418

2802

2.00

20.78

3.8

2.7

134.04

140.43

ug/l

0.23

385

2548

Endometriosis ASRM stages 3,4

5055

45471

1.22

20.77

3.1

2.9

84.16

84.03

ug/l

0.01

4719

42607

Impacted cerumen

1560

12689

1.39

20.75

3.0

2.9

137.94

141.87

ug/l

0.13

1297

11612

Speech disturbances, not elsewhere classified

1391

11160

1.42

20.75

3.5

2.8

158.66

139.21

ug/l

0.64

1229

10208

Benign neoplasm of mouth and pharynx

1844

15266

1.36

20.73

3.2

2.8

136.03

131.46

ug/l

0.29

1671

14099

Emotional disorders starting during childhood or adolescence

1223

9815

1.53

20.71

3.5

2.9

75.92

54.07

ug/l

0.48

1125

9276

Ingrowing nail

975

7524

1.54

20.70

4.0

2.8

123.81

116.96

ug/l

0.52

909

6996

Pregnancy, childbirth and the puerperium

7434

35518

1.18

20.68

2.9

70.62

83.78

ug/l

11.78

6816

32892

Systemic sclerosis (FG)

446

3036

1.95

20.67

3.9

2.6

105.53

108.20

ug/l

0.09

415

2810

Lesion of lateral popliteal nerve

832

6267

1.59

20.58

3.5

2.7

131.86

142.54

ug/l

0.56

780

5792

Other noninfective disorders of lymphatic vessels and lymph nodes

632

4584

1.73

20.55

3.7

2.7

138.34

116.50

ug/l

1.55

602

4225

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

2733

26887

0.80

20.53

2.6

2.8

239.70

145.61

ug/l

22.55

2501

24314

Alcohol-induced acute pancreatitis

561

3948

1.74

20.30

3.4

2.7

213.39

175.66

ug/l

1.44

501

3658

Other and unspecified follicular disorders

708

5250

1.67

20.29

3.9

2.8

149.19

124.22

ug/l

0.97

671

4882

Unspecified jaundice

785

5818

1.57

20.29

3.4

2.6

275.52

141.74

ug/l

5.62

726

5298

Small cell lung cancer

118

2500

0.40

20.25

2.7

270.23

166.85

ug/l

2.75

106

2236

Small cell lung cancer, helper endpoint

118

2500

0.40

20.25

2.7

270.23

166.85

ug/l

2.75

106

2236

Panniculitis affecting regions of neck and back

696

5118

1.65

20.20

3.4

2.7

120.85

121.46

ug/l

0.02

659

4738

Acute appendicitis

15542

137615

1.11

20.19

2.9

117.53

119.12

ug/l

0.36

14632

128884

Vasomotor rhinitis (mode)

1308

10530

1.45

20.12

3.2

2.8

98.54

117.03

ug/l

4.57

1212

9774

Ankylosing spondylitis, strict definition

825

6256

1.60

20.11

3.2

2.7

103.80

121.34

ug/l

2.18

792

5901

Other specified disorders of kidney and ureter

582

4181

1.76

20.06

5.2

2.7

161.75

128.78

ug/l

1.87

546

3820

therapeutic use

512

3600

1.84

20.04

3.5

2.6

160.45

133.27

ug/l

1.44

462

3268

Left ventricular outflow tract obstruction, narrow definition

830

6285

1.58

20.00

3.2

2.9

184.71

130.38

ug/l

0.42

787

5882

Scleritis and episcleritis

1127

8941

1.49

20.00

3.3

2.8

112.30

107.33

ug/l

0.37

1066

8385

COPD, hospital admission 2, with asthma infections

5073

38543

1.19

19.98

3.5

2.9

159.41

166.81

ug/l

0.79

4581

34875

Retinal breaks without detachment

2505

21350

1.29

19.93

2.9

2.7

137.56

144.63

ug/l

0.56

2281

19684

Polycystic ovarian syndrome

1490

12525

1.51

19.92

3.3

2.9

55.45

51.63

ug/l

1.26

1431

11902

Respiratory insufficiency

1182

9240

1.42

19.92

3.9

2.6

145.66

145.19

ug/l

0.02

1073

8325

Abnormal blood-pressure reading, without diagnosis

784

5875

1.59

19.89

3.2

2.6

115.05

119.00

ug/l

0.18

718

5444

Cluster headache, wide,, including avohilmo

1001

7851

1.54

19.83

3.5

2.8

95.87

104.95

ug/l

0.85

958

7386

Other symptoms and signs involving general sensations and perceptions

686

5064

1.66

19.82

3.1

2.7

147.48

119.47

ug/l

0.57

628

4636

Heterophoria

1617

13406

1.40

19.69

3.1

2.9

87.94

92.15

ug/l

0.34

1491

12566

Other/unspecified enthesopathies, not elsewhere classified

1488

12079

1.38

19.65

3.1

2.7

123.41

134.97

ug/l

1.08

1393

11128

Hypotension due to drugs

247

1473

2.42

19.63

3.3

2.7

143.63

151.54

ug/l

0.23

228

1332

Traumatic subarachnoid haemorrhage

532

3703

1.71

19.60

3.2

2.5

195.06

167.01

ug/l

0.57

474

3377

Other nutritional anaemias

183

980

2.70

19.60

4.5

2.5

241.09

131.02

ug/l

2.96

164

881

Dependence on enabling machines and devices, not elsewhere classified

224

1298

2.56

19.58

12.3

2.7

238.06

121.02

ug/l

7.06

224

1199

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

5778

52220

1.18

19.54

3.0

2.8

105.44

109.94

ug/l

0.85

5387

49188

Nonhereditary hypogammaglobulinemia

227

1354

2.71

19.53

4.4

2.7

195.45

102.80

ug/l

2.53

221

1254

Achilles tendinitis

1733

14299

1.35

19.48

3.2

2.7

128.16

144.45

ug/l

1.53

1608

13271

TMD muscular pain linked with fibromyalgia

226

1386

3.03

19.43

3.9

2.8

78.27

75.62

ug/l

0.16

217

1310

Complications of cardiac and vascular prosthetic devices, implants and grafts

340

2191

2.05

19.40

6.6

2.6

196.39

155.29

ug/l

1.92

319

1985

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

2220

18800

1.30

19.37

2.9

2.8

124.09

115.09

ug/l

0.70

2075

17472

Other strabismus

4505

40140

1.21

19.35

3.1

2.9

95.60

100.05

ug/l

0.83

4199

37717

Allergic contact dermatitis

2772

24036

1.28

19.30

3.0

2.8

97.94

98.37

ug/l

0.02

2588

22510

Polyarthritis, unspecified

646

4729

1.67

19.30

3.4

2.6

160.22

131.51

ug/l

1.36

611

4391

Benign neoplasm of urinary organs

732

5459

1.61

19.27

3.3

2.8

134.06

124.44

ug/l

0.56

677

4995

Melanocytic naevi of trunk

2202

18743

1.32

19.25

3.5

2.9

113.64

111.92

ug/l

0.15

2082

17498

Inguinal or femoral hernia, bilateral

1560

12708

1.36

19.20

3.2

2.8

167.17

189.76

ug/l

1.23

1427

11622

Cluster headache, strict, including avohilmo

952

7459

1.55

19.20

3.6

2.8

91.90

103.85

ug/l

1.51

911

7028

Kyphosis

249

1502

2.40

19.17

3.7

2.6

109.35

124.42

ug/l

0.64

230

1364

Multiple myeloma

402

2698

1.92

19.16

3.8

2.7

312.80

154.75

ug/l

5.11

372

2408

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

402

2698

1.92

19.16

3.8

2.7

312.80

154.75

ug/l

5.11

372

2408

Superficial injury of ankle and foot

2382

20416

1.30

19.16

3.3

2.8

89.70

95.59

ug/l

1.09

2235

19214

Suppurative and necrotic conditions of lower respiratory tract

826

6254

1.54

19.09

3.9

2.8

209.41

162.87

ug/l

3.15

775

5729

Oral leukoplakia and related diseases, including avohilmo

1405

11409

1.40

19.07

3.0

2.8

123.69

139.19

ug/l

1.92

1285

10507

Other specified/unspecified hearing loss

1293

10370

1.41

19.06

3.1

2.8

152.16

137.90

ug/l

0.62

1216

9522

Corneal ulcer

3329

29133

1.24

19.05

3.2

2.8

118.18

120.53

ug/l

0.26

3118

27224

Complications associated with artificial fertilization

462

3337

2.08

19.04

3.4

2.8

50.36

59.68

ug/l

2.86

448

3193

Eosinophilic disease (BM)

293

1847

2.21

18.98

4.4

2.6

149.63

132.65

ug/l

0.45

272

1696

Recurring oral aphthae

835

6421

1.58

18.91

3.7

2.7

140.36

111.35

ug/l

2.04

768

5929

Inguinal hernia, bilateral

1525

12417

1.36

18.85

3.2

2.8

167.68

191.28

ug/l

1.27

1395

11363

Pneumonia due to other infectious organisms, not elsewhere classified

549

3931

1.74

18.85

4.6

2.6

312.17

129.34

ug/l

4.01

520

3609

Malignant neoplasm of small intestine

362

2401

2.02

18.79

3.7

2.8

154.14

152.81

ug/l

0.03

341

2185

Pre-eclampsia or poor fetal growth

7501

69060

1.17

18.78

3.3

2.9

71.68

71.54

ug/l

0.02

7081

65574

Infective dermatitis

1978

16632

1.32

18.72

3.4

2.8

142.64

131.51

ug/l

0.72

1834

15427

Other infective otitis externa

1062

8412

1.48

18.68

3.2

2.8

110.05

121.52

ug/l

1.12

981

7833

Assault

2448

20963

1.28

18.67

2.9

2.8

127.59

112.43

ug/l

2.14

2260

19883

Acute laryngitis and tracheitis

2634

22387

1.28

18.63

3.3

2.7

85.04

85.08

ug/l

0.00

2480

21205

Graves disease, strict definition

2001

17017

1.34

18.61

3.0

2.9

94.81

92.03

ug/l

0.23

1872

16006

Chondrocostal junction syndrome [Tietze]

701

5296

1.66

18.57

3.1

2.7

111.40

103.26

ug/l

0.36

637

4896

Female infertility, tubal origin

1048

8335

1.50

18.54

3.1

2.7

74.58

82.20

ug/l

1.31

1000

7917

Superficial injury of forearm

1864

15684

1.34

18.53

3.0

2.8

98.66

101.79

ug/l

0.35

1724

14664

Chronic Coagulation defects

522

3808

1.87

18.50

4.5

2.8

92.00

88.81

ug/l

0.18

493

3577

Benign neoplasm: Pituitary gland, craniopharyngeal duct

937

7344

1.53

18.45

3.1

2.8

110.47

115.66

ug/l

0.42

874

6836

Golimumab

649

4849

1.69

18.37

3.1

2.7

91.90

98.65

ug/l

0.52

619

4574

Cardiomyopathy in other diseases

104

469

4.03

18.35

4.5

2.2

138.93

189.52

ug/l

1.52

422

Ovarian dysfunction

1935

16672

1.39

18.33

3.3

2.9

61.01

57.40

ug/l

0.83

1849

15851

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

495

3485

1.76

18.33

4.0

2.9

350.94

126.65

ug/l

14.83

467

3191

Arthropathic psoriasis

1931

16254

1.32

18.30

3.1

2.8

139.22

129.73

ug/l

0.80

1800

15171

Gangrene, not elsewhere classified

143

729

3.10

18.27

6.0

2.6

168.03

166.46

ug/l

0.03

133

659

Non-small cell lung cancer, squamous

327

5064

0.57

18.24

2.5

2.9

250.03

177.06

ug/l

2.98

294

4512

Non-small cell lung cancer, squamous, helper endpoint

327

5064

0.57

18.24

2.5

2.9

250.03

177.06

ug/l

2.98

294

4512

Carcinoma in situ of skin of upper limb, including shoulder

361

2411

2.00

18.22

3.9

2.8

168.70

159.05

ug/l

0.28

327

2149

Wide developmental disorders, excluding more controls

575

4127

1.69

18.19

3.0

2.7

63.41

73.39

ug/l

1.29

518

3941

Oral lichen ruber planus, including avohilmo

982

7735

1.50

18.14

3.0

2.8

102.93

120.35

ug/l

2.05

916

7163

Habitual aborter

541

4040

1.91

18.09

3.6

2.8

67.31

58.39

ug/l

0.24

523

3867

Episcleritis

968

7638

1.51

18.07

3.2

2.8

107.66

106.48

ug/l

0.07

916

7171

Hyperfunction of pituitary gland

1039

8331

1.51

18.02

3.3

2.8

95.32

86.82

ug/l

0.42

957

7842

Recurrent dislocation and subluxation of joint

1346

10968

1.40

17.95

2.9

2.7

105.81

109.13

ug/l

0.25

1260

10375

Malignant neoplasm of kidney, except renal pelvis

1324

10712

1.39

17.93

3.7

2.8

219.26

164.30

ug/l

5.95

1199

9725

Otitis externa, unspecified

2018

17151

1.32

17.87

3.5

2.9

114.93

109.56

ug/l

0.43

1861

16059

Dislocation, sprain and strain of joints and ligaments of knee

13272

115595

1.11

17.83

2.8

115.86

114.53

ug/l

0.18

12488

108712

Other and unspecified psoriasis

1082

8605

1.45

17.82

3.4

2.8

151.79

133.35

ug/l

1.31

998

7944

Drug-induced osteoporosis

228

1386

2.49

17.77

5.2

2.6

212.89

113.13

ug/l

1.31

213

1256

Drug-induced hypoglycaemia without coma

300

1932

2.12

17.74

4.9

2.7

137.42

140.05

ug/l

0.07

271

1779

Pregnancy with abortive outcome

17212

85186

1.10

17.73

3.0

2.9

79.54

83.27

ug/l

1.37

15966

79756

Toxic liver disease

293

1894

2.19

17.72

4.3

2.7

319.68

116.12

ug/l

2.05

268

1750

Lung diseases due to external agents

2088

17628

1.28

17.67

3.3

2.9

161.00

155.35

ug/l

0.46

1859

15988

Acne vulgaris

1852

15735

1.35

17.66

3.5

2.8

72.54

69.94

ug/l

0.40

1760

14899

Lichen planus

2066

17537

1.30

17.60

3.0

2.8

131.00

136.01

ug/l

0.35

1883

16086

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

389

2601

1.82

17.59

3.9

2.8

179.43

164.27

ug/l

0.50

365

2343

Benign neoplasm: Anus and anal canal

464

3262

1.78

17.58

3.4

2.7

161.35

131.16

ug/l

0.45

434

2973

Vitamin D deficiency

363

2476

2.03

17.55

4.3

2.6

120.36

94.92

ug/l

1.38

338

2307

Alzheimer’s disease (Late onset), excluding more controls

2174

12189

1.28

17.53

2.6

2.7

145.14

169.26

ug/l

3.74

1859

10884

Sequelae of injuries of lower limb

1642

13674

1.34

17.50

3.2

2.8

112.16

124.17

ug/l

1.60

1542

12768

Sudden idiopathic hearing loss

1614

13399

1.34

17.49

3.3

2.8

141.39

138.93

ug/l

0.10

1456

12352

Other renal tubulo-interstitial diseases

470

3353

1.82

17.48

4.7

2.6

151.79

94.13

ug/l

5.89

448

3103

Any event in cancer register

21533

121296

1.08

17.48

2.9

168.10

106.07

ug/l

44.25

19986

113561

Leiomyoma of uterus

11020

57924

1.13

17.42

3.0

2.8

91.42

80.40

ug/l

6.13

10244

54460

Lactose intolerance

609

4531

1.68

17.42

3.5

2.6

107.99

98.04

ug/l

0.30

571

4218

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1240

10002

1.43

17.33

3.6

2.9

67.04

68.41

ug/l

0.13

1176

9479

Other disorders of breast

2548

22212

1.28

17.32

2.9

87.41

87.95

ug/l

0.04

2386

20748

Other specified and unspecified disorders of eye and adnexa

689

5207

1.61

17.32

3.4

2.8

121.48

119.89

ug/l

0.04

647

4796

Injury of muscle and tendon at hip and thigh level

1593

13243

1.35

17.29

2.9

2.8

123.24

130.58

ug/l

0.70

1495

12386

Other endocrine disorders

1054

8144

1.48

17.26

4.0

2.9

98.44

85.44

ug/l

1.30

963

7611

Malignant neoplasm of urinary organs

1430

11707

1.36

17.26

3.7

2.8

219.03

164.86

ug/l

6.33

1296

10627

Acute suppurative otitis media

6230

53205

1.17

17.22

3.3

2.8

85.47

83.40

ug/l

0.35

5843

50469

Moderate visual impairment, binocular

492

3493

1.72

17.21

4.0

2.8

167.60

131.01

ug/l

0.93

399

3148

Open wound of wrist and hand

8549

78195

1.13

17.12

2.9

2.8

125.08

129.98

ug/l

0.82

7866

73396

Congenital malformations of aortic and mitral valves

684

5154

1.59

17.10

3.2

2.9

199.48

135.29

ug/l

0.41

649

4814

Alzheimer’s disease, wide definition, excluding more controls

2329

13422

1.26

17.10

2.6

2.7

144.04

167.76

ug/l

3.91

1983

12023

Disorder of the sleep-wake schedule

366

2523

2.01

17.02

3.8

2.7

95.10

98.00

ug/l

0.14

339

2339

Type 1 diabetes, wide definition, subgroup 2

1891

0.37

17.02

5.3

2.7

171.67

142.57

ug/l

0.53

1712

Other bullous disorders

483

3466

1.77

17.01

3.4

2.8

142.56

128.12

ug/l

0.43

457

3200

Anogenital herpesviral [herpes simplex] infection

1401

11708

1.42

17.01

3.3

2.9

76.15

77.87

ug/l

0.16

1315

11089

Ectropion of eyelid

580

4217

1.62

17.00

3.1

2.8

162.18

158.46

ug/l

0.09

524

3749

Intussusception

398

2757

1.89

17.00

3.1

2.6

119.96

104.71

ug/l

0.18

374

2530

Spermatocele

1037

8145

1.41

16.96

2.9

196.64

215.71

ug/l

0.63

952

7481

Juvenile arthritis (FINNGEN)

1044

8428

1.49

16.95

3.7

2.8

89.60

77.01

ug/l

0.64

1005

7926

Postzoster neuralgia

264

1672

2.21

16.94

3.6

2.7

307.63

132.57

ug/l

1.18

245

1507

ILD-related respiratory insufficiency

491

3510

1.73

16.93

4.1

2.8

204.41

155.52

ug/l

2.54

466

3171

Embedded and impacted teeth

6505

50804

1.17

16.87

3.1

2.9

73.42

73.52

ug/l

0.01

6238

48117

Other otitis externa (chronic)

1133

9156

1.43

16.86

3.4

2.8

120.43

121.65

ug/l

0.04

993

8501

Entropion and trichiasis of eyelid

1240

10020

1.38

16.82

3.2

2.8

148.96

156.30

ug/l

0.35

1117

9007

Volvulus

433

3016

1.77

16.80

3.9

2.6

123.43

137.19

ug/l

0.70

402

2739

Secondary and unspecified malignant neoplasm of lymph nodes

1305

10652

1.38

16.79

3.1

2.8

352.37

143.73

ug/l

13.81

1216

9748

Sequelae of injuries of upper limb

1649

13785

1.33

16.76

3.1

2.8

120.24

130.43

ug/l

1.23

1546

12879

Other diseases of gallbladder

740

5646

1.55

16.74

3.1

2.7

129.55

128.90

ug/l

0.02

693

5129

Carcinoma in situ of skin of ear and external auricular canal

223

1344

2.30

16.74

4.3

2.9

172.11

176.69

ug/l

0.10

206

1205

Speech and linguistic disorders

1774

14389

1.33

16.71

3.5

2.9

109.17

81.11

ug/l

0.47

1671

13554

Salpingitis and oophoritis

3388

30039

1.23

16.70

3.1

2.8

103.08

98.78

ug/l

0.52

3136

27970

Follicular cysts of skin and subcutaneous tissue

3149

27684

1.23

16.69

3.3

2.8

130.47

130.88

ug/l

0.03

2945

25728

489

3531

1.76

16.66

3.4

2.7

111.50

111.28

ug/l

0.01

435

3331

Portal vein thrombosis

263

1661

2.16

16.66

5.4

2.6

209.75

142.94

ug/l

1.78

247

1522

Late syphilis

241

1498

2.28

16.65

6.4

2.6

165.45

152.95

ug/l

0.37

229

1393

Chronic viral hepatitis

960

7609

1.47

16.59

3.1

2.7

118.33

113.86

ug/l

0.27

877

7209

Other congenital malformations

1742

14764

1.34

16.57

3.4

2.9

98.28

86.64

ug/l

1.15

1641

13905

Bruxism

416

2986

1.96

16.54

3.6

2.8

73.04

81.62

ug/l

1.05

393

2820

Fracture at wrist and hand level

6397

58415

1.15

16.49

3.0

2.8

136.75

128.76

ug/l

0.43

5909

54723

Psoriatic arthropathies, ICD10

1787

15093

1.32

16.44

3.1

2.8

137.22

128.71

ug/l

0.79

1671

14096

Colitis due to radiation

190

1113

2.55

16.41

4.1

2.7

187.31

160.92

ug/l

0.28

181

1011

Use of levodopa decarboxylase inhibitor

1917

16211

1.29

16.41

2.8

2.9

146.08

162.56

ug/l

1.97

1689

14582

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

610

4514

1.59

16.41

3.5

2.7

383.30

135.05

ug/l

7.24

568

4096

Benign neoplasm: Skin of other and unspecified parts of face

1758

14798

1.31

16.35

3.1

2.8

141.25

116.47

ug/l

3.08

1585

13579

Acute myeloid leukaemia and myelodysplastic syndromes

297

1928

2.00

16.31

4.8

2.6

730.17

150.10

ug/l

7.30

272

1738

Other neurotic disorders

820

6360

1.49

16.23

3.2

2.6

106.45

135.29

ug/l

5.35

751

5858

Other obstructive and reflux uropathy

850

6686

1.51

16.22

4.3

2.6

139.44

94.52

ug/l

6.92

802

6172

Other keratitis

2025

17331

1.29

16.17

3.3

2.8

115.43

113.78

ug/l

0.14

1912

16195

Acute generalized exanthematous pustulosis

809

6333

1.53

16.17

3.8

2.8

161.67

113.58

ug/l

1.45

745

5858

Diffuse large B-cell lymphoma, helper endpoint

641

4801

1.57

16.15

3.0

2.8

493.03

141.76

ug/l

10.26

586

4346

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

641

4801

1.57

16.15

3.0

2.8

493.03

141.76

ug/l

10.26

586

4346

Other psoriatic arthropathies

1738

14669

1.32

16.13

3.1

2.8

138.55

128.98

ug/l

0.90

1622

13696

Uterine polyps

1697

14295

1.32

16.04

2.9

2.7

89.54

103.91

ug/l

2.77

1577

13304

Adult-onset Still disease

104

517

4.30

16.04

8.7

2.5

235.93

97.19

ug/l

1.95

479

Long labour

6048

48652

1.18

16.02

3.0

2.9

66.10

68.64

ug/l

0.60

5806

46420

Car occupant injured in other and unspecified transport accidents

3804

34033

1.21

16.01

3.2

2.9

105.63

103.92

ug/l

0.15

3561

31953

Meralgia paraesthetica

578

4307

1.64

15.98

3.4

2.7

123.89

126.40

ug/l

0.06

535

3983

Other complications of labour and delivery, not elsewhere classified

3153

27337

1.28

15.97

3.1

3.0

45.74

53.79

ug/l

11.21

3009

26147

Other localized connective tissue disorders

370

2576

1.92

15.93

3.9

2.7

107.51

98.30

ug/l

0.64

345

2353

Pneumonitis due to solids and liquids

1171

9439

1.37

15.93

3.3

2.8

151.49

159.98

ug/l

0.55

1026

8557

Polyhydramnios

1134

9437

1.50

15.92

3.4

3.0

59.11

61.09

ug/l

0.30

1089

9038

Dental pulpitis 3

3523

22709

1.24

15.92

3.1

2.8

60.88

52.25

ug/l

0.76

3279

21472

Generalized skin eruption due to drugs and medicaments

715

5523

1.57

15.91

3.8

2.8

165.34

113.37

ug/l

1.38

659

5110

Oligomenorrhoea

823

6543

1.56

15.91

3.6

2.7

68.13

68.10

ug/l

0.00

771

6168

Disturbances of smell and taste

710

5451

1.56

15.89

3.2

2.7

109.70

126.27

ug/l

1.60

667

5028

Shock, not elsewhere classified

170

958

2.53

15.88

4.3

2.3

210.47

146.34

ug/l

1.89

162

880

Anxious personality disorder

415

2974

1.88

15.88

3.1

2.7

88.40

89.07

ug/l

0.02

388

2818

Pure hyperglyceridaemia

362

2463

1.84

15.86

4.0

2.5

173.46

155.27

ug/l

0.44

334

2251

Protein-energy malnutrition of moderate and mild degree

169

982

2.81

15.86

4.0

3.0

284.95

115.44

ug/l

0.62

149

885

Other predominantly sexually transmitted diseases, not elsewhere classified

3894

35051

1.21

15.84

3.1

2.9

87.92

83.02

ug/l

0.75

3659

33292

Complications of labour and delivery

15276

80617

1.10

15.83

2.9

78.46

83.09

ug/l

2.58

14330

75530

Fibrosis of liver

139

762

3.20

15.82

5.1

2.6

150.32

126.44

ug/l

0.57

133

705

Dislocation, sprain and strain of joint and ligaments of hip

587

4376

1.62

15.81

3.2

2.7

132.86

129.16

ug/l

0.12

549

3984

Dental pulpitis 3, only avohilmo

3281

21383

1.24

15.78

3.1

2.8

59.52

51.03

ug/l

0.68

3048

20192

Single delivery by forceps and vacuum extractor

4099

22627

1.23

15.77

3.0

52.33

61.69

ug/l

7.41

3896

21666

Other and unspecified haemorrhagic conditions

307

2061

2.05

15.75

4.1

2.7

174.22

106.11

ug/l

2.72

292

1917

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

173

1000

2.63

15.73

3.8

2.7

373.81

131.47

ug/l

2.98

165

919

Calcific tendinitis of shoulder

996

7958

1.43

15.69

2.9

2.6

106.62

127.11

ug/l

2.79

924

7428

Pyothorax

632

4745

1.57

15.69

3.7

2.8

218.32

164.23

ug/l

2.89

597

4347

Radial styloid tenosynovitis [de Quervain]

1078

8753

1.43

15.65

3.2

2.7

85.06

98.04

ug/l

2.25

996

8195

Malignant neoplasm of breast, HER-positive

5031

54592

0.86

15.62

2.5

2.8

142.74

108.17

ug/l

9.56

4593

50128

Non-small cell lung cancer

1650

19693

0.78

15.59

2.6

2.9

228.26

165.17

ug/l

8.29

1502

17683

Other condition

2454

21356

1.26

15.56

3.3

2.8

127.22

118.85

ug/l

0.62

2339

19944

Macular hole

811

6337

1.49

15.49

3.1

2.8

142.10

147.27

ug/l

0.28

737

5717

Acquired pure red cell aplasia [erythroblastopenia]

478

3.87

15.47

5.3

2.5

325.83

104.93

ug/l

2.29

427

Gluteal tendinitis

639

4855

1.58

15.44

3.1

2.6

90.80

112.07

ug/l

3.87

578

4479

Amputation of ankle bones

338

2279

1.86

15.40

8.4

2.6

242.58

167.91

ug/l

4.95

317

2065

Use of antiglaucoma preparations and miotics

1225

9993

1.37

15.40

3.3

2.9

147.46

145.96

ug/l

0.07

1084

8969

Other and unspecified tonsillitis

7851

61675

1.13

15.33

3.1

2.8

104.87

95.65

ug/l

1.81

7408

58614

Normotensive glaucoma

1242

10192

1.37

15.29

3.0

2.8

131.89

147.78

ug/l

1.62

1072

9160

Mixed conductive and sensorineural hearing loss

1937

16528

1.28

15.24

3.0

2.9

150.90

140.03

ug/l

0.61

1744

15170

Scar conditions and fibrosis of skin

766

6019

1.54

15.23

3.4

2.7

94.90

94.84

ug/l

0.00

717

5611

Benign neoplasm of meninges

1574

13227

1.32

15.21

3.0

2.8

126.88

111.94

ug/l

1.47

1424

12081

Other specified/unspecified dorsopathies

619

4672

1.58

15.21

3.2

2.7

110.08

122.12

ug/l

0.49

575

4306

Complications of other internal prosthetic devices, implants and grafts

634

4810

1.57

15.19

3.5

2.6

147.04

127.58

ug/l

0.67

581

4398

Other disorders starting during childhood or adolescence

1131

9243

1.43

15.18

3.5

3.0

60.53

64.34

ug/l

0.47

1069

8738

L02BX Other hormone antagonists and related agents

730

5630

1.51

15.17

2.5

3.0

481.61

198.53

ug/l

13.02

667

5102

Abnormal findings in nipple discharge synovial fluid wound secretions

303

2056

2.05

15.16

4.4

2.8

132.70

101.92

ug/l

1.33

285

1902

Other bursitis of hip

364

2536

1.86

15.12

3.4

2.6

121.53

119.98

ug/l

0.05

330

2308

Carcinoma in situ of skin of lower limb, including hip

307

2059

1.96

15.10

3.7

2.7

135.24

130.71

ug/l

0.16

277

1852

Pyoderma gangrenosum

158

923

2.93

15.06

4.9

2.8

176.16

104.85

ug/l

1.33

151

857

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

846

6600

1.44

15.04

3.3

2.8

214.57

146.44

ug/l

6.39

782

5976

Other peripheral vertigo

1495

12540

1.33

15.01

3.0

2.8

116.68

127.93

ug/l

0.74

1362

11539

Acute alcohol intoxication, ICD10

3428

30483

1.20

14.98

3.0

2.8

147.44

135.77

ug/l

1.31

3108

28564

Explicit fungal Sepsis

127

677

3.07

14.97

6.9

2.4

401.91

129.31

ug/l

1.93

118

616

Chronic conjunctivitis

546

4088

1.65

14.97

3.1

2.7

124.48

111.39

ug/l

0.35

521

3790

Benign neoplasm of eye and adnexa

1566

13172

1.32

14.93

3.1

2.8

125.10

116.95

ug/l

0.60

1447

12129

Autism spe, excluding more controls

437

3143

1.73

14.86

2.9

2.6

67.87

73.52

ug/l

0.43

390

2995

Melanocytic naevi, other sites/unspecified

1388

11606

1.35

14.85

3.7

2.8

116.58

100.67

ug/l

1.85

1317

10853

Xerosis cutis

263

1722

2.09

14.83

4.2

2.8

143.84

131.30

ug/l

0.45

245

1575

Disease of hard tissues of teeth, NOS

218

1373

2.31

14.82

4.3

2.6

116.07

102.93

ug/l

0.42

211

1277

Astigmatism

1136

9331

1.40

14.76

3.4

2.9

106.23

97.60

ug/l

0.64

1055

8713

Urethritis and urethral syndrome

413

2951

1.76

14.76

3.4

2.6

120.06

113.63

ug/l

0.19

381

2712

Premenstrual syndrome

277

1892

2.24

14.74

3.7

2.7

58.82

66.54

ug/l

1.13

272

1806

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

118

2261

0.45

14.71

2.7

270.23

149.75

ug/l

3.53

106

2028

Myelodysplastic syndrome

149

827

2.60

14.70

5.3

2.7

588.62

166.56

ug/l

8.87

133

733

Lesion of plantar nerve

1021

8266

1.41

14.69

2.9

2.7

116.15

124.25

ug/l

0.41

943

7595

Acquired absence of limb

165

949

2.50

14.68

7.1

2.6

236.38

143.86

ug/l

2.97

157

863

Alopecia areata

535

4048

1.69

14.63

3.0

2.8

89.30

91.27

ug/l

0.12

504

3764

Chondropathies

2889

25552

1.22

14.56

3.0

2.8

110.40

113.14

ug/l

0.28

2692

23953

Dystonia

952

7677

1.44

14.52

3.1

2.8

102.54

115.95

ug/l

1.25

874

7133

Acquired absence of organs, not elsewhere classified

213

1322

2.22

14.52

6.2

2.6

184.34

133.96

ug/l

1.36

200

1205

Thalassaemia

506

4.64

14.51

9.0

2.6

125.80

86.45

ug/l

1.51

470

Left hemicolectomy

378

2654

1.78

14.51

3.6

2.8

148.07

156.67

ug/l

0.23

346

2391

Tracheo-bronchomalasia

105

533

3.49

14.44

3.4

2.4

83.21

87.24

ug/l

0.16

509

Clear cell adenocarcinoma of kidney

673

5183

1.53

14.43

3.4

2.8

215.25

163.95

ug/l

2.90

606

4703

Gastrojejunal ulcer

206

1257

2.17

14.35

4.9

2.6

115.85

152.22

ug/l

2.21

196

1136

Early lumbar disc prolapse, operated

1956

16843

1.28

14.33

2.8

101.32

100.62

ug/l

0.04

1864

16114

Systemic sclerosis

446

3270

1.74

14.30

3.9

2.6

105.53

103.94

ug/l

0.05

415

3026

Osteonecrosis due to drugs

218

1384

2.25

14.26

4.3

2.6

279.70

144.36

ug/l

5.83

204

1254

Asthma mixed form (mode), excluding more controls

959

7685

1.40

14.26

3.1

2.5

114.57

107.19

ug/l

0.32

911

7098

Prolonged pregnancy

4002

33291

1.21

14.23

3.0

57.43

60.97

ug/l

0.44

3799

31969

Other and unspecified glaucoma

1018

8222

1.39

14.23

3.3

2.8

161.90

146.49

ug/l

0.60

899

7413

Visual field defects

1368

11425

1.34

14.20

3.2

2.8

151.11

133.52

ug/l

0.88

1252

10522

Allergic urticaria

1604

13676

1.32

14.20

3.4

2.8

114.02

93.64

ug/l

1.36

1495

12814

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

173

1034

2.50

14.18

3.8

2.6

373.81

146.86

ug/l

2.68

165

938

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

172

1024

2.47

14.13

4.3

2.6

264.03

131.55

ug/l

3.30

166

945

Other specified/unspecified spondylopathies

406

2889

1.71

14.11

3.6

2.7

135.65

142.89

ug/l

0.23

385

2596

Emphysema

993

7971

1.38

14.05

3.3

2.7

186.56

175.07

ug/l

0.43

904

7200

Protozoal diseases

454

3330

1.69

14.02

4.6

2.8

290.78

140.93

ug/l

2.38

428

3053

Other nonscarring hair loss

224

1492

2.50

14.02

3.9

2.7

93.76

70.94

ug/l

1.49

217

1392

Congenital malformations of cardiac septa

1244

10025

1.37

14.01

3.6

3.0

95.98

97.13

ug/l

0.08

1162

9387

Pemphigoid

419

3020

1.71

14.00

3.4

2.8

140.06

144.57

ug/l

0.15

379

2724

Spinal instabilities

503

3735

1.63

14.00

3.0

2.7

112.16

122.97

ug/l

0.41

470

3476

Procedures for purposes other than remedying health state

479

3568

1.68

13.88

2.9

2.6

98.46

89.36

ug/l

0.42

450

3331

Pneumonia derived septicemia

577

4383

1.58

13.88

4.0

2.8

189.43

132.11

ug/l

2.49

534

4029

Rare circulating lymphoid malignancy

495

3670

1.63

13.87

4.0

2.9

350.94

141.61

ug/l

13.02

467

3354

Benign neoplasm of urinary organs

732

5736

1.49

13.87

3.3

2.8

134.06

135.78

ug/l

0.07

677

5243

Other puerperal infections

1976

17434

1.33

13.79

3.5

3.0

57.55

57.10

ug/l

0.04

1879

16601

Other erythematous conditions

591

4521

1.57

13.77

3.6

2.7

118.29

120.23

ug/l

0.07

552

4163

Chronic hepatitis NAS

258

1726

2.09

13.73

3.6

2.6

215.63

118.02

ug/l

1.51

241

1576

Other retinal artery occlusion

361

2532

1.76

13.72

3.7

2.8

144.77

149.56

ug/l

0.17

335

2278

Benign neoplasm of middle ear and respiratory system

1171

9620

1.35

13.72

3.1

2.8

143.86

132.63

ug/l

0.51

1104

8881

Other disorders of amniotic fluid and membranes

3418

30694

1.22

13.70

3.1

3.0

57.46

63.24

ug/l

3.63

3227

29464

Other disorders of cornea

1522

12872

1.31

13.69

3.2

2.8

114.16

128.50

ug/l

2.22

1401

11907

Subacute thyroiditis

653

5081

1.54

13.69

3.2

2.7

111.21

103.38

ug/l

0.25

603

4732

Varicose veins of other sites

985

7944

1.38

13.64

3.5

2.7

149.32

154.62

ug/l

0.19

909

7355

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

2583

22671

1.22

13.62

2.4

2.8

245.73

134.70

ug/l

35.71

2402

20669

Other specified/unspecified necrotizing vasculopathies

250

1649

2.05

13.59

5.6

2.7

176.65

130.00

ug/l

2.88

234

1506

Benign neoplasm: Kidney

530

3989

1.59

13.53

3.4

2.7

130.94

119.06

ug/l

0.63

495

3652

Short Achilles tendon (acquired)

486

3616

1.64

13.51

3.0

2.6

100.21

113.14

ug/l

0.69

480

3358

Benign neoplasm: Anus and anal canal

464

3428

1.65

13.46

3.4

2.8

161.35

137.92

ug/l

0.32

434

3115

Operations for atrial fibrillation

248

1633

2.03

13.42

3.4

2.7

157.24

177.34

ug/l

0.61

228

1492

Other and specified injuries of hip and thigh

376

2687

1.76

13.39

3.6

2.7

137.00

126.11

ug/l

0.38

337

2448

Syphilis

415

3001

1.68

13.35

4.9

2.6

156.87

153.28

ug/l

0.11

398

2797

Benign neoplasm: Cerebral meninges

1418

11953

1.32

13.35

3.0

2.8

124.98

110.39

ug/l

1.38

1285

10937

Hypersomnia

286

1975

2.00

13.28

3.6

2.7

113.02

107.14

ug/l

0.14

273

1832

Stenosis and insufficiency of lacrimal passages

1565

13322

1.30

13.27

2.9

2.8

106.50

120.37

ug/l

2.59

1435

12239

Hyperprolactinaemia

750

6035

1.53

13.27

3.1

2.8

90.20

80.46

ug/l

0.36

701

5714

Postpartum hemorraghe, parous women as controls

6467

52763

1.15

13.27

3.2

2.9

63.94

65.81

ug/l

0.59

6115

50390

Wegener granulomatosis

284

1940

1.94

13.22

4.6

2.7

178.77

131.28

ug/l

2.04

277

1794

Systemic sclerosis, icd10

443

3294

1.71

13.19

3.9

2.7

105.66

104.80

ug/l

0.03

412

3049

Medical abortion

16182

83794

1.09

13.18

2.9

83.51

83.75

ug/l

0.04

14992

78500

Embolic stroke with flimmer

346

2383

1.69

13.14

3.6

2.6

136.79

166.67

ug/l

2.25

318

2116

Eosinophilia

294

2031

1.93

13.11

4.4

2.7

149.14

128.77

ug/l

0.61

273

1866

Pleural plaque

1369

11464

1.31

13.09

2.9

183.45

182.08

ug/l

0.05

1179

10238

Campylobacter enteritis

469

3496

1.64

13.07

3.7

2.8

133.43

124.61

ug/l

0.34

445

3243

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

2220

19418

1.24

13.07

2.9

2.8

124.09

128.68

ug/l

0.28

2075

18055

Other hereditary haemolytic anaemias

135

784

2.91

13.05

5.1

2.7

177.14

100.10

ug/l

3.36

129

731

Anorexia

323

2306

1.93

13.04

3.9

2.8

103.31

79.93

ug/l

1.48

311

2145

Other disorders of the genitourinary system

2063

17967

1.25

13.04

3.2

2.8

113.73

119.91

ug/l

0.60

1877

16433

Other and unspecified injuries of lower leg

1377

11655

1.33

13.04

3.2

2.8

102.67

101.92

ug/l

0.06

1271

10920

Alzheimer’s disease (undefined)

1000

0.27

13.04

2.5

2.8

123.20

153.19

ug/l

0.56

877

Other and unspecified epidermal thickening

472

3529

1.64

13.03

3.8

2.7

124.94

120.65

ug/l

0.16

450

3246

Orthopaedic devices associated with adverse incidents

285

1954

1.93

13.02

3.2

2.7

170.79

139.11

ug/l

1.10

248

1757

Bronchitis, not specified as acute or chronic

1427

12008

1.30

13.02

3.4

2.7

128.46

140.39

ug/l

0.79

1312

11095

Bicuspidal aortic valve syndrome

567

4325

1.54

12.98

3.0

2.8

226.48

146.05

ug/l

0.42

534

4029

Fentanyl

1440

12061

1.28

12.96

3.5

2.6

235.80

145.40

ug/l

6.82

1304

10878

Lactose intolerance, other/unspecified

517

3924

1.61

12.95

3.5

2.6

95.97

101.86

ug/l

0.35

484

3647

Abnormality of red blood cells

107

569

3.17

12.95

3.4

2.4

178.14

124.41

ug/l

1.68

520

Necrotizing fasciitis

451

3.40

12.95

4.8

2.4

283.88

161.63

ug/l

0.54

405

Additional codes for the location of defect, injury or illness

966

7910

1.40

12.95

3.1

2.8

117.66

120.57

ug/l

0.13

926

7307

Other and unspecified erythematous conditions

528

4016

1.59

12.89

3.6

2.7

118.97

119.76

ug/l

0.03

494

3690

Other disorders of pigmentation

720

5695

1.48

12.88

3.2

2.7

118.00

116.91

ug/l

0.05

663

5237

Retinal detachment with retinal break

1906

16444

1.25

12.86

3.2

2.8

150.11

156.31

ug/l

0.46

1736

15070

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

187

1165

2.25

12.86

3.3

2.7

139.16

132.44

ug/l

0.15

172

1058

Bullous pemphigoid

329

2306

1.79

12.85

3.4

2.8

134.35

152.52

ug/l

0.72

296

2069

Assault by bodily force

1371

11571

1.32

12.85

2.9

2.7

129.79

110.28

ug/l

1.64

1257

10953

Postpartum hemorraghe, all women as controls

6467

60111

1.15

12.81

3.2

3.0

63.94

64.72

ug/l

0.20

6115

57449

Hypoplasia of dental enamel , including avohilmo

587

4549

1.61

12.81

5.1

3.0

70.26

51.63

ug/l

2.03

570

4316

Chronic myeloid leukaemia [CML], BCR/ABL-positive

170

1039

2.37

12.79

4.3

2.6

263.93

149.00

ug/l

2.56

165

951

Pre-eclampsia or eclampsia

4817

44316

1.17

12.78

3.3

2.9

81.71

78.13

ug/l

0.63

4552

41860

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

422

3069

1.64

12.78

2.9

2.7

128.56

142.80

ug/l

0.76

404

2769

Oral lichen ruber planus, hypothyreosis or thyroxin

291

2032

1.95

12.76

3.0

2.7

121.07

98.23

ug/l

0.69

270

1867

Myopia

2581

22945

1.23

12.75

3.3

2.9

90.03

90.43

ug/l

0.03

2393

21675

Carcinoma in situ of other and unspecified sites

468

3458

1.59

12.72

3.3

2.8

162.07

164.42

ug/l

0.07

411

3126

Disorders of porphyrin and bilirubin metabolism

211

1356

2.12

12.72

4.3

2.6

154.35

136.67

ug/l

0.55

202

1257

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

490

3633

1.56

12.70

3.0

2.8

158.36

166.47

ug/l

0.21

453

3288

Other congenital malformations of the digestive system

800

6396

1.45

12.69

4.4

2.9

91.57

99.17

ug/l

0.72

770

5967

Cerebral cysts

1024

8462

1.39

12.67

4.3

2.8

104.89

108.27

ug/l

0.25

958

7884

Fracture of neck

873

7040

1.40

12.65

3.4

2.8

167.10

152.33

ug/l

0.57

799

6440

Alzheimer’s disease (Atypical or mixed), excluding more controls

1023

7161

1.34

12.58

2.6

2.8

170.25

173.33

ug/l

0.10

848

6343

Somnolence, stupor and coma

713

5617

1.45

12.56

4.1

2.7

160.51

132.30

ug/l

0.56

662

5166

Other abnormal immunological findings in serum

386

2847

1.77

12.53

3.4

2.8

91.42

89.88

ug/l

0.07

368

2647

Molar incisor enamel hypoplasia

633

4926

1.57

12.52

5.1

3.0

69.68

51.47

ug/l

2.16

613

4676

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

1422

12086

1.31

12.50

3.3

2.8

118.28

102.84

ug/l

1.79

1312

11211

Infections of genitourinary tract in pregnancy

2125

18793

1.27

12.46

3.2

2.9

68.75

73.68

ug/l

1.06

2024

17692

Congenital malformations of gallbladder, bile ducts and liver

185

1176

2.33

12.46

5.9

2.9

116.17

101.00

ug/l

0.66

179

1086

Nosocomial condition (hospital)

119

666

2.90

12.44

3.8

2.6

134.55

120.31

ug/l

0.36

108

598

Benign neoplasm: Pancreas

400

2929

1.69

12.42

4.3

2.7

132.48

130.35

ug/l

0.07

383

2657

Background retinopathy and retinal vascular changes

342

2430

1.75

12.41

5.1

2.8

149.71

140.49

ug/l

0.31

319

2231

Other disorders of optic [2nd] nerve and visual pathways

1078

8962

1.37

12.40

3.5

2.8

126.40

114.98

ug/l

0.89

993

8323

Other interventions on the root canals of the tooth

350

2534

1.80

12.39

4.6

2.8

123.90

104.82

ug/l

0.74

334

2359

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

224

1470

2.04

12.36

3.5

2.6

158.24

136.05

ug/l

0.65

211

1326

Effects of foreign body entering through natural orifice

4186

38027

1.16

12.35

2.9

2.8

131.94

137.37

ug/l

0.51

3882

35581

Labour and delivery complicated by fetal stress [distress]

6741

42097

1.15

12.34

3.1

3.0

51.60

59.37

ug/l

10.24

6432

40361

Benign leiomyoma with endometriosis

2752

24540

1.21

12.34

3.0

2.8

103.48

94.30

ug/l

0.99

2498

22598

Other prurigo

214

1402

2.13

12.33

4.2

2.7

130.42

120.14

ug/l

0.19

204

1279

Personal history of medical treatment

180

1135

2.31

12.33

4.1

2.6

130.39

102.66

ug/l

0.85

170

1040

Alzheimer’s disease (Early onset)

353

4971

0.64

12.29

2.4

2.8

136.65

141.99

ug/l

0.19

293

4418

Other immunodeficiencies

226

1515

2.14

12.29

4.6

2.8

99.27

97.95

ug/l

0.05

221

1413

Oral leukoplakia and related diseases

853

6903

1.41

12.22

3.0

2.8

132.83

143.64

ug/l

0.66

783

6321

Leiomyoma of uterus

13818

74636

1.09

12.20

2.9

2.8

97.52

94.65

ug/l

0.74

12735

69781

Congenital malformations and deformations of the musculoskeletal system

1768

15301

1.28

12.19

3.4

2.9

77.47

81.29

ug/l

0.49

1674

14436

Hidradenitis suppurativa

715

5746

1.49

12.17

3.7

2.8

109.19

89.51

ug/l

1.94

674

5412

Antepartum haemorrhage, not elsewhere classified

2075

18427

1.28

12.13

3.3

3.0

62.26

64.01

ug/l

0.15

2001

17710

Mental and behavioural disorders due to opioids

689

5466

1.47

12.12

3.3

2.8

95.75

103.17

ug/l

0.50

623

5178

Dermatitis herpetiformis

328

2346

1.79

12.03

3.1

2.7

141.21

128.15

ug/l

0.28

308

2178

Thyroiditis, unspecified

304

2159

1.86

11.98

3.5

2.6

110.05

90.39

ug/l

1.12

275

1998

Carcinoma in situ of skin of lower limb, including hip

307

2169

1.81

11.90

3.7

2.7

135.24

145.25

ug/l

0.38

277

1929

Respiratory disorders in diseases classified elsewhere

247

1685

1.97

11.81

4.0

2.7

216.15

126.22

ug/l

1.32

236

1551

COPD, hospital admissions 3, with asthma pneumonia sepsis

4090

31533

1.15

11.80

3.6

2.9

163.95

170.29

ug/l

0.56

3691

28375

Other other unspecified disorders of the circulatory system

578

4487

1.51

11.80

3.8

2.8

165.65

137.90

ug/l

1.32

532

4106

Selective deficiency of immunoglobulin G [IgG] subclasses

151

933

2.57

11.78

4.8

2.7

126.34

91.03

ug/l

1.15

146

862

Benign neoplasm: Other and unspecified parts of small intestine

273

1890

1.87

11.77

4.6

2.6

103.33

124.81

ug/l

1.55

261

1699

Nontoxic single thyroid nodule

1214

10230

1.32

11.76

3.1

2.8

114.67

112.18

ug/l

0.14

1121

9487

Foreign body in alimentary tract

912

7485

1.39

11.75

3.1

2.8

117.46

125.37

ug/l

0.49

831

6929

Haemophagocytic lymphohistiocytosis

145

12.04

11.74

21.2

2.9

3701.85

115.39

ug/l

3.88

133

Bacterial, viral and other infectious agents

1463

12500

1.28

11.73

3.5

2.8

147.12

126.84

ug/l

1.10

1386

11729

Malignant neoplasm of eye, brain and central nervous system

398

5374

0.66

11.70

2.5

2.8

206.36

135.28

ug/l

1.53

361

4935

Other diseases of peritoneum

762

6146

1.43

11.68

3.5

2.7

114.83

115.19

ug/l

0.02

712

5671

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

5091

44843

0.88

11.53

2.5

2.8

142.09

94.39

ug/l

18.14

4649

41403

Brain glioblastoma

1387

0.40

11.50

2.4

2.6

204.52

149.91

ug/l

0.70

1269

Benign lipomatous neoplasm of other sites/unspecified

1319

11159

1.29

11.49

2.8

133.99

125.90

ug/l

0.57

1192

10217

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

847

6913

1.40

11.47

3.1

2.7

108.11

112.08

ug/l

0.18

800

6464

Arterial embolism and thrombosis of lower extremity artery

506

3837

1.51

11.46

4.1

2.7

164.05

153.16

ug/l

0.39

467

3435

Asthma mixed form (mode)

959

7884

1.35

11.46

3.1

2.5

114.57

109.16

ug/l

0.22

911

7309

Von Willebrand disease

289

2084

1.94

11.42

4.7

2.8

91.51

74.56

ug/l

0.98

274

1943

Alzheimer’s disease (undefined), excluding more controls

910

0.29

11.42

2.5

2.7

123.20

157.48

ug/l

0.67

785

Collapsed vertebra, not elsewhere classified

135

790

2.41

11.41

4.2

2.6

136.70

132.01

ug/l

0.10

118

698

Examination and encounter for administrative purposes

643

5044

1.44

11.40

3.1

2.6

139.35

153.09

ug/l

0.69

604

4622

Other overlap syndromes

348

2556

1.76

11.39

3.7

2.7

138.86

101.70

ug/l

0.95

323

2365

Autonomic disorders

374

2750

1.68

11.39

3.5

2.7

124.15

137.22

ug/l

0.32

350

2527

Glaucoma, exfoliation

1586

13614

1.26

11.34

2.7

2.9

136.42

150.08

ug/l

1.45

1402

12122

Other/unspecified disorders of vestibular function

612

4819

1.48

11.34

3.1

2.7

113.09

128.25

ug/l

1.34

563

4391

Unspecified contracted kidney

112

630

2.76

11.29

8.0

2.5

228.61

121.91

ug/l

3.35

106

570

Parkinson's disease, including avohilmo

2235

19680

1.21

11.28

2.7

2.9

145.07

162.82

ug/l

3.12

1991

17722

Dislocation of lens

217

1412

1.89

11.27

3.6

2.7

180.27

163.21

ug/l

0.47

187

1263

Cachexia

500

2.91

11.25

3.4

2.5

236.75

138.13

ug/l

2.40

447

Syndrome of inappropriate secretion of antidiuretic hormone

102

560

2.95

11.24

3.0

2.5

122.69

123.20

ug/l

0.01

504

Thyrotoxicosis with toxic multinodular goitre

938

7751

1.37

11.23

3.3

2.8

116.66

119.65

ug/l

0.15

863

7080

Schizophrenia or delusion

6116

56770

1.12

11.20

2.8

114.60

117.92

ug/l

0.30

5594

53284

Pneumococcal septicemia

542

4211

1.52

11.19

3.9

2.9

191.77

131.82

ug/l

2.43

499

3874

Chronic iridocyclitis

857

7034

1.39

11.17

3.4

2.8

123.67

117.20

ug/l

0.18

800

6515

Abnormality of white blood cells, not elsewhere classified

163

1037

2.36

11.13

4.7

2.6

207.45

115.15

ug/l

1.85

154

955

Malignant neoplasm of brain

296

4148

0.62

11.08

2.3

2.8

229.68

133.90

ug/l

1.56

265

3836

Erectile dysfunction

1083

9019

1.32

11.07

3.7

3.0

183.10

205.81

ug/l

1.22

992

8192

Congenital malformations of the musculoskeletal system, not elsewhere classified

329

2454

1.87

11.07

4.3

2.9

61.95

70.45

ug/l

1.28

308

2323

Other specified and unspecified disorders of lens

147

886

2.26

11.05

3.0

2.7

135.52

138.14

ug/l

0.05

123

787

Endocrine disorders, other/unspecified

371

2756

1.69

11.03

4.0

2.8

126.46

112.45

ug/l

0.55

322

2558

Complications of genitourinary prosthetic devices, implants and grafts

448

3421

1.60

11.03

3.7

2.6

136.28

107.94

ug/l

1.78

418

3149

Neuroendocrine tumor and carcinoma of small intestine

224

1511

1.96

11.03

3.5

2.6

158.24

150.05

ug/l

0.18

211

1383

Other arterial embolism and thrombosis

417

3094

1.57

11.02

5.0

2.7

160.51

150.22

ug/l

0.39

385

2785

Haemangioma and lymphangioma, any site

1499

12928

1.27

10.97

3.3

2.8

104.99

103.76

ug/l

0.08

1411

12039

Unspecified protein-energy malnutrition

102

563

2.86

10.93

3.7

2.8

203.37

113.07

ug/l

1.87

505

Use of ropinirole

530

4115

1.51

10.93

3.0

2.8

128.75

155.84

ug/l

1.82

479

3709

Schizophrenia, schizotypal and delusional disorders

6132

56981

1.12

10.92

2.8

114.54

117.93

ug/l

0.31

5604

53470

Family history of certain disabilities and chronic diseases leading to disablement

944

7904

1.39

10.92

3.3

2.7

71.75

78.83

ug/l

1.02

886

7457

Lichen simplex chronicus

553

4314

1.49

10.91

3.7

2.7

116.52

136.71

ug/l

2.01

514

3983

Deep endometriosis

1966

17439

1.25

10.90

3.0

2.9

81.48

ug/l

0.00

1820

16284

Other sideroblastic anaemias

390

3.32

10.89

8.0

2.4

201.85

121.33

ug/l

1.35

347

Carrier of infectious disease

446

3423

1.61

10.89

4.0

2.8

127.29

102.19

ug/l

1.24

412

3196

Other and unspecified types of non-Hodgkin lymphoma, hilmo

610

4805

1.46

10.88

3.5

2.8

383.30

146.90

ug/l

6.64

568

4338

Pre-eclampsia

4499

41583

1.16

10.85

3.3

2.9

81.42

76.82

ug/l

0.84

4257

39329

Other specified and unspecified retinal disorders

538

4188

1.50

10.82

4.1

2.7

141.11

135.05

ug/l

0.18

491

3831

Adenocarcinoma and papilloma adenocarcinoma of rectum

1336

11378

1.28

10.79

2.6

2.9

173.15

159.69

ug/l

0.38

1213

10348

Dependent personality disorder

375

2799

1.67

10.79

3.6

2.6

112.32

107.86

ug/l

0.13

349

2612

Separation of retinal layers (serosa)

609

4794

1.45

10.78

3.4

2.7

177.36

158.39

ug/l

0.47

565

4447

Hypertrophic disorders of skin

1126

9566

1.34

10.78

3.3

2.8

82.15

90.89

ug/l

1.17

1049

8962

Myocardial infarction, with ST-elevation

2507

22248

1.19

10.78

3.5

2.9

170.64

178.24

ug/l

0.47

2308

20035

Other and unspecified mononeuropathies, also in other diseases

482

3694

1.53

10.77

4.1

2.6

104.22

132.82

ug/l

3.40

448

3374

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1386

11841

1.27

10.76

2.6

2.9

170.18

160.62

ug/l

0.26

1261

10767

Benign neoplasm: Skin of other and unspecified parts of face

1758

15336

1.24

10.74

3.1

2.9

141.25

129.04

ug/l

0.97

1585

14059

Leukaemia of unspecified cell type

152

939

2.24

10.73

4.6

2.7

535.25

120.98

ug/l

6.84

143

858

Symptoms and signs involving emotional state

560

4422

1.51

10.71

3.5

2.7

94.68

97.18

ug/l

0.13

534

4143

Septal defects

1144

9497

1.33

10.71

3.5

3.0

95.47

96.17

ug/l

0.04

1066

8898

Hemiplegia

845

6924

1.37

10.68

3.4

2.8

117.48

125.96

ug/l

0.48

777

6399

Exposure to other and unspecified inanimate mechanical forces

1153

9754

1.31

10.67

3.3

2.8

129.39

118.74

ug/l

0.44

1083

9107

Other inflammation of vagina/vulva

817

6830

1.45

10.65

3.2

2.9

67.21

65.32

ug/l

0.16

772

6452

Dislocation, sprain and strain of joints and ligaments of thorax

557

4381

1.50

10.63

3.1

2.8

116.29

121.93

ug/l

0.27

519

4062

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

251

1740

1.84

10.59

3.4

2.6

283.41

131.33

ug/l

3.81

235

1572

Melanocytic naevi, other sites/unspecified

1388

11971

1.29

10.58

3.7

2.8

116.58

111.64

ug/l

0.34

1317

11181

Delivery

9534

47677

1.11

10.56

2.9

74.39

87.28

ug/l

10.48

8833

44305

Benign neoplasm: Other and unspecified parts of small intestine

273

1935

1.81

10.52

4.6

2.6

103.33

131.24

ug/l

2.34

261

1747

Sequelae of injuries of neck and trunk

479

3684

1.53

10.51

3.1

2.7

127.22

136.16

ug/l

0.25

446

3422

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

676

5480

1.45

10.48

3.2

2.8

97.88

102.14

ug/l

0.17

645

5133

Recurrent and persistent haematuria

160

1018

2.23

10.47

4.7

2.5

141.16

117.68

ug/l

0.78

148

939

Infection due to other mycobacteria

248

1709

1.81

10.45

3.6

2.6

133.81

120.69

ug/l

0.50

235

1528

Contusion of toe(s) without damage to nail

489

3836

1.57

10.42

3.0

2.8

84.28

87.10

ug/l

0.18

463

3594

Medial epicondylitis

638

5092

1.44

10.40

2.9

2.6

109.78

127.08

ug/l

1.52

591

4773

Acute alcohol intoxication

4321

39603

1.14

10.39

3.1

2.8

149.12

144.21

ug/l

0.46

3938

36819

Gastrointestinal stromal tumor and sarcoma

187

1233

2.07

10.39

3.3

2.6

139.16

140.29

ug/l

0.02

172

1115

Other and unspecified nonscarring hair loss

168

1131

2.52

10.39

3.7

2.7

98.07

65.26

ug/l

1.83

161

1053

Inflammatory diseases of the central nervous system

1387

11935

1.28

10.39

3.2

2.8

130.89

122.49

ug/l

0.55

1279

11102

Other salmonella infections

615

4890

1.45

10.38

3.2

2.7

175.30

123.75

ug/l

2.03

561

4509

Benign neoplasm: Oesophagus

206

1383

1.97

10.37

4.2

2.7

115.17

124.99

ug/l

0.25

190

1259

Dermatopolymyositis (FG)

236

1618

1.84

10.35

3.5

2.6

194.51

126.46

ug/l

1.94

224

1485

Benign neoplasm of meninges

1574

13678

1.26

10.35

3.0

2.8

126.88

123.03

ug/l

0.23

1424

12519

Viral infections of the central nervous system

1259

10770

1.29

10.34

3.1

2.8

117.13

111.45

ug/l

0.43

1159

10044

Medicines for HER+ breast cancer

5594

58600

0.89

10.31

2.6

2.8

137.91

106.36

ug/l

9.64

5130

53887

Bicipital tendinitis

733

5930

1.39

10.28

2.9

2.6

138.27

148.63

ug/l

0.39

687

5508

Secondary parkinsonism, excluding more controls

347

2516

1.59

10.25

3.1

2.5

135.50

162.83

ug/l

1.55

308

2298

Other surgical follow-up care

595

4753

1.47

10.19

3.6

2.6

99.55

99.36

ug/l

0.01

560

4377

Carcinoma in situ, bladder

425

3209

1.54

10.19

3.4

2.8

159.34

167.52

ug/l

0.27

373

2906

Brain glioblastoma and astrocytoma

116

1935

0.50

10.18

2.2

2.7

156.36

140.48

ug/l

0.26

1793

Diffuse large B-cell lymphoma

641

5132

1.43

10.17

3.0

2.8

493.03

149.22

ug/l

9.88

586

4641

Leukaemia of unspecified cell type

152

954

2.19

10.15

4.6

2.8

535.25

128.19

ug/l

6.70

143

872

Ménière disease

1515

13138

1.26

10.14

2.9

2.8

123.94

128.96

ug/l

0.23

1384

12071

Benign neoplasm: Tongue

430

3277

1.55

10.14

3.2

2.7

132.01

122.29

ug/l

0.34

398

3001

Benign neoplasm: Skin of ear and external auricular canal

587

4641

1.44

10.13

3.1

2.8

144.62

125.89

ug/l

0.47

527

4234

Retinal haemorrhage

367

2730

1.61

10.10

4.0

2.7

168.02

134.40

ug/l

0.72

336

2489

Presbyopia

1002

8415

1.33

10.09

3.0

2.7

111.52

125.88

ug/l

1.47

949

7923

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

1332

0.42

10.08

2.4

2.6

204.52

139.98

ug/l

0.89

1211

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1888

16833

1.25

10.06

3.2

2.9

64.71

71.58

ug/l

2.47

1798

15954

Dementia, including avohilmo

6806

43782

1.11

10.02

2.8

2.9

146.29

161.67

ug/l

4.98

5876

39276

Ehlers-Danlos syndrome

238

1731

2.11

10.00

4.5

2.9

63.73

59.57

ug/l

0.41

219

1644

Acute nasopharyngitis (common cold)

1892

16490

1.21

9.99

2.9

2.7

149.49

142.87

ug/l

0.39

1792

15524

Intrahepatic Cholestasis of Pregnancy (ICP)

1645

14599

1.28

9.97

3.1

2.9

56.81

65.07

ug/l

4.46

1573

13926

Other disorders of electrolyte and fluid balance, not elsewhere classified

149

929

2.15

9.94

3.4

2.4

170.72

127.82

ug/l

0.96

144

819

Toxic effects of substances chiefly nonmedicinal as to source

1997

17691

1.22

9.92

2.9

2.8

113.39

113.65

ug/l

0.02

1853

16557

Use of rotigotine

194

1305

2.01

9.92

4.6

2.6

135.48

127.62

ug/l

0.23

172

1193

Other and unspecified nonorganic psychotic disorders

3734

34175

1.15

9.92

2.8

112.84

105.82

ug/l

0.48

3425

32323

Pneumonia due to Streptococcus pneumoniae

658

5282

1.40

9.89

3.6

2.7

202.26

129.68

ug/l

3.78

602

4854

Benign neoplasm of eye and adnexa

1566

13652

1.25

9.84

3.1

2.8

125.10

129.88

ug/l

0.29

1447

12573

Abdominal aortic aneurysm (AAA)

1361

11518

1.24

9.84

3.6

2.7

195.66

184.39

ug/l

0.75

1229

10206

Mental and behavioural disorders due to tobacco

1360

11741

1.27

9.82

3.3

2.8

127.18

129.96

ug/l

0.21

1216

10965

Benign neoplasm: Other and unspecified parts of mouth

530

4172

1.47

9.79

3.4

2.7

130.69

120.91

ug/l

0.40

476

3834

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

1264

10870

1.28

9.79

3.2

2.8

107.02

101.32

ug/l

0.50

1163

10080

Hypoplasia of dental enamel, prenatal

214

5.75

9.79

11.3

3.7

73.96

50.04

ug/l

0.69

206

Polyarteritis nodosa and related conditions

248

1748

1.81

9.79

4.4

2.6

203.79

112.20

ug/l

1.70

243

1608

Carcinoma in situ of skin, other sites/unspecified

186

1231

1.97

9.78

3.8

2.8

154.15

135.26

ug/l

0.69

168

1099

Ovarian hyperstimulation (induction)

430

3436

1.72

9.77

3.4

2.9

50.04

54.74

ug/l

1.26

419

3275

Abnormal findings on diagnostic imaging of central nervous system

775

6399

1.39

9.76

3.3

2.8

114.51

110.80

ug/l

0.20

731

5959

L01XE Protein kinase inhibitors

842

6981

1.36

9.76

3.2

2.8

328.10

143.35

ug/l

12.60

793

6387

Focal brain injury

939

7775

1.31

9.75

3.3

2.6

174.85

157.88

ug/l

0.51

843

7204

Nonsuppurative otitis media

5333

42903

1.13

9.73

3.2

2.8

97.93

83.22

ug/l

0.83

5027

40344

Benign neoplasm: Skin of trunk

684

5563

1.41

9.71

3.6

2.8

112.66

109.90

ug/l

0.15

626

5149

Ankylosing hyperostosis [Forestier]

213

1448

1.86

9.70

3.5

2.6

156.59

156.56

ug/l

0.00

198

1308

Glaucoma secondary to other eye disorders

622

4979

1.41

9.68

4.3

2.9

162.87

140.25

ug/l

1.33

580

4559

Unspecified lump in breast

2901

26347

1.18

9.67

2.9

2.8

94.06

96.35

ug/l

0.26

2739

24441

Lesion of radial nerve

584

4653

1.43

9.60

3.5

2.7

128.07

134.86

ug/l

0.34

536

4288

Smoking dependency

1360

11763

1.27

9.60

3.2

2.8

127.18

129.78

ug/l

0.19

1216

10990

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

1373

11794

1.25

9.57

2.8

2.9

187.68

144.13

ug/l

4.95

1250

10789

Other factor of the environment

235

1661

1.87

9.57

4.6

2.7

123.45

115.38

ug/l

0.28

220

1547

Complications of the puerperium, not elsewhere classified

939

8040

1.39

9.57

3.3

2.9

61.80

63.54

ug/l

0.17

898

7675

Drug-induced obesity

194

1341

2.09

9.56

4.2

2.8

89.70

85.80

ug/l

0.09

179

1259

Parkinson's disease, strict definition

1962

17326

1.21

9.56

2.7

2.9

145.33

163.21

ug/l

2.80

1741

15589

Other specified congenital malformation syndromes affecting multiple systems

320

2388

1.70

9.54

4.3

3.2

126.46

83.61

ug/l

1.19

300

2257

Otitis media, unspecified

2382

19726

1.20

9.54

3.3

2.8

77.49

80.48

ug/l

0.33

2253

18516

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

555

4458

1.49

9.53

3.2

2.7

81.81

79.87

ug/l

0.14

523

4192

Complications following infusion, transfusion and therapeutic injection

259

1850

1.77

9.53

4.9

2.6

219.43

118.39

ug/l

4.23

235

1699

Bursitis of shoulder

414

3168

1.54

9.51

3.1

2.6

130.15

136.21

ug/l

0.15

388

2918

Benign neoplasm: Pancreas

400

3063

1.57

9.51

4.3

2.8

132.48

143.45

ug/l

0.50

383

2782

Other nonautoimmune haemolytic anaemias

193

6.61

9.50

8.3

2.4

196.43

139.63

ug/l

1.10

172

Benign leiomyoma with endometriosis

2752

24924

1.18

9.49

3.0

2.8

103.48

105.79

ug/l

0.16

2498

22965

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1234

10591

1.28

9.48

3.0

2.8

121.23

114.93

ug/l

0.44

1132

9817

Symptoms and signs involving appearance and behaviour

174

1163

2.09

9.48

3.3

2.6

100.87

100.19

ug/l

0.02

159

1090

Hypertrophic scar

1034

8826

1.33

9.44

3.3

2.7

80.71

89.48

ug/l

1.17

965

8266

Benign neoplasm: Kidney

530

4205

1.47

9.44

3.4

2.7

130.94

131.89

ug/l

0.03

495

3834

Event of undetermined intent

1062

9033

1.30

9.39

3.4

2.8

151.18

115.28

ug/l

0.33

1001

8477

Dissection of aorta

448

3442

1.48

9.39

3.5

2.7

201.15

169.58

ug/l

0.94

409

3093

Disorders of orbit

744

6134

1.38

9.37

3.4

2.7

129.63

113.38

ug/l

0.59

696

5686

Secondary thrombocytopenia

210

1452

1.90

9.36

4.0

2.6

363.46

121.25

ug/l

7.18

205

1348

Benign neoplasm: Oesophagus

206

1416

1.90

9.36

4.2

2.6

115.17

129.58

ug/l

0.40

190

1291

Other protozoal intestinal diseases

267

1938

1.77

9.35

3.9

2.8

80.68

101.26

ug/l

1.86

250

1809

Endometriosis of intestine

379

2955

1.68

9.35

3.2

2.7

60.66

63.22

ug/l

0.30

367

2819

Idiopathic pulmonary fibrosis

1038

8766

1.29

9.33

3.1

2.8

186.50

163.71

ug/l

1.66

948

7892

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

487

2.79

9.33

4.5

2.6

86.74

115.81

ug/l

0.49

444

Benign neoplasm of major salivary glands

1444

12535

1.24

9.26

3.0

2.8

136.76

125.09

ug/l

0.82

1320

11528

Oral lichen ruber planus

388

2974

1.58

9.25

3.2

2.7

102.37

115.76

ug/l

0.99

363

2726

Malignant melanoma, excluding all cancers (controls excluding all cancers)

2545

22884

1.17

9.20

3.0

2.9

146.55

130.52

ug/l

1.86

2314

20905

Allergic purpura

557

4479

1.46

9.20

3.7

2.7

124.30

106.14

ug/l

0.94

527

4173

Specific development disorders of speech and language

1061

8699

1.30

9.19

3.4

2.8

83.29

90.00

ug/l

0.61

1009

8162

Haemangioma, any site

1371

11909

1.26

9.19

3.3

2.8

107.12

104.74

ug/l

0.16

1291

11094

Cushing syndrome

215

1510

1.91

9.18

3.7

2.6

129.11

98.42

ug/l

1.31

203

1387

Atrial septal defect

677

5519

1.41

9.16

3.7

3.0

108.16

96.48

ug/l

0.74

637

5175

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

327

4465

0.68

9.15

2.5

2.8

250.03

165.92

ug/l

3.81

294

4001

Algoneurodystrophy

612

4988

1.44

9.15

3.5

2.7

85.37

96.53

ug/l

1.20

570

4677

Other orthopaedic follow-up care

896

7501

1.32

9.14

3.0

2.5

128.72

115.82

ug/l

0.67

834

6922

Other and unspecified trigeminal disorders

281

2056

1.71

9.14

3.1

2.6

105.19

109.05

ug/l

0.18

262

1890

Deep bite

2115

16560

1.21

9.10

3.2

2.8

74.47

89.50

ug/l

3.89

1985

15555

Other misadventures during surgical and medical care

353

2678

1.61

9.08

4.1

2.8

147.14

121.95

ug/l

0.80

330

2474

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

212

1457

1.80

9.05

3.6

2.7

413.93

154.83

ug/l

7.20

196

1314

Dental caries 1 and operation codes, only avohilmo

6519

30714

1.12

9.04

2.9

3.0

103.29

119.49

ug/l

6.67

6041

28899

Open bite

1087

9391

1.32

9.03

3.3

3.0

81.25

68.47

ug/l

0.30

1042

8886

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

1650

17778

0.83

9.03

2.6

2.8

228.26

146.47

ug/l

13.55

1502

16021

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

1083

9271

1.30

9.03

3.3

2.8

103.98

100.48

ug/l

0.25

999

8605

Desensitization to allergens

1134

9804

1.31

9.01

3.0

2.9

74.00

78.30

ug/l

0.36

1073

9283

Tic and related disorders

243

1732

1.77

9.01

3.2

2.6

76.47

75.57

ug/l

0.04

229

1640

2496

22848

1.22

9.01

3.1

3.0

58.27

57.14

ug/l

0.10

2379

21900

Drug-induced headache, not elsewhere classified

124

791

2.55

9.00

4.3

2.8

71.45

83.26

ug/l

0.78

118

736

Fasciculation

219

1549

1.88

9.00

2.9

2.8

89.72

120.68

ug/l

1.97

214

1454

Injury of other and unspecified intrathoracic organs

931

7817

1.31

9.00

3.0

2.8

169.54

152.84

ug/l

0.84

860

7204

Other and unspecified mononeuropathies of lower limb

455

3561

1.50

8.98

2.9

2.6

110.20

126.20

ug/l

0.92

411

3257

Benign neoplasm: Cerebral meninges

1418

12369

1.25

8.95

3.0

2.8

124.98

121.87

ug/l

0.18

1285

11323

Mandibular retrognathia

1296

11263

1.27

8.92

3.2

2.9

75.58

85.13

ug/l

1.08

1232

10642

Granulomatous disorders of skin and subcutaneous tissue

480

3818

1.51

8.92

3.9

2.7

104.00

95.11

ug/l

0.44

447

3543

Residual foreign body in soft tissue

803

6667

1.34

8.91

2.8

2.6

125.39

133.39

ug/l

0.47

749

6200

Burns and corrosions of external body surface, specified by site

1834

16261

1.21

8.91

3.0

2.8

156.12

119.17

ug/l

0.68

1701

15227

Sexual dysfunction

254

1824

1.72

8.89

3.3

2.6

116.46

139.13

ug/l

0.94

241

1719

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

116

1875

0.52

8.89

2.2

2.7

156.36

128.94

ug/l

0.53

1724

Certolizumab pegol

361

2808

1.66

8.87

2.8

78.65

79.22

ug/l

0.02

345

2630

Surgical ablation of atrial fibrillation

563

2.58

8.87

3.1

2.5

142.09

190.26

ug/l

0.92

514

Paraplegia, diplegia of upper limbs

356

2698

1.57

8.87

3.4

2.7

167.19

141.38

ug/l

0.59

323

2485

Acute nephritic syndrome

353

2673

1.58

8.85

6.0

2.7

197.39

141.50

ug/l

3.52

336

2475

Congenital malformations of genital organs

2056

18406

1.22

8.83

3.3

2.9

66.73

71.91

ug/l

1.41

1945

17445

Acute lymphadenitis

1096

9416

1.29

8.80

3.2

2.8

128.87

103.40

ug/l

2.19

1031

8805

Disorders of speech understanding and production

721

5851

1.37

8.79

3.4

2.9

86.87

87.06

ug/l

0.01

682

5456

Herpesviral keratitis and keratoconjunctivitis

692

5693

1.38

8.79

3.4

2.8

128.60

126.26

ug/l

0.10

648

5244

Androgenic alopecia

181

1264

2.11

8.78

3.5

2.7

71.79

78.40

ug/l

0.33

175

1168

Neovascular glaucoma

619

5013

1.39

8.78

4.3

2.8

161.83

141.85

ug/l

1.11

577

4564

Drug-induced polyneuropathy

150

981

2.11

8.78

4.2

2.8

226.11

135.41

ug/l

1.64

137

898

Parkinson's disease

2116

18876

1.19

8.76

2.7

2.9

144.41

162.68

ug/l

3.17

1881

16999

Other/unspecified crystal arthropathies

110

666

2.42

8.76

3.8

2.6

146.09

129.30

ug/l

0.54

595

Localized scleroderma [morphea]

264

1935

1.74

8.75

3.1

2.6

94.64

92.06

ug/l

0.12

245

1765

Epiphora

363

2779

1.58

8.73

3.1

2.7

125.91

120.63

ug/l

0.18

335

2536

Disorders of phosphorus metabolism and phosphatases

547

2.66

8.73

5.5

2.7

186.49

108.77

ug/l

1.16

502

Recurrent dislocation of patella

1167

10152

1.30

8.71

3.2

2.8

74.19

72.83

ug/l

0.13

1107

9610

Personal history of malignant neoplasm

604

4911

1.41

8.70

2.9

2.6

125.14

97.62

ug/l

1.15

560

4527

L02BB Anti-androgens

1174

10049

1.26

8.69

2.6

3.0

374.70

192.37

ug/l

12.11

1067

8983

Idiopathic urticaria

409

3219

1.57

8.69

3.4

2.7

89.34

83.48

ug/l

0.26

390

3015

Malignant neoplasm of rectum

1323

11463

1.24

8.66

2.7

2.8

175.34

159.84

ug/l

0.45

1205

10412

Melanoma in situ

556

4463

1.42

8.66

3.2

2.8

144.13

130.98

ug/l

0.74

491

4052

Lifestyle-related condition

214

1517

1.86

8.65

4.6

2.7

127.88

115.35

ug/l

0.45

201

1415

Muscle strain

547

4398

1.43

8.64

3.3

2.7

120.87

117.10

ug/l

0.10

525

4089

Benign neoplasm: Skin, unspecified

633

5170

1.39

8.62

3.4

2.7

127.09

111.57

ug/l

0.91

588

4768

Neuroendocrine tumor and carcinoma of stomach

501

2.68

8.62

4.5

2.4

86.74

139.00

ug/l

1.07

451

Somnolence

245

1779

1.77

8.61

4.2

2.7

86.76

97.10

ug/l

0.64

231

1663

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

964

8115

1.29

8.61

3.3

2.8

129.83

150.14

ug/l

2.30

883

7307

Transepidermal elimination disorders

160

6.11

8.60

5.0

3.0

148.37

109.80

ug/l

0.69

144

Post-traumatic wound infection, not elsewhere classified

411

3192

1.51

8.59

3.7

2.7

132.89

133.31

ug/l

0.01

379

2949

Other benign neoplasms of connective and other soft tissue

1597

14065

1.22

8.59

3.1

2.8

116.61

111.22

ug/l

0.54

1488

13060

Autoimmune thyroiditis

368

2857

1.60

8.58

3.3

2.7

100.41

78.05

ug/l

1.01

341

2673

Disorders of optic nerve and visual pathways

1701

15103

1.22

8.58

3.3

2.9

115.83

103.92

ug/l

1.46

1584

14118

Disorders of myoneural junction and muscle in diseases classified elsewhere

149

987

2.14

8.54

3.9

2.7

152.56

99.42

ug/l

1.76

134

906

Other and unspecified pemphigoid

144

937

2.11

8.54

3.4

2.7

144.12

133.62

ug/l

0.26

132

839

Other acute skin changes due to ultraviolet radiation

555

4469

1.42

8.51

3.4

2.7

146.24

133.04

ug/l

0.54

518

4082

Femoral hernia

668

5471

1.36

8.49

3.1

2.7

122.84

140.52

ug/l

0.94

614

4986

Femoral hernia, unilateral

418

3253

1.50

8.49

3.0

2.7

127.43

137.00

ug/l

0.26

385

2956

Inguinal of femoral hernia, unilateral

418

3253

1.50

8.49

3.0

2.7

127.43

137.00

ug/l

0.26

385

2956

Inguinal hernia, unilateral

418

3253

1.50

8.49

3.0

2.7

127.43

137.00

ug/l

0.26

385

2956

Follow-up care involving plastic surgery

663

5466

1.38

8.48

2.8

2.6

124.28

101.66

ug/l

2.30

569

5078

Disorders of eyelid in diseases classified elsewhere

556

4497

1.43

8.48

3.5

2.7

111.02

114.01

ug/l

0.13

514

4164

Dermatopolymyositis

248

1791

1.71

8.48

3.6

2.7

189.16

119.30

ug/l

2.23

236

1646

Intentional self-harm by unspecified means

248

1821

1.79

8.48

3.2

2.8

91.36

80.71

ug/l

0.40

233

1717

Manic episode

526

4220

1.43

8.46

3.0

2.6

104.31

109.91

ug/l

0.34

477

3958

Complex cardiac defects

127

817

2.32

8.46

4.5

3.1

97.50

79.84

ug/l

0.51

121

763

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

194

1337

1.84

8.45

3.2

2.7

195.42

130.26

ug/l

1.83

180

1219

Use of rasagiline

369

2832

1.54

8.44

2.7

2.8

123.57

161.02

ug/l

3.15

322

2557

Viral meningitis

679

5635

1.39

8.43

3.2

2.8

101.13

97.91

ug/l

0.20

629

5292

Achalasia of cardia

289

2135

1.63

8.42

3.2

2.6

118.08

137.12

ug/l

0.83

267

1950

Ectopic pregnancy

3584

33126

1.15

8.41

3.1

2.8

80.71

84.74

ug/l

0.64

3370

31282

Panniculitis, unspecified

184

1264

1.89

8.40

3.9

2.7

131.86

124.80

ug/l

0.15

173

1153

Conotruncal defects

254

1862

1.74

8.39

4.1

3.3

93.62

75.82

ug/l

1.21

246

1760

Open wound of abdomen, lower back and pelvis

518

4158

1.44

8.39

3.3

2.7

118.26

117.53

ug/l

0.03

474

3875

Other and unspecified iridocyclitis

704

5839

1.36

8.38

3.4

2.7

112.90

115.95

ug/l

0.16

663

5407

!Aliquae complicationes praecoces traumatis

651

5337

1.37

8.38

3.8

2.8

148.55

135.57

ug/l

0.33

602

4943

Early complications of trauma

651

5337

1.37

8.38

3.8

2.8

148.55

135.57

ug/l

0.33

602

4943

Specific development disorders of scholastic skills

857

7183

1.33

8.37

3.6

2.9

74.81

72.65

ug/l

0.14

801

6815

Spinal osteochondrosis

197

1365

1.82

8.34

3.3

2.5

109.15

121.54

ug/l

0.50

186

1271

Fistulae involving female genital tract

282

2093

1.66

8.33

3.8

2.6

117.21

97.53

ug/l

0.89

266

1940

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

1204

10422

1.26

8.32

3.0

2.7

106.02

107.82

ug/l

0.09

1079

9844

344

2609

1.54

8.26

3.4

2.8

133.67

156.79

ug/l

1.28

311

2335

Benign neoplasm of middle ear and respiratory system

1171

10100

1.25

8.24

3.1

2.8

143.86

146.08

ug/l

0.07

1104

9283

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

1704

15299

1.24

8.23

3.5

2.9

71.56

69.45

ug/l

0.36

1637

14632

Restrictive cardiomyopathy

378

3.04

8.22

5.8

2.8

134.06

141.48

ug/l

0.13

338

Perforation of tympanic membrane

1678

14890

1.21

8.21

3.2

2.8

129.87

120.76

ug/l

0.52

1542

13823

Alcoholic gastritis

219

1535

1.71

8.21

3.5

2.5

161.62

188.40

ug/l

0.78

200

1414

Hyperaldosteronism

433

3416

1.48

8.15

4.1

2.7

153.83

137.17

ug/l

0.92

402

3150

CR(E)ST syndrome

276

2068

1.69

8.15

4.1

2.7

79.04

98.45

ug/l

2.03

256

1913

Erythema nodosum

536

4358

1.44

8.14

3.6

2.7

111.65

99.40

ug/l

0.58

513

4023

Other diseases of spinal cord

482

3846

1.44

8.12

3.2

2.8

140.30

137.49

ug/l

0.07

441

3550

Burns and corrosions

2349

21234

1.17

8.09

3.0

2.8

148.97

120.38

ug/l

0.67

2185

19913

Benign neoplasm: Tongue

430

3389

1.48

8.07

3.2

2.7

132.01

133.76

ug/l

0.05

398

3108

Inflammatory disorders of breast

1347

11936

1.27

8.06

3.2

2.9

65.67

67.70

ug/l

0.32

1273

11227

Blindness, monocular

150

992

1.98

8.05

3.8

2.6

167.55

131.18

ug/l

1.13

134

906

Malignant neoplasm of pancreas

579

7131

0.75

8.05

2.3

2.8

252.11

155.81

ug/l

5.16

533

6410

Injury of eye and orbit

2393

21628

1.17

8.03

3.0

2.8

131.69

127.71

ug/l

0.21

2237

20294

Benign neoplasm of breast

2179

19708

1.19

8.03

2.9

2.8

90.91

84.60

ug/l

0.81

2005

18236

Chalazion

1968

17650

1.19

8.02

3.1

2.8

118.91

118.46

ug/l

0.01

1848

16462

Other and unspecified injuries of wrist and hand

670

5569

1.37

8.01

3.3

2.8

98.27

99.88

ug/l

0.09

614

5192

Benign neoplasm: Skin of trunk

684

5684

1.36

8.01

3.6

2.8

112.66

122.38

ug/l

0.69

626

5244

Benign neoplasm of other and unspecified intrathoracic organs

181

1248

1.86

8.01

3.3

2.7

137.56

120.43

ug/l

0.38

168

1144

Benign neoplasm: Appendix

178

1228

1.88

8.00

3.3

2.7

135.80

116.78

ug/l

0.54

171

1117

Atopic conjunctivitis

823

6983

1.33

7.97

3.3

2.7

93.71

91.13

ug/l

0.17

779

6527

Mixed disorders of conduct and emotions, excluding more controls

484

3896

1.46

7.97

3.1

2.7

72.37

61.32

ug/l

1.12

447

3701

Exclusion endpoint for clefts

375

2934

1.55

7.96

4.0

3.1

122.69

86.44

ug/l

1.10

351

2766

Drug-induced neutropenia

1093

9448

1.27

7.94

3.1

2.8

383.53

127.73

ug/l

16.02

1031

8717

Other disorders of male genital organs

471

3699

1.40

7.93

3.0

2.7

145.18

197.33

ug/l

6.48

443

3462

Dental caries 3 and operation codes, only avohilmo

7747

36832

1.10

7.93

3.0

102.30

114.89

ug/l

4.75

7213

34661

Nonpyogenic thrombosis of intracranial venous system

177

1235

1.93

7.90

3.7

2.8

94.35

100.70

ug/l

0.19

164

1158

Impacted teeth

4476

38950

1.13

7.89

3.1

2.9

70.97

68.64

ug/l

0.44

4297

36836

Other forms of systemic lupus erythematosus

173

1213

1.99

7.88

4.3

2.8

111.42

79.95

ug/l

1.48

165

1127

Status post-ami

747

7412

0.78

7.85

3.2

2.7

141.31

184.08

ug/l

6.21

677

6447

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

359

2730

1.48

7.84

3.4

2.7

81.75

150.08

ug/l

11.08

337

2462

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

623

5098

1.35

7.83

2.6

2.7

173.73

141.20

ug/l

2.28

574

4655

Allergic colitis

470

3793

1.47

7.82

3.7

2.9

62.97

56.13

ug/l

0.61

438

3589

Nonspecific lymphadenitis

1051

9068

1.27

7.82

2.9

2.8

114.34

109.92

ug/l

0.28

991

8536

Other and unspecified injuries of shoulder and upper arm

495

3987

1.43

7.81

3.1

2.8

115.82

122.78

ug/l

0.37

461

3703

Other secondary coxarthrosis

510

4108

1.41

7.79

3.3

2.7

132.34

137.97

ug/l

0.22

470

3769

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

156

1043

1.90

7.79

5.4

2.6

211.36

155.98

ug/l

1.01

149

951

Hypermetropia

1222

10680

1.25

7.77

3.4

2.8

99.77

98.95

ug/l

0.05

1130

9946

Gender identity disorders

168

2357

0.58

7.73

2.3

2.7

49.76

57.40

ug/l

0.97

146

2211

Prepatellar bursitis

637

5226

1.34

7.72

3.0

2.7

170.88

170.56

ug/l

0.01

598

4822

Poor fetal growth

3106

28857

1.17

7.72

3.3

3.0

54.22

59.51

ug/l

2.66

2932

27611

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1888

17106

1.22

7.71

3.2

2.9

64.71

71.83

ug/l

2.59

1798

16216

Injuries involving multiple body regions

639

5300

1.37

7.70

3.3

2.8

98.48

113.83

ug/l

1.65

571

4927

Benign neoplasm of bone and articular cartilage

1392

12260

1.23

7.70

3.0

2.8

104.97

103.04

ug/l

0.16

1307

11460

Paralytic strabismus

1053

9078

1.26

7.70

3.2

2.8

162.48

136.83

ug/l

1.34

971

8338

Striae atrophicae

224

1653

1.81

7.69

3.9

2.7

127.29

86.47

ug/l

0.55

210

1547

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

505

4097

1.43

7.66

3.1

2.7

113.07

109.78

ug/l

0.11

467

3844

Crohn's disease (strict) with PSC

212

4.86

7.65

6.4

3.1

94.05

102.74

ug/l

0.13

203

Central retinal artery occlusion

304

2286

1.55

7.63

4.2

2.8

161.47

157.81

ug/l

0.11

283

2058

Vascular dementia (mixed)

204

1427

1.69

7.61

3.1

2.9

138.08

165.22

ug/l

0.90

179

1271

Encephalopathy

156

1051

1.90

7.60

4.6

2.6

150.86

151.72

ug/l

0.02

148

957

Ill-defined and unknown causes of mortality

650

7869

0.77

7.60

3.1

2.9

277.79

164.65

ug/l

1.76

567

7098

Infective bursitis

406

3178

1.45

7.55

3.6

2.7

175.80

174.97

ug/l

0.02

369

2905

Disorders of purine and pyrimidine metabolism

603

2.30

7.55

5.4

2.4

225.63

149.56

ug/l

1.36

555

Shoulder region

223

1623

1.71

7.46

3.5

2.6

121.54

123.39

ug/l

0.06

211

1493

Other vitreous opacities

595

4909

1.37

7.44

3.1

2.8

118.65

132.80

ug/l

1.09

537

4482

Benign neoplasm: Other and unspecified parts of mouth

530

4321

1.40

7.44

3.4

2.7

130.69

137.01

ug/l

0.23

476

3969

Benign neoplasm: Appendix

178

1248

1.84

7.43

3.3

2.7

135.80

128.65

ug/l

0.16

171

1140

Wide developmental disorders

575

4745

1.39

7.43

3.0

63.41

72.50

ug/l

1.12

518

4500

Exfoliative dermatitis

168

1150

1.81

7.42

3.5

2.8

206.34

172.24

ug/l

0.57

155

1046

Other congenital malformations of heart

134

896

2.09

7.40

3.9

3.1

87.29

71.87

ug/l

0.55

129

841

Car occupant injured in noncollision transport accident

654

5470

1.36

7.40

3.2

2.8

152.86

104.16

ug/l

0.56

618

5114

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

577

4728

1.36

7.38

3.3

2.7

152.63

128.71

ug/l

0.62

541

4339

Perioral dermatitis

426

3448

1.50

7.37

3.4

2.7

79.94

76.06

ug/l

0.29

395

3224

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

501

2.47

7.36

5.4

2.4

228.29

157.54

ug/l

1.02

458

Failed induction of labour

1403

12623

1.27

7.35

3.2

3.0

50.13

57.45

ug/l

2.86

1319

12079

Carcinoma in situ of skin, other sites/unspecified

186

1313

1.79

7.35

3.8

2.8

154.15

150.49

ug/l

0.09

168

1162

Other noninflammatory disorders of cervix uteri

769

6489

1.31

7.35

2.9

2.7

146.03

111.08

ug/l

0.69

708

5977

Senility

126

782

1.85

7.34

3.4

2.4

127.48

128.23

ug/l

0.01

117

682

Spirochaetal infections, other/unspecified

1288

11330

1.23

7.32

3.0

2.8

122.66

127.99

ug/l

0.27

1152

10482

Benign neoplasm: Parotid gland

1138

9894

1.24

7.32

2.9

2.8

138.03

125.58

ug/l

0.70

1040

9124

Disorders of synovium and tendon in diseases classified elsewhere

323

2477

1.52

7.30

3.4

2.6

117.00

146.89

ug/l

2.09

295

2280

Other deformities of toe(s)

545

4452

1.38

7.30

3.3

2.6

114.46

125.80

ug/l

0.43

492

4102

Liver disorders in diseases classified elsewhere

381

3.17

7.29

4.8

2.6

171.43

90.67

ug/l

1.02

352

Benign neoplasm: Skin, unspecified

633

5269

1.35

7.26

3.4

2.7

127.09

122.89

ug/l

0.17

588

4867

Hypothyroidism due to medicaments and other exogenous substances

190

1361

1.80

7.22

3.5

2.6

133.87

111.75

ug/l

0.68

172

1247

Other abnormal findings in urine

245

1816

1.64

7.21

3.3

2.7

125.39

131.65

ug/l

0.19

232

1648

Gestational [pregnancy-induced] hypertension

6126

57979

1.11

7.20

3.2

2.9

71.32

70.31

ug/l

0.23

5850

55020

Injury of muscle and tendon at lower leg level

2312

20978

1.16

7.19

3.0

2.8

151.73

151.12

ug/l

0.02

2154

19603

Peptic ulcer

160

1093

1.83

7.17

4.9

2.5

128.19

141.67

ug/l

0.34

154

993

Psoriasis (vulgaris), strict definition

478

3856

1.40

7.17

2.9

2.7

138.94

137.22

ug/l

0.06

446

3593

Autism

453

3666

1.44

7.16

3.0

2.8

66.95

74.24

ug/l

0.61

405

3476

Other acute viral hepatitis

219

1607

1.71

7.14

3.1

2.8

173.30

110.57

ug/l

1.63

205

1513

Cerebral aneurysm, nonruptured

1334

11765

1.22

7.14

3.2

2.8

130.38

128.99

ug/l

0.06

1252

10868

Hordeolum and other deep inflammation of eyelid

939

8108

1.28

7.14

3.3

2.8

120.79

110.94

ug/l

0.45

885

7543

Non-allergic asthma

1458

12926

1.21

7.13

3.0

2.8

110.30

122.66

ug/l

1.16

1362

11943

Other disorders of binocular vision

286

2216

1.65

7.13

3.3

2.8

80.83

79.70

ug/l

0.05

280

2079

Other/unspecified soft tissue disorders related to use, overuse and pressure

491

3991

1.40

7.13

3.0

2.6

94.43

114.51

ug/l

2.27

465

3731

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1645

14908

1.23

7.12

3.1

3.0

56.81

64.46

ug/l

3.93

1573

14230

Superficial injuries involving multiple body regions

457

3700

1.43

7.11

3.4

2.7

95.67

109.84

ug/l

1.09

406

3442

Benign neoplasm of male genital organs

256

1881

1.55

7.10

2.8

2.7

184.09

187.41

ug/l

0.07

229

1712

Follicular lymphoma

579

4766

1.35

7.10

2.9

2.7

299.24

134.94

ug/l

3.48

542

4336

Disorders of plasma-protein metabolism, not elsewhere classified

123

806

2.05

7.08

3.0

2.4

156.58

124.68

ug/l

0.77

117

745

Localized skin eruption due to drugs and medicaments

208

1526

1.75

7.05

3.4

2.6

121.35

104.18

ug/l

0.41

191

1409

Congenital malformation of biliary tract

323

3.26

7.04

6.7

3.3

52.77

75.10

ug/l

1.22

305

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

3320

30640

1.13

7.03

2.4

2.8

398.84

137.07

ug/l

49.73

3069

27992

Haemangioma and lymphangioma, any site

1499

13359

1.21

7.03

3.3

2.8

104.99

116.01

ug/l

1.26

1411

12429

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

105

664

2.19

7.03

4.8

2.6

148.17

128.93

ug/l

0.38

613

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

320

2503

1.56

7.01

4.7

2.9

83.44

81.88

ug/l

0.07

305

2344

Benign neoplasm of ovary

2957

27259

1.14

6.99

3.0

2.8

97.62

93.60

ug/l

0.49

2730

25047

Impaction of intestines

116

746

2.04

6.98

3.8

2.7

107.77

117.94

ug/l

0.33

105

669

Benign neoplasm of other and unspecified intrathoracic organs

181

1287

1.77

6.93

3.3

2.7

137.56

131.30

ug/l

0.12

168

1176

Malignant neoplasm of endocrine gland

1171

10290

1.24

6.93

3.4

2.8

119.28

114.83

ug/l

0.28

1081

9571

Benign neoplasm: Skin of lower limb, including hip

437

3521

1.43

6.92

3.2

2.7

108.22

109.43

ug/l

0.06

405

3257

Short stature, not elsewhere classified

457

3505

1.45

6.91

4.3

3.1

57.82

54.76

ug/l

0.19

434

3310

Autism spe

437

3539

1.44

6.89

2.9

67.87

75.60

ug/l

0.63

390

3357

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

556

4619

1.38

6.84

2.8

98.24

106.41

ug/l

0.57

505

4317

Atypical mycobacterium lung infection

181

1283

1.74

6.83

3.0

2.7

118.63

130.73

ug/l

0.46

170

1148

Hyperosmolality and hypernatraemia

192

1367

1.69

6.82

3.0

2.4

157.06

142.39

ug/l

0.38

177

1230

Intracranial and intraspinal abscess and granuloma

181

1289

1.76

6.82

3.5

2.6

190.99

146.21

ug/l

0.90

166

1181

Other specified disorders of muscle

445

3580

1.40

6.81

3.3

2.7

131.31

134.72

ug/l

0.13

420

3312

Sequelae of injuries of head

798

6797

1.28

6.81

3.1

2.8

149.79

140.41

ug/l

0.22

708

6339

Benign neoplasm: Liver/bile ducts

424

3435

1.45

6.80

3.9

2.7

115.73

95.28

ug/l

1.31

403

3219

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

304

2333

1.51

6.79

2.9

2.6

154.23

140.51

ug/l

0.47

282

2120

Hodgkin lymphoma

465

3783

1.41

6.77

3.5

2.8

267.19

111.02

ug/l

6.86

447

3510

Tooth eruption problems

3278

30211

1.14

6.77

3.2

2.9

72.29

67.43

ug/l

0.93

3144

28568

Hyphaema and other vascular disorders of iris and ciliary body

290

2217

1.53

6.75

4.9

2.7

151.28

143.16

ug/l

0.25

269

2023

Porphyria cutanea tarda

101

7.08

6.74

8.1

2.1

213.47

183.24

ug/l

0.18

Contusion of other and unspecified parts of foot

921

7998

1.28

6.74

3.3

2.8

82.57

93.10

ug/l

1.26

866

7517

Benign lipomatous neoplasm of other sites/unspecified

1319

11657

1.21

6.71

2.8

133.99

138.07

ug/l

0.24

1192

10658

Crushed, pushed or stepped on by crowd or human stampede

1268

11209

1.22

6.71

3.0

2.8

105.24

103.58

ug/l

0.09

1209

10549

Carcinoma in situ of other and unspecified sites

468

3796

1.39

6.69

3.3

2.9

162.07

176.79

ug/l

0.60

411

3442

Disorders of adrenal gland, other and/or unspecified

635

2.30

6.69

4.5

2.5

135.85

92.43

ug/l

1.09

584

Vascular dementia (subcortical)

378

2972

1.42

6.68

3.0

2.9

116.96

152.80

ug/l

4.24

341

2650

Other and unspecified acute skin changes due to ultraviolet radiation

375

2962

1.44

6.67

3.4

2.7

177.59

153.49

ug/l

0.75

346

2668

Amputation of thigh

369

2891

1.43

6.65

5.1

2.7

210.47

162.78

ug/l

2.08

332

2570

Right ventricular outflow tract obstruction

164

1171

1.87

6.64

4.3

3.3

89.94

66.78

ug/l

1.18

159

1108

Aspergillosis

132

890

1.94

6.64

4.2

2.6

448.08

147.49

ug/l

1.05

125

809

Implicit parasitic Sepsis

553

2.34

6.62

4.3

2.7

121.53

106.91

ug/l

0.31

500

Flatulence and related conditions

178

1271

1.75

6.61

3.5

2.5

109.01

113.29

ug/l

0.13

160

1165

Adenocarcinoma of pancreas

222

2993

0.66

6.60

2.3

2.8

295.02

154.42

ug/l

4.68

202

2698

Unspecified visual impairment (binocular)

244

1839

1.60

6.57

3.4

2.8

128.69

117.59

ug/l

0.23

230

1697

Pediculosis, acariasis and other infestations

922

7979

1.26

6.56

3.3

2.7

157.05

125.81

ug/l

1.96

847

7471

Other congenital malformations of skin

720

6150

1.31

6.54

3.3

2.8

102.96

97.37

ug/l

0.23

680

5746

Benign neoplasm: Liver/bile ducts

424

3452

1.44

6.54

3.9

2.7

115.73

102.57

ug/l

0.68

403

3222

Benign neoplasm: Larynx

433

3477

1.39

6.53

3.0

2.7

155.98

142.52

ug/l

0.24

410

3185

Drug-induced systemic lupus erythematosus

135

936

2.02

6.53

5.1

2.7

182.06

90.59

ug/l

1.75

130

876

Other bacterial agents as the cause of diseases classified to other chapters

173

1239

1.78

6.51

4.8

2.7

198.08

109.28

ug/l

1.67

151

1138

Other fall from one level to another

4001

37363

1.11

6.51

3.0

2.9

123.52

120.51

ug/l

0.21

3709

34923

Vestibular neuronitis

1348

11974

1.21

6.48

3.0

2.8

136.27

132.48

ug/l

0.13

1230

11089

Otorrhagia

112

734

2.05

6.48

4.5

2.7

193.60

126.66

ug/l

0.84

106

678

Measles

210

1555

1.67

6.48

3.4

2.7

131.32

104.58

ug/l

0.93

197

1485

Impetigo

792

6813

1.29

6.47

3.4

2.8

95.32

93.43

ug/l

0.11

736

6390

Crossbite

1281

10555

1.22

6.45

3.4

2.9

75.54

80.67

ug/l

0.51

1210

9940

Other and unspecified nail disorders

336

2656

1.49

6.45

4.0

2.6

110.03

113.74

ug/l

0.18

312

2445

Renal agenesis and other reduction defects of kidney

606

2.25

6.42

7.4

2.8

177.71

104.10

ug/l

2.65

567

Unspecified abortion

930

8118

1.27

6.41

3.0

2.7

85.21

89.80

ug/l

0.53

878

7725

Bitten or struck by other mammals

2097

19173

1.17

6.40

3.1

2.9

85.87

94.42

ug/l

1.80

1939

18059

Benign neoplasm of breast

2179

19948

1.17

6.40

2.9

2.8

90.91

95.29

ug/l

0.47

2005

18449

Benign neoplasm: Liver

385

3114

1.46

6.38

3.9

2.7

112.41

93.41

ug/l

1.06

365

2923

Other superficial mycoses

350

2783

1.47

6.37

3.4

2.7

111.16

110.22

ug/l

0.03

331

2610

Foreign body in respiratory tract

865

7490

1.27

6.37

3.0

2.8

115.84

108.52

ug/l

0.19

794

6964

Melanocytic naevi of lower limb, including hip

730

6253

1.30

6.36

3.7

2.8

107.09

93.53

ug/l

0.89

680

5828

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1234

10924

1.22

6.36

3.0

2.8

121.23

129.65

ug/l

0.62

1132

10134

Combined immunodeficiencies

188

1369

1.71

6.36

4.3

2.6

152.64

115.15

ug/l

1.14

176

1261

Pulmonary oedema

245

1831

1.54

6.33

6.5

2.7

244.12

156.71

ug/l

2.18

234

1643

Benign neoplasm: Liver

385

3118

1.46

6.32

3.9

2.7

112.41

97.56

ug/l

0.77

365

2918

Atlantoaxial subluxation

117

778

1.99

6.31

3.3

2.6

103.14

122.31

ug/l

0.73

112

713

Disorders of optic nerve, not elsewhere classified

312

2442

1.49

6.31

3.6

2.7

133.88

138.49

ug/l

0.17

286

2232

Disorders of parathyroid gland, other and/or unspecified

120

806

1.98

6.28

4.6

2.5

194.77

120.66

ug/l

1.61

110

726

Lupus erythematosus

395

3191

1.43

6.28

3.2

2.7

125.47

111.40

ug/l

0.93

364

2932

Injury of muscle and tendon at ankle and foot level

405

3277

1.42

6.26

2.8

2.7

115.99

118.76

ug/l

0.11

377

3058

Other disorders of iris and ciliary body

399

3211

1.41

6.26

4.3

2.7

136.84

133.80

ug/l

0.11

367

2927

Major anomalies of jaw size

467

3845

1.39

6.21

3.3

2.7

108.57

105.37

ug/l

0.12

447

3594

Cysts of oral region, not elsewhere classified

658

5551

1.30

6.20

3.2

2.5

154.16

131.25

ug/l

0.72

607

5179

Corneal scars and opacities

402

3248

1.41

6.19

4.0

2.7

136.18

136.23

ug/l

0.00

364

2969

Cystic fibrosis with pulmonary manifestations

161

5.02

6.19

6.0

2.4

92.06

71.80

ug/l

0.44

146

Marginal zone B-cell lymphoma

137

946

1.86

6.17

3.6

2.6

290.01

140.37

ug/l

1.91

128

860

Other encephalitis

439

3591

1.40

6.15

3.3

2.7

136.53

115.25

ug/l

0.70

401

3334

Benign neoplasm: Conjunctiva

496

4103

1.36

6.14

3.3

2.7

122.60

112.77

ug/l

0.27

460

3784

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

363

2886

1.42

6.13

2.7

2.6

153.89

143.09

ug/l

0.38

336

2626

Factitial dermatitis

101

662

2.15

6.13

4.2

2.6

108.05

91.95

ug/l

0.42

603

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

584

4884

1.32

6.13

2.7

2.8

257.76

132.39

ug/l

2.61

548

4461

Acute myeloid leukaemia, helper endpoint

149

1036

1.76

6.13

4.3

2.6

860.87

127.60

ug/l

3.73

140

948

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

149

1036

1.76

6.13

4.3

2.6

860.87

127.60

ug/l

3.73

140

948

Gilbert syndrome

129

880

1.89

6.12

3.0

2.6

153.73

122.83

ug/l

1.06

123

827

Benign neoplasm: Skin of ear and external auricular canal

587

4924

1.32

6.11

3.1

2.8

144.62

137.56

ug/l

0.14

527

4494

Pseudomembranous colitis

152

1074

1.80

6.11

4.1

2.5

107.82

101.60

ug/l

0.15

145

1001

Malignant neoplasm of bladder

914

7891

1.23

6.10

3.1

2.8

172.18

181.57

ug/l

0.53

841

7062

Conductive hearing loss, unspecified

1361

12152

1.20

6.09

3.0

2.8

108.40

118.40

ug/l

0.76

1270

11291

Spondylopathies in diseases classified elsewhere

180

1303

1.68

6.08

3.5

2.6

245.91

147.12

ug/l

1.94

170

1170

Single spontaneous delivery

9294

47433

1.08

6.07

2.9

75.18

87.50

ug/l

9.62

8605

44081

Lung cancer and mesothelioma

2295

21511

0.88

6.06

2.6

245.80

149.61

ug/l

19.09

2090

19340

Osteomyelitis of vertebra

346

2.62

6.06

4.6

2.3

161.03

166.22

ug/l

0.07

312

Dementia

6288

41081

1.08

6.04

2.7

2.9

145.46

161.09

ug/l

4.84

5401

36817

Other and unspecified bullous disorders

170

1234

1.75

6.04

3.9

2.6

139.84

119.86

ug/l

0.41

163

1145

Urticaria due to cold and heat

174

1285

1.80

6.02

3.3

2.7

115.06

80.18

ug/l

1.70

164

1206

Eustachian salpingitis and obstruction

1482

13342

1.19

6.02

3.0

2.9

111.90

96.02

ug/l

0.66

1399

12708

Maze procedure for atrial fibrillation

493

2.30

6.01

3.1

2.6

142.34

167.37

ug/l

0.53

453

Schizoid personality disorder

279

2160

1.50

6.00

3.0

2.6

134.35

137.40

ug/l

0.07

255

2025

Early lumbar disc prolapse operation

1995

18217

1.16

5.99

2.8

2.9

101.86

101.35

ug/l

0.03

1903

17420

Other and unspecified medical devices associated with adverse incidents

594

2.21

5.97

4.4

2.6

160.38

133.43

ug/l

0.39

542

Hypersensitivity angiitis

580

2.16

5.97

7.9

2.6

181.42

127.90

ug/l

1.83

525

Other disorders of optic disc

227

1733

1.62

5.97

3.8

2.8

118.54

103.22

ug/l

0.45

215

1609

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

2080

18957

1.15

5.96

3.0

2.9

147.06

129.75

ug/l

1.66

1897

17334

Type 1 diabetes, definitions combined

1932

17551

1.16

5.96

3.8

2.8

109.44

92.67

ug/l

1.19

1812

16660

Fall on and from ladder

1042

9141

1.22

5.90

2.7

2.8

178.30

169.90

ug/l

0.20

956

8418

Diastasis of muscle

153

1108

1.85

5.88

3.2

2.7

100.74

91.62

ug/l

0.32

142

1036

Dislocation, sprain and strain of joints and ligaments of head

746

6441

1.28

5.88

3.1

2.9

98.22

94.61

ug/l

0.23

697

6060

Other articular cartilage disorders

360

2874

1.41

5.88

3.2

2.5

126.84

151.83

ug/l

1.25

344

2658

Mantle cell lymphoma

130

892

1.83

5.88

3.3

2.7

517.23

185.89

ug/l

5.24

117

805

Metabolic disorder, other/unspecified

336

2.65

5.86

4.7

2.4

166.46

103.66

ug/l

0.97

302

Osteopathy in diseases classified elsewhere

114

767

1.95

5.86

4.7

2.6

270.15

130.40

ug/l

4.26

107

699

Abnormal findings in cerebrospinal fluid

400

2.72

5.82

3.8

2.5

121.92

101.44

ug/l

0.34

365

Pedestrian injured in transport accident

1121

9929

1.22

5.79

3.0

2.8

104.75

117.99

ug/l

1.16

1035

9220

Encephalitis

466

3861

1.36

5.77

3.3

2.8

136.17

115.03

ug/l

0.74

426

3586

Open wound of shoulder and upper arm

310

2449

1.46

5.76

3.2

2.7

121.44

124.57

ug/l

0.07

280

2275

Foreign body in ear

329

2640

1.47

5.76

3.0

2.7

102.23

106.58

ug/l

0.15

302

2447

Type 1 diabetes, strict (exclude DM2)

1917

17442

1.16

5.76

3.8

2.8

109.43

92.54

ug/l

1.19

1798

16551

151

1086

1.79

5.74

3.2

2.6

89.06

89.08

ug/l

0.00

143

1013

Other obstructed labour

1506

13662

1.20

5.74

3.0

2.9

76.64

80.36

ug/l

0.60

1417

12924

Scabies

709

6085

1.28

5.74

3.1

2.8

130.30

118.92

ug/l

0.57

644

5712

Other disorders of choroid

212

1588

1.58

5.73

3.5

2.7

129.51

130.06

ug/l

0.01

198

1458

Personal history of certain other diseases

419

3507

1.45

5.72

3.3

2.8

67.16

60.14

ug/l

0.66

379

3293

Perichondritis of external ear

268

2083

1.50

5.70

2.8

2.7

152.11

141.16

ug/l

0.23

235

1906

Benign neoplasm of brain and other parts of central nervous system

972

8533

1.23

5.69

2.8

118.30

113.31

ug/l

0.24

889

7881

Other and unspecified acne

273

2161

1.55

5.68

4.5

2.7

98.60

76.99

ug/l

1.57

255

2016

All dysplastic lesions of the vulva

769

6699

1.28

5.68

3.5

2.8

100.53

82.41

ug/l

1.89

723

6279

Torsion of ovary, ovarian pedicle and fallopian tube

453

3780

1.39

5.68

3.0

2.7

64.31

73.85

ug/l

1.23

440

3578

Tic disorders

233

1790

1.57

5.66

3.1

2.9

78.01

73.36

ug/l

0.22

219

1683

Undefined dementia

1188

12372

0.85

5.64

2.8

162.80

153.02

ug/l

0.64

1008

10852

Benign neoplasm: Skin of lower limb, including hip

437

3608

1.37

5.63

3.2

2.7

108.22

119.32

ug/l

0.76

405

3346

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

916

7998

1.23

5.63

2.8

125.69

132.29

ug/l

0.35

857

7394

Open wound of neck

135

941

1.78

5.62

3.6

2.6

106.18

137.88

ug/l

1.31

126

880

Haemangioma, any site

1371

12326

1.19

5.61

3.3

2.8

107.12

117.10

ug/l

0.99

1291

11461

Melanocytic naevi of other and unspecified parts of face

1002

8854

1.23

5.61

3.2

2.8

101.18

93.84

ug/l

0.29

949

8266

Other melanin hyperpigmentation

324

2586

1.44

5.60

3.1

2.7

110.19

128.49

ug/l

1.10

295

2338

Pathological resorption of teeth

485

4039

1.34

5.59

3.3

2.6

115.14

114.11

ug/l

0.04

447

3770

Other disorders of peripheral nervous system

106

712

1.97

5.57

3.5

2.5

124.06

127.85

ug/l

0.06

100

644

Personal history of risk-factors, not elsewhere classified

242

1881

1.56

5.57

3.7

2.6

94.85

85.88

ug/l

0.42

228

1747

Other spirochaetal diseases

4251

40016

1.10

5.57

2.8

2.9

118.89

129.51

ug/l

1.78

3846

37053

Congenital malformations of great arteries

368

2945

1.42

5.56

3.8

3.2

79.71

80.61

ug/l

0.05

352

2777

440

3702

1.42

5.56

3.2

2.8

58.69

48.18

ug/l

1.31

411

3483

Inflammatory disorders of male genital organs, not elsewhere classified

165

1174

1.61

5.54

3.6

2.6

175.25

218.43

ug/l

0.91

153

1079

Injury of nerves and spinal cord at neck level

329

2633

1.43

5.50

3.0

2.7

126.17

151.53

ug/l

1.49

301

2427

Effects of other external causes

490

4100

1.34

5.49

3.0

2.8

107.12

109.28

ug/l

0.08

458

3869

Carcinoma in situ, bladder

425

3492

1.36

5.49

3.4

2.9

159.34

179.53

ug/l

0.90

373

3173

Cholera

615

5225

1.29

5.48

3.0

2.6

112.96

121.61

ug/l

0.51

596

4771

Acute myeloid leukaemia

149

1061

1.70

5.47

4.3

2.7

860.87

137.12

ug/l

3.65

140

970

Behavioural disorders, excluding more controls

376

3056

1.39

5.46

3.0

2.6

73.77

78.96

ug/l

0.30

349

2910

Other maltreatment syndromes

496

4139

1.33

5.45

2.8

2.7

132.46

125.70

ug/l

0.22

467

3925

Hypoplasia of dental enamel, prenatal , including avohilmo

613

2.18

5.45

7.9

3.3

59.99

59.59

ug/l

0.01

578

Other abnormal auditory perceptions

201

1531

1.64

5.45

2.6

2.7

99.03

90.54

ug/l

0.42

190

1426

Benign neoplasm: Choroid

815

7089

1.24

5.44

2.9

2.8

122.59

122.12

ug/l

0.02

743

6495

Alcohol abuse counselling and surveillance

265

2070

1.49

5.43

2.6

2.7

175.77

141.66

ug/l

0.69

253

1932

Toxic effect of other and unspecified substances

233

1803

1.55

5.43

3.0

2.7

98.86

104.10

ug/l

0.15

219

1706

Other acquired deformities of musculoskeletal system and connective tissue

699

6013

1.27

5.42

2.9

2.7

139.42

134.48

ug/l

0.20

653

5583

Melanocytic naevi of lower limb, including hip

730

6341

1.28

5.41

3.7

2.8

107.09

104.31

ug/l

0.12

680

5902

Benign neoplasm of thyroid gland

525

4431

1.33

5.39

2.7

114.84

100.56

ug/l

0.84

476

4092

Obstructed labour due to malposition and malpresentation of fetus

5372

48225

1.10

5.38

2.9

67.55

69.39

ug/l

0.38

5148

46161

Thyrotoxicosis factitia

436

2.59

5.37

3.6

2.5

79.74

74.04

ug/l

0.26

396

Iridocyclitis in diseases classified elsewhere

293

2330

1.46

5.36

3.8

2.8

114.84

124.50

ug/l

0.38

273

2151

Causalgia

292

2327

1.47

5.36

3.5

2.7

80.37

104.51

ug/l

2.32

282

2168

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

374

3082

1.42

5.35

4.5

2.9

85.37

81.39

ug/l

0.23

361

2872

Enteritis due to Yersinia enterocolitica

630

2.03

5.34

3.2

2.6

124.93

98.96

ug/l

0.34

589

Other benign neoplasms of connective and other soft tissue

1597

14494

1.17

5.34

3.1

2.8

116.61

122.81

ug/l

0.63

1488

13437

Other disorders of Eustachian tube

477

4002

1.35

5.33

3.4

2.7

101.10

111.30

ug/l

0.76

449

3707

Glaucoma-related operations

770

6682

1.25

5.33

2.8

2.9

119.86

141.11

ug/l

2.58

691

6035

Other intracranial haemorrhages

412

3374

1.35

5.31

3.0

2.8

186.57

159.86

ug/l

0.93

368

3034

Papilloedema, unspecified

394

3261

1.40

5.28

3.8

2.8

139.97

101.18

ug/l

2.05

372

3034

Hodgkin lymphoma, hilmo

465

3890

1.35

5.28

3.5

2.8

267.19

121.07

ug/l

6.07

447

3615

Other injuries of lower limb, level unspecified

137

979

1.77

5.28

3.6

2.5

158.58

105.08

ug/l

1.68

130

901

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

117

802

1.81

5.28

3.4

2.7

187.82

153.18

ug/l

0.69

107

731

Any dementia, excluding more controls

5138

33686

1.09

5.28

2.8

2.9

147.53

161.85

ug/l

3.30

4395

30210

Guillain-Barre syndrome

249

1941

1.50

5.26

3.0

2.7

283.89

134.71

ug/l

0.68

224

1802

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

8.67

5.26

4.0

3.0

175.07

123.02

ug/l

0.53

Infectious mononucleosis

1810

16614

1.17

5.26

3.0

2.8

90.16

75.20

ug/l

2.07

1711

15744

Varicella [chickenpox]

712

6143

1.26

5.25

4.0

2.8

156.83

128.69

ug/l

0.65

667

5812

Other and unspecified injuries of ankle and foot

754

6579

1.26

5.25

3.2

2.8

92.50

94.83

ug/l

0.15

695

6159

Intentional self-harm by sharp object

500

4247

1.35

5.23

3.6

2.7

76.92

78.96

ug/l

0.10

456

3997

Malignant neoplasm of thyroid gland

1084

9664

1.21

5.23

3.3

2.8

108.49

114.50

ug/l

0.46

999

8985

Other and unspecified vaccines and biological substances

138

1012

1.88

5.23

4.4

2.9

110.06

75.67

ug/l

0.48

132

950

Foreign body entering into or through eye or natural orifice

1243

11131

1.19

5.22

3.0

2.8

140.16

134.78

ug/l

0.23

1166

10381

Family history of other conditions

249

1969

1.54

5.22

3.8

2.6

77.93

75.76

ug/l

0.10

233

1842

Benign neoplasm of major salivary glands

1444

13038

1.17

5.21

3.0

2.8

136.76

139.43

ug/l

0.13

1320

11990

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

186

1385

1.58

5.20

3.8

2.7

657.63

143.44

ug/l

3.44

172

1261

Inflammatory disease of cervix uteri

1068

9522

1.21

5.20

2.9

2.8

93.83

96.16

ug/l

0.24

986

8798

Hereditary deficiency of other clotting factors

177

1343

1.70

5.19

4.5

2.8

93.28

89.90

ug/l

0.13

165

1262

Adenocarcinoma and Papillary adenocarcinoma of kidney

156

1139

1.67

5.16

5.4

2.6

211.36

173.97

ug/l

0.57

149

1035

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

245

1959

1.59

5.16

3.2

2.7

63.62

59.39

ug/l

0.24

232

1871

L02BA Anti-estrogens

2437

26265

0.89

5.15

2.5

2.8

153.14

100.72

ug/l

7.89

2274

24367

Ulcer of vagina/vulva

468

3970

1.37

5.14

3.6

2.8

71.60

73.38

ug/l

0.14

443

3666

Congenital malformations of uterus and cervix

480

4124

1.40

5.13

3.5

2.9

57.41

57.63

ug/l

0.02

450

3880

Pigmented purpuric dermatosis

156

1144

1.68

5.12

3.2

2.7

124.18

127.21

ug/l

0.08

145

1053

Pyogenic granuloma

286

2284

1.46

5.12

3.6

2.7

106.99

109.30

ug/l

0.09

273

2115

Benign neoplasm of bone and articular cartilage

1392

12588

1.18

5.12

3.0

2.8

104.97

113.77

ug/l

1.08

1307

11756

Pulmonary eosinophilia, not elsewhere classified

184

1378

1.59

5.11

3.2

2.6

134.20

131.22

ug/l

0.06

169

1255

Blood alcohol or alcohol intoxication level

412

3418

1.36

5.11

3.2

2.7

134.33

115.88

ug/l

0.86

378

3203

Lyme disease

4175

39392

1.10

5.11

2.8

2.9

116.92

129.93

ug/l

2.62

3772

36462

All dysplastic lesions of the cervix uteri, vagina or vulva

6791

64738

1.08

5.10

2.9

3.0

74.95

70.98

ug/l

1.32

6417

61552

Other and unspecified disorders of autonomic nervous system

535

2.26

5.10

4.4

2.6

144.77

100.28

ug/l

0.30

501

Other disorders of breast and lactation associated with childbirth

426

3647

1.45

5.09

3.3

3.0

46.35

51.75

ug/l

1.95

410

3447

Benign neoplasm: Bladder

137

974

1.71

5.08

3.2

2.6

146.54

137.89

ug/l

0.15

127

889

Benign neoplasm: salivary glands, exclude unknown (D119)

1285

11554

1.18

5.07

3.0

2.8

134.00

138.84

ug/l

0.23

1179

10652

Other facial nerve disorders

449

3753

1.34

5.07

3.2

2.7

103.99

119.51

ug/l

0.90

412

3450

Multifocal fibrosclerosis

112

779

1.88

5.06

3.4

2.6

110.00

121.63

ug/l

0.33

101

706

Cauda equina syndrome

214

1654

1.56

5.05

3.6

2.7

111.28

114.24

ug/l

0.09

205

1527

Erythema multiforme

374

3078

1.38

5.05

3.2

2.7

132.24

114.14

ug/l

0.51

349

2851

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

460

3934

1.39

5.03

3.2

2.7

58.43

60.23

ug/l

0.21

431

3744

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

230

1797

1.53

5.03

3.7

2.7

91.16

101.74

ug/l

0.51

220

1684

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

534

6305

0.79

5.03

2.4

2.8

195.42

119.95

ug/l

2.55

489

5817

Tetraplegia

118

824

1.80

5.03

3.1

2.6

119.64

135.11

ug/l

0.41

758

Male infertility

549

4607

1.26

5.00

3.1

2.5

171.86

181.96

ug/l

0.44

526

4376

Other disorders of amino-acid metabolism

532

2.06

4.99

6.4

2.5

382.35

114.74

ug/l

1.68

484

Vascular dementia

1064

9084

1.18

4.98

3.0

2.9

135.41

156.59

ug/l

2.49

923

8059

Other and unspecified mononeuropathies of upper limb

470

3947

1.32

4.97

3.0

2.7

136.97

131.64

ug/l

0.09

442

3661

Benign neoplasm of ovary

2957

27653

1.12

4.97

3.0

2.8

97.62

103.32

ug/l

0.78

2730

25461

Tic and related disorders

243

1917

1.51

4.96

3.2

3.0

76.47

73.19

ug/l

0.15

229

1794

Toxic effect of carbon monoxide

272

2163

1.45

4.95

3.2

2.7

131.30

137.64

ug/l

0.17

257

2000

Schizoaffective disorder

1321

11940

1.18

4.94

2.6

2.8

104.42

108.84

ug/l

0.42

1237

11243

Family history of other specific disorders

243

1931

1.53

4.93

3.6

2.8

73.98

73.49

ug/l

0.03

231

1799

Diffuse brain injury

544

4598

1.28

4.93

2.9

2.6

150.59

144.01

ug/l

0.12

493

4286

Vascular syndromes of brain in cerebrovascular disorders

611

5232

1.27

4.91

3.3

2.9

136.25

154.23

ug/l

1.29

566

4755

Scleritis

219

1709

1.54

4.90

3.5

2.7

114.14

95.32

ug/l

0.97

210

1592

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

232

1812

1.50

4.89

2.8

2.6

116.12

124.32

ug/l

0.27

220

1659

Disorder of pancreatic internal secretion, other and/or unspecified

121

857

1.79

4.88

4.4

2.7

114.30

107.13

ug/l

0.19

116

789

Assault by unspecified means

338

2760

1.39

4.87

2.8

2.7

113.06

113.34

ug/l

0.01

304

2612

Respiratory conditions due to other external agents

286

2288

1.42

4.84

3.5

2.7

188.40

132.38

ug/l

2.43

268

2070

Polypectomy (DHB20)

968

8578

1.20

4.83

2.9

2.8

125.23

156.39

ug/l

4.48

907

7911

Other and unspecified disorders of adult personality and behaviour

122

883

1.86

4.83

3.1

2.6

74.47

81.02

ug/l

0.34

112

838

Migraine without aura, drug-induced

226

1787

1.55

4.82

3.2

2.7

81.74

81.15

ug/l

0.03

219

1674

Other disorders of binocular movement

431

3640

1.36

4.82

3.4

2.8

92.39

85.09

ug/l

0.28

409

3413

Use of other anti-dementia drugs

3449

28128

1.10

4.82

2.5

3.0

138.23

158.47

ug/l

4.84

2940

24913

Use of memantine

3449

28128

1.10

4.82

2.5

3.0

138.23

158.47

ug/l

4.84

2940

24913

Galactorrhea

226

1813

1.61

4.82

3.2

2.9

65.58

63.41

ug/l

0.16

219

1710

Other ill-defined and unspecified causes of mortality

591

6906

0.81

4.81

3.1

2.8

285.30

165.58

ug/l

1.67

515

6227

Other bursitis of knee

209

1607

1.51

4.79

2.7

107.00

152.96

ug/l

3.17

199

1493

Congenital malformations of the nervous system

420

3540

1.36

4.78

3.3

2.9

73.80

79.01

ug/l

0.36

397

3335

Status epilepticus

518

4386

1.29

4.78

3.3

2.7

178.44

138.85

ug/l

1.45

469

4042

Amblyopia ex anopsia

724

6343

1.25

4.76

3.4

2.9

91.21

92.07

ug/l

0.04

671

5922

Necrobiosis lipoidica, not elsewhere classified

123

899

1.87

4.74

5.8

2.9

105.36

74.45

ug/l

1.38

114

839

Carcinoid syndrome

142

1037

1.67

4.73

3.0

2.6

179.00

142.94

ug/l

0.83

133

944

Marfan's syndrome

685

1.93

4.73

3.2

2.6

203.40

119.73

ug/l

0.65

646

Other specified and unspecified disorders of eyelid

211

1638

1.52

4.71

3.0

2.6

99.44

144.32

ug/l

3.66

198

1499

Disorders of lacrimal system and orbit in diseases classified elsewhere

411

3447

1.35

4.70

3.5

2.7

91.02

102.95

ug/l

0.86

380

3199

Embedded teeth, including avohilmo

1966

18218

1.15

4.70

3.2

2.9

79.62

72.81

ug/l

1.00

1885

17179

Cardiomyopathy due to drugs and other external agents

235

2.97

4.69

3.0

2.5

174.69

90.18

ug/l

1.04

213

Persistent delusional disorders

1131

10136

1.18

4.69

2.7

112.62

131.01

ug/l

2.45

1021

9379

Melanoma in situ

556

4767

1.28

4.68

3.2

2.8

144.13

143.67

ug/l

0.02

491

4313

Hyposplenism

173

3.78

4.66

13.1

2.6

352.67

87.93

ug/l

0.85

155

Pedestrian injured in collision with pedal cycle

494

4196

1.30

4.64

2.9

2.8

106.56

125.48

ug/l

0.97

468

3877

Benign neoplasm: Bladder

137

992

1.66

4.63

3.2

2.7

146.54

151.80

ug/l

0.08

127

910

Benign neoplasm: Conjunctiva

496

4226

1.30

4.60

3.3

2.7

122.60

122.34

ug/l

0.01

460

3896

Other injuries of upper limb, level unspecified

177

1350

1.58

4.58

3.7

2.7

114.20

116.53

ug/l

0.04

164

1263

Injury of muscle and tendon at wrist and hand level

2092

19330

1.13

4.55

2.8

135.52

144.75

ug/l

0.74

1948

18077

Embolic stroke

618

5310

1.24

4.54

3.4

2.8

136.98

166.99

ug/l

3.17

566

4732

Tobacco use

841

7459

1.22

4.53

3.1

2.8

135.56

117.63

ug/l

0.79

774

6974

Congenital malformations of pulmonary and tricuspid valves

145

1086

1.70

4.53

4.3

3.1

80.02

67.19

ug/l

0.62

139

1018

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

193

1483

1.52

4.53

3.7

2.7

133.98

145.56

ug/l

0.41

178

1341

Papillary adenocarcinoma of thyroid gland

825

7310

1.22

4.51

3.4

2.7

110.56

112.12

ug/l

0.08

764

6772

L02BG Aromatase inhibitors

4252

44846

0.92

4.51

2.6

2.8

143.97

111.12

ug/l

7.72

3864

40972

Other and unspecified corneal deformities and disorders

485

4124

1.30

4.50

3.3

2.7

103.46

120.72

ug/l

1.42

454

3831

Benign neoplasm of thyroid gland

525

4508

1.29

4.50

2.7

114.84

109.37

ug/l

0.24

476

4151

Congenital malformations of the respiratory system

271

2186

1.43

4.50

3.5

2.9

104.71

107.75

ug/l

0.11

259

2035

Carcinoma in situ of oral cavity, oesophagus and stomach

515

1.92

4.47

3.5

2.7

123.27

136.18

ug/l

0.28

465

Traction detachment of retina

137

1005

1.66

4.47

5.4

2.7

189.15

130.37

ug/l

1.48

129

926

Fourth [trochlear] nerve palsy

337

2779

1.37

4.47

3.1

2.8

149.40

137.53

ug/l

0.31

315

2554

Benign neoplasm: Heart

381

2.24

4.46

3.9

2.7

98.32

110.63

ug/l

0.26

353

Alport

160

3.65

4.46

8.3

2.7

197.21

82.19

ug/l

0.67

154

Choroidal haemorrhage and rupture

297

2.30

4.46

3.5

2.6

136.48

152.73

ug/l

0.15

262

Use of biperiden

776

6825

1.22

4.45

2.8

2.7

145.04

136.47

ug/l

0.14

706

6339

Other congenital malformations of nervous system

210

1678

1.58

4.43

3.5

2.9

69.21

64.60

ug/l

0.18

202

1572

Myotonic disorders

144

1075

1.67

4.43

2.9

2.7

118.27

120.42

ug/l

0.04

138

1004

Malignant neoplasm of rectosigmoid junction

218

1704

1.47

4.43

2.8

2.7

128.51

157.03

ug/l

1.40

204

1545

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

577

4977

1.26

4.42

3.3

2.8

152.63

141.00

ug/l

0.24

541

4559

Other disorders of carbohydrate metabolism

548

1.95

4.40

4.1

2.7

162.93

123.12

ug/l

0.59

505

Intermittent heterotropia

1107

10013

1.19

4.40

3.1

2.9

80.83

79.35

ug/l

0.13

1035

9432

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

124

891

1.67

4.40

2.5

2.6

233.30

151.34

ug/l

1.76

114

807

Other disorders of prostate

407

3376

1.30

4.39

3.2

2.8

184.71

218.39

ug/l

1.15

383

3083

Hyperkinetic disorders (excl. ADHD)

311

2527

1.38

4.36

3.6

3.1

83.92

84.90

ug/l

0.03

295

2409

Complications peculiar to reattachment and amputation

102

709

1.77

4.36

5.5

2.4

207.68

155.66

ug/l

1.10

649

LSIL lesion of the vulva

522

4517

1.30

4.36

3.4

2.8

98.02

81.73

ug/l

1.14

503

4251

Cardiomyopathies, Secondary/extrinsic

597

1.81

4.36

3.8

2.3

197.33

187.91

ug/l

0.10

549

Diabetes insipidus

154

1164

1.62

4.33

3.5

2.6

122.08

100.83

ug/l

0.48

146

1076

Macular cyst

343

2837

1.35

4.31

3.3

2.7

160.51

146.51

ug/l

0.36

315

2550

Benign neoplasm: Parathyroid gland

167

1276

1.57

4.27

5.0

2.7

148.13

115.92

ug/l

1.12

160

1170

Placenta praevia

1008

9156

1.22

4.26

3.1

2.9

71.17

63.51

ug/l

0.37

967

8786

Hypertrichosis

473

4114

1.34

4.24

3.4

2.8

75.37

58.67

ug/l

1.25

455

3883

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

205

1621

1.51

4.24

3.7

2.7

149.85

99.60

ug/l

1.87

191

1510

Calculus of lower urinary tract

699

6116

1.22

4.24

3.1

2.9

154.34

176.54

ug/l

1.28

608

5582

Biological medicines for asthma

227

1816

1.48

4.22

3.3

2.7

98.62

112.92

ug/l

0.37

214

1697

Other and unspecified disorders of pigmentation

127

937

1.69

4.21

3.4

2.6

133.85

93.76

ug/l

1.08

115

878

Vertigo of central origin

230

1829

1.45

4.21

3.0

2.7

129.35

132.42

ug/l

0.09

199

1667

Unattended death

820

0.52

4.17

3.0

2.6

217.23

153.08

ug/l

0.54

750

Benign neoplasm: Skin of scalp and neck

387

3255

1.32

4.17

3.1

2.7

134.16

107.73

ug/l

0.54

363

3000

Severe combined immunodeficiency [SCID] with reticular dysgenesis

375

2.25

4.16

4.3

2.6

200.81

103.69

ug/l

1.20

344

Follicular lymphoma, hilmo

579

5021

1.25

4.16

2.9

2.8

299.24

147.86

ug/l

3.03

542

4554

Localized adiposity

699

1.87

4.14

4.8

2.6

128.15

87.30

ug/l

1.05

657

Mature T/NK-cell lymphomas, hilmo

186

1438

1.49

4.14

3.8

2.7

657.63

162.04

ug/l

3.23

172

1309

Routine general health check-up of defined subpopulation

394

3327

1.32

4.13

2.6

2.4

86.68

85.37

ug/l

0.06

380

3162

Alcohol induced polyneuropathy

144

1074

1.58

4.13

3.4

2.5

267.38

182.63

ug/l

0.98

133

984

Granuloma annulare

258

2104

1.44

4.12

3.2

2.7

105.00

90.83

ug/l

0.50

241

1941

Allergic contact dermatitis due to drugs in contact with skin

362

3041

1.34

4.12

3.0

2.7

112.17

112.32

ug/l

0.00

338

2804

Melanocytic naevi of other and unspecified parts of face

1002

9037

1.19

4.12

3.2

2.8

101.18

103.17

ug/l

0.07

949

8402

Personal history of allergy to drugs, medicaments and biological substances

196

1548

1.52

4.11

3.6

2.6

139.93

84.66

ug/l

0.70

181

1444

Secondary uncertain malignant neoplasm

1780

16407

1.13

4.11

2.9

363.22

146.70

ug/l

21.05

1637

14965

Distal bite

706

6216

1.24

4.11

3.5

2.9

68.04

71.06

ug/l

0.12

665

5860

Infections of breast associated with childbirth

801

7212

1.24

4.09

3.1

2.9

59.02

61.58

ug/l

0.19

763

6836

Benign neoplasm: Parotid gland

1138

10298

1.17

4.08

2.9

2.8

138.03

139.48

ug/l

0.05

1040

9478

Venous complications and haemorrhoids in pregnancy

412

3565

1.37

4.08

3.2

2.8

60.99

59.81

ug/l

0.07

390

3403

Unspecified event, undetermined intent

404

3424

1.32

4.07

3.7

2.8

104.79

118.24

ug/l

0.68

386

3201

Viral encephalitis, not elsewhere classified/unspecified

303

2494

1.37

4.07

3.1

2.8

131.51

124.00

ug/l

0.25

276

2307

Adenocarcinoma and papillary adenocarcinoma of stomach

359

2979

1.31

4.06

3.4

2.8

81.75

161.82

ug/l

14.74

337

2680

Abscess of tendon sheath

103

736

1.77

4.05

4.4

2.5

151.69

130.42

ug/l

0.40

677

Other bursitis of elbow

119

864

1.66

4.05

4.1

2.6

152.79

169.84

ug/l

0.40

114

783

Narcolepsy and cataplexy

128

951

1.66

4.04

3.8

2.6

70.90

95.67

ug/l

1.48

120

888

Migraine with aura, drug-induced

199

1581

1.51

4.04

3.2

2.8

92.36

91.15

ug/l

0.05

188

1473

Convergence insufficiency and excess

276

2286

1.43

4.03

3.4

2.8

74.43

74.68

ug/l

0.01

264

2149

Problems related to social environment

470

4031

1.28

4.03

3.3

2.7

92.76

101.79

ug/l

0.69

442

3728

Loose body in joint

345

2863

1.32

4.03

2.5

2.6

148.05

157.76

ug/l

0.24

321

2652

Disorder of mineral metabolism, other/unspecified

268

2.51

4.02

3.7

2.4

257.78

100.62

ug/l

0.62

245

Anomalies of pupillary function

358

3018

1.35

4.02

2.7

2.8

89.03

92.50

ug/l

0.16

337

2819

Disorder of external ear, unspecified

470

4030

1.28

4.02

3.4

2.7

132.39

135.62

ug/l

0.10

428

3737

Acute epiglottitis

249

2016

1.41

3.99

3.4

2.6

139.24

120.50

ug/l

0.44

228

1880

Motor disorders, excluding more controls

243

1862

1.41

3.98

3.9

2.9

65.05

64.23

ug/l

0.03

235

1775

Iliotibial band syndrome

190

1491

1.49

3.97

3.2

2.6

90.58

104.80

ug/l

0.66

179

1376

Abnormal spermatozoa

1465

13404

1.14

3.96

3.0

254.01

205.71

ug/l

3.54

1232

12253

Sequelae of infectious and parasitic diseases

1178

10683

1.16

3.96

3.3

2.8

127.37

128.42

ug/l

0.06

1109

9907

Vascular dementia (other)

554

1.81

3.95

2.8

2.9

122.90

162.43

ug/l

1.16

500

Mental and behavioural disorders due to cannabinoids

481

4127

1.27

3.95

2.6

2.7

96.99

106.83

ug/l

0.59

433

3916

Horner syndrome

193

1519

1.48

3.95

3.1

2.6

117.62

125.78

ug/l

0.26

180

1410

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

910

8140

1.18

3.93

2.7

2.8

267.35

129.57

ug/l

5.46

850

7439

Anuria and oliguria

100

707

1.71

3.92

5.2

2.7

185.71

141.91

ug/l

0.88

648

Corneal degeneration

219

1751

1.44

3.92

3.4

2.7

118.21

123.54

ug/l

0.12

204

1598

Twin gestation

1972

18451

1.14

3.92

3.1

2.9

71.15

67.89

ug/l

0.23

1885

17715

Social disorders starting during childhood or adolecense, excluding more controls

145

1103

1.59

3.91

3.7

2.9

75.21

65.59

ug/l

0.34

140

1041

Spinal enthesopathy

381

3158

1.27

3.91

3.0

2.7

159.10

148.01

ug/l

0.28

346

2751

Cerebral palsy

295

2443

1.38

3.91

3.4

2.9

299.60

84.69

ug/l

0.61

266

2317

Injury of intra-abdominal organs

387

3272

1.31

3.90

3.2

2.7

154.41

122.71

ug/l

0.89

359

3051

Kissing spine

200

2.67

3.89

3.7

2.5

82.31

136.50

ug/l

2.33

184

Contracture of joint

184

1430

1.47

3.89

2.9

2.4

98.82

140.51

ug/l

2.46

170

1326

Polymyositis

129

959

1.61

3.88

3.4

2.6

165.88

114.54

ug/l

1.17

121

882

Myasthenia gravis

255

2079

1.40

3.87

3.5

2.7

164.74

137.40

ug/l

0.55

247

1903

Graves ophthalmopathy

403

3441

1.31

3.86

3.5

2.8

91.04

102.30

ug/l

0.78

372

3197

Injury of nerves at wrist and hand level

569

4959

1.24

3.86

3.0

2.7

130.79

133.84

ug/l

0.11

532

4628

Pneumothorax

957

8589

1.17

3.84

3.2

2.7

211.75

152.69

ug/l

3.15

879

7861

Habit and impulse disorders

266

2176

1.38

3.83

2.8

2.6

87.08

114.95

ug/l

2.69

236

2073

Congenital malformations of trachea and bronchus

148

1133

1.57

3.82

3.5

2.8

99.97

113.15

ug/l

0.39

139

1036

Dissocial personality disorder

225

1794

1.40

3.82

2.7

123.98

154.09

ug/l

1.31

212

1697

Multiple gestation

2032

19051

1.13

3.81

3.1

2.9

70.68

67.93

ug/l

0.20

1942

18288

Melanoma in situ of other and unspecified parts of face

154

1179

1.54

3.81

3.6

2.7

148.04

133.49

ug/l

0.36

134

1062

Sequelae of other and unspecified infectious and parasitic diseases

879

7887

1.19

3.79

3.2

2.8

120.91

119.37

ug/l

0.08

830

7442

Haemophilus septicemia

203

2.67

3.79

5.4

2.4

155.36

116.92

ug/l

0.51

187

Carcinoma in situ of oral cavity, oesophagus and stomach

537

1.82

3.78

3.5

2.7

123.27

155.54

ug/l

0.89

487

Other acquired deformities of ankle and foot

133

1000

1.59

3.77

2.7

2.6

99.08

110.07

ug/l

0.43

120

922

Benign neoplasm of other and unspecified sites

474

4086

1.27

3.77

2.9

2.7

124.18

116.97

ug/l

0.24

432

3768

Benign neoplasm: Parathyroid gland

167

1302

1.52

3.76

5.0

2.7

148.13

127.88

ug/l

0.57

160

1184

Other deformity of hallux (acquired)

130

975

1.60

3.76

3.2

2.6

100.34

110.68

ug/l

0.37

118

899

Overjet

448

3859

1.30

3.76

3.7

3.1

69.67

65.53

ug/l

0.15

418

3649

Other specified and unspecified disorders of conjunctiva

149

1143

1.55

3.75

3.3

2.6

139.25

118.33

ug/l

0.51

141

1051

Endometriosis of fallopian tube

146

1128

1.60

3.74

3.3

2.7

86.95

80.46

ug/l

0.22

134

1070

Other congenital malformations of intestine

143

1091

1.57

3.74

4.4

2.7

101.36

104.49

ug/l

0.07

134

1007

Dementia due to Parkinsons disease, excluding more controls

250

2012

1.36

3.74

2.6

2.7

164.09

179.42

ug/l

0.41

193

1781

Rheumatic fever incl heart disease

445

3801

1.26

3.73

4.3

2.7

167.62

140.79

ug/l

0.59

416

3431

Non-small cell lung cancer, adenocarcinoma

639

7267

0.83

3.73

2.7

2.8

253.63

162.43

ug/l

4.78

578

6531

Non-small cell lung cancer, adenocarcinoma, helper endpoint

639

7267

0.83

3.73

2.7

2.8

253.63

162.43

ug/l

4.78

578

6531

Contact with heat and hot substances

844

7571

1.19

3.71

3.2

2.8

189.83

114.92

ug/l

0.63

782

7061

Other and unspecified paralytic syndromes

222

1792

1.42

3.70

3.2

2.7

110.40

122.06

ug/l

0.40

206

1666

Evidence of alcohol involvement determined by blood alcohol level

238

1934

1.40

3.69

3.1

2.7

147.84

130.03

ug/l

0.46

213

1800

Unspecified chronic bronchitis

492

4229

1.24

3.69

3.3

2.7

134.91

151.27

ug/l

0.63

438

3818

Periodontal disease, other/unspecified

423

1.99

3.68

3.7

2.7

218.32

132.07

ug/l

0.43

390

Benign neoplasm: Larynx

433

3702

1.27

3.68

3.0

2.8

155.98

155.18

ug/l

0.01

410

3388

Benign neoplasm: Scrotum

342

1.98

3.68

3.3

2.3

165.30

171.19

ug/l

0.09

310

Other papulosquamous disorders

182

1440

1.49

3.68

3.3

2.7

97.24

103.96

ug/l

0.35

165

1340

Burn and corrosion of trunk

442

3799

1.27

3.68

3.1

2.9

130.43

133.73

ug/l

0.07

411

3520

Degeneration of the brain due to alcohol

286

2354

1.34

3.67

2.9

2.7

276.72

185.75

ug/l

0.83

261

2157

Viral agents as the cause of diseases classified to other chapters

357

3032

1.32

3.67

3.7

2.8

182.66

108.59

ug/l

1.21

344

2846

Perineal laceration during delivery

4228

36134

1.09

3.67

3.0

52.38

57.98

ug/l

1.74

4022

34511

Alzheimer’s disease (Early onset), excluding more controls

351

3975

0.79

3.66

2.4

2.6

136.93

160.88

ug/l

1.25

292

3542

Poisoning by narcotics and psychodysleptics [hallucinogens]

270

2228

1.37

3.66

3.3

2.7

80.71

101.81

ug/l

1.60

238

2096

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

222

2763

0.74

3.65

2.3

2.7

295.02

140.99

ug/l

5.48

202

2486

Juvenile rheumatoid arthirtis

439

3804

1.29

3.65

3.7

2.7

115.32

77.62

ug/l

0.95

423

3573

Malignant neoplasm of anus and anal canal

515

1.87

3.64

3.4

2.7

236.19

123.51

ug/l

1.40

468

Other conjunctival vascular disorders and cysts

346

2921

1.32

3.64

2.9

2.7

119.38

130.15

ug/l

0.38

316

2673

Melanoma in situ of trunk

177

1388

1.47

3.62

3.1

2.7

131.30

138.96

ug/l

0.22

154

1263

Congenital malformations of ovaries, fallopian tubes and broad ligaments

1189

10959

1.17

3.62

3.1

2.9

65.53

67.16

ug/l

0.23

1126

10384

Benign neoplasm: Heart

404

2.06

3.62

3.9

2.7

98.32

117.85

ug/l

0.46

369

Pyoderma

295

2453

1.34

3.61

3.3

2.7

135.42

120.19

ug/l

0.37

271

2283

Morphin

210

1666

1.39

3.60

3.0

2.5

172.86

154.73

ug/l

0.51

191

1499

Acute drug-induced interstitial lung disorder

108

790

1.65

3.60

3.5

2.7

205.12

136.02

ug/l

1.20

101

715

Nail dystrophy

106

778

1.68

3.60

4.4

2.4

74.86

110.90

ug/l

3.77

100

706

Hirsutism in women

418

3657

1.34

3.59

3.4

2.8

75.46

57.87

ug/l

1.15

400

3460

Complications following abortion and ectopic and molar pregnancy

561

4932

1.24

3.59

3.0

2.8

97.09

97.25

ug/l

0.01

494

4587

Benign neoplasm of male genital organs

256

2084

1.35

3.58

2.8

184.09

203.04

ug/l

0.55

229

1903

Postdysenteric arthropathy

155

1204

1.52

3.57

2.9

2.7

131.25

119.61

ug/l

0.32

150

1115

Acanthosis nigricans

430

2.01

3.57

3.3

2.7

136.16

99.62

ug/l

0.74

404

Abscess of lung

203

1617

1.41

3.56

4.3

2.7

167.50

164.96

ug/l

0.05

188

1482

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

4.65

3.56

13.4

2.8

305.84

120.65

ug/l

0.85

Other contact dermatitis

1389

12792

1.14

3.55

3.1

2.8

111.91

110.86

ug/l

0.06

1268

11931

Benign neoplasm: Ill-defined sites within the digestive system

703

1.71

3.54

3.6

2.6

127.85

107.46

ug/l

0.56

638

Lack of expected normal physiological development

429

3219

1.28

3.53

4.0

2.6

53.21

46.58

ug/l

0.66

414

3025

Degeneration of nervous system due to alcohol

286

2365

1.33

3.53

2.9

2.7

276.72

183.07

ug/l

0.87

261

2167

Disorders of other and unspecified cranial nerves

598

1.75

3.52

4.1

2.6

123.86

117.33

ug/l

0.14

549

Family history of malignant neoplasm

1917

17921

1.12

3.52

2.9

2.7

106.77

91.34

ug/l

1.69

1816

16879

Retinoschisis and retinal cysts

326

2741

1.31

3.51

3.0

2.7

139.16

150.78

ug/l

0.41

299

2494

Injury of nerves at lower leg level

160

1251

1.50

3.50

3.2

2.5

102.77

127.33

ug/l

0.92

154

1165

Transient synovitis

152

1184

1.53

3.50

3.2

2.7

94.32

92.49

ug/l

0.04

147

1096

Ulcer of oesophagus, drug-induced

497

1.81

3.50

3.6

2.6

140.75

170.64

ug/l

0.63

446

Malignant neoplasm of ovary

531

6049

0.82

3.49

2.5

2.8

199.38

102.36

ug/l

6.92

494

5528

Hereditary corneal dystrophies

448

3875

1.26

3.48

3.3

2.7

112.46

133.31

ug/l

1.79

406

3526

Perforation of oesophagus

525

1.80

3.47

3.5

2.5

139.29

177.30

ug/l

0.74

471

Focal epilepsy

3534

33563

1.08

3.47

3.0

2.9

136.45

124.30

ug/l

1.36

3250

31150

Helminthiases

283

2362

1.35

3.45

3.8

2.7

108.64

107.73

ug/l

0.03

261

2166

Unspecific neurodegenerative disorder

5885

38924

1.06

3.44

2.6

3.0

143.28

162.00

ug/l

6.62

5053

34741

Congenital malformations of eye, ear, face and neck

1209

11120

1.16

3.44

3.2

2.9

86.24

88.86

ug/l

0.23

1133

10456

Hirsprung

122

3.26

3.43

7.5

2.8

56.95

67.32

ug/l

0.33

114

Burn and corrosion of ankle and foot

207

1669

1.41

3.43

3.4

2.7

117.88

135.76

ug/l

0.71

189

1549

Effects of heat and light

111

822

1.60

3.41

2.8

2.7

158.81

133.76

ug/l

0.34

102

744

Nontraumatic intracranial haemmorrhage

2564

27245

0.92

3.39

3.2

2.8

167.52

153.31

ug/l

1.29

2320

24657

Cholinergic urticaria

662

1.75

3.39

3.0

2.6

148.18

93.59

ug/l

0.47

623

Cytomegaloviral pneumonitis

190

2.71

3.38

4.9

2.3

333.85

149.64

ug/l

1.53

167

Other specified/unspecified disorders of bone/cartilage

404

3468

1.27

3.38

3.3

2.7

138.73

143.60

ug/l

0.16

373

3204

Benign neoplasm of brain and other parts of central nervous system

972

8831

1.17

3.37

2.8

118.30

126.75

ug/l

0.46

889

8156

Polyclonal hypergammaglobulinaemia

117

3.45

3.37

6.8

3.0

122.35

138.91

ug/l

0.23

105

Other specified disorders of external ear

492

4286

1.24

3.37

2.9

2.8

164.85

164.64

ug/l

0.00

442

3946

Mental and behavioural disorders associated with the puerperium

245

2064

1.44

3.36

3.2

2.8

63.62

58.57

ug/l

0.30

232

1957

Other osteochondropathies

1140

10436

1.15

3.36

3.0

2.8

112.49

121.63

ug/l

0.92

1076

9784

Unspecified threat to breathing

176

1414

1.48

3.34

3.5

2.7

148.15

88.15

ug/l

0.47

166

1323

Primary angle-closure glaucoma

581

5116

1.21

3.32

3.0

2.8

140.29

140.22

ug/l

0.00

513

4613

Pedal cyclist injured in other and unspecified transport accidents

1807

16859

1.12

3.32

2.9

2.8

114.87

117.94

ug/l

0.26

1683

15729

Other hyperalimentation

379

2.02

3.31

4.1

2.7

103.80

102.10

ug/l

0.03

344

Disorder of thyroid, unspecified

205

1666

1.42

3.31

3.6

2.6

105.79

106.83

ug/l

0.02

189

1525

Hypothermia

247

2031

1.35

3.30

3.5

2.6

141.33

160.82

ug/l

0.77

223

1856

Whooping cough

120

921

1.62

3.30

3.7

2.7

111.39

65.80

ug/l

1.96

109

863

Injury of urinary and pelvic organs

298

2500

1.32

3.29

3.1

2.7

118.26

143.83

ug/l

1.42

274

2321

Open wound of hip and thigh

503

4405

1.24

3.29

3.1

2.7

131.35

121.58

ug/l

0.31

460

4103

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

133

1020

1.53

3.29

3.1

2.6

110.17

141.40

ug/l

0.99

122

931

Other specified/unspecified nutritional deficiencies

119

901

1.58

3.29

3.5

2.7

124.24

112.84

ug/l

0.24

112

841

Telogen effluvium

277

2.54

3.28

5.0

2.5

107.49

79.71

ug/l

0.49

255

Benign neoplasm: Short bones of upper limb

250

2077

1.36

3.27

2.9

2.7

101.97

106.18

ug/l

0.15

227

1937

Severe visual impairment, binocular

514

1.77

3.26

5.6

2.8

176.07

134.93

ug/l

0.62

472

Other congenital malformations of circulatory system

385

3317

1.28

3.26

2.9

2.8

127.14

119.89

ug/l

0.23

362

3083

Nystagmus and other irregular eye movements

228

1880

1.39

3.25

3.3

2.8

144.26

98.56

ug/l

0.62

213

1756

Malignant neoplasm, without specification of site

272

3279

0.78

3.25

2.7

304.52

152.92

ug/l

3.45

240

2934

Meningitis, viral

602

1.79

3.25

3.1

2.8

82.89

84.02

ug/l

0.04

564

Graves ophthalmopathy, strict

352

3021

1.30

3.24

3.6

2.8

91.32

102.84

ug/l

0.69

324

2812

Thyrotoxicosis with toxic single thyroid nodule

154

1224

1.52

3.23

3.2

2.8

89.28

97.26

ug/l

0.33

142

1126

Benign neoplasm: Ill-defined sites within the digestive system

716

1.66

3.22

3.6

2.5

127.85

116.81

ug/l

0.25

658

Childhood allergy (age < 16)

3763

29650

1.08

3.22

3.1

2.9

57.41

56.19

ug/l

0.24

3580

28067

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

223

1829

1.38

3.21

3.0

2.7

105.42

112.31

ug/l

0.25

213

1702

Osteolysis

3.21

2.3

2.0

191.63

129.96

ug/l

0.45

Other infective (teno)synovitis

479

1.83

3.19

3.4

2.5

216.52

114.02

ug/l

0.45

435

Interstitial cystitis (chronic), drug-induced

407

1.95

3.19

2.4

2.6

79.43

96.62

ug/l

0.65

373

Benign mammary dysplasia

2373

22396

1.10

3.18

2.8

91.77

103.03

ug/l

3.02

2205

20554

Mental and behavioural disorders of puerperium, not classified elsewhere

245

2077

1.42

3.17

3.2

2.9

63.62

58.50

ug/l

0.31

232

1970

Lumbosacral plexus disorders

390

1.95

3.17

3.3

2.6

124.08

113.18

ug/l

0.17

358

Exposure to other specified electric current

215

1764

1.39

3.17

2.9

98.51

108.08

ug/l

0.34

207

1656

Benign neoplasm: Endocrine pancreas

665

1.67

3.16

3.3

2.7

164.41

119.18

ug/l

0.70

607

Other appendicitis

1374

12715

1.13

3.16

3.0

2.8

127.95

120.83

ug/l

0.28

1285

11874

Nontoxic diffuse goitre

471

4119

1.24

3.16

3.0

2.6

111.94

110.22

ug/l

0.06

419

3807

Other disorders of bone density and structure

422

3673

1.26

3.16

3.3

2.7

104.04

110.00

ug/l

0.28

389

3415

Other and unspecified injuries of thorax

268

2239

1.33

3.16

3.3

2.7

129.82

132.38

ug/l

0.06

246

2080

Benign neoplasm: Short bones of upper limb

250

2085

1.36

3.16

2.9

2.7

101.97

115.60

ug/l

0.62

227

1949

Focal epilepsy, strict definition

3190

30305

1.08

3.15

3.1

2.9

139.64

126.12

ug/l

1.41

2928

28098

Abscess of Bartholin gland

530

4724

1.25

3.15

3.4

2.8

75.61

69.96

ug/l

0.34

495

4437

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

417

3593

1.24

3.14

3.7

2.7

233.78

144.87

ug/l

5.02

373

3245

Peritonsillar abscess

4089

39118

1.07

3.13

3.0

2.8

107.13

108.80

ug/l

0.16

3870

36896

Acne conglobata

693

1.66

3.13

2.9

2.5

100.17

83.60

ug/l

0.49

642

Other proliferative retinopathy

480

1.81

3.13

5.7

2.4

148.29

114.13

ug/l

1.01

435

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

113

856

1.57

3.13

3.3

2.8

203.25

97.32

ug/l

2.49

108

794

Benign neoplasm: Skin of scalp and neck

387

3347

1.27

3.12

3.1

2.8

134.16

119.44

ug/l

0.25

363

3083

Other leukaemias of specified cell type

287

2.15

3.11

6.9

2.5

327.93

105.68

ug/l

3.56

264

Unspecified dementia

1174

11578

0.89

3.11

2.8

2.9

163.16

155.77

ug/l

0.43

997

10246

Acute inflammation of orbit

111

842

1.59

3.11

3.6

2.6

168.16

111.71

ug/l

0.77

105

779

Disorders in reading

285

2416

1.33

3.10

3.7

3.0

66.64

71.10

ug/l

0.33

271

2278

Divergent concomitant strabismus

1314

12164

1.14

3.10

3.1

2.8

105.37

106.59

ug/l

0.06

1237

11424

Other specific arthropathies, wide

318

2698

1.29

3.10

3.0

2.6

101.01

129.51

ug/l

2.48

304

2502

Melanoma in situ of other and unspecified parts of face

154

1217

1.46

3.10

3.6

2.7

148.04

145.99

ug/l

0.04

134

1091

Viral conjunctivitis

357

3080

1.29

3.09

3.1

2.7

112.22

96.21

ug/l

0.46

342

2888

Parodontitis, operation under 40 years and operation codes

1996

18813

1.11

3.08

3.5

2.9

81.35

65.91

ug/l

2.65

1878

17944

Crowding of teeth, including avohilmo

1954

15172

1.12

3.08

3.2

2.8

56.73

63.88

ug/l

1.95

1856

14303

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

565

5026

1.22

3.05

3.8

3.0

107.59

84.63

ug/l

1.02

536

4744

Glycosuria

220

2.43

3.04

3.5

2.9

69.22

70.65

ug/l

0.04

206

Parodontitis, under 40 years and operation codes

1992

18784

1.11

3.04

3.5

2.9

81.16

65.86

ug/l

2.60

1874

17915

Unspecified multiple injuries

377

1.93

3.03

2.6

2.7

102.47

110.81

ug/l

0.15

346

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

145

1129

1.44

3.03

3.9

2.7

259.44

159.75

ug/l

1.20

131

1005

Occupational exposure to risk-factors

479

4211

1.23

3.02

2.7

2.8

279.14

146.88

ug/l

0.64

450

3900

Toxic effect of ethanol

673

6044

1.19

3.01

2.9

2.8

97.08

110.60

ug/l

1.05

628

5662

Paranoid personality disorder

310

2649

1.30

2.99

3.2

2.7

101.37

111.74

ug/l

0.40

283

2485

Prolapse and hernia of ovary and fallopian tube

521

4539

1.21

2.98

3.0

2.8

116.76

123.60

ug/l

0.26

469

3987

Use of levodopa decarbox-comt-inhibitor

407

3532

1.24

2.98

2.8

128.06

161.13

ug/l

2.40

360

3174

conjunctival degenerations and deposits

315

2688

1.29

2.97

2.8

2.7

106.94

130.71

ug/l

1.84

291

2454

Other conditions related to polyarteritis nodosa

310

2.12

2.96

4.1

2.3

322.77

110.04

ug/l

0.63

285

Monoplegia

230

1913

1.35

2.96

3.2

2.6

118.09

120.48

ug/l

0.05

207

1767

Tibial collateral bursitis [Pellegrini-Stieda]

170

1367

1.42

2.96

3.3

2.6

90.10

114.60

ug/l

1.87

164

1263

Migraine, unspecified, drug-induced

131

1034

1.54

2.95

3.0

2.7

84.57

93.92

ug/l

0.41

122

962

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1621

15193

1.12

2.94

3.4

2.8

86.15

86.03

ug/l

0.01

1531

14186

Donors of organs and tissues

219

1816

1.36

2.94

2.8

2.4

241.51

100.73

ug/l

2.55

211

1709

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

664

5962

1.19

2.93

3.1

2.7

112.54

112.33

ug/l

0.01

632

5551

Classical phenylketonuria

4.29

2.93

4.3

2.3

96.44

86.04

ug/l

0.14

Non-Hodgkin lymphoma, all

491

4313

1.21

2.92

3.4

2.8

650.84

160.26

ug/l

11.08

446

3863

Systemic sclerosis,strict definition

160

1295

1.47

2.91

3.9

2.7

89.05

88.97

ug/l

0.00

154

1197

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

684

6187

1.19

2.90

3.8

2.9

93.60

79.37

ug/l

1.22

648

5832

417

1.88

2.89

5.9

2.6

90.22

101.06

ug/l

0.35

394

Other bursal cyst

228

1895

1.34

2.88

3.1

2.6

145.65

138.12

ug/l

0.22

209

1723

Brain meningioma, excluding all cancers (controls excluding all cancers)

721

6508

1.17

2.88

2.8

135.76

110.44

ug/l

1.37

649

5946

Benign neoplasm: Scrotum

366

1.81

2.87

3.3

2.4

165.30

190.99

ug/l

0.47

336

Sequelae of intentional self-harm, assault and events of undetermined intent

114

881

1.55

2.87

2.9

2.6

99.54

99.45

ug/l

0.00

108

828

Disorders of sphingolipid metabolism and other lipid storage disorders

433

1.84

2.87

4.8

2.4

149.10

93.67

ug/l

1.16

397

Other specified and unspecified strabismus

193

1588

1.39

2.87

3.6

2.6

130.78

99.74

ug/l

0.68

177

1479

Benign neoplasm of other and unspecified sites

474

4180

1.22

2.86

2.9

2.7

124.18

128.06

ug/l

0.12

432

3850

Mental and behavioural disorders due to use of other stimulants, including caffeine

462

4069

1.23

2.86

2.8

84.69

107.00

ug/l

2.86

419

3878

LSIL lesion of the cervix uteri, vagina or vulva

2998

28669

1.09

2.85

3.0

2.9

73.89

72.43

ug/l

0.24

2856

27190

Hypertrophy of (infrapatellar) fat pad

169

1368

1.42

2.85

3.7

2.6

111.48

102.90

ug/l

0.29

149

1273

Intercostal neuropathy

120

930

1.51

2.85

3.2

2.5

90.84

129.39

ug/l

2.08

112

838

Acute and transient psychotic disorders

1951

18351

1.10

2.84

2.9

2.8

127.11

117.50

ug/l

0.47

1779

17268

Previous suicide attempt

179

1471

1.43

2.84

3.6

2.7

90.76

84.00

ug/l

0.24

169

1378

Maternal care for known or suspected disproportion

930

8584

1.17

2.83

3.1

3.0

59.99

68.45

ug/l

3.31

896

8268

Benign neoplasm: Lip

296

2518

1.28

2.83

3.1

2.7

144.11

116.87

ug/l

0.54

258

2291

Benign neoplasm: Prostate

619

1.60

2.83

2.8

2.6

210.22

190.47

ug/l

0.23

556

Struck by thrown, projected or falling objec

723

6534

1.17

2.83

2.8

114.45

130.86

ug/l

0.94

683

6098

Pityriasis rubra pilaris

288

2.11

2.83

3.5

2.4

89.22

101.55

ug/l

0.30

263

Diseases of thymus

311

2.02

2.82

4.1

2.6

123.83

115.70

ug/l

0.11

285

Haemorrhagic disorder due to circulating anticoagulants

151

1198

1.41

2.80

3.9

2.7

165.89

163.56

ug/l

0.04

129

1068

Other rupture of muscle

730

1.58

2.80

3.4

2.6

145.72

128.53

ug/l

0.24

678

Gonococcal infection

468

4125

1.22

2.78

2.8

2.6

126.33

119.25

ug/l

0.11

419

3838

171

1381

1.39

2.78

2.9

2.6

123.20

139.04

ug/l

0.54

161

1276

Benign neoplasm: Nasopharynx

128

1001

1.47

2.78

2.8

2.6

126.21

114.79

ug/l

0.21

117

923

Chorioretinal inflammation

421

3694

1.23

2.77

3.1

2.7

127.62

120.59

ug/l

0.30

381

3424

Valgus deformity, not elsewhere classified

128

1008

1.49

2.76

4.1

2.6

85.33

97.12

ug/l

0.52

120

921

Anoxic brain damage

117

1507

0.70

2.76

3.6

2.7

165.90

162.32

ug/l

0.06

104

1378

Hyperprolactinaemia, drug-induced

102

787

1.60

2.75

3.3

2.7

90.19

88.99

ug/l

0.03

735

Lesion of femoral nerve

123

964

1.50

2.75

3.1

2.5

109.39

108.84

ug/l

0.02

111

887

Sixth [abducent] nerve palsy

458

4040

1.22

2.74

3.1

2.8

176.75

141.12

ug/l

0.85

416

3701

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

916

8383

1.15

2.74

2.8

125.69

146.94

ug/l

1.78

857

7740

Secondary parkinsonism+Parkinsonism in other disease

355

3067

1.24

2.73

3.1

2.8

134.95

159.44

ug/l

1.58

316

2792

HSIL lesion of the vulva

277

2376

1.31

2.72

3.4

2.8

107.74

84.85

ug/l

1.27

249

2190

Malignant neoplasm of breast, HER-negative

3018

31603

0.93

2.71

2.6

2.8

122.93

109.02

ug/l

1.77

2688

28894

Other lesions of median nerve

394

3443

1.23

2.69

3.4

2.7

116.13

129.58

ug/l

0.71

350

3101

Puerperal sepsis

2236

21197

1.09

2.68

3.0

2.8

95.80

95.20

ug/l

0.04

2061

19785

Secondary parkinsonism

347

2999

1.24

2.67

3.1

2.8

135.50

159.53

ug/l

1.49

308

2726

Meningitis

762

6935

1.16

2.65

3.0

2.8

112.26

119.40

ug/l

0.45

709

6454

Benign neoplasm: Choroid

815

7441

1.16

2.65

2.9

2.8

122.59

134.59

ug/l

0.87

743

6817

Palindromic rheumatism

155

1249

1.40

2.64

2.9

2.6

116.45

124.78

ug/l

0.25

150

1168

Other injuries of spine and trunk, level unspecified

131

1041

1.47

2.64

4.2

2.7

120.99

111.48

ug/l

0.28

120

974

Pedal cyclist injured in transport accident

3866

37099

1.07

2.63

2.8

2.9

107.81

118.32

ug/l

2.38

3615

34713

Contact with other hot fluids

486

4328

1.21

2.63

3.0

2.8

109.31

107.35

ug/l

0.08

442

4051

Malignant melanoma

2084

19684

1.09

2.62

3.0

2.9

147.33

145.94

ug/l

0.07

1887

18009

Cutis laxa senilis

125

993

1.49

2.62

2.7

142.06

98.59

ug/l

0.42

119

895

Other corneal oedema

109

844

1.51

2.61

3.6

2.7

164.48

135.27

ug/l

0.40

101

769

Simple and mucopurulent chronic bronchitis

564

5029

1.18

2.61

3.6

2.8

135.97

148.80

ug/l

0.35

508

4543

Parodontitis, under 40 years, or operation codes

2098

19910

1.10

2.61

3.5

2.9

82.29

66.62

ug/l

2.88

1974

19008

Other, unspecified and serous retinal detachments

397

3475

1.23

2.61

3.3

2.8

145.19

148.69

ug/l

0.09

365

3178

Adenocarcinoma and ductal carcinoma of pancreas

320

3708

0.81

2.61

2.2

2.8

284.02

156.88

ug/l

5.71

297

3340

Preterm labour and delivery

5162

49897

1.06

2.61

3.0

2.9

86.43

85.20

ug/l

0.16

4828

47115

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

1357

12655

1.12

2.60

2.7

2.8

153.28

103.20

ug/l

9.74

1223

11413

Contusion of toe(s) with damage to nail

184

1525

1.38

2.60

3.4

2.7

94.22

98.80

ug/l

0.20

175

1423

Other/unspecified mastoiditis and related conditions

559

1.65

2.60

3.4

2.6

151.99

116.02

ug/l

0.70

509

Melanoma in situ of trunk

177

1452

1.37

2.60

3.1

2.7

131.30

160.66

ug/l

1.15

154

1320

Vascular dementia (multiple infarctions)

1203

0.70

2.59

2.8

141.21

165.33

ug/l

0.53

1076

Other leukaemias of specified cell type

302

1.99

2.58

6.9

2.4

327.93

102.21

ug/l

3.65

277

Respiratory tuberculosis, confirmed

244

2050

1.29

2.58

3.8

2.7

199.37

158.62

ug/l

0.92

226

1855

Cytomegaloviral hepatitis

346

1.95

2.57

4.4

2.4

111.61

96.43

ug/l

0.30

319

Other operation for atrial fibrillation

550

1.64

2.57

4.1

2.7

193.10

184.33

ug/l

0.09

501

Rheumatic valve diseases

305

2612

1.25

2.57

4.2

2.7

168.70

143.34

ug/l

0.55

284

2342

Dacryoadenitis

125

993

1.47

2.56

3.9

2.7

111.42

113.12

ug/l

0.04

118

907

Pustulosis palmaris et plantaris

629

5684

1.18

2.56

3.0

2.7

131.80

114.05

ug/l

0.34

576

5272

Myocardial infarction, unclassifiable

2892

27104

0.93

2.56

3.7

2.9

160.61

168.23

ug/l

0.70

2621

24151

Tarsal tunnel syndrome

159

1296

1.40

2.56

3.2

2.6

121.50

108.23

ug/l

0.23

152

1189

Parodontitis, under 40 years

2093

19877

1.10

2.54

3.5

2.9

82.13

66.50

ug/l

2.86

1969

18975

Benign neoplasm: Tonsil

177

1459

1.37

2.54

2.9

2.6

141.77

112.12

ug/l

0.80

164

1341

Pilonidal cyst

1441

13476

1.11

2.53

3.2

2.7

135.92

117.03

ug/l

0.79

1373

12742

Osteopathy after poliomyelitis

4.24

2.52

4.6

2.1

157.21

78.37

ug/l

0.76

Parapsoriasis

294

2538

1.27

2.51

3.1

2.7

108.28

116.41

ug/l

0.28

287

2369

Benign neoplasm: other/unspecified salivary gland

360

3138

1.23

2.51

3.4

2.7

128.33

123.80

ug/l

0.16

330

2867

Organ-limited amyloidosis

345

1.77

2.51

4.1

2.5

178.93

156.69

ug/l

0.29

307

Complications of anaesthesia during labour and delivery

731

1.74

2.50

4.2

3.1

53.94

56.55

ug/l

0.11

685

Dementia in other diseases classified elsewhere

580

5209

1.17

2.49

3.1

2.9

130.94

147.69

ug/l

1.04

471

4718

Evidence of alcohol involvement determined by level of intoxication

185

1540

1.36

2.49

3.2

2.6

112.25

96.88

ug/l

0.60

176

1445

Malignant neoplasm of oral cavity

427

3769

1.21

2.48

2.6

2.7

183.49

160.12

ug/l

0.98

393

3428

Combined immunodeficiency, unspecified

133

2.85

2.46

3.5

2.8

127.76

77.36

ug/l

1.13

121

Other lack of coordination

241

2048

1.30

2.46

2.9

2.7

153.53

133.81

ug/l

0.39

226

1872

Secondary malignant neoplasm of other and unspecified sites

118

1488

0.72

2.45

1.9

2.7

656.17

151.74

ug/l

4.92

105

1360

Other disorders of central nervous system

182

1511

1.36

2.45

3.8

2.7

122.49

103.13

ug/l

0.53

166

1412

Other drug-induced secondary parkinsonism

124

983

1.44

2.44

3.2

2.6

145.07

146.23

ug/l

0.02

112

895

Synovial hypertrophy, not elsewhere classified

161

1321

1.38

2.44

2.8

2.6

97.07

118.02

ug/l

0.83

154

1221

Oesophagitis, drug-induced

273

2.00

2.44

3.3

2.8

158.78

120.23

ug/l

0.42

251

Peroneal tendinitis

245

2089

1.29

2.43

3.2

2.5

95.84

109.11

ug/l

0.57

234

1944

Use of entacapone

841

0.64

2.43

2.8

2.7

150.71

149.72

ug/l

0.01

748

Disorder of carbohydrate metabolism, other/unspecified

352

1.79

2.42

2.7

2.5

131.03

127.78

ug/l

0.05

320

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

831

9067

0.88

2.41

2.6

2.8

184.06

123.20

ug/l

3.35

769

8358

Toxic effect of corrosive substances

646

1.57

2.40

3.1

2.5

110.38

93.69

ug/l

0.29

604

Failed attempted abortion

281

2474

1.33

2.40

3.2

2.9

57.30

55.44

ug/l

0.16

268

2358

Severe visual impairment, monocular

132

1062

1.43

2.40

3.7

2.6

141.03

119.52

ug/l

0.51

113

969

Acute bronchiolitis

1147

9606

1.12

2.39

3.4

2.8

84.10

67.83

ug/l

1.40

1078

8990

Superficial injury of neck

334

2928

1.25

2.39

3.2

2.8

83.63

99.84

ug/l

1.30

317

2753

Asymmetry of jaw

276

2398

1.29

2.39

2.7

2.8

71.21

85.51

ug/l

1.30

265

2251

Hair colour and hair shaft abnormalities

456

1.69

2.38

3.1

2.6

147.08

152.12

ug/l

0.06

409

Aphakia

182

1490

1.31

2.38

3.3

2.6

184.35

146.17

ug/l

0.78

168

1357

Mixed disorders of conduct and emotions

484

4357

1.21

2.38

3.1

2.9

72.37

62.07

ug/l

1.05

447

4094

Vitiligo

181

1510

1.35

2.37

3.3

2.6

104.79

114.32

ug/l

0.28

168

1411

Injury of cranial nerves

103

806

1.50

2.37

3.0

2.5

158.96

130.86

ug/l

0.37

758

Other congenital malformations of peripheral vascular system

228

1949

1.32

2.37

4.2

2.9

89.54

83.69

ug/l

0.19

210

1819

Benign neoplasm: Spinal cord

207

1744

1.32

2.37

2.7

102.23

111.17

ug/l

0.44

192

1605

Benign neoplasm: Endocrine pancreas

701

1.54

2.37

3.3

2.6

164.41

145.29

ug/l

0.23

644

Exposure to unspecified smoke, fire and flames

143

1161

1.40

2.36

2.9

2.6

130.32

132.97

ug/l

0.06

131

1084

Circumscribed brain atrophy

180

2168

0.77

2.35

2.8

136.08

155.15

ug/l

0.62

163

1942

Subarachnoid haemorrhage

1266

13571

0.90

2.35

3.0

2.8

145.87

146.12

ug/l

0.01

1162

12360

Other degenerative diseases of the basal ganglia

200

1679

1.32

2.34

2.3

2.7

145.76

168.90

ug/l

0.95

182

1518

Contact with blunt object, undetermined intent

764

1.52

2.34

2.8

2.7

93.72

105.99

ug/l

0.49

708

Oral leukoplakia

238

2027

1.28

2.34

2.9

2.7

138.35

138.28

ug/l

0.00

215

1842

Contact with other sharp object(s)

1070

9949

1.13

2.34

2.8

110.18

111.04

ug/l

0.03

990

9365

Foreign body or object entering through skin

944

8725

1.13

2.33

3.0

2.8

113.64

128.86

ug/l

1.74

875

8163

LeFortI or BSSRO operation

732

6723

1.16

2.32

2.6

2.8

74.56

90.71

ug/l

3.87

702

6366

All dysplastic lesions of the cervix uteri

5994

58184

1.06

2.32

2.9

3.0

71.78

68.29

ug/l

1.06

5673

55419

Abscess of external ear

224

1907

1.30

2.32

3.5

2.7

138.21

111.83

ug/l

0.73

208

1779

Other bursitis, not elsewhere classified

144

1169

1.38

2.32

2.7

2.6

123.77

139.16

ug/l

0.42

131

1080

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

527

1.62

2.31

3.6

2.8

274.86

132.37

ug/l

1.10

494

Benign neoplasm: Other/unspecified site

227

1931

1.29

2.31

3.1

2.7

105.72

114.98

ug/l

0.42

205

1777

Lower leg

100

788

1.52

2.30

3.0

2.7

85.52

87.75

ug/l

0.07

718

Iodine-deficiency-related thyroid disorders and allied conditions

120

2.80

2.30

3.7

2.2

96.81

106.46

ug/l

0.13

110

Malignant neoplasm of other and unspecified parts of tongue

190

1590

1.32

2.29

3.0

2.6

158.69

142.14

ug/l

0.44

180

1458

Maternal care for cervical incompetence

705

6484

1.17

2.29

3.1

2.8

75.92

78.90

ug/l

0.23

656

6040

Enterobiasis

627

1.63

2.28

4.5

2.8

78.19

63.84

ug/l

0.41

582

Other and unspecified primary disorders of muscles

113

898

1.45

2.28

3.6

2.8

124.04

109.04

ug/l

0.29

107

838

Chronic mastoiditis

370

3264

1.22

2.27

3.2

2.8

139.61

142.41

ug/l

0.08

324

2963

Dementia in Alzheimer disease

2063

18629

0.93

2.26

2.6

3.0

158.05

159.48

ug/l

0.07

1621

16523

Respiratory tuberculosis, bacteriologically and histologically confirmed

250

2133

1.26

2.25

3.8

2.7

199.23

159.03

ug/l

0.93

232

1928

Peripheral retinal degeneration

459

4110

1.19

2.24

3.0

2.7

140.53

122.85

ug/l

0.52

423

3801

Liposarcoma, excluding all cancers (controls excluding all cancers)

133

1076

1.39

2.22

2.7

2.6

239.55

127.75

ug/l

1.33

126

988

Benign intracranial hypertension

199

1713

1.36

2.21

4.3

2.9

77.90

61.53

ug/l

1.39

188

1606

Enduring personality changes

526

1.62

2.21

3.5

2.6

88.06

98.69

ug/l

0.19

495

Epidural haemorrhage

120

952

1.39

2.20

2.7

2.6

141.99

183.08

ug/l

1.26

109

886

Malignant neoplasm of head and neck

1031

9564

1.12

2.19

2.7

2.8

196.91

165.26

ug/l

1.93

932

8709

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

340

2995

1.22

2.18

2.9

2.7

133.89

111.93

ug/l

1.13

305

2751

Disorders of puberty, other/unspecified

624

1.62

2.17

3.1

2.7

58.35

56.96

ug/l

0.04

572

Traumatic ischaemia of muscle

187

1571

1.31

2.17

4.1

2.7

187.49

128.20

ug/l

0.54

175

1464

Pustular psoriasis

688

6305

1.15

2.16

3.0

2.7

133.73

117.69

ug/l

0.32

630

5850

Exposure to other and unspecified man-made environmental factors

250

2162

1.27

2.16

3.2

2.6

143.79

111.22

ug/l

0.38

231

2016

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

290

1.90

2.16

4.6

2.4

107.98

92.96

ug/l

0.22

274

Other zoonotic bacterial diseases, not elsewhere classified

129

2.48

2.14

2.8

110.86

86.54

ug/l

0.46

122

Universal erythroderma, KELA reimbursement

196

1654

1.30

2.13

3.2

2.6

147.78

149.75

ug/l

0.04

173

1527

Calcaneal spur

185

1560

1.31

2.12

2.6

89.20

117.56

ug/l

2.58

173

1419

Erosion and ectropion of cervix uteri

429

3839

1.19

2.12

3.2

2.7

145.38

105.95

ug/l

0.48

391

3528

Keratoconus

349

3082

1.21

2.11

3.0

2.7

119.74

127.38

ug/l

0.29

313

2881

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

161

1337

1.33

2.11

3.3

2.7

408.61

125.16

ug/l

1.17

148

1232

Exposure to other and unspecified forces of nature

745

1.51

2.11

3.1

2.7

99.06

95.11

ug/l

0.11

703

Juvenile osteochondrosis

578

5274

1.17

2.11

3.2

2.8

101.58

93.47

ug/l

0.36

547

4946

Dermatitis due to ingested food

696

6173

1.15

2.11

3.2

3.0

54.75

59.36

ug/l

0.41

650

5831

Sequelae of malnutrition and other nutritional deficiencies

230

1.92

2.10

5.5

2.4

240.04

117.01

ug/l

1.30

209

Malignant neoplasm of tongue

250

2158

1.25

2.10

2.8

2.7

166.22

154.57

ug/l

0.30

233

1978

Benign neoplasm: Other parts of oropharynx

140

1154

1.38

2.09

3.5

2.7

137.11

109.86

ug/l

0.56

128

1074

Drug-induced tremor

732

1.49

2.09

3.0

2.6

130.56

118.94

ug/l

0.21

665

Other specified and unspecified disorders of iris and ciliary body

496

1.62

2.08

3.0

2.6

100.52

97.90

ug/l

0.07

457

Contusion of ankle

645

5914

1.16

2.08

3.3

2.8

99.74

99.52

ug/l

0.01

598

5524

Fatigue fracture of vertebra

546

1.57

2.08

2.9

2.8

108.02

108.41

ug/l

0.01

500

Oral leukoplakia, including avohilmo

359

3181

1.21

2.08

2.9

2.7

137.63

141.88

ug/l

0.11

317

2916

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

202

1722

1.30

2.07

3.6

2.7

95.14

108.47

ug/l

0.70

192

1585

Cicatricial alopecia [scarring hair loss]

115

929

1.42

2.07

3.5

2.5

159.96

107.13

ug/l

0.69

104

849

Secondary malignant neoplasm of respiratory and digestive organs

106

1329

0.73

2.06

1.9

2.7

337.51

153.46

ug/l

2.52

1199

Cyst of Bartholin Gland

692

6389

1.16

2.06

2.9

2.8

76.70

75.25

ug/l

0.14

659

6007

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

664

6090

1.15

2.05

3.1

2.7

112.54

122.67

ug/l

0.67

632

5663

Assault by blunt object

206

1755

1.28

2.05

2.8

2.7

143.30

128.34

ug/l

0.42

179

1664

Human immunodeficiency virus [HIV] disease resulting in other conditions

228

1953

1.26

2.05

2.4

2.7

150.83

152.59

ug/l

0.03

219

1860

Other disorders of thyroid

209

1795

1.29

2.04

3.7

2.8

106.76

98.96

ug/l

0.13

192

1651

Hepatocellular carcinoma

236

2026

1.25

2.03

4.0

2.8

193.82

185.37

ug/l

0.17

218

1827

Type 1 diabetes, strict definition, subgroup 1

1470

13858

1.10

2.03

3.6

2.8

89.16

82.89

ug/l

0.78

1377

13198

Other and unspecified hypertrophic disorders of skin

110

892

1.45

2.03

3.0

2.7

100.11

98.49

ug/l

0.03

101

828

Acute hepatitis A

569

1.56

2.02

3.0

2.6

92.20

107.33

ug/l

0.41

523

Normal-pressure hydrocephalus

514

5675

0.87

2.02

2.5

2.9

136.01

155.41

ug/l

1.31

458

5073

Benign neoplasm: Other/unspecified site

227

1957

1.27

2.01

3.1

2.7

105.72

121.87

ug/l

0.92

205

1806

Lagophthalmos

170

1431

1.32

2.01

4.0

2.7

123.76

134.88

ug/l

0.29

155

1295

Other and unspecified injuries of abdomen, lower back and pelvis

237

2057

1.27

2.01

3.3

2.7

103.76

107.21

ug/l

0.13

221

1911

Benign neoplasm: Retina

656

1.50

2.00

2.6

2.7

122.79

104.86

ug/l

0.23

606

Vertical strabismus

515

4681

1.17

2.00

3.0

2.8

101.63

111.81

ug/l

0.76

479

4358

HSIL lesion of the cervix uteri, vagina or vulva

4450

43217

1.06

2.00

2.9

3.0

75.19

68.83

ug/l

1.83

4188

41150

Disease of thymus, other/unspecified

204

2.06

2.00

3.4

2.7

124.24

105.19

ug/l

0.21

188

Contact with sharp glass

622

5703

1.15

1.99

3.0

2.8

109.13

102.85

ug/l

0.37

585

5365

Dislocation, sprain and strain of joints and ligaments of elbow

1059

9918

1.11

1.98

2.9

2.8

94.59

98.29

ug/l

0.20

992

9306

Postinfectious hypothyroidism

740

1.47

1.97

4.3

2.6

68.97

87.57

ug/l

1.66

682

Chromophobe cell carcinoma of kidney

543

1.55

1.96

3.6

2.6

274.86

139.67

ug/l

1.02

502

Torsion of testis

209

1769

1.24

1.96

2.3

2.6

132.02

163.36

ug/l

1.84

197

1673

Pemphigus

104

836

1.43

1.96

3.8

2.6

150.95

111.66

ug/l

1.41

764

Maltreatment syndromes

925

8634

1.12

1.95

3.1

2.8

112.45

89.48

ug/l

1.67

847

8165

ILD medications: nintedanib

611

1.49

1.95

2.4

234.16

173.28

ug/l

0.99

551

171

1454

1.33

1.95

4.1

2.7

76.85

77.06

ug/l

0.01

157

1364

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

228

1960

1.25

1.94

2.8

2.7

209.37

139.24

ug/l

2.89

215

1757

Benign neoplasm: Tonsil

177

1504

1.31

1.94

2.9

2.5

141.77

123.24

ug/l

0.41

164

1386

Malignant neoplasm of bone and articular cartilage

128

1053

1.37

1.94

3.3

2.6

417.21

136.87

ug/l

0.93

122

969

Erythema elevatum diutinum

3.86

1.94

4.2

2.6

146.85

98.48

ug/l

0.21

Benign neoplasm: Spinal meninges

145

1208

1.34

1.94

3.3

2.7

153.59

110.98

ug/l

0.73

134

1104

Defect, injury or illness of neck

755

1.48

1.93

3.1

2.7

129.62

87.48

ug/l

0.34

695

Benign neoplasm: Urinary organ, other/unspecified

302

1.74

1.93

3.6

2.6

116.50

107.09

ug/l

0.13

282

Congenital malformations of breast

357

3230

1.24

1.92

3.0

2.9

64.24

56.59

ug/l

0.88

336

3040

Benign neoplasm: Nasopharynx

128

1054

1.36

1.91

2.7

2.6

126.21

125.02

ug/l

0.02

117

960

Benign neoplasm: Long bones of lower limb

503

4577

1.17

1.91

2.8

2.7

113.74

100.42

ug/l

0.83

473

4276

Ankylosis of joint

556

1.48

1.91

2.8

2.4

147.02

115.98

ug/l

0.58

505

Benign neoplasm: Connective and other soft tissue of head, face and neck

249

2171

1.24

1.90

3.0

2.7

104.41

104.60

ug/l

0.01

235

1997

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

639

1.46

1.89

2.4

2.6

216.36

119.65

ug/l

2.43

584

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

123

998

1.34

1.89

2.9

2.7

248.68

151.78

ug/l

0.95

114

902

Convergent concomitant strabismus

1023

9593

1.11

1.88

3.0

2.8

96.56

92.32

ug/l

0.33

961

9054

Cerebral amyloid angiopathy

389

1.63

1.88

2.3

2.7

190.23

173.71

ug/l

0.15

344

Unequal limb length (acquired)

160

1356

1.33

1.87

2.9

2.5

98.53

74.62

ug/l

0.79

144

1255

Certain zoonotic bacterial diseases

262

2296

1.23

1.87

3.3

2.7

133.76

127.72

ug/l

0.16

239

2117

Patellar tendinitis

268

2352

1.23

1.85

2.8

2.7

107.22

109.96

ug/l

0.07

258

2210

Unspecified parasitic disease

120

985

1.37

1.85

4.5

2.7

212.41

150.42

ug/l

0.78

113

921

Benign neoplasm: Pharynx, unspecified

114

932

1.38

1.85

3.0

2.6

114.32

106.55

ug/l

0.15

854

Benign neoplasm: Other parts of oropharynx

140

1171

1.34

1.85

3.5

2.7

137.11

112.90

ug/l

0.49

128

1079

Benign neoplasm: Hypopharynx

484

1.54

1.85

3.6

2.5

182.96

127.72

ug/l

1.18

443

Filariasis

144

2.28

1.84

4.1

2.5

66.07

91.88

ug/l

1.03

134

Sclerosis of liver

3.37

1.84

6.2

3.0

121.31

90.00

ug/l

0.23

Acute myringitis

117

965

1.39

1.84

3.6

2.8

117.27

95.09

ug/l

0.24

111

897

Hypertrophy of tongue papillae

186

1596

1.29

1.84

3.5

2.7

130.58

120.23

ug/l

0.23

170

1486

Bacterial meningitis

495

4504

1.16

1.83

2.9

2.8

117.47

129.84

ug/l

0.68

457

4189

Onycholysis

103

837

1.42

1.83

3.4

2.7

123.89

100.10

ug/l

0.78

774

Inflammation of lacrimal passages (acute and unspecified)

260

2284

1.23

1.83

3.5

2.7

120.37

113.49

ug/l

0.16

247

2099

Benign neoplasm: Spinal cord

207

1790

1.27

1.83

2.7

2.6

102.23

124.47

ug/l

1.62

192

1638

Osteomalacia

138

1155

1.34

1.83

3.1

2.7

110.35

117.06

ug/l

0.13

131

1074

COPD, hospital admissions 1, only main diagnosis

5154

42598

1.04

1.82

3.4

2.9

157.51

166.91

ug/l

0.95

4636

38488

Other sexually transmitted chlamydial diseases

1394

13244

1.10

1.81

3.0

2.9

73.14

70.03

ug/l

0.38

1296

12583

Congenital deformities of hip

338

3038

1.21

1.81

3.4

2.9

84.46

60.78

ug/l

2.06

319

2853

Retained placenta and membranes, without haemorrhage

2262

21720

1.07

1.79

3.0

2.9

87.25

85.58

ug/l

0.16

2120

20439

Juvenile dermatomyositis

145

2.23

1.79

3.0

3.2

70.90

60.36

ug/l

0.24

139

Benign neoplasm of other and unspecified female genital organs

671

6213

1.14

1.79

3.0

2.8

87.18

85.16

ug/l

0.17

604

5742

Diseases caused by chlamydiae

190

1646

1.29

1.78

2.9

2.7

97.14

78.33

ug/l

1.21

183

1556

Mesothelioma

117

1422

0.76

1.78

2.7

2.8

427.12

166.35

ug/l

2.38

110

1279

Cerebral arteritis

337

1.71

1.77

3.5

2.5

101.57

100.52

ug/l

0.02

307

Exposure to other and unspecified animate mechanical forces

487

4456

1.17

1.77

3.3

2.8

111.75

93.08

ug/l

0.57

454

4188

Bilateral sagittal split ramus osteotomy operation

595

5494

1.15

1.77

2.6

2.7

75.47

90.79

ug/l

2.94

571

5198

Burn and corrosion of wrist and hand

571

5245

1.15

1.77

2.9

2.8

117.35

111.95

ug/l

0.14

529

4914

Benign neoplasm: Urinary organ, other/unspecified

308

1.69

1.77

3.6

2.7

116.50

104.78

ug/l

0.17

290

Acquired stenosis of external ear canal

127

1053

1.34

1.76

2.7

139.48

156.83

ug/l

0.41

113

965

Mandibular hypoplasia

116

965

1.40

1.76

2.9

2.8

61.17

86.51

ug/l

3.84

111

908

Injury of blood vessels at hip and thigh level

317

1.69

1.76

2.4

2.7

106.23

136.92

ug/l

1.03

293

Other diseases caused by chlamydiae

204

1777

1.27

1.76

2.8

2.7

98.49

84.70

ug/l

0.79

196

1679

Acne varioliformis

321

1.73

1.75

4.8

2.5

150.71

92.17

ug/l

0.84

301

Contact with other hot metals

213

1847

1.25

1.75

3.3

2.7

370.21

134.85

ug/l

0.48

201

1704

Burn and corrosion of head and neck

303

2691

1.20

1.75

2.6

2.7

295.87

132.46

ug/l

0.46

278

2513

Benign neoplasm: Prostate

673

1.42

1.74

2.8

2.7

210.22

192.08

ug/l

0.21

610

Tularaemia

182

1562

1.27

1.74

3.2

2.6

138.70

127.88

ug/l

0.25

167

1438

Other acute disseminated demyelination

184

1595

1.30

1.74

3.1

2.8

106.45

78.85

ug/l

1.09

175

1500

Intracerebral haemorrhage

1476

15580

0.93

1.74

3.3

2.8

185.22

158.58

ug/l

1.71

1325

13978

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

707

1.40

1.74

3.7

2.7

247.66

150.97

ug/l

1.02

634

Nocardiosis

2.47

1.73

8.0

2.5

298.44

119.25

ug/l

0.84

Other obstetric trauma

1145

10865

1.11

1.73

3.1

2.9

61.49

64.44

ug/l

0.40

1109

10392

Focal epilepsy, mode (most common among epilepsy diagnosis)

2999

28907

1.06

1.73

3.0

2.9

140.84

125.57

ug/l

1.61

2763

26824

Type 1 diabetes, strict definition

1539

14600

1.08

1.72

3.6

2.8

90.57

84.64

ug/l

0.75

1442

13917

Human immunodeficiency virus [HIV] disease

252

2210

1.22

1.72

2.5

2.7

185.04

152.21

ug/l

0.39

242

2099

Increased muscle tone

112

928

1.38

1.70

3.2

2.6

98.55

99.01

ug/l

0.01

107

845

Contact with nonpowered hand tool

580

5329

1.14

1.70

2.8

178.08

154.41

ug/l

0.90

523

4973

Other and unspecified injuries of forearm

120

1000

1.36

1.69

3.0

2.6

111.36

108.44

ug/l

0.06

114

930

Injury of muscle and tendon at forearm level

268

2369

1.21

1.69

3.0

2.7

123.99

138.58

ug/l

0.45

250

2220

Cerebral atherosclerosis

139

1154

1.29

1.68

4.0

2.7

113.58

162.55

ug/l

3.00

130

1026

Other superficial injuries of ankle and foot

104

857

1.39

1.68

3.7

2.9

86.78

88.07

ug/l

0.04

810

Reactive perforating collagenosis

3.58

1.68

6.0

3.0

170.36

82.23

ug/l

—

Benign neoplasm: Spinal meninges

145

1228

1.31

1.67

3.3

2.7

153.59

114.29

ug/l

0.66

134

1109

Unspecified human immunodeficiency virus [HIV] disease

133

1112

1.31

1.67

2.6

2.7

241.25

164.62

ug/l

0.55

126

1055

Guttate psoriasis

223

1958

1.24

1.67

3.4

2.8

99.91

108.64

ug/l

0.32

211

1834

Premature separation of placenta [abruptio placentae]

451

4142

1.18

1.66

3.2

2.9

56.57

68.26

ug/l

2.58

427

3963

Exophthalmic conditions

158

1348

1.29

1.66

3.1

2.7

151.24

121.12

ug/l

0.58

149

1241

Torticollis

272

2415

1.21

1.66

3.3

2.7

100.23

94.91

ug/l

0.23

253

2260

Congenital deformities of feet

420

3827

1.17

1.66

3.2

2.8

88.68

95.60

ug/l

0.26

401

3579

Benign neoplasm: Brain, supratentorial

240

2114

1.23

1.66

3.1

2.7

106.04

99.57

ug/l

0.26

217

1965

Mumps

372

3354

1.17

1.66

2.6

2.7

122.96

132.06

ug/l

0.30

339

3134

Multiple superficial injuries of ankle and foot

157

2.13

1.65

2.8

2.7

118.71

75.70

ug/l

0.67

152

Burn and corrosion of hip and lower limb, except ankle and foot

349

3146

1.18

1.63

3.0

2.8

115.67

119.62

ug/l

0.15

317

2923

Actinomycosis

416

1.54

1.63

3.7

2.4

258.90

104.36

ug/l

1.70

380

Pedestrian injured in other and unspecified transport accidents

178

1537

1.27

1.63

3.1

2.7

83.05

122.96

ug/l

2.90

162

1427

Anisometropia and aniseikonia

479

4390

1.15

1.63

3.4

2.8

125.05

106.78

ug/l

0.36

426

4047

Benign neoplasm: Retina

677

1.43

1.62

2.6

122.79

116.91

ug/l

0.07

622

Other specified air transport accidents

3.16

1.62

2.3

2.9

120.70

125.95

ug/l

—

Colorectal neuroendocrine tumor and carcinoma

202

1763

1.25

1.62

3.6

2.7

95.14

121.85

ug/l

1.88

192

1632

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

244

2148

1.21

1.62

3.4

2.8

337.07

118.60

ug/l

1.49

227

1961

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

841

8974

0.90

1.60

2.7

2.8

182.87

92.14

ug/l

12.37

787

8197

Aneurysms, operations, SAH

2411

23180

1.06

1.59

3.1

2.8

138.42

140.55

ug/l

0.14

2235

21247

Hereditary motor and sensory neuropathy

131

1106

1.32

1.59

2.7

2.5

102.22

112.89

ug/l

0.22

121

1018

Melanocytic naevi of scalp and neck

383

3482

1.17

1.59

3.3

2.8

89.10

95.47

ug/l

0.45

369

3246

Benign neoplasm: Brain, infratentorial

771

1.40

1.59

2.5

2.8

129.82

92.92

ug/l

0.70

717

Other and unspecified intracranial injuries

413

3752

1.16

1.59

3.0

2.8

133.31

136.87

ug/l

0.11

369

3460

Other disorders of skin and subcutaneous tissue related to radiation

208

1.90

1.59

2.5

2.7

71.63

86.02

ug/l

0.50

187

Impacted maxillary molar

1218

11597

1.10

1.58

3.1

2.9

64.84

60.10

ug/l

0.68

1183

10934

Tooth agenesis EXCLUDE clefts and syndromes

740

6933

1.13

1.58

3.9

2.9

66.12

65.46

ug/l

0.03

699

6541

Viral infections of central nervous system, not elsewhere classified/unspecified

168

1447

1.27

1.58

3.0

2.6

100.50

115.18

ug/l

0.66

151

1348

Moderate visual impairment, monocular

501

1.50

1.58

2.5

2.7

122.74

118.51

ug/l

0.06

461

Benign neoplasm: Connective and other soft tissue of thorax

508

1.48

1.57

2.7

2.6

107.01

107.21

ug/l

0.00

477

Explicit viral Sepsis

2.89

1.56

3.4

2.5

240.28

90.55

ug/l

0.39

Conduct disorder

377

3426

1.17

1.56

3.0

2.9

74.09

85.34

ug/l

0.79

350

3232

Disorders of male genital organs in diseases classified elsewhere

554

1.41

1.56

3.0

2.4

214.53

220.85

ug/l

0.04

516

Other and unspecified syphilis

288

1.63

1.56

3.2

2.3

135.86

175.22

ug/l

0.39

271

Kela-code for behavioural disturbances in mental retardation

1004

0.74

1.56

2.5

2.6

106.19

128.66

ug/l

0.58

916

Other specified/unspecified deforming dorsopathies

282

2518

1.20

1.55

3.2

2.6

99.27

105.24

ug/l

0.31

264

2349

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

916

0.72

1.54

2.6

2.7

105.39

84.26

ug/l

0.66

846

Tuberculosis, IBD comorbidity

950

8917

1.09

1.54

3.5

2.8

155.02

152.89

ug/l

0.08

858

8041

Melanoma in situ, other sites/unspecified

317

1.62

1.53

4.0

2.7

200.56

122.66

ug/l

0.87

291

Relapsing polychondritis

286

1.70

1.52

3.6

2.6

124.21

103.06

ug/l

0.33

266

Vascular dementia (sudden onset)

344

0.59

1.50

3.0

2.9

96.00

155.22

ug/l

1.30

317

Hypergammalglobulinemia, unspecified

103

2.26

1.49

5.2

2.1

155.59

84.13

ug/l

1.03

Caught, crushed, jammed or pinched in or between objects

725

6775

1.11

1.49

2.9

2.8

100.22

123.21

ug/l

3.24

679

6338

Benign neoplasm: Long bones of lower limb

503

4642

1.14

1.48

2.8

113.74

110.49

ug/l

0.13

473

4332

Cicatricial pemphigoid

254

1.76

1.48

2.7

2.5

242.49

112.10

ug/l

1.03

228

Benign neoplasm: Testis

392

1.49

1.48

2.6

2.3

178.31

175.03

ug/l

0.03

359

Other and unspecified injuries of neck

143

1230

1.29

1.48

3.1

2.7

128.30

85.29

ug/l

1.07

135

1150

Assault by other specified means

146

1253

1.28

1.47

2.6

2.7

117.25

106.40

ug/l

0.22

135

1183

Social disorders starting during childhood or adolescence

145

1252

1.30

1.47

3.7

3.1

75.21

63.95

ug/l

0.43

140

1167

Glaucoma secondary to eye inflammation

123

1038

1.30

1.47

2.7

2.5

112.57

120.47

ug/l

0.20

118

947

Motorcycle rider injured in other and unspecified transport accidents

868

8154

1.10

1.47

2.7

172.92

125.52

ug/l

0.37

810

7659

Benign neoplasm: Lip

296

2660

1.18

1.47

3.1

2.7

144.11

130.16

ug/l

0.23

258

2429

Benign neoplasm: Pelvic bones, sacrum and coccyx

498

1.48

1.47

3.0

2.5

125.83

98.98

ug/l

0.28

456

Alzheimer disease

3887

30193

0.96

1.46

2.6

3.0

146.14

157.61

ug/l

1.84

3288

26803

Knuckle pads

176

1.85

1.45

5.4

2.5

90.17

130.72

ug/l

0.96

162

Malignant neoplasm of other connective and soft tissue

299

2687

1.18

1.45

2.7

2.8

345.91

143.04

ug/l

2.00

279

2444

Pervasive developmental disorders excl. Autism + Asperger

184

1601

1.24

1.45

2.9

3.1

55.33

66.73

ug/l

1.32

164

1512

Benign neoplasm: Skin of lip

189

1654

1.23

1.45

3.5

2.7

138.44

109.83

ug/l

1.02

176

1512

Scissor bite

464

4266

1.15

1.45

3.3

3.0

105.66

65.11

ug/l

0.43

438

4032

Third [oculomotor] nerve palsy

238

2114

1.20

1.44

3.9

2.7

149.75

135.79

ug/l

0.31

217

1932

Lesion of sciatic nerve

583

5398

1.12

1.44

3.1

2.7

137.33

150.87

ug/l

0.60

549

4828

Felty syndrome

649

1.39

1.44

4.0

2.6

268.29

114.40

ug/l

0.62

586

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

340

3085

1.17

1.44

2.9

2.8

133.89

125.20

ug/l

0.31

305

2846

Benign neoplasm: Hypopharynx

505

1.45

1.44

3.6

2.6

182.96

140.25

ug/l

0.80

461

Injury of blood vessels at wrist and hand level

803

1.34

1.43

3.5

2.6

248.07

147.41

ug/l

0.52

748

Benign neoplasm: Pelvic bones, sacrum and coccyx

500

1.47

1.43

3.0

2.6

125.83

89.60

ug/l

0.41

458

Hydrocephalus

911

9671

0.92

1.42

2.7

2.8

129.27

142.66

ug/l

1.18

813

8757

Acromegaly and pituitary gigantism

106

890

1.34

1.42

3.2

2.5

96.54

108.39

ug/l

0.46

816

Lumbosacral root disorders, not elsewhere classified

169

1469

1.24

1.42

2.9

2.5

114.45

130.92

ug/l

0.53

161

1349

Amoebiasis

716

1.37

1.40

3.1

2.5

116.95

101.38

ug/l

0.25

658

Benign neoplasm of other and unspecified female genital organs

671

6282

1.12

1.40

3.0

2.8

87.18

95.47

ug/l

0.95

604

5803

Alzheimer’s disease, wide definition

2994

25888

0.95

1.40

2.6

3.0

139.63

156.58

ug/l

2.96

2556

22965

Benign neoplasm: other/unspecified salivary gland

360

3274

1.16

1.40

3.3

2.7

128.33

138.65

ug/l

0.42

330

2992

Deaf mutism, not elsewhere classified

577

1.40

4.1

2.5

100.28

113.47

ug/l

0.28

532

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

246

2188

1.19

1.40

2.7

2.6

225.24

150.14

ug/l

2.77

223

1994

Rickettsioses

213

1.78

1.40

3.7

2.6

166.85

124.52

ug/l

0.51

198

Mild or no visual impairment, binocular

600

1.41

1.39

3.8

2.6

103.66

90.57

ug/l

0.21

559

All dysplastic lesions of the vagina

429

3959

1.15

1.39

3.3

2.8

92.75

81.39

ug/l

0.86

401

3696

Transient global amnesia

1207

11475

1.08

1.38

2.7

2.8

127.80

146.13

ug/l

1.76

1095

10411

Beningn neoplasm: Meninges, unspecified

208

1837

1.21

1.38

3.0

2.7

108.28

105.87

ug/l

0.08

187

1672

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

151

1309

1.26

1.37

3.2

2.7

101.19

96.09

ug/l

0.16

140

1205

Contact with sharp object, undetermined intent

316

2864

1.17

1.37

3.1

2.7

111.19

127.31

ug/l

0.37

291

2688

Abnormal reflex

647

1.39

1.37

3.6

2.7

98.19

102.97

ug/l

0.11

604

Schizotypal disorder

369

3372

1.16

1.37

2.7

152.53

109.70

ug/l

0.44

339

3188

Alzheimer’s disease (Atypical or mixed)

1062

10018

1.08

1.36

2.6

2.9

167.89

154.10

ug/l

0.65

878

8843

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

223

1968

1.19

1.36

2.8

2.7

181.00

168.23

ug/l

0.27

208

1782

Other conditions originating in the perinatal period

117

2.28

1.36

7.3

3.8

47.83

73.96

ug/l

0.58

112

LSIL lesion of the cervix uteri

2405

23313

1.06

1.35

3.0

69.00

68.47

ug/l

0.08

2293

22177

Burn and corrosion, body region unspecified

682

1.37

1.35

2.8

2.6

122.01

109.40

ug/l

0.32

641

Injury of nerves and spinal cord at thorax level

553

1.40

1.35

3.3

2.6

135.37

147.90

ug/l

0.21

514

Malignant neoplasm of trachea

0.00

1.35

0.0

3.0

—

128.36

—

Ophthalmic devices associated with adverse incidents

2.42

1.35

2.3

2.5

100.28

130.49

ug/l

0.52

Undescended testicle

120

1008

1.27

1.35

4.5

3.2

86.03

107.94

ug/l

1.43

120

954

Brain meningioma

694

6505

1.11

1.34

2.8

2.7

135.62

119.29

ug/l

0.68

624

5964

Other disorders originating in the perinatal period

175

1547

1.25

1.33

4.0

3.3

51.13

52.65

ug/l

0.08

170

1469

Benign neoplasm: Connective and other soft tissue of head, face and neck

249

2233

1.19

1.33

3.0

2.7

104.41

114.60

ug/l

0.57

235

2070

Arthropod-borne viral fevers and viral haemorrhagic fevers

1377

13151

1.07

1.33

2.9

2.8

151.17

141.10

ug/l

0.79

1312

12216

Mandibular retrognathia AND surgery (BSSRO)

448

4151

1.14

1.32

2.6

2.7

70.73

90.73

ug/l

4.00

433

3935

Behavioural disorders

376

3452

1.15

1.32

3.0

2.9

73.77

83.99

ug/l

0.70

349

3258

Malignant neoplasm of corpus uteri

1104

10495

1.08

1.32

2.7

2.8

160.21

113.86

ug/l

6.94

997

9412

Benign neoplasm: Peripheral nerves and autonomic nervous system

210

1866

1.20

1.30

2.7

131.12

125.25

ug/l

0.12

190

1719

Pedestrian injured in collision with car, pick-up truck or van

375

3441

1.15

1.30

3.0

2.7

106.78

114.02

ug/l

0.21

335

3166

Abnormalities of forces of labour

2104

20348

1.06

1.30

2.8

2.9

82.33

75.42

ug/l

0.69

2012

19469

Tuberculosis of other organs

273

2458

1.17

1.29

3.7

2.7

151.47

138.82

ug/l

0.41

249

2209

Hypothyroidism, autoimmune, DX-based

635

1.44

1.28

3.5

2.7

58.55

63.60

ug/l

0.37

590

Benign neoplasm: Peripheral nerves and autonomic nervous system

210

1868

1.20

1.28

2.7

131.12

117.45

ug/l

0.31

190

1721

Benign neoplasm: Brain, supratentorial

240

2156

1.19

1.28

3.1

2.7

106.04

105.61

ug/l

0.01

217

2000

Benign neoplasm: Connective and other soft tissue of thorax

524

1.41

1.28

2.7

2.6

107.01

107.62

ug/l

0.01

482

Chloasma

629

1.40

1.28

2.7

87.03

78.98

ug/l

0.28

581

Suppurative otitis media, unspecified

427

3946

1.14

1.28

3.2

2.7

107.08

97.08

ug/l

0.23

406

3665

Disseminated intravascular coagulation [defibrination syndrome]

392

1.51

1.28

7.6

2.7

299.85

110.72

ug/l

2.50

367

Calcification and ossification of muscle

285

1.59

1.27

3.0

2.5

302.63

124.72

ug/l

0.89

257

Sequelae of burns, corrosions and frostbite

569

1.39

1.27

2.8

2.6

124.63

114.27

ug/l

0.17

531

Sequelae of other and unspecified effects of external causes

624

1.37

1.27

3.4

2.6

98.93

116.99

ug/l

0.48

580

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

107

904

1.29

1.27

2.4

2.7

170.04

122.19

ug/l

1.07

814

Burn and corrosion of other internal organs

391

1.49

1.26

2.7

2.4

126.30

100.55

ug/l

0.58

356

Melanocytic naevi of lip

140

1221

1.26

1.25

3.4

2.7

103.93

90.39

ug/l

0.48

135

1134

Polymorphous light eruption

134

1170

1.28

1.25

3.2

2.8

89.54

81.38

ug/l

0.30

127

1106

Motor- or nonmotor-vehicle accident in traffic area

106

902

1.30

1.24

3.5

2.6

100.39

99.71

ug/l

0.02

839

Communicating hydrocephalus

226

2524

0.85

1.24

2.7

2.8

110.88

139.58

ug/l

2.00

212

2288

Disorders of puberty

282

2570

1.18

1.24

3.9

2.9

61.51

56.21

ug/l

0.29

258

2412

Acquired clawhand, clubhand, clawfoot and clubfoot

664

1.36

1.24

3.4

2.5

113.61

112.20

ug/l

0.02

623

Specific developmental disorder of motor function

244

2157

1.18

1.24

3.9

3.1

64.98

59.65

ug/l

0.27

236

2043

Acute alcohol intoxication ICD-9

433

3990

1.12

1.23

3.1

2.7

141.30

161.31

ug/l

0.75

401

3661

Digestive system disorders of fetus and newborn

162

1.96

1.23

7.0

3.2

62.13

42.45

ug/l

0.30

153

Ovarian dysfunction, other/unspecified

112

971

1.33

1.23

3.5

2.8

75.88

66.11

ug/l

0.23

104

906

Trichomoniasis

115

985

1.28

1.23

3.6

2.6

114.68

105.27

ug/l

0.28

889

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

3562

35135

0.96

1.23

2.6

2.8

121.12

95.97

ug/l

6.35

3198

32200

Benign neoplasm: Rectum/anal canal icd-9

111

938

1.26

1.23

3.7

2.7

175.78

130.60

ug/l

1.08

838

Toxic effect of contact with venomous animals

590

5527

1.11

1.22

2.7

2.8

125.07

115.72

ug/l

0.28

538

5138

Assault by sharp object

221

1973

1.18

1.22

2.9

2.6

143.53

142.38

ug/l

0.03

201

1864

Contact with hot air and gases

715

1.32

1.22

3.6

2.5

204.47

147.49

ug/l

0.38

657

Renal cell carcinoma of kidney

417

3842

1.13

1.21

3.7

2.8

233.78

159.54

ug/l

3.63

373

3445

HSIL lesion of the cervix uteri

4101

40117

1.04

1.21

2.9

3.0

72.92

67.02

ug/l

1.54

3872

38261

Indeterminate sex and pseudohermaphroditism

119

2.06

1.21

3.1

2.4

71.87

97.31

ug/l

0.82

101

Injury of nerves at shoulder and upper arm level

149

1302

1.23

1.21

3.4

2.6

112.45

142.14

ug/l

1.17

136

1215

Benign neoplasm: Brain, infratentorial

797

1.33

1.21

2.5

2.8

129.82

97.82

ug/l

0.57

737

Other benign neoplasms of uterus

730

6883

1.10

1.20

3.0

2.8

101.54

100.36

ug/l

0.09

646

6163

Burn and corrosion of shoulder and upper limb, except wrist and hand

287

2607

1.16

1.20

3.1

2.7

329.45

134.43

ug/l

0.55

270

2414

Melanocytic naevi of upper limb, including shoulder

352

3240

1.15

1.20

3.2

2.8

129.27

96.65

ug/l

0.70

332

3008

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

243

2218

1.21

1.20

2.9

2.8

56.44

60.68

ug/l

0.33

232

2091

Other cranial nerve disorders in other disorders

324

1.53

1.19

4.5

2.6

161.14

111.87

ug/l

0.68

300

Histrionic personality disorder

678

1.35

1.19

3.1

2.5

93.08

93.82

ug/l

0.01

631

Melanocytic naevi of scalp and neck

383

3540

1.14

1.19

3.3

2.8

89.10

102.51

ug/l

1.27

369

3300

Tuberculosis, wide

973

9230

1.08

1.18

3.5

2.8

155.08

153.11

ug/l

0.08

878

8314

Certain conditions originating in the perinatal period

1764

15087

1.06

1.18

3.4

2.8

65.76

61.74

ug/l

0.60

1658

14214

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1128

10764

1.08

1.17

2.9

2.8

153.00

137.17

ug/l

1.31

1081

10007

Myositis ossificans

332

1.49

1.17

2.9

2.4

160.20

133.50

ug/l

0.17

299

Motor disorders

244

2200

1.18

1.16

3.9

3.2

64.98

59.29

ug/l

0.29

236

2084

Congenital malformations of anterior segment of eye

132

1154

1.26

1.16

3.2

2.7

100.78

94.17

ug/l

0.19

121

1060

541

1.38

1.16

3.3

2.6

87.96

110.70

ug/l

1.02

509

Personality and behavioural disorders due to brain disease, damage and dysfunction

195

1734

1.19

1.16

2.9

2.7

140.37

149.25

ug/l

0.19

169

1601

Benign neoplasm: Pharynx, unspecified

114

984

1.27

1.15

3.0

2.5

114.32

116.18

ug/l

0.03

901

Carcinoma in situ of vulva

122

1063

1.27

1.15

3.1

2.7

106.42

82.82

ug/l

0.81

107

980

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

483

1.38

1.14

2.8

2.4

188.22

159.87

ug/l

0.51

438

Retarded development following protein-energy malnutrition

2.34

1.14

3.8

2.5

85.07

115.70

ug/l

0.38

Foreign body in genitourinary tract

161

1432

1.23

1.14

2.7

2.8

95.91

85.32

ug/l

0.39

147

1340

Benign neoplasm: Skin of lip

189

1687

1.20

1.14

3.5

2.7

138.44

119.05

ug/l

0.58

176

1543

Other infiltrative disorders of skin and subcutaneous tissue

578

1.36

1.13

3.3

2.6

152.24

115.35

ug/l

0.64

530

Benign neoplasm: Bronchus and lung

163

1437

1.21

1.13

3.2

2.7

127.29

134.96

ug/l

0.18

156

1313

Exposure to smoke, fire and flames

326

2988

1.14

1.13

2.8

2.7

125.62

142.62

ug/l

0.79

299

2770

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

145

1.82

1.13

9.0

2.6

70.67

91.60

ug/l

0.51

134

Abscess of spleen

2.33

1.12

7.3

2.3

285.25

120.20

ug/l

1.37

Pedal cyclist injured in noncollision transport accidents

1779

17171

1.06

1.11

2.8

105.67

117.14

ug/l

1.64

1661

16073

Disorders of copper metabolism

120

1.89

1.11

7.2

2.3

86.78

103.91

ug/l

0.35

106

Accidental poisoning by and exposure to alcohol

249

2735

0.86

1.10

3.0

2.8

82.70

97.91

ug/l

0.65

233

2542

Hip and thigh

294

1.55

1.10

2.8

2.7

111.06

101.61

ug/l

0.19

277

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

115

992

1.25

1.10

3.1

2.6

165.71

136.42

ug/l

0.79

104

914

Melanocytic naevi of upper limb, including shoulder

352

3256

1.14

1.09

3.2

2.8

129.27

107.42

ug/l

0.41

332

3024

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

278

2531

1.15

1.09

2.6

2.7

213.55

154.02

ug/l

2.08

253

2318

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

114

1.98

1.08

2.6

2.8

75.71

86.89

ug/l

0.23

102

Beningn neoplasm: Meninges, unspecified

208

1872

1.18

1.08

3.0

2.6

108.28

118.02

ug/l

0.35

187

1707

Use of interferon beta-1a

355

3823

0.88

1.07

2.7

2.8

97.82

82.17

ug/l

0.76

331

3634

Other osteochondrodysplasias

136

1198

1.24

1.07

3.0

2.8

96.81

98.74

ug/l

0.04

126

1120

Injury of blood vessels at lower leg level

545

1.35

1.07

5.5

2.5

301.50

121.70

ug/l

0.59

504

Other meningitis

235

2134

1.17

1.06

3.4

2.8

113.75

99.42

ug/l

0.50

222

1982

Carcinoma in situ of vulva

122

1071

1.26

1.06

3.1

2.8

106.42

79.47

ug/l

0.98

107

989

Delayed puberty

132

1160

1.23

1.06

3.0

2.9

72.74

66.09

ug/l

0.18

122

1095

Melanoma in situ, other sites/unspecified

339

1.46

1.05

4.0

2.6

200.56

125.35

ug/l

0.82

305

Bus occupant injured in other and unspecified transport accidents

853

1.28

1.05

4.4

2.6

95.66

96.70

ug/l

0.03

783

Delayed milestone in childhood

276

2289

1.15

1.04

4.4

3.4

52.07

56.05

ug/l

0.25

267

2174

Other specified/unspecified diseases of inner ear

564

1.33

1.04

2.7

181.31

112.65

ug/l

0.46

514

Muscle wasting and atrophy, not elsewhere classified

664

1.30

1.04

3.3

2.4

176.14

148.48

ug/l

0.45

608

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

198

1777

1.17

1.04

2.7

233.27

147.69

ug/l

2.53

180

1629

Meningococcal infection

115

1001

1.25

1.03

2.8

2.6

111.75

90.85

ug/l

0.53

106

934

Pemphigus foliaceus

115

1.93

1.03

3.4

2.7

207.19

108.33

ug/l

1.03

103

Benign neoplasm: Skin of upper limb, including shoulder

273

2501

1.15

1.02

3.3

2.7

147.60

110.13

ug/l

1.62

258

2304

Carcinoma in situ of anus and anal canal

116

1.96

1.02

4.3

2.5

124.12

93.07

ug/l

0.59

108

Other cestode infections

353

0.67

1.02

1.7

2.5

142.65

116.80

ug/l

0.20

313

Glaucoma secondary to eye trauma

712

1.28

1.01

3.3

2.7

134.08

161.20

ug/l

0.69

655

Benign neoplasm: Vulva

321

2971

1.14

1.01

3.2

2.8

81.46

90.37

ug/l

0.81

293

2726

Muscular dystrophy

110

956

1.25

1.01

2.9

116.27

111.38

ug/l

0.10

102

876

Melanocytic naevi of lip

140

1244

1.23

1.01

3.4

2.7

103.93

87.37

ug/l

0.64

135

1159

Need for immunization against combinations of infectious diseases

119

2.09

1.01

5.2

3.2

60.94

63.25

ug/l

0.05

114

Primary ovarian failure

355

3313

1.14

1.00

3.0

2.8

80.78

65.43

ug/l

1.16

338

3143

Degenerative diseases of the nervous system

4500

34614

0.97

1.00

2.7

2.9

155.49

158.99

ug/l

0.25

3844

30865

Benign neoplasm: Vulva

321

2973

1.14

1.00

3.2

2.8

81.46

85.87

ug/l

0.32

293

2742

Thoracic root disorders

209

1.59

1.00

4.7

2.4

100.07

115.28

ug/l

0.29

191

Crystalline deposits in vitreous body

111

965

1.24

0.99

3.4

2.6

121.37

147.01

ug/l

0.76

875

Carcinoma in situ of anus and anal canal

117

1.93

0.99

4.3

2.6

124.12

100.91

ug/l

0.40

108

Benign neoplasm: Ciliary body

306

1.47

0.99

3.1

2.7

119.82

127.54

ug/l

0.09

283

Carcinoma in situ of breast, other/unspecified

155

1734

0.84

0.99

2.5

2.6

110.42

100.15

ug/l

0.40

131

1565

Burkitt lymphoma

2.09

0.99

5.2

2.7

450.54

163.54

ug/l

0.74

Burkitt lymphoma, helper endpoint

2.09

0.99

5.2

2.7

450.54

163.54

ug/l

0.74

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

104

1192

0.81

0.99

3.1

2.7

114.21

90.32

ug/l

0.66

1083

Drowning to ice

121

0.49

0.98

2.6

2.5

61.14

126.63

ug/l

—

107

Use of dimethyl fumarate

129

1448

0.82

0.98

2.4

2.9

102.73

65.84

ug/l

0.68

121

1387

Drug-induced androgenic alopecia

2.62

0.97

5.3

2.4

57.50

84.76

ug/l

—

Carcinoma in situ of other and unspecified genital organs

257

2362

1.15

0.97

2.9

2.8

116.77

82.76

ug/l

1.76

234

2173

Otosclerosis

1088

10434

1.07

0.97

2.7

2.8

135.66

129.52

ug/l

0.24

995

9634

Mucocutaneous lymph node syndrome [Kawasaki]

282

1.50

0.96

3.3

2.9

156.58

72.45

ug/l

0.84

266

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

639

6762

0.92

0.96

2.7

2.8

253.63

147.50

ug/l

6.31

578

6095

Cardiovascular devices associated with adverse incidents

2.10

0.96

4.4

2.4

103.92

105.69

ug/l

0.02

Hydatidiform mole

268

2480

1.16

0.96

3.1

2.8

64.97

69.23

ug/l

0.41

259

2355

Acute appendicitis, with complications

3194

31175

1.04

0.95

2.9

2.8

140.01

136.14

ug/l

0.33

2973

29015

Endovascular or surgical operations to intracerebral aneurysms

783

8226

0.93

0.95

3.0

2.7

137.35

136.16

ug/l

0.05

736

7556

Benign neoplasm: Bronchus and lung

163

1457

1.18

0.95

3.2

2.7

127.29

137.69

ug/l

0.28

156

1341

Use of selegiline

564

5315

1.09

0.95

2.9

2.8

139.18

156.22

ug/l

0.89

485

4779

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

162

1815

0.86

0.95

2.7

420.26

140.25

ug/l

3.97

150

1635

Malignant neoplasm of liver and intrahepatic bile ducts

362

3357

1.11

0.95

3.5

2.8

245.82

173.48

ug/l

2.48

327

3021

Exposure to excessive natural cold

1111

0.82

0.94

3.6

2.5

160.41

142.11

ug/l

0.36

1017

Failure in dosage during surgical and medical care

171

1.72

0.93

5.7

2.5

130.48

83.13

ug/l

0.85

152

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

320

3461

0.90

0.93

2.2

2.7

284.02

144.39

ug/l

6.71

297

3115

Interstitial myositis

127

1.81

0.92

2.2

2.4

62.19

108.47

ug/l

1.51

118

Other demyelinating diseases of the central nervous system

633

6018

1.09

0.92

2.8

97.35

90.02

ug/l

0.37

603

5690

Glycogen storage disease

2.08

0.91

9.1

3.0

271.79

131.28

ug/l

0.44

Calcific tendinitis

131

1163

1.20

0.90

2.8

2.5

138.79

143.33

ug/l

0.07

123

1077

Liveborn infants according to place of birth

172

1448

1.20

0.90

3.1

3.0

43.18

40.56

ug/l

0.11

162

1361

Endometroid carcinoma of ovary

104

1183

0.82

0.90

3.1

2.6

114.21

94.58

ug/l

0.51

1074

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

551

1.28

0.90

4.2

2.6

228.45

190.97

ug/l

0.36

496

Other assisted single delivery

348

3270

1.14

0.90

3.2

3.1

48.13

60.81

ug/l

5.10

320

3124

Persistent hyperplasia of thymus

1.99

0.90

3.5

2.6

110.08

99.29

ug/l

0.13

Rhinophyma

629

1.28

0.89

2.9

2.5

147.60

168.92

ug/l

0.54

572

Malignant melanoma of skin

1535

14847

1.05

0.88

3.0

2.9

147.33

146.91

ug/l

0.02

1392

13612

Myelofibrosis

2.06

0.88

2.3

2.4

279.78

121.10

ug/l

—

Mental retardation, wide definition

555

5857

0.92

0.88

3.4

3.0

98.81

103.55

ug/l

0.30

514

5494

Dyshidrosis [pompholyx]

253

2336

1.15

0.88

2.7

167.48

99.50

ug/l

0.59

226

2176

Mandibular prognathia

251

2316

1.14

0.88

3.3

2.9

179.65

84.17

ug/l

0.43

234

2174

Osteitis due to dental implant

726

1.27

0.88

3.7

2.6

167.11

121.45

ug/l

0.54

657

Forearm

121

1.86

0.88

3.0

2.9

115.78

69.15

ug/l

0.91

108

Serous carcinoma of ovary

413

4396

0.91

0.87

2.5

2.8

232.27

103.90

ug/l

9.03

392

3995

Carcinoma in situ of bronchus and lung

118

1.72

0.87

2.8

2.9

109.12

156.33

ug/l

0.56

107

Systemic atrophies primarily affecting the central nervous system

459

4878

0.91

0.86

2.8

162.56

147.18

ug/l

0.33

420

4432

Other fibroblastic disorders

429

1.34

0.86

3.5

2.3

93.49

130.67

ug/l

1.47

390

Postpartum haemorrhage due to retained placenta

2814

27555

1.04

0.86

3.0

2.9

64.81

65.11

ug/l

0.05

2671

26310

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

105

924

1.23

0.86

2.8

2.7

96.02

118.37

ug/l

0.91

857

Benign neoplasm: Testis

427

1.32

0.86

2.6

2.5

178.31

192.75

ug/l

0.15

394

Acute otitis externa, noninfective

226

2073

1.14

0.86

3.6

2.7

106.02

114.59

ug/l

0.35

207

1909

Early syphilis

145

1296

1.18

0.86

2.6

153.39

157.93

ug/l

0.08

140

1217

Optic atrophy

246

2265

1.14

0.86

3.2

2.8

140.19

122.07

ug/l

0.57

220

2100

351

3183

1.12

0.86

4.0

3.2

51.44

55.19

ug/l

0.18

335

3026

Chronic suppurative otitis media, including avohilmo

1229

11859

1.06

0.85

3.1

2.9

112.13

113.22

ug/l

0.05

1131

10982

Mesothelioma, excluding all cancers (controls excluding all cancers)

117

1324

0.84

0.85

2.7

427.12

158.51

ug/l

2.49

110

1197

Carcinoma in situ of other and unspecified genital organs

257

2380

1.14

0.84

2.9

2.8

116.77

90.56

ug/l

1.15

234

2187

Use of fingolimod

147

1618

0.84

2.7

2.9

79.46

68.88

ug/l

0.32

137

1546

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

2.10

0.84

11.4

3.3

446.00

71.50

ug/l

0.92

Sequelae of other accidents

162

1794

0.86

0.84

3.3

2.6

155.25

134.66

ug/l

0.44

154

1651

Frostbite

139

1243

1.18

0.84

2.8

2.4

129.78

144.99

ug/l

0.37

126

1146

Neuropathy in association with hereditary ataxia

2.46

0.84

1.6

2.0

121.55

106.96

ug/l

—

Use of donepezil

2400

23689

0.96

0.83

2.4

2.9

134.15

156.87

ug/l

4.89

2029

20987

Benign neoplasm: Orbit, unspecified

767

1.25

0.83

3.4

2.6

96.81

98.69

ug/l

0.06

703

Exclusion endpoint for supernumerary teeth

205

1882

1.16

0.83

3.2

2.9

74.47

81.88

ug/l

0.41

196

1772

Carcinoma in situ of breast, other/unspecified

155

1713

0.86

0.83

2.5

2.6

110.42

93.58

ug/l

0.79

131

1556

Use of amantadine

219

2011

1.14

0.82

2.6

2.7

125.58

113.32

ug/l

0.38

198

1851

Tuberculosis of other organs, strict

302

2803

1.11

0.82

3.6

2.7

159.17

138.73

ug/l

0.76

274

2515

Other congenital malformations of ear

264

2462

1.14

0.82

2.8

2.9

62.44

61.99

ug/l

0.02

250

2317

Malignant neoplasm of lip

723

1.23

0.82

3.0

2.7

291.56

174.03

ug/l

0.73

646

Abnormal findings on diagnostic imaging of breast

196

1796

1.16

0.82

2.8

2.7

103.11

95.36

ug/l

0.38

182

1641

Seminoma of testis, excluding all cancers (controls excluding all cancers)

102

891

1.20

0.82

4.0

2.4

203.07

164.15

ug/l

0.96

829

Chondromalacia

416

3918

1.10

0.82

2.7

112.62

119.49

ug/l

0.31

389

3659

Placental disorders

186

1715

1.18

0.81

3.6

2.9

54.09

57.99

ug/l

0.27

173

1632

Disorders of puberty, all

316

2961

1.12

0.80

3.8

3.0

66.01

55.80

ug/l

0.59

288

2780

Demyelinating diseases of the central nervous system

1534

14895

1.05

0.80

2.9

104.86

92.29

ug/l

1.24

1446

14066

Lichen ruber moniliformis

2.12

0.80

3.5

2.8

120.27

129.84

ug/l

—

Other specified/unspecified disorders of ear

382

1.37

0.80

3.8

2.7

89.62

86.19

ug/l

0.06

361

Benign neoplasm: Connective and other soft tissue, unspecified

162

1470

1.17

0.79

3.4

2.6

107.95

102.91

ug/l

0.17

151

1357

Disorders of tyrosine metabolism

103

1.70

0.79

7.4

2.6

265.90

163.74

ug/l

0.37

Birth injury to scalp

2.06

0.79

5.5

3.5

52.45

45.12

ug/l

0.16

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

195

1776

1.13

0.78

3.7

2.5

207.64

173.38

ug/l

1.13

178

1643

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

451

1.29

0.78

2.0

2.5

195.06

126.30

ug/l

0.98

414

Burns and corrosions confined to eye and internal organs

390

3671

1.10

0.77

3.0

2.7

116.87

123.26

ug/l

0.16

366

3430

Benign neoplasm: Rectum/anal canal icd-9

111

982

1.19

0.77

3.7

2.7

175.78

143.20

ug/l

0.64

866

Congenital absence, atresia and stenosis of small intestine

177

1.62

0.77

8.8

2.6

63.78

49.86

ug/l

0.47

164

Benign neoplasm: Cranial nerves

365

3428

1.10

0.77

2.8

2.7

126.93

121.13

ug/l

0.11

333

3134

Disorders of sexual preference

226

1.44

0.77

2.8

2.5

178.83

162.50

ug/l

0.15

209

Postpartum haemorrhage due to anatomy

2557

25081

1.04

0.77

3.1

57.93

55.32

ug/l

0.53

2376

23930

Acute mastoiditis

131

1179

1.18

0.77

4.2

2.7

122.81

115.01

ug/l

0.15

118

1110

Other congenital malformations of posterior segment of eye (coloboma)

115

1.76

0.76

3.8

2.8

50.71

89.75

ug/l

1.80

104

Typhoid and paratyphoid fevers

576

1.27

0.76

3.1

2.6

186.38

116.43

ug/l

0.39

536

Tick-borne viral encephalitis

418

1.32

0.76

2.4

2.9

176.17

118.32

ug/l

0.75

390

Mental retardation

527

5538

0.92

0.76

3.5

3.0

99.64

99.96

ug/l

0.02

489

5199

Flatback syndrome

1.93

0.75

3.6

3.0

89.67

116.95

ug/l

0.45

Melanoma in situ of upper limb, including shoulder

735

1.23

0.75

3.3

2.7

185.45

114.59

ug/l

1.29

674

Malignant neoplasm of other and unspecified parts of mouth

575

1.26

0.75

2.4

2.7

171.22

139.15

ug/l

0.41

520

Other congenital malformations of female genitalia

195

1815

1.17

0.74

2.9

2.8

62.54

51.77

ug/l

0.76

185

1709

Mental retardation, excluding more controls

527

4920

1.08

0.74

3.5

2.7

99.64

100.95

ug/l

0.07

489

4635

Sequelae of poliomyelitis

847

1.20

0.74

3.0

2.5

134.92

143.67

ug/l

0.15

759

Benign neoplasm: Ciliary body

320

1.37

0.74

3.1

2.5

119.82

130.60

ug/l

0.13

291

Inhalation and ingestion of other objects causing obstruction of respiratory tract

794

1.22

0.74

3.3

2.6

83.59

104.47

ug/l

0.80

739

Rifle, shotgun and larger firearm discharge

162

0.60

0.73

2.1

107.38

166.26

ug/l

0.57

156

Disorders of brain, other and unspecified

124

1113

1.18

0.73

3.6

2.6

119.52

144.50

ug/l

0.59

113

1029

Ankyloglossia

266

2475

1.12

0.73

3.9

3.1

69.63

61.35

ug/l

0.45

255

2322

Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)

139

1.55

0.73

3.6

2.6

175.55

191.38

ug/l

0.08

126

Malaria

625

1.25

0.73

3.5

2.7

125.75

115.31

ug/l

0.15

582

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

467

4933

0.93

0.73

2.8

2.7

313.39

139.38

ug/l

5.86

418

4458

Deformity of finger(s)

766

1.22

0.73

3.3

2.5

152.51

129.36

ug/l

0.32

700

Other specified acquired deformities of limbs

646

1.25

0.72

2.8

2.5

77.05

90.93

ug/l

0.38

603

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

787

1.22

0.72

3.2

2.6

146.38

98.97

ug/l

0.82

734

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

105

939

1.20

0.71

2.8

2.6

96.02

125.67

ug/l

1.89

861

Traumatic amputation of part of head

167

1.50

0.71

3.3

2.7

136.45

131.10

ug/l

0.05

154

Apocrine sweat disorders, other sweat gland disorders

506

1.28

0.71

3.2

2.4

100.05

117.37

ug/l

0.50

454

Mild mental retardation

331

3518

0.91

0.71

3.4

2.9

101.10

104.87

ug/l

0.17

310

3298

Defect, injury or illness of skull

127

1.72

0.70

2.8

3.0

69.73

81.92

ug/l

0.31

115

Toxic effect of alcohol

280

2615

1.11

0.70

3.1

2.7

114.61

139.82

ug/l

1.32

259

2437

Erythema ab igne [dermatitis ab igne]

1.86

0.69

2.4

2.5

66.29

86.55

ug/l

0.53

410

3707

1.09

0.69

4.0

3.2

51.15

54.64

ug/l

0.19

390

3517

Maxillary retrognathism

305

2869

1.11

0.69

2.9

85.39

80.67

ug/l

0.22

289

2690

Other benign neoplasm of uterus: Other parts/unspecified

531

5061

1.08

0.69

2.9

2.8

106.33

106.37

ug/l

0.00

461

4488

Photocontact dermatitis [berloque dermatitis]

188

1.51

0.69

4.8

2.7

79.88

90.86

ug/l

0.20

167

Schizophrenia

2563

25081

1.03

0.69

2.7

2.8

110.72

126.97

ug/l

1.48

2368

23595

Discontinuity and dislocation of ear ossicles

658

1.23

0.68

2.7

2.6

123.13

113.22

ug/l

0.20

608

Congenital hydrocephalus

499

1.27

0.67

2.6

2.4

71.54

96.55

ug/l

1.23

465

Any dementia

5401

37483

1.02

0.67

2.8

2.9

147.08

158.52

ug/l

2.48

4620

33532

Cellulitis of external ear

178

1643

1.14

0.67

3.2

2.8

104.77

110.04

ug/l

0.15

162

1530

Congenital malformations of eyelid, lacrimal apparatus and orbit

144

1318

1.16

0.66

3.6

3.1

79.55

64.02

ug/l

0.62

134

1233

Malignant neoplasm of heart, mediastinum and pleura

120

1329

0.86

0.66

2.5

2.8

443.02

159.65

ug/l

2.78

111

1202

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

655

1.21

0.66

3.1

2.5

156.21

158.96

ug/l

0.04

588

Benign neoplasm: Orbit, unspecified

783

1.21

0.66

3.4

2.6

96.81

108.56

ug/l

0.44

710

Carcinoma in situ of prostate

563

1.23

0.66

2.1

2.6

208.12

204.58

ug/l

0.03

514

Other and unspecified cicatricial alopecia

298

1.36

0.66

3.6

2.5

249.62

95.20

ug/l

0.65

264

Bartonellosis

1.78

0.65

2.9

2.2

139.67

91.91

ug/l

—

Benign neoplasm: Skin of upper limb, including shoulder

273

2561

1.11

0.65

3.3

2.7

147.60

120.08

ug/l

0.99

258

2362

Complicated migraine, drug-induced

155

1.58

0.65

2.7

96.94

69.91

ug/l

0.74

148

Burns and corrosions of multiple and unspecified body regions

302

2840

1.10

0.65

3.2

2.7

119.07

129.36

ug/l

0.37

285

2634

Other benign neoplasm of uterus: Cervix uteri

883

1.20

0.65

3.3

2.9

85.19

71.64

ug/l

0.68

821

Injury of blood vessels at forearm level

352

1.31

0.64

3.5

2.6

126.06

129.11

ug/l

0.04

329

Benign neoplasm: Connective and other soft tissue, unspecified

162

1490

1.14

0.64

3.4

2.6

107.95

116.47

ug/l

0.30

151

1379

Effects of other deprivation

346

1.33

0.64

3.0

2.7

119.17

90.61

ug/l

0.67

318

Genetic anomalies of leukocytes

1.75

0.63

3.2

2.8

81.92

108.15

ug/l

0.42

Epileptic seizures related to alcohol

641

1.21

0.63

3.8

2.5

238.20

175.76

ug/l

1.08

597

Localized hypertrichosis

141

1.73

0.63

2.9

2.5

65.44

54.71

ug/l

0.25

131

Squamous cell neoplasms and carcinoma of cervix

100

902

1.19

0.63

3.1

2.9

170.79

84.67

ug/l

1.50

839

Melanocytic naevi of eyelid, including canthus

134

1225

1.16

0.62

3.0

2.8

169.72

99.11

ug/l

0.43

129

1126

Other congenital malformations of tongue, mouth and pharynx

233

2170

1.12

0.62

3.9

2.9

64.20

63.00

ug/l

0.06

226

2036

Phakomatoses, not elsewhere classified

165

1523

1.14

0.62

3.6

2.8

107.36

95.26

ug/l

0.35

153

1426

Otitis media in diseases classified elsewhere

131

1.69

0.62

2.9

2.5

77.98

79.22

ug/l

0.02

118

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

2789

26895

1.03

0.62

2.7

2.8

161.88

96.77

ug/l

29.03

2554

24541

Malignant neoplasm of meninges

0.52

0.61

1.4

2.7

649.60

104.18

ug/l

—

Hydrocephalus in other diseases

676

0.82

0.61

3.6

2.7

167.78

114.91

ug/l

0.80

623

Toxic effect of other gases, fumes and vapours

643

1.21

0.61

4.0

2.5

141.64

128.08

ug/l

0.18

599

Malignant neoplasm of testis

172

1582

1.12

0.61

3.6

2.6

192.26

190.88

ug/l

0.03

155

1485

Deep bite that required surgery

199

1857

1.13

0.60

2.6

2.7

70.88

98.84

ug/l

2.99

192

1763

Venous complications and haemorrhoids in the puerperium

180

1676

1.14

0.60

2.8

2.7

91.34

77.37

ug/l

0.51

172

1570

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

100

905

1.18

0.60

3.1

2.9

170.79

68.44

ug/l

2.01

846

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

105

948

1.17

0.60

2.5

2.6

242.19

122.96

ug/l

1.03

866

Constitutional tall stature

849

0.83

0.59

2.6

2.8

50.88

49.25

ug/l

0.08

794

Vascular dementia (undefined)

394

3695

1.07

0.59

3.0

2.9

154.42

155.57

ug/l

0.03

334

3254

Frontotemporal dementia

541

1.22

0.59

2.9

2.7

90.40

158.62

ug/l

3.23

493

Open bite that required surgery (Lefort1 or BSSRO)

174

1622

1.14

0.59

3.0

2.9

58.56

72.50

ug/l

1.35

168

1538

Open wound of thorax

194

1802

1.12

0.59

3.3

2.6

154.73

148.89

ug/l

0.12

179

1689

Personal history of allergy to analgesic agent

831

1.19

0.59

3.1

2.8

100.41

88.49

ug/l

0.13

777

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

485

1.23

0.58

3.5

2.7

254.52

91.57

ug/l

1.56

431

Injury of nerves at forearm level

178

1652

1.12

0.58

3.5

2.6

110.39

124.22

ug/l

0.45

161

1540

Respiratory tuberculosis, not confirmed

455

4772

0.94

0.58

3.1

2.7

142.56

156.15

ug/l

0.55

402

4264

Café au lait spots

163

0.64

0.58

3.6

2.9

49.50

60.23

ug/l

0.41

152

Disorders of conjunctiva in diseases classified elsewhere

1.74

0.58

2.3

2.7

99.59

119.72

ug/l

0.23

Caries in Clefts patients

159

1476

1.13

0.56

3.2

2.9

76.32

87.47

ug/l

0.55

152

1394

Hereditary ataxia

158

1460

1.13

0.56

3.0

2.7

108.35

142.35

ug/l

2.02

144

1343

Pterygium

360

3421

1.08

0.56

2.8

146.89

153.67

ug/l

0.20

320

3114

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

803

1.18

0.56

3.2

2.6

146.38

107.46

ug/l

0.62

742

Carcinoma in situ of bronchus and lung

130

1.50

0.55

2.8

109.12

157.51

ug/l

0.59

118

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

444

1.25

0.55

3.6

2.7

128.25

94.94

ug/l

0.27

409

Wiskott-Aldrich syndrome

2.31

0.55

2.0

1.7

79.06

61.24

ug/l

—

Intentional self-harm by jumping from a high place

747

1.18

0.54

2.6

111.42

90.52

ug/l

0.71

702

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

215

2017

1.10

0.54

2.8

2.6

219.58

108.98

ug/l

5.70

199

1825

Disorders of glycoprotein metabolism

131

1.50

0.54

5.2

2.3

106.18

88.78

ug/l

0.18

120

Type1 diabetes, definitions combined, early onset

1260

12245

1.04

0.53

3.8

2.9

80.27

79.39

ug/l

0.08

1187

11632

Injury of nerves at ankle and foot level

104

949

1.16

0.53

3.2

2.7

97.31

100.93

ug/l

0.11

885

Complications following myocardial infarction

758

0.85

0.53

3.3

2.3

137.14

180.62

ug/l

1.03

669

Burns classified according to extent of body surface involved

127

1168

1.14

0.53

4.1

2.6

117.02

137.06

ug/l

0.51

122

1092

Chromosomal abnormalities, not elsewhere classified

331

3145

1.09

0.53

3.6

3.2

84.71

77.77

ug/l

0.35

311

2987

Carcinoma in situ of cervix uteri, exocervix

127

1177

1.16

0.53

2.6

3.0

84.06

66.09

ug/l

1.20

117

1122

Use of cabergoline

192

1799

1.11

0.53

2.6

2.8

94.70

108.93

ug/l

0.49

182

1683

Cleft palate

176

1647

1.12

0.52

3.0

2.9

71.45

75.44

ug/l

0.23

169

1557

Other disorders of kidney and ureter in diseases classified elsewhere

1.75

0.52

2.6

2.1

518.13

127.67

ug/l

—

Other changes in lacrimal passages

178

1.44

0.52

3.6

2.6

211.10

75.28

ug/l

0.60

164

HSIL lesion of the vagina

214

2017

1.11

0.52

3.4

2.8

97.58

80.48

ug/l

0.84

203

1869

Pneumoconiosis due to asbestos and other mineral fibres

234

2197

1.09

0.52

3.2

2.9

174.92

183.70

ug/l

0.24

199

1974

Reiter disease

700

1.18

0.52

3.7

2.6

251.53

162.45

ug/l

0.79

649

Benign neoplasm: Female genital organ, unspecified

420

1.26

0.51

3.2

2.7

87.98

78.08

ug/l

0.14

389

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

579

1.21

0.51

4.2

2.6

173.01

107.46

ug/l

0.59

535

Rhabdomyosarcoma

1.60

0.51

3.9

2.7

1738.46

73.95

ug/l

0.54

Other benign neoplasms of uterus

730

7069

1.05

0.51

3.0

2.8

101.54

110.40

ug/l

0.99

646

6358

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

113

1036

1.14

0.51

2.7

2.8

193.40

105.61

ug/l

2.57

104

947

Malignant neoplasm of other and ill-defined digestive organs

710

0.85

0.50

2.3

2.9

441.48

147.33

ug/l

0.61

644

Benign neoplasm: Female genital organ, unspecified

421

1.25

0.50

3.2

2.7

87.98

75.38

ug/l

0.19

392

Intentional self-harm by smoke, fire and flames

224

1.35

0.50

3.6

2.6

114.99

103.16

ug/l

0.19

212

Cholesteatoma of external ear

827

1.16

0.50

3.0

2.6

125.37

149.05

ug/l

0.47

759

Benign neoplasm: Vertebral column

298

1.29

0.50

4.5

2.6

120.94

110.32

ug/l

0.12

271

Benign neoplasm: Respiratory system, unspecified

223

1.33

0.49

4.8

2.6

190.41

108.41

ug/l

0.58

207

Adult respiratory distress syndrome

152

1412

1.12

0.49

5.4

2.7

324.60

143.05

ug/l

2.01

142

1283

Retinoblastoma, excluding all cancers (controls excluding all cancers)

117

1.56

0.48

5.3

3.0

95.27

79.48

ug/l

0.24

110

Defects in post-translational modification of lysosomal enzymes

1.61

0.48

5.0

2.5

76.33

114.30

ug/l

—

Retinoblastoma

108

1.59

0.48

5.4

2.9

97.50

81.70

ug/l

0.23

103

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

516

4964

1.06

0.48

3.4

2.8

229.26

163.87

ug/l

3.30

471

4459

Optic neuritis

718

6970

1.05

0.48

2.8

98.61

90.53

ug/l

0.58

681

6572

Chronic suppurative otitis media

1035

10085

1.04

0.48

3.1

2.8

117.05

115.95

ug/l

0.05

951

9324

Melanocytic naevi of eyelid, including canthus

134

1245

1.13

0.47

3.0

2.7

169.72

104.73

ug/l

0.38

129

1145

Tuberculosis

785

7609

1.04

0.47

3.4

2.8

157.48

156.79

ug/l

0.02

711

6833

Respiratory tuberculosis, clinically confirmed

124

1345

0.90

0.47

3.4

2.7

130.05

160.10

ug/l

1.16

110

1202

Respiratory distress of newborn

207

1810

1.10

0.47

4.1

3.5

59.10

48.95

ug/l

0.52

199

1721

Postpolio syndrome

215

1.32

0.47

3.2

2.5

144.96

124.64

ug/l

0.16

193

Benign neoplasm: Vertebral column

300

1.28

0.47

4.5

2.6

120.94

106.43

ug/l

0.17

269

Other congenital malformations of spinal cord

190

1.38

0.47

3.3

2.7

69.96

85.41

ug/l

0.45

180

Physiological and behavioural disorders associated with sexual development and orientation

217

1.34

0.46

6.1

2.6

144.42

81.56

ug/l

0.52

209

Melanoma in situ of upper limb, including shoulder

764

1.16

0.46

3.3

2.6

185.45

126.86

ug/l

0.97

688

Testicular hypofunction, drug-induced

0.00

0.46

0.0

1.6

—

123.18

—

Other benign neoplasm of uterus: Cervix uteri

903

1.16

0.46

3.3

2.8

85.19

78.24

ug/l

0.28

842

Malignant neoplasm of retroperitoneum and peritoneum

832

1.15

0.46

2.4

2.6

234.63

115.66

ug/l

2.76

749

Drug-induced chorea

1.92

0.46

2.8

1.7

65.33

144.41

ug/l

—

Acute poliomyelitis

173

1623

1.10

0.45

2.9

2.6

136.90

122.16

ug/l

0.36

156

1481

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

413

4297

0.94

0.45

2.5

2.8

232.27

95.35

ug/l

10.21

392

3915

Malignant neoplasm of oesophagus

267

2536

1.08

0.45

2.6

2.9

183.12

182.43

ug/l

0.01

242

2282

LSIL lesion of the vagina

232

2207

1.09

0.44

3.4

2.8

89.12

75.79

ug/l

0.77

213

2067

Other diseases of appendix

159

1491

1.11

0.44

2.9

2.6

143.78

111.87

ug/l

0.45

145

1358

Hereditary retinal dystrophy

192

1810

1.09

0.44

3.0

2.7

110.76

118.44

ug/l

0.26

176

1674

Poisoning by medicine, drug-induced

197

1862

1.10

0.44

3.3

2.7

97.18

110.26

ug/l

0.49

175

1746

Congenital malformations of ear causing impairment of hearing

512

1.20

0.43

3.2

2.8

106.92

86.10

ug/l

0.20

472

Granuloma faciale [eosinophilic granuloma of skin]

1.61

0.43

3.7

2.7

53.55

61.23

ug/l

0.28

Non-neuropathic heredofamilial amyloidosis

136

1.42

0.43

6.5

2.3

207.09

104.04

ug/l

0.62

119

Irritant contact dermatitis due to drugs in contact with skin

1.62

0.42

1.5

3.3

199.00

92.09

ug/l

0.39

Unspecified organic or symptomatic mental disorder

384

0.82

0.42

3.0

2.5

93.96

119.24

ug/l

0.44

349

Internuclear ophthalmoplegia

474

1.20

0.42

3.5

2.7

169.50

125.85

ug/l

0.25

449

Congenital glaucoma

146

1.40

0.42

3.1

2.8

138.01

90.75

ug/l

0.43

138

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

146

1.39

0.41

2.5

2.6

42.41

59.55

ug/l

0.73

139

General hospital and personal-use devices associated with adverse incidents

202

1.33

0.41

3.3

2.7

144.86

101.38

ug/l

0.35

187

Inflammation of lacrimal passages (chronic)

198

1873

1.09

0.41

2.5

2.7

120.71

129.71

ug/l

0.29

180

1682

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

123

1146

1.11

0.40

3.5

2.7

187.24

109.33

ug/l

1.95

117

1057

Respiratory and cardiovascular disorders specific to the perinatal period

366

3143

1.06

0.40

3.9

3.3

52.48

56.58

ug/l

0.20

346

2992

Obstructed labour due to maternal pelvic abnormality

2590

25552

1.02

0.39

2.9

2.8

99.45

96.05

ug/l

0.37

2457

23971

Superficial frostbite

781

1.13

0.39

3.4

2.4

133.97

131.53

ug/l

0.04

719

Disorders of globe

305

2922

1.07

0.39

3.6

2.7

143.83

134.52

ug/l

0.25

279

2655

Malignant neoplasm of parotid gland

878

1.13

0.39

3.3

2.6

174.95

133.86

ug/l

0.39

806

Parodontitis or/and operation codes

13703

81930

0.99

0.38

3.2

2.9

134.35

113.98

ug/l

14.32

12574

76698

Unspecified visual impairment

1.62

0.37

2.3

3.4

73.05

67.29

ug/l

—

Other congenital malformations of eye

167

1.34

0.37

3.3

2.8

129.36

88.46

ug/l

0.40

159

Melanoma in situ of lower limb, including hip

728

1.14

0.37

2.8

2.7

130.60

97.06

ug/l

0.95

672

Sequelae of tuberculosis

204

1935

1.07

0.37

3.7

2.7

151.57

153.08

ug/l

0.03

190

1711

Malignant neoplasm of cervix uteri

244

2339

1.08

0.36

2.8

2.9

180.18

79.52

ug/l

4.50

232

2179

Contact with lifting and transmission devices, not elsewhere classified

226

2156

1.07

0.36

2.5

2.7

137.84

154.07

ug/l

0.53

217

2014

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

750

7680

0.96

0.36

2.6

2.8

84.97

91.79

ug/l

0.69

725

7182

Later onset COPD

3910

30366

1.02

0.36

3.4

2.9

169.45

171.19

ug/l

0.09

3476

27006

Malignant neoplasm of tonsil

162

1532

1.09

0.35

2.7

2.6

241.63

171.68

ug/l

1.45

147

1393

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

966

9446

1.03

0.35

2.5

2.8

225.69

140.09

ug/l

8.89

901

8553

Mandibular prognathia AND surgery (LeFortI or BSSRO)

711

1.14

0.35

2.7

81.60

95.71

ug/l

0.41

667

Compression of brain

105

0.69

0.35

3.0

2.2

96.00

90.63

ug/l

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

177

1676

1.08

0.35

2.8

2.7

322.09

136.21

ug/l

1.33

164

1504

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

114

1066

1.11

0.35

3.1

2.6

174.21

134.14

ug/l

0.47

978

Benign neoplasm: Scapula and long bones of upper limb

138

1301

1.10

0.35

2.8

2.7

115.21

95.20

ug/l

0.79

124

1221

Haemorrhagic and haematological disorders of fetus and newborn

279

2560

1.07

0.35

4.3

3.4

53.90

51.12

ug/l

0.17

263

2434

Occlusion and stenosis of arteries, not leading to stroke

136

1447

0.92

0.35

3.1

2.7

128.39

163.66

ug/l

1.43

129

1289

Hypersensitivity pneumonitis due to organic dust

210

2004

1.07

0.34

3.3

2.7

152.22

135.84

ug/l

0.45

202

1830

Fetal death of unspecified cause

284

1.27

0.34

3.8

2.8

61.98

60.79

ug/l

0.04

269

Congenital malformations of nose

196

1.28

0.34

3.1

3.0

86.53

93.68

ug/l

0.13

186

Other chronic cystitis, drug-induced

104

1.42

0.33

5.0

2.3

55.25

70.84

ug/l

0.61

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

123

1.39

0.33

4.0

4.8

39.13

52.25

ug/l

0.31

117

Unspecified maternal hypertension

234

2255

1.08

0.33

3.2

2.9

57.94

57.36

ug/l

0.04

229

2151

Carcinoma in situ of cervix uteri, endocervix

205

2135

0.93

0.33

2.9

73.79

60.47

ug/l

1.16

194

2032

Other disorders of bone development and growth

132

1.36

0.33

2.6

2.9

66.81

66.96

ug/l

0.00

122

Seminoma of testis

102

951

1.10

0.33

4.0

2.6

203.07

189.38

ug/l

0.23

888

Respiratory tuberculosis

669

6521

1.04

0.33

3.4

2.8

154.91

153.83

ug/l

0.03

601

5861

Atypical virus infections of central nervous system

126

1188

1.10

0.33

3.1

2.5

148.06

116.35

ug/l

1.07

114

1096

Intracranial and intraspinal phlebitis and thrombophlebitis

1.46

0.32

1.4

3.1

119.90

87.01

ug/l

—

Respiratory tuberculosis, confirmed and not-confirmed

669

6522

1.04

0.32

3.4

2.8

154.91

153.82

ug/l

0.03

601

5861

Unspecified drowning and submersion

1.41

0.32

2.3

2.5

108.92

124.35

ug/l

0.11

Carcinoma in situ of cervix uteri

1882

19056

0.98

0.32

2.9

3.0

73.93

63.85

ug/l

1.85

1754

18074

Purulent endophthalmitis

577

1.13

0.32

3.3

2.6

182.63

143.44

ug/l

0.54

506

Toxic effect of metals

1.44

0.32

4.7

2.0

111.78

96.88

ug/l

—

Birth injury to skeleton

161

1.32

0.31

4.0

2.9

41.73

47.67

ug/l

0.21

148

Other infections specific to the perinatal period

796

0.89

0.31

4.5

3.5

75.57

51.43

ug/l

0.36

747

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

391

3796

1.05

0.31

3.0

2.8

165.57

75.00

ug/l

7.38

364

3541

Dementia due to Parkinson's disease

250

2401

1.06

0.31

2.6

2.8

164.09

164.52

ug/l

0.01

193

2131

Reduction defects of unspecified limb

1.50

0.31

2.7

1.8

96.11

95.26

ug/l

—

Other congenital malformations of face and neck

464

4516

1.05

0.31

3.1

2.8

87.73

96.25

ug/l

0.65

435

4239

Other benign neoplasm of uterus: Other parts/unspecified

531

5173

1.04

0.31

2.9

2.8

106.33

115.23

ug/l

0.76

461

4590

Exposure to high and low air pressure and changes in air pressure

133

1.33

0.30

2.8

2.6

74.99

100.71

ug/l

0.73

126

Motor neuron disease

169

1777

0.93

0.30

2.3

2.5

150.24

171.50

ug/l

0.79

154

1623

Palatinal maxillary operation

164

1569

1.09

0.30

3.0

2.9

46.61

44.64

ug/l

0.13

158

1464

Motorcycle rider injured in noncollision transport accidents

419

4068

1.05

0.30

2.6

2.7

102.20

123.47

ug/l

2.01

399

3815

Disorders of accommodation

1.78

0.30

5.4

2.3

72.60

70.15

ug/l

—

Carcinoma in situ of cervix uteri, exocervix

127

1208

1.10

0.30

2.6

2.9

84.06

65.38

ug/l

1.28

117

1146

Benign neoplasm: Uterine tubes and ligaments

814

1.11

0.30

3.2

2.8

100.48

92.50

ug/l

0.27

738

Labour and delivery complicated by umbilical cord complications

926

9098

1.03

0.30

2.9

75.00

72.52

ug/l

0.21

891

8638

Carcinoma in situ of cervix uteri, endocervix

205

2128

0.93

0.29

2.9

73.79

62.93

ug/l

0.85

194

2030

Dietary calcium deficiency

1.73

0.29

3.4

1.7

139.80

145.77

ug/l

—

Dysplastic lesion of unknown severity of the cervix uteri

169

1762

0.93

0.29

2.9

2.8

71.94

63.14

ug/l

0.46

164

1674

Lordosis

342

1.18

0.29

3.6

2.1

91.44

140.33

ug/l

1.03

307

ILD medications: acetylcysteine

820

1.10

0.29

4.3

2.5

122.91

132.01

ug/l

0.20

729

Crushing injury of wrist and hand

177

1691

1.07

0.29

3.7

2.8

175.48

166.74

ug/l

0.17

164

1576

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

158

1509

1.08

0.29

3.1

2.9

66.72

77.97

ug/l

0.69

148

1411

Carcinoma in situ of prostate

601

1.12

0.29

2.1

2.6

208.12

211.14

ug/l

0.03

546

Generalized epilepsy

702

6878

1.03

0.28

3.0

2.9

112.21

95.21

ug/l

0.73

655

6490

Polydactyly

163

1.29

0.28

3.6

3.0

50.19

74.52

ug/l

0.63

149

652

6650

0.97

0.28

3.2

2.7

109.29

133.18

ug/l

3.12

603

5934

Balanced rearrangements and structural markers, not elsewhere classified

596

1.14

0.28

3.0

2.9

66.11

69.53

ug/l

0.11

564

Explosion of other materials

342

1.16

0.28

3.2

2.4

170.13

148.54

ug/l

0.21

316

Bladder disorders in in diseases classified elsewhere

1.36

0.27

2.7

2.5

237.00

138.52

ug/l

0.86

Frontotemporal dementia, wide, incl. Pick's disease

660

1.11

0.27

3.3

2.7

89.56

154.99

ug/l

3.69

600

Burn and corrosion confined to eye and adnexa

323

3131

1.05

0.27

3.0

2.7

112.44

123.07

ug/l

0.24

305

2942

Kwashiorkor

182

1.25

0.27

4.3

2.8

135.69

93.92

ug/l

0.37

169

Benign neoplasm: Vagina

190

1827

1.07

0.27

2.5

2.8

96.42

81.63

ug/l

0.78

165

1683

Alzheimer’s disease (Late onset)

2742

23740

0.99

0.26

2.6

3.0

139.91

157.07

ug/l

2.79

2342

20994

Malignant neoplasm of nasal cavity and sinuses

699

0.90

0.26

2.0

2.6

200.36

141.93

ug/l

0.85

630

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

585

1.12

0.26

2.7

2.6

135.55

123.49

ug/l

0.16

553

Malignant neoplasm of vagina

221

1.22

0.26

4.2

2.7

224.77

86.48

ug/l

1.12

195

Bullous keratopathy

905

1.09

0.26

3.4

2.8

132.06

126.56

ug/l

0.11

811

Carcinoma in situ of breast, intraductal

1148

11655

0.98

0.26

2.6

2.8

103.58

106.67

ug/l

0.24

1033

10724

Neuropathic heredofamilial amyloidosis

1.58

0.26

5.0

2.5

56.83

89.71

ug/l

—

malignant neoplasm of female genital organs

2124

21475

0.98

0.26

2.7

2.8

176.37

109.16

ug/l

19.77

1950

19500

Other and unspecified disorders of refraction

108

1.35

0.26

5.7

2.3

194.94

95.93

ug/l

0.49

Pustulosis subcornealis

1.53

0.26

3.2

2.2

165.00

73.79

ug/l

—

Solar urticaria

194

1.26

0.25

2.8

2.7

82.35

93.54

ug/l

0.18

182

Brain medulloblastoma

1.64

0.25

3.6

3.1

294.75

48.17

ug/l

—

Brain medulloblastoma, excluding all cancers (controls excluding all cancers)

1.59

0.25

3.6

3.0

294.75

44.47

ug/l

—

Disorders of optic chiasm

1.36

0.25

2.1

2.3

86.83

127.98

ug/l

0.60

Benign neoplasm: Cranial nerves

365

3553

1.04

0.25

2.8

2.7

126.93

138.03

ug/l

0.24

333

3254

Rubella [German measles]

344

3340

1.04

0.25

2.9

2.6

188.85

210.54

ug/l

0.57

329

3177

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

520

0.88

0.25

2.0

2.7

90.99

86.60

ug/l

0.09

496

Brain astrocytoma

520

0.88

0.25

2.0

2.6

90.99

90.31

ug/l

0.01

495

Mesial bite

158

1518

1.07

0.25

3.0

2.8

67.34

73.91

ug/l

0.30

149

1420

Staphylococcal scalded skin syndrome

156

1.28

0.25

4.2

2.6

89.88

58.74

ug/l

0.94

145

Precocious central puberty

106

1009

1.09

0.24

4.5

2.8

93.01

64.80

ug/l

0.80

943

Motor neuron disease (with DMD)

179

1865

0.95

0.24

2.3

2.6

144.74

166.48

ug/l

0.87

164

1707

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

328

3376

0.96

0.24

3.0

2.7

145.64

155.92

ug/l

0.28

289

3006

Other specified transport accidents

647

1.10

0.23

2.5

2.7

85.75

113.56

ug/l

0.79

596

Noise effects on inner ear

439

4498

0.97

0.23

2.5

2.8

162.20

183.00

ug/l

1.18

413

4172

Unspecified pneumoconiosis

122

0.77

0.23

3.1

2.6

85.63

150.79

ug/l

—

110

Neuroendocrine tumor and carcinoma of lung

878

0.92

0.23

2.3

2.6

123.39

119.39

ug/l

0.08

799

Crushing injury of neck

1.44

0.23

3.3

3.2

65.96

74.13

ug/l

—

Infections specific to the perinatal period

174

1677

1.06

0.23

3.9

3.3

57.67

46.52

ug/l

0.39

165

1587

Benign neoplasm: Vagina

190

1836

1.06

0.23

2.5

2.8

96.42

85.41

ug/l

0.51

165

1691

Benign neoplasm: Respiratory system, unspecified

242

1.18

0.22

4.8

2.7

190.41

108.45

ug/l

0.58

219

Yaws

147

1.25

0.22

4.4

2.4

228.76

99.64

ug/l

0.70

135

Other chronic figurate erythema

1.37

0.22

3.0

2.7

131.43

62.12

ug/l

—

Foreign body on external eye

2027

20063

1.02

0.22

2.8

150.74

156.52

ug/l

0.36

1904

18821

Cholesteatoma of middle ear

679

6671

1.03

0.22

3.0

2.8

134.32

143.47

ug/l

0.30

624

6087

Carcinoma in situ of other/unspecified female genital organs

1.41

0.22

1.8

3.0

46.69

59.39

ug/l

—

Malignant neoplasm of other and unspecified parts of biliary tract

135

1294

1.06

0.21

2.8

2.6

215.70

153.00

ug/l

1.27

125

1175

Disorders of glycine metabolism

1.37

0.21

7.0

2.2

242.38

96.57

ug/l

—

Niacin deficiency [pellagra]

1.24

0.20

2.5

2.6

92.13

88.97

ug/l

—

Melanoma in situ of lower limb, including hip

751

1.09

0.19

2.8

2.6

130.60

109.04

ug/l

0.50

687

Carcinoma in situ of endometrium

585

1.10

0.19

2.2

2.6

114.95

90.84

ug/l

0.57

534

Convulsions of newborn

1.33

0.19

1.9

3.2

38.44

36.17

ug/l

—

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

176

1704

1.05

0.19

3.1

2.7

160.13

90.19

ug/l

3.19

154

1538

Use of glatiramer acetate

273

2796

0.96

0.19

3.0

2.8

84.97

77.92

ug/l

0.20

258

2667

Lymphocyte function antigen-1 [LFA-1] defect

1.29

0.19

3.3

3.1

118.09

104.44

ug/l

0.09

Infantile muscular atrophy

1.25

0.19

5.4

2.5

95.19

96.66

ug/l

—

Labyrinthine fistula

371

1.12

0.19

3.1

2.7

221.72

132.49

ug/l

0.43

341

Myasthenia gravis, drug-induced

198

1.18

0.18

3.0

2.6

175.23

92.55

ug/l

0.48

180

Malignant neoplasm of mesothelium and soft tissue

525

5159

1.03

0.18

2.6

2.8

342.64

145.08

ug/l

4.11

489

4682

Hirsutism, drug-induced

296

1.16

0.18

3.4

2.9

92.99

67.34

ug/l

0.57

277

Exposure to ignition or melting of other clothing and apparel

285

0.87

0.17

2.9

2.4

106.93

164.00

ug/l

0.86

254

Contact with venomous snakes and lizards

124

1286

0.95

0.17

2.7

2.6

148.50

122.00

ug/l

0.19

112

1175

Fibrosarcoma

792

1.07

0.17

2.7

2.6

190.46

130.17

ug/l

0.87

721

Keratopathy (bullous aphakic) following cataract surgery

1.31

0.17

2.2

2.5

96.30

106.70

ug/l

—

Carcinoma in situ of cervix uteri

1882

18961

0.99

0.17

2.9

3.0

73.93

60.18

ug/l

3.16

1754

17984

Injury of heart

208

1.15

0.16

5.0

2.3

165.23

121.73

ug/l

0.56

197

Lichenoid drug reaction

335

0.89

0.16

3.9

2.6

104.67

103.77

ug/l

0.02

303

Severe combined immunodeficiency [SCID] with low or normal B-cell numbers

1.32

0.16

1.9

2.6

161.89

91.57

ug/l

—

Other and unspecified mental retardation

201

2062

0.96

0.16

3.3

3.2

92.78

91.61

ug/l

0.04

185

1945

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

204

1967

1.04

0.15

3.6

43.34

48.70

ug/l

0.55

195

1868

Benign neoplasm: Scapula and long bones of upper limb

138

1338

1.05

0.15

2.8

2.6

115.21

103.82

ug/l

0.37

124

1258

Exposure to uncontrolled fire in building or structure

805

1.06

0.15

2.9

2.5

119.30

151.38

ug/l

0.57

758

Benign neoplasm: Uterine tubes and ligaments

836

1.07

0.15

3.2

2.7

100.48

88.52

ug/l

0.46

760

Injury of blood vessels of thorax

384

1.10

0.15

3.7

2.6

116.17

122.90

ug/l

0.09

354

Craniosynostosis EXCLUDE syndromes

292

0.88

0.15

2.4

3.2

45.52

64.15

ug/l

0.99

277

Carcinoma in situ of endometrium

591

1.08

0.15

2.2

2.9

114.95

85.27

ug/l

0.77

547

Dengue fever [classical dengue]

220

1.14

0.14

2.5

2.8

213.26

106.48

ug/l

0.54

200

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

864

0.94

0.14

2.3

2.6

123.39

113.31

ug/l

0.21

792

Moderate mental retardation

802

0.94

0.14

3.2

2.9

100.72

88.63

ug/l

0.39

749

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

886

1.06

0.14

2.2

2.5

161.40

148.46

ug/l

0.19

818

Fetal alcohol syndrome (dysmorphic)

105

1.23

0.14

2.3

2.5

40.75

58.08

ug/l

1.01

Transitory endocrine and metabolic disorders specific to fetus and newborn

204

1951

1.04

0.14

3.8

3.5

48.76

50.35

ug/l

0.07

191

1852

Follicular adenocarcinoma of thyroid gland

779

1.06

0.14

3.3

2.7

102.37

104.57

ug/l

0.05

707

Congenital and developmental myasthenia

144

1.19

0.13

2.5

53.49

80.92

ug/l

0.90

134

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

198

1897

1.04

0.13

3.9

3.5

48.40

50.18

ug/l

0.08

186

1802

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

811

0.95

0.13

2.7

2.6

135.08

123.46

ug/l

0.17

738

Malignant neoplasm of vulva

109

1124

0.95

0.13

2.9

2.6

171.16

104.58

ug/l

1.59

1007

Malignant neoplasm of renal pelvis

514

1.07

0.13

3.6

2.7

248.10

155.27

ug/l

1.16

460

Psoriatic arthropathies, strict definition

1.29

0.12

6.0

2.2

252.00

172.84

ug/l

—

Use of galantamine

780

7879

0.99

0.12

2.4

2.9

131.82

150.94

ug/l

2.00

678

6961

Malignant neoplasm of oropharynx

175

1711

1.03

0.12

2.7

231.77

172.71

ug/l

1.25

159

1557

Alzheimer disease, including avohilmo

4734

34039

1.01

0.11

2.6

3.0

141.15

158.36

ug/l

4.68

4074

30258

Malignant neoplasm of larynx

157

1608

0.97

0.11

2.7

190.68

184.62

ug/l

0.09

145

1461

Q fever

1.27

0.11

3.8

3.0

286.58

168.84

ug/l

—

Neonatal jaundice due to other excessive haemolysis

1.23

0.11

10.2

2.4

180.33

43.41

ug/l

—

Contact with machinery

1345

13354

1.01

0.11

3.0

2.8

165.39

180.60

ug/l

0.78

1220

12385

Senile degeneration of the brain, not elsewhere classified

359

1.08

0.11

3.6

2.6

171.71

140.13

ug/l

0.41

315

Hereditary angioödema type 2

1.22

0.11

1.9

2.7

104.00

71.81

ug/l

—

Carcinoma in situ of breast, intraductal

1148

11397

1.01

0.11

2.6

2.8

103.58

95.35

ug/l

0.88

1033

10491

Familial dysautonomia

1.24

0.11

1.8

3.0

90.33

135.13

ug/l

—

Other/unspecified postprocedural disorders of ear and mastoid process

339

0.92

0.11

3.4

2.6

142.56

130.08

ug/l

0.11

312

Other benign neoplasm of uterus: Corpus uteri

103

1002

1.05

0.10

3.8

2.7

99.62

90.92

ug/l

0.28

913

Induced delusional disorder

107

1.20

0.10

2.4

2.9

44.08

76.44

ug/l

0.90

Inhalation and ingestion of food causing obstruction of respiratory tract

107

1100

0.96

0.10

3.0

2.7

99.87

132.56

ug/l

1.37

997

Complications specific to multiple gestation

757

1.06

0.10

2.9

3.0

75.11

56.30

ug/l

0.48

722

Benign neoplasm: Brain, unspecified

755

1.05

0.10

2.7

2.6

125.71

100.37

ug/l

0.75

701

Other benign neoplasm of uterus: Corpus uteri

103

1003

1.04

0.10

3.8

2.8

99.62

85.54

ug/l

0.54

913

Palatinal maxillary canine

129

1262

1.04

0.10

3.0

2.8

49.08

45.20

ug/l

0.22

123

1177

Cleft lip, lip and palate or palate

250

2461

1.03

0.10

2.9

2.8

82.38

90.29

ug/l

0.48

241

2332

Murder, homicide, or other assault by handgun discharge

0.82

0.10

2.6

2.1

82.80

123.77

ug/l

—

Crushing injuries involving multiple body regions

0.82

0.10

3.6

2.3

54.32

140.15

ug/l

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

213

2097

1.03

0.09

3.0

2.8

87.80

67.99

ug/l

1.08

206

1982

Other hypertrophic osteoarthropathy

1.19

0.09

3.5

2.7

58.64

118.04

ug/l

1.28

Echinococcosis

1.17

0.09

2.3

2.9

90.88

133.22

ug/l

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

383

1.07

0.08

4.3

2.7

175.11

82.74

ug/l

1.25

347

Slow fetal growth and fetal malnutrition

880

1.04

0.08

3.4

51.36

52.23

ug/l

0.03

829

Use of anticholinesterases

4368

35241

1.00

0.08

2.5

3.0

134.72

159.52

ug/l

9.39

3740

31317

N06DA Anticholinesterases

4368

35241

1.00

0.08

2.5

3.0

134.72

159.52

ug/l

9.39

3740

31317

Use of benzatropine

1.17

0.08

2.0

2.5

114.07

90.13

ug/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

174

1771

0.98

0.08

2.5

126.61

154.93

ug/l

1.27

168

1665

Malignant neoplasm of base of tongue

580

1.05

0.08

2.3

2.4

191.79

170.23

ug/l

0.23

542

Pneumoconiosis due to dust containing silica

357

0.93

0.08

2.6

2.8

269.29

169.11

ug/l

1.00

327

Retained (old) intraocular foreign body

1.12

0.08

2.3

2.1

101.78

134.01

ug/l

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

937

1.04

0.08

2.6

130.43

123.98

ug/l

0.09

872

Burns and corrosions of multiple body regions

104

1064

0.97

0.08

2.9

2.6

98.20

143.31

ug/l

1.50

984

Post-traumatic hydrocephalus, unspecified

275

0.92

0.08

3.3

2.5

129.14

119.51

ug/l

0.15

250

Other and unspecified neuropathies

522

1.05

0.08

2.5

2.7

118.21

127.16

ug/l

0.18

472

Use of rivastigmine

1688

16765

1.01

0.07

2.6

2.9

129.85

152.69

ug/l

3.42

1456

14824

Carcinoma in situ of breast, lobular

921

0.96

0.07

2.4

2.7

137.35

91.43

ug/l

0.82

832

Sequelae of transport accidents

572

1.05

0.07

3.6

2.5

134.46

111.04

ug/l

0.22

539

Mixed specific developmental disorders

328

3021

1.02

0.07

3.3

3.1

63.93

61.38

ug/l

0.18

307

2864

Benign neoplasm: Brain, unspecified

761

1.04

0.07

2.7

2.6

125.71

94.34

ug/l

1.04

704

Unspecified renal colic

801

1.04

0.07

3.8

2.7

111.65

121.76

ug/l

0.27

747

Other and unspecified disorders of psychological development

156

1510

1.02

0.06

3.1

3.2

408.58

70.17

ug/l

0.49

143

1432

Traumatic amputation of wrist and hand

479

4829

0.99

0.06

3.0

2.8

170.88

174.45

ug/l

0.10

451

4452

Malignant neoplasm of hypopharynx

386

1.05

0.06

2.7

2.5

202.08

184.47

ug/l

0.13

354

Xanthelasma of eyelid

113

1111

1.03

0.06

3.2

2.6

109.20

123.03

ug/l

0.51

107

1018

Dysplastic lesion of the vagina of unknown severity

150

1.12

0.05

4.2

3.1

139.18

80.84

ug/l

0.37

139

Exposure to excessive heat of man-made origin

834

1.03

0.05

3.3

2.6

192.38

143.40

ug/l

0.32

757

Benign neoplasm: Bones of skull and face

135

1332

1.02

0.05

3.1

2.7

72.95

90.81

ug/l

1.51

126

1236

Superficial injury of ankle and foot, unspecified

726

1.03

0.04

3.1

2.6

81.98

85.99

ug/l

0.09

675

Oher contracture of tendon (sheath)

408

1.04

0.04

3.3

2.4

133.25

110.69

ug/l

0.30

379

Scarlet fever

925

1.03

0.04

3.3

2.4

99.43

95.10

ug/l

0.08

878

Other and unspecified spinal muscular atrophies

935

0.98

0.04

3.1

2.7

299.38

145.57

ug/l

0.94

855

Haemolytic disease of fetus and newborn

149

0.90

0.04

8.9

3.2

66.38

59.91

ug/l

0.07

140

Precocious puberty

927

1.03

0.04

5.4

2.8

48.35

49.85

ug/l

0.06

865

Albinism

1.15

0.04

4.5

2.7

75.70

55.69

ug/l

—

Other congenital malformations of male genital organs

667

1.03

0.04

3.0

3.5

117.93

113.47

ug/l

0.06

635

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

179

1775

1.01

0.03

3.2

2.7

179.40

134.36

ug/l

1.19

170

1607

Benign neoplasm of mesothelial tissue

158

0.92

0.03

2.3

2.8

71.44

89.27

ug/l

0.50

148

Other and unspecified degenerative diseases of nervous system

253

2514

1.01

0.03

2.5

2.7

146.52

156.74

ug/l

0.24

228

2248

Leiomyosarcoma

789

1.02

0.03

2.9

2.7

179.29

118.52

ug/l

1.57

723

Carcinoma in situ of larynx

178

0.94

0.02

3.6

2.7

193.24

166.10

ug/l

0.17

159

Adhesive middle ear disease

232

2334

0.99

0.02

2.8

2.7

122.05

105.61

ug/l

0.47

215

2159

Toxoplasmosis

750

1.02

0.02

3.8

2.6

136.08

105.34

ug/l

0.70

700

Abnormalities of ear ossicles

242

1.05

0.02

2.6

2.7

113.17

110.73

ug/l

0.02

217

Degenerative myopia

830

0.98

0.02

3.8

2.7

83.90

101.59

ug/l

0.66

758

Disorders of acoustic nerve

107

0.90

0.02

1.9

2.1

82.80

132.64

ug/l

—

Other and unspecified hydrocephalus

220

2212

0.99

0.02

3.0

2.7

113.50

127.69

ug/l

0.49

189

2022

MS-disease / Multiple Sclerosis

1264

12620

1.00

0.02

2.8

2.9

102.83

89.37

ug/l

1.18

1187

11922

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

104

1050

0.99

0.02

2.3

2.6

203.50

133.54

ug/l

1.41

954

Generalized epilepsy, strict definition

358

3593

0.99

0.02

3.0

2.9

116.78

88.14

ug/l

0.68

333

3386

Pedal cyclist injured in collision with motor vehicle

462

4634

1.00

0.02

2.6

2.8

87.64

109.61

ug/l

2.81

425

4299

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

741

1.02

0.02

2.4

2.6

213.52

129.93

ug/l

1.27

673

Use of teriflunomide

164

1649

0.99

0.01

2.5

2.8

96.77

88.68

ug/l

0.35

155

1580

Exposure to ignition of highly flammable material

453

1.02

0.01

2.4

2.6

148.94

150.97

ug/l

0.03

421

Congenital musculoskeletal deformities of head, face, spine and chest

162

1613

1.01

0.00

2.8

2.9

81.38

91.29

ug/l

0.53

150

1519

Carcinoma in situ of larynx

164

1.05

0.00

3.6

2.7

193.24

164.53

ug/l

0.18

147

Neonatal jaundice from other and unspecified causes

202

1961

0.99

0.00

4.0

3.5

49.02

49.79

ug/l

0.04

192

1867

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

326

3253

1.00

0.00

2.4

2.7

204.71

96.98

ug/l

10.00

306

2948

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

163

1625

1.00

0.00

3.2

2.6

205.24

123.82

ug/l

3.49

151

1459

Multiple delivery

1509

15089

1.00

0.00

3.0

3.1

78.44

82.26

ug/l

0.20

1430

14242

Generalized epilepsy, mode (most common among epilepsy diagnosis)

498

4984

1.00

0.00

3.1

2.9

116.40

94.33

ug/l

0.69

470

4697

Benign neoplasm: Bones of skull and face

135

1354

1.00

0.00

3.1

2.7

72.95

89.37

ug/l

1.38

126

1254

Contact with other specified venomous animals

871

1.00

0.00

3.7

2.7

105.72

106.91

ug/l

0.02

801

Carcinoma in situ of breast, lobular

899

1.00

0.00

2.4

2.6

137.35

94.68

ug/l

0.74

811

Contact urticaria

482

0.99

0.00

3.0

2.5

85.56

70.16

ug/l

0.37

449

Other and unspecified disease of Bartholin gland

412

4122

1.00

0.00

2.8

88.55

90.32

ug/l

0.10

384

3795

Traumatic subcutaneous emphysema

133

0.97

0.00

2.3

2.8

144.85

148.52

ug/l

0.03

125

Benign neoplasm of mesothelial tissue

153

0.97

0.00

2.3

2.7

71.44

88.30

ug/l

0.47

137

Traumatic amputation of hip and thigh

137

1.03

0.00

7.3

2.2

165.79

136.52

ug/l

0.21

124

Pediculosis and phthiriasis

361

1.00

0.00

3.6

2.7

330.37

133.42

ug/l

0.75

345

Severe mental retardation

287

1.02

0.00

2.4

3.2

67.18

87.00

ug/l

0.54

275

Obstructive hydrocephalus

186

1857

1.00

0.00

3.0

2.7

122.13

120.73

ug/l

0.04

169

1713

Pemphigus erythematosus

123

0.96

0.00

2.7

2.6

84.33

87.30

ug/l

0.02

114

Accident to watercraft causing other injury

115

1.07

0.00

3.1

2.7

74.33

130.42

ug/l

1.87

101

Calculus of urinary tract in diseases classified elsewhere

1.08

0.00

2.8

100.11

161.80

ug/l

—

Other respiratory conditions originating in the perinatal period

210

1.00

0.00

3.5

27.92

49.29

ug/l

1.83

194

Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge

1.03

0.00

7.4

2.9

345.50

136.19

ug/l

—

Other eccrine sweat disorders

108

1.03

0.00

2.9

2.1

118.64

80.18

ug/l

0.48

Unspecified contact dermatitis due to drugs in contact with skin

121

0.99

0.00

2.7

2.5

165.83

79.96

ug/l

0.69

112

Hereditary angioödema type 1

147

1.03

0.00

3.8

2.5

91.47

80.12

ug/l

0.14

141

Toxic effect of other inorganic substances

0.90

0.00

2.4

2.3

48.31

134.85

ug/l

—

Congenital viral diseases

0.97

0.00

2.6

2.2

33.40

34.77

ug/l

—

Other early complications of trauma

0.83

0.00

5.6

2.9

100.70

135.85

ug/l

—

Anhidrosis

1.06

0.00

2.6

67.76

101.99

ug/l

—

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

104

1040

1.00

0.00

2.6

113.06

130.23

ug/l

0.61

943

Fetal blood loss

1.04

0.00

4.1

3.6

131.78

35.03

ug/l

—

Leprosy [Hansen's disease]

0.90

0.00

3.2

2.6

570.67

94.86

ug/l

—

Histoplasmosis

0.96

0.00

6.4

2.9

39.00

71.64

ug/l

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

1.06

0.00

2.9

2.7

79.90

72.25

ug/l

—

Myiasis

0.88

0.00

2.0

3.1

208.77

93.31

ug/l

—

Melanoma in situ of eyelid, including canthus

1.02

0.00

2.7

77.57

129.06

ug/l

—

Drowning and submersion, undetermined intent

0.85

0.00

5.0

2.0

33.80

85.47

ug/l

—

Pseudosarcomatous fibromatosis

0.92

0.00

4.6

2.5

61.00

115.34

ug/l

—

Vertiginous syndromes in diseases classified elsewhere

0.88

0.00

1.9

2.4

102.36

110.08

ug/l

—

Melanoma in situ of eyelid, including canthus

0.98

0.00

2.7

3.2

77.57

131.43

ug/l

—

Exposure to excessive cold of man-made origin

1.04

0.00

3.4

2.5

149.45

157.38

ug/l

—

Glanders and melioidosis

0.98

0.00

2.5

2.6

199.29

129.03

ug/l

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.93

0.00

2.9

2.7

79.90

78.12

ug/l

—

Pedestrian injured in collision with railway train or railway vehicle

110

1.00

0.00

4.5

2.7

167.91

109.19

ug/l

0.43

105

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ferritin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS